0000934549-18-000079.txt : 20180810 0000934549-18-000079.hdr.sgml : 20180810 20180809185734 ACCESSION NUMBER: 0000934549-18-000079 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180810 DATE AS OF CHANGE: 20180809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACACIA RESEARCH CORP CENTRAL INDEX KEY: 0000934549 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 954405754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37721 FILM NUMBER: 181006726 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 9494808300 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 10-Q 1 actg10q06302018.htm 10-Q Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 10-Q
________________________________________

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2018
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM                      TO                     
 
Commission File Number: 0-26068
________________________________________
graphicactga02a10.jpg
(Exact name of registrant as specified in its charter)
________________________________________
 
DELAWARE
 
95-4405754
 
 
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
520 Newport Center Drive, 12th Floor, Newport Beach, California 92660
(Address of principal executive offices, Zip Code)
 
(949) 480-8300
(Registrant’s telephone number, including area code)
________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     x  Yes    o  No
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     x  Yes    o  No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer  o
 
Accelerated filer  x
 
Non-accelerated filer  o (Do not check if a smaller reporting company)
 
Smaller reporting company  o
 
 
 
Emerging growth company  o
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  o    No  x

As of August 7, 2018, 49,495,064 shares of the registrant’s common stock, $0.001 par value, were issued and outstanding.




ACACIA RESEARCH CORPORATION
Table Of Contents
 
 
 
 
Part I.
Financial Information
 
 
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
 
 
 
 
Item 3.
 
 
 
 
 
Item 4.
 
 
 
 
 
 
 
 
Part II.
Other Information
 
 
 
 
 
Item 6.
 
 
 
 
 
 
 
 
Signatures
 
 
 
 
 
Exhibit Index
 


i


PART I--FINANCIAL INFORMATION

Item 1.  FINANCIAL STATEMENTS

ACACIA RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share information)
(Unaudited)

 
June 30,
2018
 
December 31,
2017
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
100,150

 
$
136,604

Short-term investments
34,694

 
—

Accounts receivable
5,629

 
153

Prepaid expenses and other current assets
3,509

 
2,938

Total current assets
143,982

 
139,695

 
 
 
 
Investment at fair value (Note 5) 
75,004

 
104,754

Other investments (Note 5)
8,195

 
2,195

Patents, net of accumulated amortization
23,099

 
61,917

Other assets
187

 
207

 
$
250,467

 
$
308,768

 
 

 
 

LIABILITIES AND STOCKHOLDERS’ EQUITY
 

 
 

Current liabilities:
 

 
 

Accounts payable and accrued expenses
$
8,855

 
$
7,956

Royalties and contingent legal fees payable
4,765

 
1,601

Total current liabilities
13,620

 
9,557

Other liabilities
2,471

 
3,552

Total liabilities
16,091

 
13,109

Commitments and contingencies (Note 6)


 


Stockholders’ equity:
 

 
 

Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding
—

 
—

Common stock, par value $0.001 per share; 100,000,000 shares authorized; 49,495,064 and 50,639,926 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively
49

 
51

Treasury stock, at cost, 2,919,828 and 1,729,408 shares as of June 30, 2018 and December 31, 2017, respectively
(39,272
)
 
(34,640
)
Additional paid-in capital
650,265

 
648,996

Accumulated comprehensive loss
(202
)
 
(88
)
Accumulated deficit
(377,977
)
 
(320,018
)
Total Acacia Research Corporation stockholders’ equity
232,863

 
294,301

Noncontrolling interests
1,513

 
1,358

Total stockholders’ equity
234,376

 
295,659

 
$
250,467

 
$
308,768







The accompanying notes are an integral part of these condensed consolidated financial statements.

1


ACACIA RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share information)
(Unaudited)
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
Revenues
$
6,485

 
$
16,457

 
$
68,578

 
$
25,311

Operating costs and expenses:
 

 
 

 
 

 
 

Cost of revenues:
 

 
 

 
 

 
 

Inventor royalties
1,241

 
4,273

 
22,985

 
4,939

Contingent legal fees
1,037

 
3,236

 
16,796

 
3,863

Other
—

 
—

 
4,000

 
—

Litigation and licensing expenses - patents
2,130

 
4,134

 
4,875

 
10,520

Amortization of patents
5,278

 
5,571

 
10,608

 
11,086

General and administrative expenses(1)
7,098

 
6,734

 
10,477

 
13,650

Other expenses - business development
327

 
433

 
493

 
753

Impairment of patent-related intangible and other assets
29,210

 
—

 
29,210

 
—

Total operating costs and expenses
46,321

 
24,381

 
99,444

 
44,811

Operating loss
(39,836
)
 
(7,924
)
 
(30,866
)
 
(19,500
)
 
 

 
 

 
 

 
 

Other income (expense):
 
 
 
 
 
 
 
Gain on conversion of loans and accrued interest (Note 5)
—

 
2,671

 
—

 
2,671

Gain on exercise of Primary Warrant (Note 5)
—

 
4,616

 
—

 
4,616

Change in fair value of investment, net (Note 5)
11,347

 
(12,698
)
 
(29,750
)
 
(12,698
)
Equity in losses of investee (Note 5)
—

 
(14
)
 
—

 
(14
)
Interest income and other
268

 
563

 
475

 
1,259

Total other income (expense)
11,615

 
(4,862
)
 
(29,275
)
 
(4,166
)
Loss before provision for income taxes
(28,221
)
 
(12,786
)
 
(60,141
)
 
(23,666
)
Provision for income taxes
(285
)
 
(1,478
)
 
(476
)
 
(2,719
)
Net loss including noncontrolling interests in subsidiaries
(28,506
)
 
(14,264
)
 
(60,617
)
 
(26,385
)
Net loss attributable to noncontrolling interests in subsidiaries
79

 
12

 
152

 
303

Net loss attributable to Acacia Research Corporation
$
(28,427
)
 
$
(14,252
)
 
$
(60,465
)
 
$
(26,082
)
 
 

 
 

 
 

 
 

Net loss attributable to common stockholders - basic and diluted
$
(28,427
)
 
$
(14,252
)
 
$
(60,465
)
 
$
(26,082
)
Basic and diluted net loss per common share
$
(0.57
)
 
$
(0.28
)
 
$
(1.20
)
 
$
(0.52
)
Weighted average number of shares outstanding - basic and diluted
50,061,812

 
50,499,248

 
50,345,808

 
50,416,611

____________________________________________ 
(1) General and administrative expenses were comprised of the following:
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
General and administrative expenses
$
5,892

 
$
5,247

 
$
10,295

 
$
10,035

Non-cash stock compensation expense - G&A
521

 
1,449

 
1,225

 
3,561

Non-cash stock compensation expense - Profits Interests (Note 7)
685

 
38

 
(1,043
)
 
54

Total general and administrative expenses
$
7,098

 
$
6,734

 
$
10,477

 
$
13,650





The accompanying notes are an integral part of these condensed consolidated financial statements.

2


ACACIA RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
(Unaudited)

 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
Net loss including noncontrolling interests
$
(28,506
)
 
$
(14,264
)
 
$
(60,617
)
 
$
(26,385
)
Other comprehensive income (loss):
 

 
 

 
 

 
 

Unrealized gain (loss) on short-term investments, net of tax of $0
10

 
(9
)
 
(10
)
 
5

Unrealized gain (loss) on foreign currency translation, net of tax of $0
(87
)
 
(4
)
 
(104
)
 
9

Total other comprehensive loss
(28,583
)
 
(14,277
)
 
(60,731
)
 
(26,371
)
Comprehensive loss attributable to noncontrolling interests
79

 
12

 
152

 
303

Comprehensive loss attributable to Acacia Research Corporation
$
(28,504
)
 
$
(14,265
)
 
$
(60,579
)
 
$
(26,068
)





































The accompanying notes are an integral part of these condensed consolidated financial statements.

3


ACACIA RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
Six Months Ended
June 30,
 
2018
 
2017
Cash flows from operating activities:
 
 
 
Net loss including noncontrolling interests in subsidiaries
$
(60,617
)
 
$
(26,385
)
Adjustments to reconcile net loss including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:
 

 
 

Gain on conversion of loans and accrued interest(1)
—

 
(2,671
)
Gain on exercise of Primary Warrant(1)
—

 
(4,616
)
Change in fair value of investment, net(1)
29,750

 
12,698

Depreciation and amortization
10,627

 
11,134

Non-cash stock compensation
182

 
3,615

Impairment of patent-related intangible and other assets
29,210

 
—

Other
(313
)
 
(598
)
Changes in assets and liabilities:
 
 
 

Accounts receivable
(934
)
 
12,505

Prepaid expenses and other assets
(571
)
 
(1,474
)
Accounts payable and accrued expenses
861

 
(5,054
)
Royalties and contingent legal fees payable
1,436

 
(4,481
)
Net cash provided by (used in) operating activities
9,631

 
(5,327
)
 
 

 
 

Cash flows from investing activities:
 

 
 

Investments in Investees (1)
(7,000
)
 
(31,514
)
Advances to Investee (1)
—


(4,000
)
Purchases of available-for-sale investments
(49,895
)
 
(331,412
)
Maturities and sales of available-for-sale investments
15,400

 
295,807

Net cash used in investing activities
(41,495
)
 
(71,119
)
 
 

 
 

Cash flows from financing activities:
 

 
 

Repurchase of common stock
(4,634
)
 
—

Repurchased restricted common stock
(7
)
 
(35
)
Proceeds from exercises of stock options
51

 
649

Net cash (used in) provided by financing activities
(4,590
)
 
614

 
 

 
 

Decrease in cash and cash equivalents
(36,454
)
 
(75,832
)
Cash and cash equivalents, beginning
136,604

 
139,052

Cash and cash equivalents, ending
$
100,150

 
$
63,220


____________________________________________ 
(1) Refer to Note 5 for additional information.








The accompanying notes are an integral part of these condensed consolidated financial statements.

4
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)



1.  DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia also identifies opportunities to partner with high-growth and potentially disruptive technology companies. These partnerships usually involve an equity or debt investment by Acacia, along with entering into intellectual property (“IP”) related agreements where Acacia provides IP and other patent related services to these companies. Acacia leverages its experience, expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement Acacia’s primary licensing and enforcement business.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of IP rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.

Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia’s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.    

During the six months ended June 30, 2018, Acacia did not obtain control of any new patent portfolios. During fiscal year 2017 Acacia obtained control of one new patent portfolio. In fiscal year 2016, Acacia obtained control of two new patent portfolios, compared to three new patent portfolios, and six new patent portfolios in fiscal years 2015 and 2014, respectively.

Basis of Presentation.  The accompanying condensed consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.
    
The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly reporting requirements of the Securities and Exchange Commission (“SEC”).  These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2017, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC.  The December 31, 2017 condensed consolidated balance sheet was derived from audited financial statements but does not include all disclosures required by U.S. GAAP.

The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of Acacia’s consolidated financial position as of June 30, 2018, and results of its operations and its cash flows for the interim periods presented.  The consolidated results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the entire fiscal year.


2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition. Revenue is recognized upon transfer of control of promised bundled IP rights (hereinafter “IP Rights”) and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time

5
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have been met.

For the periods presented, revenue contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia (“Paid-up Revenue Agreements”). Revenues also included license fees from sales-based revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees (“Recurring Revenue Agreements”). IP Rights granted included the following, as applicable:  (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer IP Rights in the contract.

Since the promised IP Rights are not individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were “functional IP rights” that have significant standalone functionality. Acacia's subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia’s operating subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support or services.  The contracts provide for the grant (i.e. transfer of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectibility is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.
 
For sales-based royalties, the Company includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.

Revenues from contracts with significant financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.
 
In general, the Company is required to make certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.










6
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Revenues were comprised of the following for the periods presented (in thousands):
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
Paid-up Revenue Agreements
$
3,183

 
$
14,964

 
$
63,246

 
$
22,160

Recurring Revenue Agreements
3,302

 
1,493

 
5,332

 
3,151

 
$
6,485

 
$
16,457

 
$
68,578

 
$
25,311


Refer to “Inventor Royalties and Contingent Legal Expenses” below for information on related direct costs of revenues.
 
Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.  These costs are included under the caption “Cost of revenues” in the accompanying condensed consolidated statements of operations. Cost of revenues for the six months ended June 30, 2018 included $4.0 million of costs to acquire certain rights related to revenues recognized in the period.  

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized.  In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues.  Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the condensed consolidated statements of operations.  Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the condensed consolidated statements of operations.

Contingent legal fees are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Inventor royalty and contingent legal agreements typically provide for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments are received from licensees by the Company.

Use of Estimates.  The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of equity instruments, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.

Concentrations. Two licensees individually accounted for 48% and 42% of revenues recognized during the three months ended June 30, 2018, and one licensee accounted for 87% of revenues recognized during the six months ended June 30, 2018. One licensee accounted for 85% of revenues recognized during the three months ended June 30, 2017 and two licensees accounted for 55% and 26% of revenues recognized during the six months ended June 30, 2017. For the three and six months ended June 30, 2018, 43% and 6%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and six months ended June 30, 2017, 90% and 87%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations. Two licensees individually represented approximately 47% and 43% of accounts receivable at June 30, 2018. One licensee individually represented approximately 100% of accounts receivable at December 31, 2017.

7
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)



Fair Value Measurements. U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

(i)
Level 1 - Observable Inputs:  Quoted prices in active markets for identical investments;
(ii)
Level 2 - Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
(iii)
Level 3 - Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
 
Level 1
 
Level 2
 
Level 3
Assets as of June 30, 2018:
 
 
 
 
 
Short-term investments
$
34,694

 
$
—

 
$
—

Investment at fair value (Note 5)(1)

—

 
—

 
75,004

Total recurring fair value measurements
$
34,694

 
$
—

 
$
75,004

Assets as of December 31, 2017:
 
 
 
 
 
Investment at fair value (Note 5)(1)
$
—

 
$
—

 
$
104,754

____________________
(1)  
As of December 31, 2017, the Veritone common shares were subject to a lock-up agreement that expired on February 15, 2018 and measured at fair value using level 3 inputs. As of March 31, 2018, the Veritone common shares were not subject to a lock-up agreement and measured at fair value using level 1 inputs. At June 30, 2018, the Veritone common shares are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws.

A reconciliation of the activity for fair value measurements categorized within Level 3 for the six months ended June 30, 2018 is as follows (in thousands):
 
Investment at Fair Value
 
Common Stock
 
Warrants
 
Total
Opening balance as of January 1, 2018
$
90,795

 
$
13,959

 
$
104,754

Total gains and losses included in earnings for the period(1)
 
 
 
 
 
Change in fair value of investment, net
(24,968
)
 
(4,782
)
 
(29,750
)
Total recurring fair value measurements(1)
$
65,827

 
$
9,177

 
$
75,004

____________________
(1) All gains and losses included in earnings for the period presented relate to assets and liabilities held as of June 30, 2018.

Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. The Company accounts for forfeitures of awards as they occur.

Profits Interest Units (“Units”) are accounted for in accordance with Accounting Standards Codification (“ASC”) 718-10, “Compensation - Stock Compensation.” The Units vest as described at Note 7, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as

8
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying condensed consolidated statements of operations.

Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.
 
Short-term Investments.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).

Short-term marketable securities for the periods presented were comprised of the following (in thousands):
 
 
 
Gross Unrealized
 
 
Security Type
Cost
 
Gains
 
Losses
 
Fair Value
June 30, 2018:
 
 
 
 
 
 
 
U.S. government fixed income securities (Maturity dates in 2018)
$
34,704

 
$
1

 
$
(11
)
 
$
34,694


Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to six years.

Investments at Fair Value. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).

Other Investments. Equity investments in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the condensed consolidated statements of operations.

Investments in preferred stock with substantive liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. In-substance common stock is an

9
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


investment in an entity that has risk and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially all of the investee's losses, if any.

The initial determination of whether an investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence over the operating and financial policies of the investee. That determination is reconsidered if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest. Refer to Note 5 for additional information.

Impairment of Investments. Acacia reviews its investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements of operations and a new cost basis in the investment is established.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s condensed consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

The provision for income taxes for interim periods is determined using an estimate of Acacia’s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative adjustment is recorded.  

The Company’s effective tax rates were (1%) and (1%) for the three and six months ended June 30, 2018, respectively and (12%) and (11%) for the three and six months ended June 30, 2017, respectively. Tax expense for the periods presented

10
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


primarily reflects the impact of state taxes and foreign withholding taxes incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.

On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to 21%, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of the changes were effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (“IRS”), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities.
While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately $25,261,000 in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets for the periods presented herein, the change in tax law did not have a material impact on our condensed consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.


3.  LOSS PER SHARE

The Company computes net loss attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.” The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted net loss per share:
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
 
2018
 
2017
 
2018
 
2017
Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted
 
50,061,812

 
50,499,248

 
50,345,808

 
50,416,611

Basic and diluted net loss per common share
 
$
(0.57
)
 
$
(0.28
)
 
$
(1.20
)
 
$
(0.52
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share
 
4,793,037

 
4,598,443

 
4,851,737

 
4,598,443

Maximum price of awards excluded from the computation of diluted loss per share
 
$
6.75

 
$
6.75

 
$
6.75

 
$
6.75



4.  PATENTS

Acacia’s only identifiable intangible assets at June 30, 2018 and December 31, 2017 are patents and patent rights. Patent-related accumulated amortization totaled $421,038,000 and $382,220,000 as of June 30, 2018 and December 31, 2017, respectively. Acacia’s patents have remaining estimated economic useful lives ranging from one to six years. The weighted-average remaining estimated economic useful life of Acacia’s patents is approximately two years.  









11
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


The following table presents the scheduled annual aggregate amortization expense as of June 30, 2018 (in thousands):
For the years ending December 31,
 
Remainder of 2018
$
15,534

2019
3,508

2020
1,683

2021
822

2022
817

Thereafter
735

 
$
23,099


During the three months ended June 30, 2018, Acacia recorded impairment of patent-related intangible asset charges of $28,210,000. The impairment charges were realized in the period due to a reduction in expected estimated future net cash flows for certain patents due to second quarter 2018 developments in the ongoing litigation. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of June 30, 2018. Assumptions utilized in the cash flow analysis included margins on estimated net proceeds ranging from 53% to 86% and a discount for the time value of money of zero percent, due to the relatively short time-frame associated with estimated cash flows.


5. INVESTMENTS

Investment at Fair Value
Veritone Investment Agreement. On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provided for Acacia to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permitted Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum (included in Other Income (Expense) in the condensed consolidated statements of operations). On August 15, 2016, Acacia funded the initial $10 million loan (the “First Loan”). On November 25, 2016, Acacia funded the second $10 million loan (the “Second Loan”). The First Loan and the Second Loan were due and payable on November 25, 2017. In conjunction with the First Loan and Second Loan, Veritone issued Acacia a total of three four-year $700,000 warrants to purchase shares of Veritone’s common stock at an exercise price of $13.6088 per share. Upon Veritone’s consummation of its public offering of its common stock on May 17, 2017 (“IPO”), all outstanding principal and accrued interest under the Veritone Loans, totaling $20.7 million, automatically converted into 1,523,746 shares of Veritone’s common stock based on a conversion price of $13.6088 per share.
In addition, in August 2016, Veritone issued Acacia a five-year Primary Warrant to purchase up to $50.0 million, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at an exercise price of $13.6088 per share. Pursuant to an amendment to the Primary Warrant effective March 15, 2017, the Primary Warrant was exercised automatically upon the consummation of Veritone’s IPO, resulting in the purchase by Acacia of an additional 2,150,335 shares of Veritone common stock, at an aggregate purchase price of $29.3 million. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone issued to Acacia an additional 10% Warrant that provides for the issuance of an additional 809,400 shares of Veritone common stock at an exercise price of $13.6088 per share, with 50% of the shares underlying the 10% warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of the shares underlying the 10% warrant vesting on the first anniversary of the issuance date of the 10% Warrant.
Veritone Bridge Loan. On March 14, 2017, Acacia entered into an additional secured convertible promissory note with Veritone (the “Veritone Bridge Loan”), which permitted Veritone to borrow up to an additional $4.0 million, bearing interest at the rate of 8.0% per annum. On March 17, 2017, Acacia funded the initial $1.0 million advance (the “First Bridge Loan”). On April 14, 2017, Acacia funded the second $1.0 million advance (the “Second Bridge Loan”). All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, Acacia elected to make an additional advance to Veritone totaling $2.0 million, representing all principal amounts not advanced upon Veritone’s consummation of its IPO. Upon consummation of Veritone’s IPO, the outstanding principal and accrued interest under the Veritone Bridge Loan of $4.0 million and $21,000, respectively, automatically converted into 295,440 shares of Veritone’s common stock at a conversion price of $13.6088 per share.

12
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


In conjunction with the Veritone Bridge Loan, Veritone issued to Acacia (i) 60,000 shares of Veritone common stock (“Upfront Shares”), (ii) 90,000 shares of Veritone common stock (the “Bridge Installment Shares”), and (iii) 10-year warrants to purchase up to 157,000 shares of Veritone common stock with other terms and conditions similar to the warrants described above.

All share amounts above have been adjusted to reflect a 0.6-for-1 reverse stock split of Veritone’s common stock, which was effected by Veritone in April 2017. The Veritone common shares and the common shares underlying the warrants are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. All of the Veritone common stock held by Acacia was unregistered as of the issue date and are unregistered as of June 30, 2018.

Accounting Prior to Veritone IPO. Prior to conversion, Acacia’s Investment Agreement and the Veritone Bridge Loan represented variable interests in Veritone for which Acacia was not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. In addition, the Veritone Loans and Veritone Bridge Loan (the “Loans”) were not considered in-substance common stock, the common stock purchase warrants were unexercised, and the right to receive the Upfront Shares and the Bridge Installment shares (“Veritone Shares”) were considered in-substance common stock, however, application of the equity method was not material, therefore, the equity method of accounting was not applied prior to the IPO.

Prior to conversion, the Loans and the related common stock purchase warrants and Veritone Shares were accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the respective transactions, with the face amount of the loans allocated to (1) the Loans, which were accounted for as long-term loan receivables and (2) the common stock purchase warrants and Veritone Shares. The estimated relative fair value allocation was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone’s equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Loans. Assumptions used in connection with estimating the relative fair values included: (1) volatility ranging from 40% to 50%, (2) financing probabilities ranging from 25% to 75%, (3) marketability discount of 7% and (4) 100% investment recovery assumption. The loan discount, representing the difference between the face amount of the Loans and the relative fair value allocated to the Loans, was accreted over the expected life of the Loans, using the effective interest method, with the related interest amounts reflected in other income (expense) in the condensed consolidated statements of operations. Interest income for the six months ended June 30, 2017 was $1.1 million, including accretion of the loan discount of $630,000. The effective yield on the Loans for the six months ended June 30, 2017 ranged from 9% to 53%.
Accounting Subsequent to Veritone IPO. Upon Veritone’s consummation of its IPO on May 17, 2017, the Loans were converted into shares of Veritone common stock and the Primary Warrant was automatically exercised in full, as described above, resulting in a 20% ownership interest in Veritone (excluding warrants). Based on Acacia’s representation on the Veritone board of directors and Acacia’s 20% ownership interest in Veritone, Acacia management determined that the equity method of accounting was applicable. Upon becoming eligible for the equity method of accounting, Acacia elected to apply the fair value option to account for its equity investment in Veritone, including all of its investments in Veritone common stock and warrants, due to the availability of quoted prices in an active market for the Veritone common stock. As of June 30, 2018, Acacia’s ownership interest in Veritone, on a fully-diluted basis, was approximately 19%.
Acacia’s equity investment in Veritone common shares is recorded at fair value based on the quoted market price of Veritone’s common stock on The NASDAQ Global Market on the applicable valuation date, as adjusted for an estimated discount for lack of marketability (“DLOM”) associated with the restricted nature of the common shares acquired (Level 3 input). Acacia’s investment in Veritone warrants is recorded at fair value, as adjusted for an estimated DLOM, based on the Black-Scholes option-pricing model, utilizing the following assumptions at June 30, 2018: risk-free interest rates ranging from 2.52% to 2.81%; expected terms ranging from 2 years to 9 years; volatility of 60%; and a dividend yield of zero. The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:
 
 
Veritone Common Stock
 
Veritone Warrants
 
 
 
 
IPO Date
 
December 31,
2017
 
June 30,
2018
 
IPO Date
 
December 31,
2017
 
June 30,
2018
Estimated DLOM applied
 
5.7%
 
5%
 
5%
 
5.7%
 
10%
 
10%
-
15%
Volatility assumptions
 
35%
 
37%
 
90%
 
35%
 
72
%
-
87%
 
66%
-
110%
Term assumptions
 
6 months
 
2 months
 
2 months
 
6 months
 
5 months
 
5 months

13
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


At June 30, 2018, the fair value of the 4,119,521 shares of Veritone common stock owned by Acacia totaled $65,827,000. At June 30, 2018, the fair value of the 1,120,432 common stock purchase warrants held by Acacia totaled $9,177,000. At June 30, 2018, the cumulative net unrealized gain (since the IPO) on our Veritone investment was $19,776,000. A 10% increase in the DLOM assumptions utilized at all applicable valuation dates would result in an approximate 11% decrease in the fair value of our investment in Veritone warrants at June 30, 2018, and a corresponding decrease in the net investment gain or loss reflected in the condensed consolidated statements of operations for the applicable period. Changes in the fair value of Acacia’s investment in Veritone are recorded as unrealized gains or losses in the condensed consolidated statements of operations.
Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):
 
 
Three Months Ended March 31, 2018
Revenues
 
$
4,388

Gross profit
 
3,824

Operating expenses
 
17,054

Other income (expense), net
 
183

Net loss attributable to common stockholders
 
(13,049
)
 
 
 
Net loss per share attributable to common stockholders - basic and diluted
 
$
(0.81
)
 
 
March 31,
2018
 
December 31, 2017
Current assets
 
$
71,567

 
$
83,805

Noncurrent assets
 
6,161

 
4,753

Total Assets
 
$
77,728

 
$
88,558

 
 
 
 
 
Current liabilities
 
$
26,582

 
$
27,256

Noncurrent liabilities
 
—

 
—

Total liabilities
 
26,582

 
27,256

Preferred stock
 
—

 
—

Total stockholder's equity (deficit)
 
51,146

 
61,302

Total liabilities, preferred stock and stockholders’ equity
 
$
77,728

 
$
88,558

Other Investment
    
In June 2017, Acacia made an investment in the Series A Preferred financing round for Miso Robotics, Inc. (“Miso Robotics”), an innovative leader in robotics and artificial intelligence solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Series A preferred stock of Miso Robotics, and one board seat. In February 2018, Acacia made an additional equity investment in the Series B Preferred financing round for Miso Robotics totaling $6,000,000, increasing its ownership interest (Series B preferred stock) in Miso Robotics to approximately 30%, and acquiring an additional board seat. In addition, in June 2017, Acacia also entered into an IP services agreement with Miso Robotics to help Miso Robotics drive AI-based solutions for the restaurant industry. Miso Robotics will use the funding to deliver an adaptable AI-driven robotic kitchen assistant that will work alongside kitchen staff to improve operational efficiency for the restaurant industry.

As of February 2018, the preferred stock was not deemed to be in-substance common stock due to the substantive liquidation preference associated with the preferred stock. As such, as of February 2018, the cumulative investment in Miso Robotics is recorded at cost and assessed for any impairment at each balance sheet date. Prior to February 2018, the equity method of accounting was applied.





14
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


6.  COMMITMENTS AND CONTINGENCIES
Patent Enforcement
    Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights.  In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions.  In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material.


Other
Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business.  Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s condensed consolidated financial position, results of operations or cash flows.

7. STOCKHOLDERS’ EQUITY
    
Repurchases of Common Stock. In February 2018, Acacia’s Board of Directors authorized the repurchase of up to $20,000,000 of the Company’s outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion (the “Stock Repurchase Program”). In determining whether or not to repurchase any shares of Acacia’s common stock, Acacia’s Board of Directors consider such factors as the impact of the repurchase on Acacia’s cash position, as well as Acacia’s capital needs and whether there is a better alternative use of Acacia’s capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding share count and enhance stockholder value. The repurchase shares are expected to be retired. Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were as follows:
 
Total Number of Shares Purchased
Average Price paid per Share
Approximate Dollar Value of
Shares that May Yet be
Purchased under the Program
Plan Expiration
 
 
 
 
 
May 1, 2018- May 30, 2018
1,190,420

$
3.89

$
15,366,000

February 28, 2019
Totals for 2018
1,190,420

$
3.89

 
 

Profits Interest Plan. On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of membership interests in AIP to certain members of management and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each Unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership interests. The membership interests are represented by Units reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones (one-third upon 150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia’s aggregate investment in Veritone), subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement. The Units were fully vested as of June 30, 2018.

Acacia owns 60% of the membership interests in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be

15
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


awarded as one-time, discretionary grants to recipients. As of June 30, 2018, AIP holds the Veritone 10% Warrant described at Note 5.

Profits interests totaling 400 Units, or 40% of the membership interests in AIP, were granted in February 2017 pursuant to the Plan, with an aggregate grant date fair value of $722,000. The fair value of the Units totaled $1,998,000 as of June 30, 2018. Upon full vesting of the units in September 2017, all previously unrecognized compensation expense was immediately recognized.

The fair value of the Units is estimated utilizing a Geometric Brownian Motion model (“GBM”) which considers probable vesting dates and values for the applicable instruments (i.e. common stock and warrants related to Acacia’s Veritone investment described at Note 5) underlying or associated with the Units. At the estimated end of the term of the underlying warrant (May 2022), the model estimates the total proceeds from the hypothetical exercise of the warrant and estimates the value of the Units by allocating the proceeds based on the waterfall described in the terms of the underlying agreement. The value of the Units on a marketable basis is the average allocation across all GBM simulation paths discounted to the applicable valuation date using the risk-free rate. This estimated value is adjusted for an estimate of a DLOM using the Finnerty model, based on a security specific volatility calculated by changing Veritone’s common stock price by 1% and measuring the corresponding change in the value of the Units. For the three months ended June 30, 2018, assumptions utilized in the GBM included a term of 3.9 years, stock price of $16.82, volatility of 60%, and risk free interest rates ranging from 2.33% to 2.85% for terms ranging from one to 10 years. The estimated DLOM utilized was 30%, based on assumptions including a term of approximately 3.9 years and a volatility of 90% for Veritone’s common stock. Volatility was estimated based on the historical volatilities of a set of comparable public companies, adjusted for leverage, over a term matching the term of the underlying warrant asset, which was approximately 3.9 years.


8.  RECENT ACCOUNTING PRONOUNCEMENTS
 
Recent Accounting Pronouncements - Recently Adopted.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company is required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under previous guidance, as described in Note 2. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity’s IP as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its IP as the performance occurs, and (ii) an entity’s promise to provide a customer with the right to use its IP is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The Company used the modified retrospective method of adoption and recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings on January 1, 2018. Comparative prior year periods were not adjusted. The new accounting standard was applied to all contracts at the date of initial application. The cumulative effect of applying the new revenue standard, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods, was as follows (in thousands):

16
ACACIA RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


 
 
Balance at December 31, 2017
 
Adjustments
 
Balance at January 1, 2018
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
153

 
$
4,542

 
$
4,695

Royalties and contingent legal fees payable
 
1,601

 
1,728

 
3,329

Accumulated deficit
 
(320,018
)
 
2,506

 
(317,512
)
Noncontrolling interests
 
1,358

 
308

 
1,666


The impact of the adoption of the new accounting standard on the consolidated balance sheet and statement of operations was as follows (in thousands):
 
 
Balance as Reported
 
Balance at January 1, 2018 Prior to Adoption
 
Effect of Change
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
5,629

 
$
3,599

 
$
2,030

Royalties and contingent legal fees payable
 
4,765

 
3,953

 
812

 
 
 
 
 
 
 
Statements of Operations:
 
 
 
 
 
 
Revenues
 
$
68,578

 
$
66,548

 
$
2,030

Inventor royalties
 
22,985

 
22,287

 
698

Contingent legal fees
 
16,796

 
16,682

 
114


In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017. The adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements - Not Yet Adopted.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures and expects to adopt the new standard effective January 1, 2018.


9. SUBSEQUENT EVENTS

Board Composition. On August 8, 2018, the Company announced that Joseph E. Davis, Fred A. deBoom and James F. Sanders have resigned from the Board, effective immediately.

Personnel. On August 8, 2018, the Company announced that Robert B. Stewart Jr., President, Edward J. Treska, Executive Vice President, General Counsel and Clayton J. Haynes, Chief Financial Officer, SVP Finance, Treasurer, are transitioning out of their roles at Acacia effective August 10, 2018, pursuant to a board approved transition arrangement. Mr. Treska and Mr. Haynes have agreed to provide consulting services to the Company to aid in the transition of their duties subsequent to August 10, 2018. Severance payments related to the personnel changes described above total $2.5 million.



17


Item 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statement Regarding Forward Looking Statements

You should read the following discussion and analysis in conjunction with the condensed consolidated financial statements and related notes thereto contained in Part I, Item 1 of this Quarterly Report on Form 10-Q. The information contained in this Quarterly Report on Form 10-Q is not a complete description of our business or the risks associated with an investment in our common stock. We urge you to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange Commission, or the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2017, filed with the SEC on March 7, 2018, amended by Amendment No. 1 to our Annual Report on Form 10-K, filed with the SEC on April 2, 2018, and Amendment No. 2 to our Annual Report on Form 10-K, filed with the SEC on April 30, 2018. Our Annual Report on Form 10-K, as amended, is referred to herein as our “Annual Report.”

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and which concern matters that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Reference is made in particular to the description of our plans and objectives for future operations, assumptions underlying such plans and objectives, and other forward-looking statements set forth under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other sections of this Quarterly Report on Form 10-Q. Such statements may be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “could,” “expect,” “plan,” “believe,” “estimate,” “anticipate,” “intend,” “predict,” “potential,” “continue” or similar terms, variations of such terms or the negative of such terms, although not all forward-looking statements contain these terms. Such statements are based on management’s current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. Such statements address future events and conditions concerning intellectual property, or IP acquisition and development, licensing and enforcement activities, other related business activities, capital expenditures, earnings, litigation, regulatory matters, markets for our services, liquidity and capital resources and accounting matters. Actual results in each case could differ materially from those anticipated in such statements by reason of factors such as our ability to invest in new technologies and patents, future global economic conditions, changes in demand for our services, legislative, regulatory and competitive developments in markets in which we and our subsidiaries operate, results of litigation and other circumstances affecting anticipated revenues and costs. We expressly disclaim any intent, obligation or undertaking to update or revise any forward-looking statements contained herein to conform such statements to actual results or to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Readers are urged to carefully review and consider the various disclosures made by us, which attempt to advise interested parties of the risks, uncertainties, and other factors that affect our business, including without limitation the disclosures made under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Financial Statements” in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and notes thereto and disclosures made under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors” and  “Financial Statements and Supplementary Data” included in our Annual Report on Form 10-K for the year ended December 31, 2017.

General

As used in this Quarterly Report on Form 10-Q, “we,” “us” “our” and “Company” refer to Acacia Research Corporation, a Delaware corporation, and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All IP acquisition, development, licensing and enforcement activities are conducted solely by certain of Acacia Research Corporation’s wholly and majority-owned and controlled operating subsidiaries.
    
We invest in, license and enforce patented technologies. We partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We generate revenues and related cash flows from the granting of patent rights for the use of patented technologies that our operating subsidiaries control or own. We assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. We are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.


18


We have a proven track record of licensing and enforcement success with over 1,560 license agreements executed to date, across 193 patent portfolio licensing and enforcement programs. To date, we have generated gross licensing revenue of approximately $1.5 billion, and have returned more than $754 million to our patent partners.
We also identify opportunities to partner with high-growth and potentially disruptive technology companies. We leverage our experience, expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement our primary licensing and enforcement business.

Executive Summary

Overview

Our operating activities during the periods presented were focused on the continued operation of our patent licensing and enforcement business, including the continued pursuit of our ongoing patent licensing and enforcement programs. We continue to experience challenges in the existing patent and licensing environment, including challenges in identifying and acquiring new high-quality patent assets as discussed below. Despite these challenges, we intend to continue to invest in and monetize our existing quality patent assets.

Partnerships. In June 2017, we partnered with Miso Robotics, an innovative leader in robotics and AI solutions, which included an equity investment totaling $2.25 million, as part of Miso Robotics’ closing of $3.1 million in Series A funding. In addition, in February 2018, we made an additional strategic equity investment totaling $6.0 million in the Series B financing round for Miso Robotics, increasing our fully diluted ownership interest to approximately 30% as of March 31, 2018. Miso Robotics will use the capital to expand its suite of collaborative, adaptable robotic kitchen assistants and to broaden applications for Miso AI, the company’s machine learning cloud platform. In addition, we also entered into an IP services agreement with Miso Robotics to help the company drive AI-based solutions for the entire restaurant industry. Our partnership with Miso Robotics represents our second partnership with companies seeking to transform the marketplace through AI.

In August 2016, we announced the formation of a partnership with Veritone, a cloud-based Artificial Intelligence technology company that is pioneering next generation search and analytics through their proprietary Cognitive Media Platform™. Upon Veritone’s consummation of its initial public offering in May 2017, or the IPO, our loans and accrued interest were automatically converted into 1,969,186 shares of Veritone common stock and we exercised certain warrants, acquiring 2,150,335 additional shares of Veritone common stock. At June 30, 2018, the cumulative net unrealized gain (since the IPO) on our Veritone investment was $19.8 million. Our Veritone common shares are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. Refer to Note 5 to the condensed consolidated financial statements elsewhere herein for additional information regarding our partnership with Veritone.

Patent Portfolio Intake. One of the significant challenges in our industry continues to be quality patent intake due to the challenges and complexity of the current patent environment. With respect to our licensing, enforcement and overall business, neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents, inventions and companies that own IP through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then we may not be able to identify new technology-based patent opportunities for sustainable revenue and /or revenue growth.
 
Our current or future relationships may not provide the volume or quality of technologies necessary to sustain our licensing, enforcement and overall business. In some cases technology sources compete against us as they seek to develop and commercialize technologies. Strategies employed by potential partners may reduce the number of technology sources and potential clients to whom we can market our solutions. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain our licensing and enforcement business.

For example, during the six months ended June 30, 2018, Acacia did not obtain control of any new patent portfolios. Further, we obtained control of only one, two and three new patent portfolios during fiscal years 2017, 2016 and 2015, respectively, compared to 6 new patent portfolios and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. This decrease in our patent portfolio intake reflects in part our strategic decision in 2013 to shift the focus of our operating business to serving a smaller number of customers, each having higher quality patent portfolios. As a result, our gross number of patent portfolio acquisitions has decreased significantly. This decrease in our patent portfolio intake also reflects in part industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the

19


complexity of patent enforcement actions and may significantly affect the market availability of suitable patent portfolios for acquisition. As a result of these continuing industry trends, our recent and future patent portfolio intake has been and may continue to be negatively impacted, resulting in further decreases in future revenue generating opportunities, and continued negative adverse impacts on the sustainability of our licensing and enforcement business. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our licensing and enforcement revenues will continue to decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

Operating Activities. Operating activities during the periods presented included the following:
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
Revenues (in thousands)
$
6,485

 
$
16,457

 
$
68,578

 
$
25,311

New agreements executed
2

 
9

 
6

 
15

Licensing and enforcement programs generating revenues
5

 
8

 
6

 
9


In addition to the portfolio intake trend described above, our revenues historically have fluctuated quarterly, and can vary significantly, based on a number of factors including the following:
•
the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;
•
the specific terms and conditions of agreements executed each period including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments;
•
fluctuations in the total number of agreements executed each period;
•
the number of, timing, results and uncertainties associated with patent licensing negotiations, mediations, patent infringement actions, trial dates and other enforcement proceedings relating to our patent licensing and enforcement programs;
•
the relative maturity of licensing programs during the applicable periods;
•
other external factors, including the periodic status or results of ongoing negotiations, the status or results of ongoing litigations and appeals, actual or perceived shifts in the regulatory environment, impact of unrelated patent related judicial proceedings and other macroeconomic factors; and
•
fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above.
  
Our management does not attempt to manage for smooth sequential periodic growth in revenues period to period, and therefore, periodic results can be uneven. In some cases, with respect to our existing portfolios, revenues not generated in a current period are not necessarily foregone, but depending on whether negotiations, litigation or both continue into subsequent periods, and depending on a number of other factors, such potential revenues may be pushed into subsequent fiscal periods.

Revenues for the six months ended June 30, 2018 and 2017 included fees from the following technology licensing and enforcement programs:
•
Bone Wedge technology(1)(2)
 
•
Optical Networking technology(2)
•
Cardiology and Vascular Device technology(2)
 
•
Speech codes used in wireless and wireline systems technology(1)(2)
•
DisplayPort and MIPI DSI technology(2)
 
•
Super Resolutions Microscopy technology(1)(2)
•
Electronic Access Control technology(2)
 
•
Video Conferencing technology(1)
•
Innovative Display technology(2)
 
•
Wireless Infrastructure and User Equipment technology(1)
•
Online Auction Guarantee technology(1)(2)
 
 
 
__________________________
(1) 2018 period
(2) 2017 period





20



Summary of Results of Operations - Overview
For the Three and Six Months Ended June 30, 2018 and 2017
(In thousands, except percentage change values)
 
Three Months Ended
June 30,
 
%
 
Six Months Ended
June 30,
 
%
 
2018
 
2017
 
Change
 
2018
 
2017
 
Change
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
$
6,485

 
$
16,457

 
(61
)%
 
$
68,578

 
$
25,311

 
171
 %
Operating costs and expenses
46,321

 
24,381

 
90
 %
 
99,444

 
44,811

 
122
 %
Operating loss
(39,836
)
 
(7,924
)
 
*

 
(30,866
)
 
(19,500
)
 
58
 %
Other income (expense), net
11,615

 
(4,862
)
 
*

 
(29,275
)
 
(4,166
)
 
*

Loss before provision for income taxes
(28,221
)
 
(12,786
)
 
121
 %
 
(60,141
)
 
(23,666
)
 
154
 %
Provision for income taxes
(285
)
 
(1,478
)
 
(81
)%
 
(476
)
 
(2,719
)
 
(82
)%
Net loss attributable to Acacia Research Corporation
(28,427
)
 
(14,252
)
 
99
 %
 
(60,465
)
 
(26,082
)
 
132
 %
* Percentage change in excess of 200%

Overview - Three months ended June 30, 2018 compared with the three months ended June 30, 2017

•
Revenues decreased $10.0 million to $6.5 million for the three months ended June 30, 2018, as compared to $16.5 million in the comparable prior year quarter, due primarily to a decrease in the number of agreements executed during the quarter. Refer to “Investments in Patent Portfolios” below for additional information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related revenues.

•
Loss before provision for income taxes was $28.2 million for the three months ended June 30, 2018, as compared to $12.8 million for the three months ended June 30, 2017. The net change was primarily comprised of the change in revenues described above, an $11.3 million unrealized gain for the three months ended June 30, 2018 as compared to a $12.7 million unrealized loss for the comparable prior year period on our equity investment in Veritone, and other changes in operating expenses as follows:

•
Inventor royalties and contingent legal fees, on a combined basis, decreased $5.2 million, primarily due to the decrease in related revenues for the periods.

•
Litigation and licensing expenses-patents decreased $2.0 million, or 48%, to $2.1 million, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with ongoing licensing and enforcement programs and a continued overall decrease in portfolio related enforcement activities. Refer to “Investments in Patent Portfolios” below for additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current and future licensing and enforcement related revenues.

•
General and administrative expenses, excluding non-cash stock compensation, increased $645,000 or 12%, to $5.9 million, due primarily to an increase in corporate, general and administrative costs related to the 2018 proxy contest, which was partially offset by a reduction in employee related severance costs.

•
Net non-cash stock compensation expense decreased $281,000, or 19%, due primarily to second quarter 2017 non-cash stock compensation expense including amounts related to the August 2016 grant of options with market-based vesting conditions with graded vesting features, resulting in higher non-cash stock compensation expense during the earlier stages of the applicable service period. Excluding non-cash stock compensation related to the Profits Interest, non-cash stock compensation expense decreased $928,000, or 64%.

•
During the three months ended June 30, 2018, Acacia recorded impairment of patent-related intangible asset charges of $28.2 million. The impairment charges were realized in the period due to a reduction in expected estimated future net cash flows for certain patent portfolios. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of June 30, 2018.





21


Overview - Six months ended June 30, 2018 compared with the six months ended June 30, 2017

•
Revenues increased $43.3 million to $68.6 million for the six months ended June 30, 2018, as compared to $25.3 million in the comparable prior year period, due primarily to an increase in the average revenue per agreement executed during the 2018 period. Refer to “Investments in Patent Portfolios” below for additional information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related revenues.

•
Loss before provision for income taxes was $60.1 million for the six months ended June 30, 2018, as compared to $23.7 million for the six months ended June 30, 2017. The net change was primarily comprised of the change in revenues described above, a $17.1 million increase in the unrealized loss on our equity investment in Veritone and other changes in operating expenses as follows:

•
Inventor royalties, contingent legal fees and other costs of revenue, on a combined basis, increased $35.0 million primarily due to the increase in related revenues for the periods.

•
Litigation and licensing expenses-patents decreased $5.6 million, or 54%, to $4.9 million, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with ongoing licensing and enforcement programs and a continued overall decrease in portfolio related enforcement activities. Refer to “Investments in Patent Portfolios” below for additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current and future licensing and enforcement related revenues.

•
General and administrative expenses, excluding non-cash stock compensation, increased $260,000 or 3%, to $10.3 million due primarily to increase in corporate, general and administrative costs related to the 2018 proxy contest, which was partially offset by a reduction in employee related personnel and severance costs.

•
Net non-cash stock compensation expense decreased $3.4 million or 95%, primarily due to the first and second quarter 2017 non-cash stock compensation expense including amounts related to the August 2016 grant of options with market-based vesting conditions with graded vesting features, resulting in higher non-cash stock compensation expense during the earlier stages of the applicable service period. Excluding non-cash stock compensation related to the Profits Interest, non-cash stock compensation expense decreased $2.3 million, or 66%.

•
During the six months ended June 30, 2018, we recorded impairment of patent-related intangible asset charges of $28.2 million, as described above.

Investments in Patent Portfolios

Neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents, inventions and companies that own IP through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and to continue to identify and grow new relationships, then we may not be able to identify new technology-based opportunities for sustainable revenue and / or revenue growth.
 
Our current or future relationships may not provide the volume or quality of technologies necessary to sustain our licensing, enforcement and overall business. In some cases,technology sources compete against us as they seek to develop and commercialize technologies. Strategies employed by potential partners may reduce the number of technology sources and potential clients to whom we can market our solutions. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain our licensing and enforcement business.

For example, during the six months ended June 30, 2018, we did not obtain control of any new patent portfolios. During fiscal year 2017, 2016 and 2015, we obtained control of only one, two and three, respectively, new patent portfolios, compared to six new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. This decrease in our patent portfolio intake reflects in part our strategic decision in 2013 to shift the focus of our operating business to serving a smaller number of customers, each having higher quality patent portfolios. As a result, our gross number of patent portfolio acquisitions has decreased significantly. This decrease in our patent portfolio intake also reflects in part industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the complexity of patent enforcement actions and may significantly affect the market availability of suitable patent portfolios for acquisition. These industry trends have continued, and as a result, our recent and future patent portfolio intake has been and may continue to be negatively impacted, resulting in further decreases in future revenue generating opportunities, and continued negative

22


adverse impacts on the sustainability of our licensing and enforcement business. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our licensing and enforcement revenues will continue to decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

Patent Licensing and Enforcement

Patent Litigation Trial Dates and Related Trials.  As of the date of this report, our operating subsidiaries have three pending patent infringement case with a scheduled trial date in the next six months.  Patent infringement trials are components of our overall patent licensing process and are one of many factors that contribute to possible future revenue generating opportunities for us.  Scheduled trial dates, as promulgated by the respective court, merely provide an indication of when, in future periods, the trials may occur according to the court’s scheduling calendar at a specific point in time.  A court may change previously scheduled trial dates.  In fact, courts often reschedule trial dates for various reasons that are unrelated to the underlying patent assets and typically for reasons that are beyond our control.  While scheduled trial dates provide an indication of the timing of possible future revenue generating opportunities for us, the trials themselves represent the possible future revenue generating opportunities.  These future opportunities can result in varying outcomes.  In fact, it is difficult to predict the outcome of patent enforcement litigation at the trial level and outcomes can be unfavorable. It can be difficult to understand complex patented technologies, and as a result, this may lead to a higher rate of unfavorable litigation outcomes. Moreover, in the event of a favorable outcome, there is a higher rate of successful appeals in patent enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased costs and a potential for delayed or foregone revenue opportunities in the event of modification or reversal of favorable outcomes. Although we diligently pursue enforcement litigation, we cannot predict with reliability the decisions made by juries and trial courts. 

Litigation and Licensing Expense. We expect patent-related legal expenses to continue to fluctuate from period to period based on the factors summarized elsewhere herein, and in connection with future trial dates and enforcement activities. Refer to “Investments in Patent Portfolios” above for additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current and future licensing and enforcement related revenues. The pursuit of enforcement actions in connection with our licensing and enforcement programs can involve certain risks and uncertainties, including the following:

•
Our patented technologies and enforcement actions are complex and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents. Moreover, such appeals may not be successful; and

•
Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position.


Critical Accounting Estimates

Our unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Preparation of these condensed consolidated statements requires management to make judgments and estimates. Some accounting policies have a significant impact on amounts reported in these condensed consolidated financial statements. The SEC has defined a company’s critical accounting policies as the ones that are most important to the portrayal of a company’s financial condition and results of operations, and which require a company to make its most difficult and subjective judgments. A summary of significant accounting policies and a description of accounting policies that are considered critical may be found in the audited consolidated financial statements and notes thereto and under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies” included in our Annual Report on Form 10-K for the year ended December 31, 2017. In addition, as set forth in Note 2 to the condensed consolidated financial statements included in this report, certain accounting policies were identified during the current period, based on activities occurring during the current period, as critical and requiring significant judgments and estimates.

Revenue Recognition

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, we are required to recognize revenue when we transfer promised IP rights to customers in an amount that reflects the consideration

23


to which we expect to be entitled in exchange for those IP rights. In doing so, we are required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under previous guidance, as described at Note 2 to the condensed consolidated financial statements contained elsewhere herein. Under the standard, (i) an entity should account for a promise to provide a customer with a “right to access” the entity’s IP as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its IP as the performance occurs, and (ii) an entity’s promise to provide a customer with the “right to use” its IP is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the IP rights when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires us to include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

We elected to use the modified retrospective method of adoption and recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings on January 1, 2018. Comparative prior year periods were not be adjusted. The new accounting standard was applied to all contracts at the date of initial application. The cumulative effect of applying the new revenue standard, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods, was as follows (in thousands):
 
 
Balance at December 31, 2017
 
Adjustments Due to ASC 606
 
Balance at January 1, 2018
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
153

 
$
4,542

 
$
4,695

Royalties and contingent legal fees payable
 
1,601

 
1,728

 
3,329

Accumulated deficit
 
(320,018
)
 
2,506

 
(317,512
)
Noncontrolling interests
 
1,358

 
308

 
1,666


The impact of the adoption of the new accounting standard on the consolidated balance sheet and statement of operations was as follows (in thousands):
 
 
Balance as Reported
 
Balance Before ASC 606 Adoption
 
Effect of Change
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
5,629

 
$
3,599

 
$
2,030

Royalties and contingent legal fees payable
 
4,765

 
3,953

 
812

 
 
 
 
 
 
 
Statements of Operations:
 
 
 
 
 
 
Revenues
 
$
68,578

 
$
66,548

 
$
2,030

Inventor royalties
 
22,985

 
22,287

 
698

Contingent legal fees
 
16,796

 
16,682

 
114


Except as described above, the adoption of the new revenue recognition standard did not have a material impact on the condensed consolidated financial statements.

Other Investments

Investment in Miso Robotics. In June 2017, we made an investment in the Series A Preferred financing round for Miso Robotics, an innovative leader in robotics and AI solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Series A preferred stock of Miso Robotics, and one board seat. In February 2018, we made an additional equity investment in the Series B Preferred financing round for Miso Robotics totaling $6,000,000, increasing our ownership interest (Series B preferred stock) in Miso Robotics to approximately 30%, and acquiring an additional board seat. As of February 2018, the preferred stock was not deemed to be in-substance common stock due to the substantive liquidation preference associated with the preferred stock. As such, as of February 2018, our investment in Miso Robotics is recorded at cost and assessed for any impairment at each balance sheet date. Prior to February 2018, the equity method of accounting was applied.


24


Equity investments in common stock and in-substance common stock without readily determinable fair values in companies over which we have the ability to exercise significant influence, are accounted for using the equity method of accounting. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, are not substantially similar to the common stock, and therefore is not considerer in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially all of the investee's losses. Investments in preferred stock with substantive liquidation preferences, and therefore not deemed to be in-substance common stock, are accounted for at cost (subject to impairment considerations, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

Determination of whether an equity investment is in-substance common stock requires significant judgment, including an estimation of the fair value of the equity investments in relation to the fair value of subordinated equity of the investee, if any. A change in estimates or judgments resulting in the determination that an equity investment is or is not in-substance common stock would result in the application of either the equity method of accounting, or the cost method of accounting to the investment.
 
The fair value of subordinated equity (i.e. common stock) and preferred stock for purposes of determining whether a liquidation preference is substantive was determined utilizing an option pricing methodology, with assumptions including: volatility of 70%, risk free rate of return of 2.50% and a term of five years. A discount for lack of marketability was determined for the common stock using a Finnerty model, based on the security-specific volatilities ranging from 80% to 89%. A one percent change in the DLOM assumptions utilized to estimate the fair value of common stock would not have a material impact on the analysis.
 
Valuation of Long-lived and Intangible Assets

We review long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows.

For the three and six months ended June 30, 2018, we recorded $28.2 million of patent portfolio impairment charges. The impairment charges were recorded in the periods due to developments in the ongoing litigation. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date. Estimated fair value was determined based on estimates of future cash flows and estimates of probabilities of realization given the ongoing litigation.

    
Consolidated Results of Operations
Comparison of the Results of Operations for the Three and Six Months Ended June 30, 2018 and 2017

Revenues and Pretax Net Loss
 
 
Three Months Ended
June 30,
 
Change
 
Six Months Ended
June 30,
 
Change
 
 
2018
 
2017
 
$
 
%
 
2018
 
2017
 
$
 
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues (in thousands, except percentage change values)
 
$
6,485

 
$
16,457

 
$
(9,972
)
 
(61
)%
 
$
68,578

 
$
25,311

 
$
43,267

 
171
%
New agreements executed
 
2

 
9

 
 
 
 
 
6

 
15

 
 
 
 


Two licensees individually accounted for 48% and 42% of revenues recognized during the three months ended June 30, 2018, and one licensee accounted for 87% of revenues recognized during the six months ended June 30, 2018. One

25


licensee accounted for 85% of revenues recognized during the three months ended June 30, 2017 and two licensees accounted for 55% and 26% of revenues recognized during the six months ended June 30, 2017.

For the periods presented herein, a portion of the revenue agreements executed provided for the payment of one-time, paid-up license fees in consideration for the grant of certain IP rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents. Refer to “Investments in Patent Portfolios” above for information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related revenues. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our licensing and enforcement revenues will continue to decline and we will be unable to profitably sustain our licensing and enforcement business going forward.
 
 
Three Months Ended
June 30,
 
Change
 
Six Months Ended
June 30,
 
Change
 
 
2018
 
2017
 
$
 
%
 
2018
 
2017
 
$
 
%
 
 
(in thousands, except percentage change values)
Loss before provision for income taxes
 
$
(28,221
)
 
$
(12,786
)
 
$
(15,435
)
 
121
%
 
$
(60,141
)
 
$
(23,666
)
 
$
(36,475
)
 
(154
)%

A reconciliation of the change in pretax loss for the periods presented is as follows:
 
Three Months Ended
June 30,
 
 
 
Six Months Ended
June 30,
 
 
 
2018 vs. 2017
 
%
 
2018 vs. 2017
 
%
 
(in thousands, except percentage values)
Increase (decrease) in revenues
$
(9,972
)
 
65
 %
 
$
43,267

 
(119
)%
(Increase) decrease in inventor royalties, contingent legal fees and other
5,231

 
(34
)%
 
(34,979
)
 
96
 %
(Increase) decrease in general and administrative expenses
(645
)
 
4
 %
 
(260
)
 
1
 %
Decrease in non-cash stock compensation expenses
281

 
(2
)%
 
3,433

 
(9
)%
Decrease in litigation and licensing expenses
2,004

 
(13
)%
 
5,645

 
(15
)%
Decrease in patent amortization expenses
293

 
(2
)%
 
478

 
(1
)%
Increase in patent-related impairment charges and other
(29,210
)
 
189
 %
 
(29,210
)
 
80
 %
Change in unrealized gain (loss) on investment
16,758

 
(108
)%
 
(24,339
)
 
68
 %
Other
(175
)
 
1
 %
 
(510
)
 
1
 %
Total change in loss before provision for income taxes
$
(15,435
)
 
100
 %
 
$
(36,475
)
 
102
 %

Cost of Revenues
 
 
Three Months Ended
June 30,
 
Change
 
Six Months Ended
June 30,
 
Change
 
 
2018
 
2017
 
$
 
%
 
2018
 
2017
 
$
 
%
 
 
(in thousands, except percentage change values)
Inventor royalties
 
$
1,241

 
$
4,273

 
$
(3,032
)
 
(71
)%
 
$
22,985

 
$
4,939

 
$
18,046

 
*
Contingent legal fees
 
$
1,037

 
$
3,236

 
$
(2,199
)
 
(68
)%
 
$
16,796

 
$
3,863

 
$
12,933

 
*
Other
 
$
—

 
$
—

 
$
—

 
—
 %
 
$
4,000

 
$
—

 
$
4,000

 
*
* Percentage change in excess of 200%

Inventor Royalties, Contingent Legal Fees Expense and Other.  Inventor royalties and contingent legal fee expenses fluctuate period to period based on the amount of revenues recognized each period, the terms and conditions of agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Other operating expenses for the six months ended June 30, 2018 also included $4.0 million in other direct cost of revenues related to rights acquired and licensed in the first quarter of 2018. A summary of the main drivers of the

26


change in inventor royalties expense and contingent legal fees expense for the comparable periods presented, using the current year period as the base period, is as follows (in thousands, except percentage values):
 
 
Three Months Ended
June 30,
 
%
 
Six Months Ended
June 30,
 
%
 
 
2018 vs. 2017
 
 
2018 vs. 2017
 
Inventor Royalties:
 
 
(Decrease) increase in total revenues
 
$
(3,657
)
 
121
 %
 
$
15,188

 
84
%
Increase in inventor royalty rates
 
625

 
(21
)%
 
2,858

 
16
%
Total change in inventor royalties expense
 
$
(3,032
)
 
100
 %
 
$
18,046

 
100
%

 
 
Three Months Ended
June 30,
 
%
 
Six Months Ended
June 30,
 
%
 
 
2018 vs. 2017
 
 
2018 vs. 2017
 
Contingent Legal Fees:
 
 
 
 
 
 
 
 
(Decrease) increase in total revenues
 
$
(1,688
)
 
77
%
 
$
10,712

 
83
%
(Decrease) increase in contingent legal fee rates
 
(511
)
 
23
%
 
2,221

 
17
%
Total change in contingent legal fees expense
 
$
(2,199
)
 
100
%
 
$
12,933

 
100
%

 
 
Three Months Ended
June 30,
 
Change
 
Six Months Ended
June 30,
 
Change
 
 
2018
 
2017
 
$
 
%
 
2018
 
2017
 
$
 
%
 
 
(in thousands, except percentage change values)

Litigation and licensing expenses - patents
 
$
2,130

 
$
4,134

 
$
(2,004
)
 
(48
)%
 
$
4,875

 
$
10,520

 
$
(5,645
)
 
(54
)%
Amortization of patents
 
$
5,278

 
$
5,571

 
$
(293
)
 
(5
)%
 
$
10,608

 
$
11,086

 
$
(478
)
 
(4
)%
Impairment of patent-related intangible and other assets
 
$
29,210

 
$
—

 
$
29,210

 
100
 %
 
$
29,210

 
$
—

 
$
29,210

 
100
 %

Litigation and Licensing Expenses - Patents.  Litigation and licensing expenses-patents decreased for the periods presented due to a net decrease in litigation support, patent prosecution and litigation expenses associated with ongoing licensing and enforcement programs and a continued overall decrease in portfolio related enforcement activities. We expect patent-related legal expenses to continue to decrease in relation to the applicable comparable prior periods based upon the overall decrease in portfolio related enforcement activities as we continue monetizing our existing patent assets. Refer to “Investments in Patent Portfolios” above for additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current and future licensing and enforcement related revenues.

Impairment of Patent-Related Intangible Assets. During the three months ended June 30, 2018, Acacia recorded impairment of patent-related intangible asset charges of $28.2 million. The impairment charges were realized in the period due to a reduction in expected estimated future net cash flows for certain patents due to second quarter 2018 developments in the ongoing litigation. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of June 30, 2018. Assumptions utilized in the cash flow analysis included margins on estimated net proceeds ranging from 53% to 86% and a discount for the time value of money of zero percent, due to the relatively short time-frame associated with estimated cash flows.










27



Operating Expenses (in thousands, except percentage change values)
 
 
Three Months Ended
June 30,
 
Change
 
Six Months Ended
June 30,
 
Change
 
 
2018
 
2017
 
$
 
%
 
2018
 
2017
 
$
 
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General and administrative expenses
 
$
5,892

 
$
5,247

 
$
645

 
12
 %
 
$
10,295

 
$
10,035

 
$
260

 
3
 %
Non-cash stock compensation expense - G&A
 
521

 
1,449

 
(928
)
 
(64
)%
 
1,225

 
3,561

 
(2,336
)
 
(66
)%
Non-cash stock compensation expense - Profits Interests
 
$
685

 
$
38

 
$
647

 
>100%

 
$
(1,043
)
 
$
54

 
$
(1,097
)
 
>100%

Total general and administrative expenses
 
$
7,098

 
$
6,734

 
$
364

 
5
 %
 
$
10,477

 
$
13,650

 
$
(3,173
)
 
(23
)%

General and Administrative Expenses.  A summary of the main drivers of the change in general and administrative expenses for the periods presented, is as follows (in thousands, except percentage values):
 
Three Months Ended
June 30,
 
 
 
Six Months Ended
June 30,
 
 
 
2018 vs. 2017
 
%
 
2018 vs. 2017
 
%
 
 
 
 
Personnel cost reductions due to headcount reductions
$
(135
)
 
(37
)%
 
$
(719
)
 
23
 %
Variable performance-based compensation costs
(129
)
 
(35
)%
 
582

 
(18
)%
Corporate, general and administrative costs
1,967

 
540
 %
 
1,792

 
(56
)%
Non-cash stock compensation expense
(282
)
 
(77
)%
 
(3,434
)
 
108
 %
Non-recurring employee severance costs
(1,057
)
 
(291
)%
 
(1,394
)
 
43
 %
Total change in general and administrative expenses
$
364

 
100
 %
 
$
(3,173
)
 
100
 %

The decrease in non-cash stock compensation expense - G&A for the periods presented was primarily due to inclusion in the prior period of expenses related to the August 2016 grant of options with market-based vesting conditions with graded vesting features, resulting in higher non-cash stock compensation expense during the earlier stages of the applicable service period. The fluctuation in our Profits Interests related non-cash stock compensation expense was due to a fluctuations in the estimated fair value of our Profits Interests, as a result of the changes in Veritone's stock price during the reporting periods. Profits Interests are classified as liability awards, which are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled, with changes in fair value reflected in the statement of operations each period.
    
Other Operating Income (Expense)

Change in Fair Value of Investment, net. Acacia’s investment in Veritone is recorded at fair value, and marked to market at each balance sheet date, with changes in fair value, primarily based on changes in Veritone's stock price, reflected in the statement of operations each period. Results for the three months ended June 30, 2018 included an unrealized gain on our investment in Veritone totaling $11.3 million. Results for the six months ended June 30, 2018 included an unrealized loss on our investment in Veritone totaling $29.8 million.

Results for the three and six months ended June 30, 2017 included a net unrealized loss totaling $5.4 million, comprised of an unrealized gain on conversion of our Veritone loans to equity of $2.7 million, an unrealized gain on the exercise of our Primary Warrant of $4.6 million and an unrealized loss related to the application of the fair value method of accounting as of June 30, 2017 of $12.7 million. At June 30, 2018, the cumulative net unrealized gain (since the IPO) on our Veritone investment was $19.8 million.







28


Income Taxes
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
Provision for income taxes (in thousands)
$
(285
)
 
$
(1,478
)
 
$
(476
)
 
$
(2,719
)
Effective tax rate
(1
)%
 
(12
)%
 
(1
)%
 
(11
)%
    
Tax expense for the periods presented primarily reflects the impact of state taxes and foreign withholding taxes incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.


Liquidity and Capital Resources

General

Our primary sources of liquidity are cash and cash equivalents on hand generated from our operating activities. Our management believes that our cash and cash equivalent balances and anticipated cash flows from operations will be sufficient to meet our cash requirements through at least August 2019 and for the foreseeable future. We may, however, encounter unforeseen difficulties that may deplete our capital resources more rapidly than anticipated, including those set forth in our Annual Report on Form 10-K for the year ended December 31, 2017. Any efforts to seek additional funding could be made through issuances of equity or debt, or other external financing.  However, additional funding may not be available on favorable terms, or at all. The capital and credit markets have experienced extreme volatility and disruption periodically and such volatility and disruption may occur in the future. If we fail to obtain additional financing when needed, we may not be able to execute our business plans and our business, conducted by our operating subsidiaries, may suffer.

Certain of our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of our operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions.  In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material.

Cash, Cash Equivalents and Investments

Our consolidated cash and cash equivalents and investments on hand totaled $134.8 million at June 30, 2018, compared to $136.6 million at December 31, 2017.  The net change in cash and cash equivalents for the periods presented was comprised of the following (in thousands):
 
Six Months Ended
June 30,
 
2018
 
2017
 
 
 
 
Net cash provided by (used in):
 
 
 
Operating activities
$
9,631

 
$
(5,327
)
Investing activities
(41,495
)
 
(71,119
)
Financing activities
(4,590
)
 
614


Cash Flows from Operating Activities.  Cash receipts from licensees for the six months ended June 30, 2018 increased 83% to $67.8 million, as compared to $37.1 million in the comparable 2017 period, due to an increase in revenues and the net impact of the timing of cash receipts from licensees. Cash outflows from operations for the six months ended June 30, 2018 increased 37% to $58.1 million, as compared to $42.4 million in the comparable 2017 period, primarily due to the net impact of the timing of related payments of inventor royalties and contingent legal fees and the timing of payments to other third-parties in the ordinary course, for the same periods. Refer to “Working Capital” below for additional information.


29


Cash Flows from Investing Activities. Cash flows from investing activities and related changes were comprised of the following for the periods presented (in thousands):
 
Six Months Ended
June 30,
 
2018
 
2017
 
 
 
 
Investments in Investees
$
(7,000
)
 
$
(31,514
)
Advances to Investee
—

 
(4,000
)
Available-for-sale investments, net (cash management activities)
(34,495
)
 
(35,605
)
Net cash used in investing activities
$
(41,495
)
 
$
(71,119
)
•
    Partnership with Miso Robotics, Inc. In June 2017, we partnered with Miso Robotics, an innovative leader in robotics and AI solutions, which included an equity investment totaling $2.25 million, as part of Miso Robotics’ closing of $3.1 million in Series A funding. In addition, in February 2018, we made an additional strategic equity investment totaling $6.0 million in the Series B financing round for Miso Robotics, increasing our fully diluted ownership interest to approximately 30% as of June 30, 2018.
        
•
    Investment in Veritone. On March 14, 2017, we entered into an additional secured convertible promissory note with Veritone, or the Veritone Bridge Loan, which permitted Veritone to borrow up to an additional $4.0 million, bearing interest at the rate of 8.0% per annum. On March 17, 2017, we funded the initial $1.0 million advance, or the First Bridge Loan. On April 14, 2017, we funded the second $1.0 million advance, or the Second Bridge Loan. All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, we elected to make an additional advance to Veritone totaling $2.0 million, representing all principal amounts not advanced upon Veritone’s consummation of its IPO. Upon consummation of Veritone’s IPO, the outstanding principal balance and accrued interest under the Veritone Bridge Loan, totaling $4.0 million, automatically converted into 295,440 shares of Veritone’s common stock based on a conversion price of $13.6088 per share.

Cash Flows from Financing Activities - Repurchases of Common Stock. In February 2018, our Board of Directors authorized the repurchase of up to $20,000,000 of our outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by our Board of Directors at its discretion (the “Stock Repurchase Program”). In determining whether or not to repurchase any shares of our common stock, our Board of Directors considers such factors as the impact of the repurchase on our cash position, as well as our capital needs and whether there is a better alternative use of our capital. We have no obligation to repurchase any amount of our common stock under the Stock Repurchase Program. Repurchases to date were made in the open market in compliance with applicable Securities and Exchange Commission rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding share count and enhance stockholder value. Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were as follows:
 
Total Number of Shares Purchased
Average Price paid per Share
Approximate Dollar Value of
Shares that May Yet be
Purchased under the Program
Plan Expiration
 
 
 
 
 
May 1, 2018- May 30, 2018
1,190,420

$
3.89

$
15,366,000

February 28, 2019
Totals for 2018
1,190,420

$
3.89

 
 

Working Capital

Working capital at June 30, 2018 increased to $130.4 million, compared to $130.1 million at December 31, 2017. Consolidated accounts receivable from licensees increased to $5.6 million at June 30, 2018, compared to $153,000 at December 31, 2017. Consolidated royalties and contingent legal fees payable increased to $4.8 million at June 30, 2018, compared to $1.6 million at December 31, 2017.  


30


The majority of royalties and contingent legal fees payable are scheduled to be paid in the third and fourth quarter of 2018, subsequent to receipt by us of the related fee payments from licensees, in accordance with the underlying contractual arrangements.


Off-Balance Sheet Arrangements

Except as set forth below, we have not entered into off-balance sheet financing arrangements.  We have no long-term debt. The following table lists our known contractual obligations and future cash commitments as of June 30, 2018 (in thousands): 
 
Payments Due by Period (In thousands)
Contractual Obligations
Total
 
Less than 1 year
 
1-3 years
 
3-5 years
 
 
 
 
 
 
 
 
Operating leases, net of guaranteed sublease income
$
1,936

 
$
552

 
$
1,384

 
$
—

Severance related payments
$
2,211

 
$
2,211

 
$
—

 
$
—

Total
$
4,147

 
$
2,763

 
$
1,384

 
$
—



Recent Accounting Pronouncements

Refer to Note 8 to the condensed consolidated financial statements included in this report.


Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The primary objective of our short-term investment activities is to preserve principal while concurrently maximizing the income we receive from our short-term investments without significantly increasing risk. Some of the securities that we invest in may be subject to interest rate risk and/or market risk. This means that a change in prevailing interest rates, with respect to interest rate risk, or a change in the value of the United States equity markets, with respect to market risk, may cause the principal amount or market value of the short-term investments to fluctuate. For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the prevailing interest rate later rises, the current value of the principal amount of our investment may decline. To minimize these risks in the future, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, high-grade corporate bonds, government and non-government debt securities and certificates of deposit.

During the applicable periods presented, short-term investments were comprised of AAA rated money market funds that invest in first-tier only securities, which primarily include domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements (included in cash and cash equivalents in the accompanying consolidated balance sheets), and direct investments in highly liquid, AAA, U.S. government securities (included in short-term investments in the accompanying consolidated balance sheets). In general, money market funds are not subject to market risk because the interest paid on such funds fluctuates with the prevailing interest rate. Accordingly, a 100 basis point increase in interest rates or a 10% decline in the value of the United States equity markets would not be expected to have a material impact on the value of such money market funds. Investments in U.S. government fixed income securities are subject to interest rate risk and will decline in value if interest rates increase. However, due to the relatively short duration of our short-term investment portfolio, an immediate 10% change in interest rates would have no material impact on our financial condition, results of operations or cash flows. Declines in interest rates over time will, however, reduce our interest income.

Investment Risk. We are exposed to investment risks related to changes in the underlying financial condition of certain of our partnerships with high-growth and potentially disruptive technology companies, and our related equity investments in these companies. The fair value of these investments can be significantly impacted by the risk of adverse changes in securities markets generally, as well as risks related to the performance of the companies whose securities we have invested in, risks associated with specific industries, and other factors. These investments are subject to significant fluctuations in fair value due to the volatility of the securities markets and of the underlying businesses. As of June 30, 2018, the carrying value of our common stock and warrants in public and private companies was $83.2 million. We record our common stock and warrant investments in publicly traded companies at fair value, which is subject to market price volatility, and represents $75.0 million

31


of our non-current investments as of June 30, 2018. A hypothetical 10% adverse change in the market price of Veritone's publicly traded common stock would have resulted in a decrease of approximately $7.9 million in the fair value of our equity and equity warrant investments in Veritone. We evaluate our equity and equity warrant investments in private companies for impairment when events and circumstances indicate that the decline in fair value of such assets below the carrying value is other-than temporary. Our analysis includes a review of recent operating results and trends, recent sales/acquisitions of the investee securities, and other publicly available data. The current global economic climate provides additional uncertainty. Valuations of private companies are inherently more complex due to the lack of readily available market data. As such, we believe that market sensitivities are not practicable for our private company equity investments.


Item 4.  CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures. Our management, with the participation and under the supervision of our president and chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended, or the Exchange Act) as of the end of the period covered by this quarterly report.
Based on that evaluation, our president and our chief financial officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure, and that such information is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter (the quarter ended June 30, 2018) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls. Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.


32


PART II--OTHER INFORMATION

Item 6.  EXHIBITS
___________________________
#
Filed herewith.
**
The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any of the Registrant’s filings under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in any such filing.


33


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 
ACACIA RESEARCH CORPORATION
 
 
 
/s/  Robert Stewart
 
By: Robert Stewart
 
President
 
(Principal Executive Officer and Duly Authorized Signatory)
 
 
 
/s/  Clayton J. Haynes  
 
By: Clayton J. Haynes
 
Chief Financial Officer and Treasurer
 
(Principal Financial and Accounting Officer)
 

Date:     August 9, 2018


34


EXHIBIT INDEX
                   
EXHIBIT
NUMBER
EXHIBIT
31.1#
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2#
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
32.1**#
Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
32.2**#
Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
101#
Interactive Data Files Pursuant to Rule 405 of Regulation S-T.
___________________________
#
Filed herewith.
**
The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any of the Registrant’s filings under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in any such filing.




35
 EX-31.1 2 ex31106302018.htm EXHIBIT 31.1 Exhibit



EXHIBIT 31.1
 
CERTIFICATION
 
I, Robert Stewart, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Acacia Research Corporation;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


August 9, 2018
 
/s/ Robert Stewart
 
 
Robert Stewart
President
 
 




 EX-31.2 3 ex31206302018.htm EXHIBIT 31.2 Exhibit


EXHIBIT 31.2
 
CERTIFICATION
 
I, Clayton J. Haynes, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Acacia Research Corporation;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


August 9, 2018
/s/ Clayton J. Haynes
 
 
Clayton J. Haynes
Chief Financial Officer and Treasurer
 




 EX-32.1 4 ex32106302018.htm EXHIBIT 32.1 Exhibit


 
EXHIBIT 32.1
CERTIFICATION
 
In connection with the Quarterly Report of Acacia Research Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2018, as filed with the Securities and Exchange Commission on August 9, 2018 (the “Report”), I, Robert Stewart, President of the Company, hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that:
 
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 780(d)); and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
By: /s/ Robert Stewart                                      
Robert Stewart
President
 
August 9, 2018
 
 
 


This certification accompanies the Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.  This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.




 EX-32.2 5 ex32206302018.htm EXHIBIT 32.2 Exhibit



EXHIBIT 32.2
 
CERTIFICATION
 
In connection with the Quarterly Report of Acacia Research Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2018, as filed with the Securities and Exchange Commission on August 9, 2018 (the “Report”), I, Clayton J. Haynes, Chief Financial Officer of the Company, hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that:
 
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 780(d)); and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
By: /s/ Clayton J. Haynes                                    
Clayton J. Haynes
Chief Financial Officer and Treasurer
 
August 9, 2018
 
 
 


This certification accompanies the Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.  This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.



 EX-101.INS 6 actg-20180630.xml XBRL INSTANCE DOCUMENT 0000934549 2018-01-01 2018-06-30 0000934549 2017-01-01 2017-06-30 0000934549 2018-08-07 0000934549 2018-06-30 0000934549 2017-12-31 0000934549 2018-04-01 2018-06-30 0000934549 2017-04-01 2017-06-30 0000934549 2017-06-30 0000934549 2016-12-31 0000934549 2016-01-01 2016-12-31 0000934549 2015-01-01 2015-12-31 0000934549 2014-01-01 2014-12-31 0000934549 2017-01-01 2017-12-31 0000934549 2017-10-01 2017-12-31 0000934549 us-gaap:MaximumMember 2018-01-01 2018-06-30 0000934549 actg:Licensee2Member 2018-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2017-04-01 2017-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2018-04-01 2018-06-30 0000934549 us-gaap:MinimumMember 2018-01-01 2018-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2017-01-01 2017-06-30 0000934549 actg:Licensee1Member 2018-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2018-01-01 2018-06-30 0000934549 actg:Licensee1Member 2017-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2017-01-01 2017-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2018-04-01 2018-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2018-01-01 2018-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2018-04-01 2018-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2017-04-01 2017-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2017-01-01 2017-06-30 0000934549 us-gaap:MaximumMember 2017-04-01 2017-06-30 0000934549 us-gaap:MaximumMember 2017-01-01 2017-06-30 0000934549 us-gaap:MaximumMember 2018-04-01 2018-06-30 0000934549 actg:VeritoneMember 2018-03-31 0000934549 actg:VeritoneMember 2017-12-31 0000934549 2017-05-17 0000934549 2017-03-14 0000934549 us-gaap:MinimumMember actg:MonteCarloMember 2018-01-01 2018-06-30 0000934549 2016-08-15 0000934549 us-gaap:WarrantMember 2017-12-31 0000934549 actg:VeritoneMember 2018-01-01 2018-06-30 0000934549 us-gaap:MaximumMember actg:BlackScholesMember 2018-01-01 2018-06-30 0000934549 us-gaap:MinimumMember actg:BlackScholesMember 2018-01-01 2018-06-30 0000934549 actg:VeritoneLoansMember actg:VeritoneMember 2017-05-17 0000934549 us-gaap:CommonStockMember 2017-12-31 0000934549 us-gaap:CommonStockMember 2018-06-30 0000934549 actg:BlackScholesMember 2018-01-01 2018-06-30 0000934549 us-gaap:WarrantMember 2018-06-30 0000934549 actg:PrimarywarrantMember actg:VeritoneMember 2017-05-17 0000934549 us-gaap:BridgeLoanMember actg:VeritoneMember 2017-05-17 0000934549 actg:VeritoneMember 2018-01-01 2018-03-31 0000934549 actg:FinnertyWarrantsMember 2017-05-17 2017-05-17 0000934549 actg:FinnertyCommonStockMember 2017-01-01 2017-12-31 0000934549 actg:FinnertyWarrantsMember 2017-01-01 2017-12-31 0000934549 us-gaap:MinimumMember actg:FinnertyWarrantsMember 2017-01-01 2017-12-31 0000934549 actg:FinnertyCommonStockMember 2018-04-01 2018-06-30 0000934549 actg:FinnertyWarrantsMember 2018-04-01 2018-06-30 0000934549 actg:FinnertyCommonStockMember 2017-05-17 2017-05-17 0000934549 us-gaap:MaximumMember actg:FinnertyWarrantsMember 2017-01-01 2017-12-31 0000934549 us-gaap:MinimumMember actg:FinnertyWarrantsMember 2018-04-01 2018-06-30 0000934549 us-gaap:MaximumMember actg:FinnertyWarrantsMember 2018-04-01 2018-06-30 0000934549 2017-02-16 0000934549 actg:GeometricBrownianMotionMember 2018-01-01 2018-06-30 0000934549 us-gaap:MaximumMember actg:GeometricBrownianMotionMember 2018-01-01 2018-06-30 0000934549 actg:VeritoneMember 2018-06-30 0000934549 actg:FinnertyProfitsInterestsMember 2018-01-01 2018-06-30 0000934549 us-gaap:MinimumMember actg:GeometricBrownianMotionMember 2018-01-01 2018-06-30 0000934549 us-gaap:NewAccountingPronouncementMember 2018-01-01 0000934549 2018-01-01 0000934549 us-gaap:NewAccountingPronouncementMember 2018-06-30 0000934549 us-gaap:NewAccountingPronouncementMember 2018-04-01 2018-06-30 0000934549 actg:BalancebeforeadjustmentMember 2018-06-30 0000934549 actg:BalancebeforeadjustmentMember 2018-04-01 2018-06-30 iso4217:USD xbrli:shares actg:patent_portfolios xbrli:shares xbrli:pure iso4217:USD 809400 0.60 90000 157000 0.08 29300000 3236000 3863000 1037000 16682000 114000 16796000 19776000 1998000 722000 1 700000 2671000 2671000 0 0 -4616000 -4616000 0 0 5247000 10035000 5892000 10295000 -4481000 1436000 2250000 6000000 90795000 65827000 104754000 75004000 65827000 9177000 13959000 9177000 1.00 0.47 0.43 4134000 10520000 2130000 4875000 50000000 1449000 3561000 521000 1225000 38000 54000 685000 -1043000 6 3 2 1 382220000 421038000 61917000 23099000 0.226 0.30 0.2 433000 753000 327000 493000 14964000 22160000 3183000 63246000 1493000 3151000 3302000 5332000 1601000 4765000 3953000 812000 3329000 1728000 20000000 10000000 0.90 88558000 77728000 -4782000 -24968000 60000 1000000 2000000 50000000 25261000 false --12-31 Q2 2018 2018-06-30 10-Q 0000934549 49495064 Accelerated Filer ACACIA RESEARCH CORP 7956000 8855000 153000 5629000 3599000 2030000 4695000 4542000 630000 -88000 -202000 P2Y 648996000 650265000 5571000 11086000 5278000 10608000 4598443 4598443 4793037 4851737 6.75 6.75 6.75 6.75 308768000 88558000 77728000 250467000 139695000 83805000 71567000 143982000 4753000 6161000 34694000 34704000 1000 11000 4000000 4000000 139052000 63220000 136604000 100150000 -75832000 -36454000 0.001 0.001 100000000 100000000 50639926 49495064 50639926 49495064 2150335 1523746 295440 51000 49000 -14265000 -26068000 -28504000 -60579000 -14277000 -26371000 -28583000 -60731000 0.85 0.90 0.55 0.26 0.87 0.48 0.42 0.43 0.87 0.06 13.6088 11134000 10627000 -0.52 -810 -1.20 -0.28 -0.52 -0.57 -1.20 -0.12 0.11 -0.01 0.01 0.21 0.19 2195000 8195000 0 P6M P6M P2M P5M P2M P5M P9Y P10Y P2Y P3Y11M P3Y11M 0.35 0.35 0.87 0.72 0.37 1.10 0.66 0.00 0.5 0.60 0.4 0.60 0.0281 0.03 0.0252 0.02 0.06 0.06 0.05 0.10 0.15 0.10 0.05 0.07 0.30 0.75 0.25 P6Y P1Y 735000 15534000 817000 822000 1683000 3508000 23099000 6734000 13650000 7098000 10477000 3824000 0 0 0 29210000 29210000 29210000 -12786000 -23666000 -28221000 -60141000 -14000 -14000 0 0 1478000 2719000 285000 476000 -5054000 861000 -12505000 934000 1474000 571000 1100000 21000 4119521 1120432 13109000 27256000 26582000 16091000 308768000 250467000 9557000 27256000 26582000 13620000 0 0 16457000 25311000 6485000 66548000 2030000 68578000 20700000 1358000 1513000 1666000 308000 614000 -4590000 -71119000 -41495000 -5327000 9631000 -14252000 -26082000 -28427000 -60465000 -12000 -303000 -79000 -152000 -14252000 -26082000 -28427000 -60465000 -13049000 -4862000 -4166000 11615000 -29275000 24381000 44811000 46321000 99444000 17054000 -7924000 -19500000 -39836000 -30866000 207000 187000 -4000 9000 -87000 -104000 -9000 5000 10000 -10000 0 0 0 0 0 0 0 4000000 4000000 3552000 2471000 563000 1259000 268000 475000 -598000 -313000 183000 35000 7000 331412000 49895000 4000000 0 31514000 7000000 0.001 0.001 10000000 10000000 0 0 0 0 0 0 0 0 2938000 3509000 0 -4634000 295807000 15400000 649000 51000 -14264000 -26385000 -28506000 -60617000 0.53 0.09 -320018000 -377977000 -317512000 2506000 16457000 25311000 4388000 6485000 68578000 4273000 4939000 1241000 22287000 698000 22985000 2500000 3615000 182000 16.82 0 34694000 2019-02-28 20000000 15366000 294301000 61302000 51146000 232863000 295659000 234376000 0.06 3.89 1729408 2919828 1190420 34640000 39272000 -12698000 -12698000 11347000 -29750000 50416611 50499248 50416611 50061812 50345808 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of Revenues</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;Cost of revenues include the costs and expenses incurred in connection with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.&#160;&#160;These costs are included under the caption &#8220;Cost of revenues&#8221; in the accompanying condensed consolidated statements of operations. Cost of revenues for the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> included </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> of costs to acquire certain rights related to revenues recognized in the period.&#160;&#160;</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Investments. </font><font style="font-family:inherit;font-size:10pt;">Acacia reviews its investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements of operations and a new cost basis in the investment is established.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventor Royalties and Contingent Legal Expenses. </font><font style="font-family:inherit;font-size:10pt;">Inventor royalties are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized.&#160;&#160;In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia&#8217;s operating subsidiaries are recoverable from future net revenues.&#160;&#160;Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the condensed consolidated statements of operations.&#160;&#160;Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the condensed consolidated statements of operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventor royalty and contingent legal agreements typically provide for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments are received from licensees by the Company.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patents.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Patents include the cost of patents or patent rights (hereinafter, collectively &#8220;patents&#8221;) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">six years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</font><font style="font-family:inherit;font-size:10pt;">. Repurchases of the Company&#8217;s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Description of Business. </font><font style="font-family:inherit;font-size:10pt;">As used herein, &#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia&#8217;s operating subsidiaries invest in, license and enforce patented technologies. Acacia&#8217;s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia also identifies opportunities to partner with high-growth and potentially disruptive technology companies. These partnerships usually involve an equity or debt investment by Acacia, along with entering into intellectual property (&#8220;IP&#8221;) related agreements where Acacia provides IP and other patent related services to these companies. Acacia leverages its experience, expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement Acacia&#8217;s primary licensing and enforcement business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia&#8217;s operating subsidiaries generate revenues and related cash flows from the granting of IP rights for the use of patented technologies that its operating subsidiaries control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Acacia&#8217;s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#8217;s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, Acacia did not obtain control of any new patent portfolios. During fiscal year 2017 Acacia obtained control of </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> new patent portfolio. In fiscal year 2016, Acacia obtained control of </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> new patent portfolios, compared to </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> new patent portfolios, and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> new patent portfolios in fiscal years 2015 and 2014, respectively. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;The accompanying condensed consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&#160;&#160;Accordingly, certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly reporting requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC.&#160;&#160;The </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> condensed consolidated balance sheet was derived from audited financial statements but does not include all disclosures required by U.S. GAAP.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of Acacia&#8217;s consolidated financial position as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and results of its operations and its cash flows for the interim periods presented.&#160;&#160;The consolidated results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results to be expected for the entire fiscal year.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash and Cash Equivalents</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents.&#160;For the periods presented, Acacia&#8217;s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia&#8217;s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patent Enforcement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"> &#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Certain of Acacia&#8217;s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights.&#160;&#160;In connection with any of Acacia&#8217;s operating subsidiaries&#8217; patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions.&#160;&#160;In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney&#8217;s fees and/or expenses to a defendant(s), which could be material.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business.&#160;&#160;Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia&#8217;s condensed consolidated financial position, results of operations or cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">Two</font><font style="font-family:inherit;font-size:10pt;"> licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">48%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">42%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and one licensee accounted for </font><font style="font-family:inherit;font-size:10pt;">87%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. One licensee accounted for </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and two licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">55%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">26%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. For the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">43%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">6%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and six months ended June 30, 2017, </font><font style="font-family:inherit;font-size:10pt;">90%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">87%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations. Two licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">47%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">43%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. One licensee individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2017. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INVESTMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investment at Fair Value</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Veritone Investment Agreement. </font><font style="font-family:inherit;font-size:10pt;">On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (&#8220;Veritone&#8221;), which provided for Acacia to invest up to </font><font style="font-family:inherit;font-size:10pt;">$50 million</font><font style="font-family:inherit;font-size:10pt;"> in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the &#8220;Veritone Loans&#8221;), which permitted Veritone to borrow up to </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> through two </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> advances, each bearing interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">6.0%</font><font style="font-family:inherit;font-size:10pt;"> per annum (included in Other Income (Expense) in the condensed consolidated statements of operations). On August 15, 2016, Acacia funded the initial </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> loan (the &#8220;First Loan&#8221;).&#160;On November 25, 2016, Acacia funded the second </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> loan (the &#8220;Second Loan&#8221;). The First Loan and the Second Loan were due and payable on November 25, 2017. In conjunction with the First Loan and Second Loan, Veritone issued Acacia a total of three four-year </font><font style="font-family:inherit;font-size:10pt;">$700,000</font><font style="font-family:inherit;font-size:10pt;"> warrants to purchase shares of Veritone&#8217;s common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share. Upon Veritone&#8217;s consummation of its public offering of its common stock on May 17, 2017 (&#8220;IPO&#8221;), all outstanding principal and accrued interest under the Veritone Loans, totaling </font><font style="font-family:inherit;font-size:10pt;">$20.7 million</font><font style="font-family:inherit;font-size:10pt;">, automatically converted into </font><font style="font-family:inherit;font-size:10pt;">1,523,746</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone&#8217;s common stock based on a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, in August 2016, Veritone issued Acacia a five-year Primary Warrant to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;">, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone&#8217;s common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share.&#160;Pursuant to an amendment to the Primary Warrant effective March 15, 2017, the Primary Warrant was exercised automatically upon the consummation of Veritone&#8217;s IPO, resulting in the purchase by Acacia of an additional </font><font style="font-family:inherit;font-size:10pt;">2,150,335</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock, at an aggregate purchase price of </font><font style="font-family:inherit;font-size:10pt;">$29.3 million</font><font style="font-family:inherit;font-size:10pt;">. Immediately following Acacia&#8217;s exercise of the Primary Warrant in full, Veritone issued to Acacia an additional 10% Warrant that provides for the issuance of an additional </font><font style="font-family:inherit;font-size:10pt;">809,400</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock at an exercise price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share, with 50% of the shares underlying the 10% warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of the shares underlying the 10% warrant vesting on the first anniversary of the issuance date of the 10% Warrant.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Veritone Bridge Loan</font><font style="font-family:inherit;font-size:10pt;">. On March 14, 2017, Acacia entered into an additional secured convertible promissory note with Veritone (the &#8220;Veritone Bridge Loan&#8221;), which permitted Veritone to borrow up to an additional </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">, bearing interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">8.0%</font><font style="font-family:inherit;font-size:10pt;"> per annum. On March 17, 2017, Acacia funded the initial </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> advance (the &#8220;First Bridge Loan&#8221;). On April 14, 2017, Acacia funded the second </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> advance (the &#8220;Second Bridge Loan&#8221;). All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, Acacia elected to make an additional advance to Veritone totaling </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, representing all principal amounts not advanced upon Veritone&#8217;s consummation of its IPO. Upon consummation of Veritone&#8217;s IPO, the outstanding principal and accrued interest under the Veritone Bridge Loan of </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$21,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, automatically converted into </font><font style="font-family:inherit;font-size:10pt;">295,440</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone&#8217;s common stock at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$13.6088</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In conjunction with the Veritone Bridge Loan, Veritone issued to Acacia (i) </font><font style="font-family:inherit;font-size:10pt;">60,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock (&#8220;Upfront Shares&#8221;), (ii) </font><font style="font-family:inherit;font-size:10pt;">90,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock (the &#8220;Bridge Installment Shares&#8221;), and (iii) 10-year warrants to purchase up to </font><font style="font-family:inherit;font-size:10pt;">157,000</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock with other terms and conditions similar to the warrants described above.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All share amounts above have been adjusted to reflect a 0.6-for-1 reverse stock split of Veritone&#8217;s common stock, which was effected by Veritone in April 2017. The Veritone common shares and the common shares underlying the warrants are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. All of the Veritone common stock held by Acacia was unregistered as of the issue date and are unregistered as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Prior to Veritone IPO</font><font style="font-family:inherit;font-size:10pt;">. Prior to conversion, Acacia&#8217;s Investment Agreement and the Veritone Bridge Loan represented variable interests in Veritone for which Acacia was not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. In addition, the Veritone Loans and Veritone Bridge Loan (the &#8220;Loans&#8221;) were not considered in-substance common stock, the common stock purchase warrants were unexercised, and the right to receive the Upfront Shares and the Bridge Installment shares (&#8220;Veritone Shares&#8221;) were considered in-substance common stock, however, application of the equity method was not material, therefore, the equity method of accounting was not applied prior to the IPO. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to conversion, the Loans and the related common stock purchase warrants and Veritone Shares were accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the respective transactions, with the face amount of the loans allocated to (1) the Loans, which were accounted for as long-term loan receivables and (2) the common stock purchase warrants and Veritone Shares. The estimated relative fair value allocation was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone&#8217;s equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Loans. Assumptions used in connection with estimating the relative fair values included: (1) volatility ranging from </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">, (2) financing probabilities ranging from </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">75%</font><font style="font-family:inherit;font-size:10pt;">, (3) marketability discount of </font><font style="font-family:inherit;font-size:10pt;">7%</font><font style="font-family:inherit;font-size:10pt;"> and (4) </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> investment recovery assumption. The loan discount, representing the difference between the face amount of the Loans and the relative fair value allocated to the Loans, was accreted over the expected life of the Loans, using the effective interest method, with the related interest amounts reflected in other income (expense) in the condensed consolidated statements of operations. Interest income for the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">, including accretion of the loan discount of </font><font style="font-family:inherit;font-size:10pt;">$630,000</font><font style="font-family:inherit;font-size:10pt;">. The effective yield on the Loans for the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> ranged from </font><font style="font-family:inherit;font-size:10pt;">9%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">53%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Subsequent to Veritone IPO</font><font style="font-family:inherit;font-size:10pt;">. Upon Veritone&#8217;s consummation of its IPO on May 17, 2017, the Loans were converted into shares of Veritone common stock and the Primary Warrant was automatically exercised in full, as described above, resulting in a </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in Veritone (excluding warrants). Based on Acacia&#8217;s representation on the Veritone board of directors and Acacia&#8217;s </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in Veritone, Acacia management determined that the equity method of accounting was applicable. Upon becoming eligible for the equity method of accounting, Acacia elected to apply the fair value option to account for its equity investment in Veritone, including all of its investments in Veritone common stock and warrants, due to the availability of quoted prices in an active market for the Veritone common stock. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, Acacia&#8217;s ownership interest in Veritone, on a fully-diluted basis, was approximately </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia&#8217;s equity investment in Veritone common shares is recorded at fair value based on the quoted market price of Veritone&#8217;s common stock on The NASDAQ Global Market on the applicable valuation date, as adjusted for an estimated discount for lack of marketability (&#8220;DLOM&#8221;) associated with the restricted nature of the common shares acquired (Level 3 input). Acacia&#8217;s investment in Veritone warrants is recorded at fair value, as adjusted for an estimated DLOM, based on the Black-Scholes option-pricing model, utilizing the following assumptions at </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">: risk-free interest rates ranging from </font><font style="font-family:inherit;font-size:10pt;">2.52%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">2.81%</font><font style="font-family:inherit;font-size:10pt;">; expected terms ranging from </font><font style="font-family:inherit;font-size:10pt;">2 years</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">9 years</font><font style="font-family:inherit;font-size:10pt;">; volatility of </font><font style="font-family:inherit;font-size:10pt;">60%</font><font style="font-family:inherit;font-size:10pt;">; and a dividend yield of </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">. The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.3828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Veritone Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Veritone Warrants</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">IPO Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">IPO Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated DLOM applied</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility assumptions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term assumptions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 months</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the </font><font style="font-family:inherit;font-size:10pt;">4,119,521</font><font style="font-family:inherit;font-size:10pt;"> shares of Veritone common stock owned by Acacia totaled </font><font style="font-family:inherit;font-size:10pt;">$65,827,000</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the </font><font style="font-family:inherit;font-size:10pt;">1,120,432</font><font style="font-family:inherit;font-size:10pt;"> common stock purchase warrants held by Acacia totaled </font><font style="font-family:inherit;font-size:10pt;">$9,177,000</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the cumulative net unrealized gain (since the IPO) on our Veritone investment was </font><font style="font-family:inherit;font-size:10pt;">$19,776,000</font><font style="font-family:inherit;font-size:10pt;">. A 10% increase in the DLOM assumptions utilized at all applicable valuation dates would result in an approximate 11% decrease in the fair value of our investment in Veritone warrants at </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and a corresponding decrease in the net investment gain or loss reflected in the condensed consolidated statements of operations for the applicable period. Changes in the fair value of Acacia&#8217;s investment in Veritone are recorded as unrealized gains or losses in the condensed consolidated statements of operations.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:79.4921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,388</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss per share attributable to common stockholders - basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:84.375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,728</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,558</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholder's equity (deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities, preferred stock and stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,728</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,558</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Investment</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2017, Acacia made an investment in the Series A Preferred financing round for Miso Robotics, Inc. (&#8220;Miso Robotics&#8221;), an innovative leader in robotics and artificial intelligence solutions, totaling </font><font style="font-family:inherit;font-size:10pt;">$2,250,000</font><font style="font-family:inherit;font-size:10pt;">, acquiring a </font><font style="font-family:inherit;font-size:10pt;">22.6%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in Series A preferred stock of Miso Robotics, and one board seat. In February 2018, Acacia made an additional equity investment in the Series B Preferred financing round for Miso Robotics totaling </font><font style="font-family:inherit;font-size:10pt;">$6,000,000</font><font style="font-family:inherit;font-size:10pt;">, increasing its ownership interest (Series B preferred stock) in Miso Robotics to approximately </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">, and acquiring an additional board seat. In addition, in June 2017, Acacia also entered into an IP services agreement with Miso Robotics to help Miso Robotics drive AI-based solutions for the restaurant industry. Miso Robotics will use the funding to deliver an adaptable AI-driven robotic kitchen assistant that will work alongside kitchen staff to improve operational efficiency for the restaurant industry.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of February 2018, the preferred stock was not deemed to be in-substance common stock due to the substantive liquidation preference associated with the preferred stock. As such, as of February 2018, the cumulative investment in Miso Robotics is recorded at cost and assessed for any impairment at each balance sheet date. Prior to February 2018, the equity method of accounting was applied.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;LOSS PER SHARE</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company computes net loss attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company&#8217;s outstanding unvested restricted stock, are considered &#8220;participating securities.&#8221; The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted net loss per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended <br clear="none"/>June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended <br clear="none"/>June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders &#8211; basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,061,812</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,499,248</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,345,808</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,416,611</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.57</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,793,037</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,598,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,851,737</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,598,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maximum price of awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Investments</font><font style="font-family:inherit;font-size:10pt;">. Equity investments in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the condensed consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in preferred stock with substantive liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially all of the investee's losses, if any. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The initial determination of whether an investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence over the operating and financial policies of the investee.&#160;That determination is reconsidered if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest. Refer to Note 5 for additional information. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:79.4921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,388</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss per share attributable to common stockholders - basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:84.375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,728</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,558</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholder's equity (deficit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities, preferred stock and stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,728</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,558</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the activity for fair value measurements categorized within Level 3 for the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investment at Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Opening balance as of January 1, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total gains and losses included in earnings for the period</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,782</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,827</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,177</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements.</font><font style="font-family:inherit;font-size:10pt;"> U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(i)</font></div></td><td style="vertical-align:top;padding-left:42px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-42px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:&#160;&#160;Quoted prices in active markets for identical investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(ii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pricing Models with Significant Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:&#160;&#160;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(iii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3 </font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unobservable Inputs</font><font style="font-family:inherit;font-size:10pt;">:&#160;&#160;Significant unobservable inputs, including the entity&#8217;s own assumptions in determining the fair value of investments.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of June 30, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 5)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December&#160;31, 2017:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 5)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December 31, 2017, the Veritone common shares were subject to a lock-up agreement that expired on February 15, 2018 and measured at fair value using level 3 inputs. As of March 31, 2018, the Veritone common shares were not subject to a lock-up agreement and measured at fair value using level 1 inputs. At June 30, 2018, the Veritone common shares are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the activity for fair value measurements categorized within Level 3 for the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investment at Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Opening balance as of January 1, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total gains and losses included in earnings for the period</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,782</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,827</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,177</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:inherit;font-size:8pt;">All gains and losses included in earnings for the period presented relate to assets and liabilities held as of </font><font style="font-family:inherit;font-size:8pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:8pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments at Fair Value</font><font style="font-family:inherit;font-size:10pt;">. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PATENTS</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia&#8217;s only identifiable intangible assets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> are patents and patent rights. Patent-related accumulated amortization totaled </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$421,038,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$382,220,000</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. Acacia&#8217;s patents have remaining estimated economic useful lives ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">six years</font><font style="font-family:inherit;font-size:10pt;">. The weighted-average remaining estimated economic useful life of Acacia&#8217;s patents is approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two years</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the scheduled annual aggregate amortization expense as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:56.640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">For the years ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,534</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,508</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">735</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,099</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended June 30, 2018, Acacia recorded impairment of patent-related intangible asset charges of </font><font style="font-family:inherit;font-size:10pt;">$28,210,000</font><font style="font-family:inherit;font-size:10pt;">. The impairment charges were realized in the period due to a reduction in expected estimated future net cash flows for certain patents due to second quarter 2018 developments in the ongoing litigation. The impairment charges consisted of the excess of the asset&#8217;s carrying value over its estimated fair value as of June 30, 2018. Assumptions utilized in the cash flow analysis included margins on estimated net proceeds ranging from 53% to 86% and a discount for the time value of money of zero percent, due to the relatively short time-frame associated with estimated cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-lived Assets.</font><font style="font-family:inherit;font-size:10pt;"> Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset&#8217;s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value is generally estimated using the &#8220;Income Approach,&#8221; focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes.&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia&#8217;s condensed consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for income taxes for interim periods is determined using an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative adjustment is recorded.&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s effective tax rates were (</font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;">) and (</font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;">) for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively and (</font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;">) and (</font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">) for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. Tax expense for the periods presented primarily reflects the impact of state taxes and foreign withholding taxes incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of the changes were effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (&#8220;IRS&#8221;), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately </font><font style="font-family:inherit;font-size:10pt;">$25,261,000</font><font style="font-family:inherit;font-size:10pt;"> in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets for the periods presented herein, the change in tax law did not have a material impact on our condensed consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term Investments.&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia&#8217;s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders&#8217; equity until realized.&#160;Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method.&#160;Interest is included in other income (expense).</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term marketable securities for the periods presented were comprised of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Security Type</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 30, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government fixed income securities (Maturity dates in 2018)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term marketable securities for the periods presented were comprised of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Security Type</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 30, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government fixed income securities (Maturity dates in 2018)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements - Recently Adopted. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company is required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under previous guidance, as described in Note 2. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity&#8217;s IP as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity&#8217;s performance of providing access to its IP as the performance occurs, and (ii) an entity&#8217;s promise to provide a customer with the right to use its IP is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is&#160;probable&#160;that a significant reversal in the amount of cumulative&#160;revenue&#160;recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company used the modified retrospective method of adoption and recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings on January 1, 2018. Comparative prior year periods were not adjusted. The new accounting standard was applied to all contracts at the date of initial application. The cumulative effect of applying the new revenue standard, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods, was as follows (in thousands): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.453125%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at January 1, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,542</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties and contingent legal fees payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,601</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated deficit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(320,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,506</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(317,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">308</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact of the adoption of the new accounting standard on the consolidated balance sheet and statement of operations was as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.9921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance as Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at January 1, 2018 Prior to Adoption</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effect of Change</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties and contingent legal fees payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">812</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Statements of Operations:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,578</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,985</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,682</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017. The adoption of this standard did not have a material impact on the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements - Not Yet Adopted. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures and expects to adopt the new standard effective January 1, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition. </font><font style="font-family:inherit;font-size:10pt;">Revenue is recognized upon transfer of control of promised bundled IP rights (hereinafter &#8220;IP Rights&#8221;) and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have been met.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods presented, revenue contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia (&#8220;Paid-up Revenue Agreements&#8221;).&#160;Revenues also included license fees from sales-based revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). IP Rights granted included the following, as applicable:&#160;&#160;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&#160;The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer IP Rights in the contract. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since the promised IP Rights are not individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were &#8220;functional IP rights&#8221; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support or services.&#160;&#160;The contracts provide for the grant (i.e. transfer of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract.&#160;Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectibility is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For sales-based royalties, the Company includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is&#160;probable&#160;that a significant reversal in the amount of cumulative&#160;revenue&#160;recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue&#160;is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the&#160;performance obligation&#160;to which some or all of the sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from contracts with significant financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In general, the Company is required to make certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues were comprised of the following for the periods presented (in thousands):</font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.3984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended <br clear="none"/>June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended <br clear="none"/>June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Paid-up Revenue Agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,183</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,964</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,246</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,160</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recurring Revenue Agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,493</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,151</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,485</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,457</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,578</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,311</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refer to &#8220;Inventor Royalties and Contingent Legal Expenses&#8221; below for information on related direct costs of revenues.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.3828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Veritone Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Veritone Warrants</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">IPO Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">IPO Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated DLOM applied</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.05</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility assumptions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term assumptions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 months</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted net loss per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended <br clear="none"/>June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended <br clear="none"/>June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders &#8211; basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,061,812</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,499,248</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,345,808</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,416,611</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.57</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,793,037</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,598,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,851,737</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,598,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maximum price of awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of June 30, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 5)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December&#160;31, 2017:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 5)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The cumulative effect of applying the new revenue standard, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods, was as follows (in thousands): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.453125%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at January 1, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,542</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties and contingent legal fees payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,601</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,329</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated deficit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(320,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,506</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(317,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">308</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact of the adoption of the new accounting standard on the consolidated balance sheet and statement of operations was as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.9921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance as Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at January 1, 2018 Prior to Adoption</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effect of Change</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties and contingent legal fees payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">812</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Statements of Operations:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,578</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,985</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,682</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Board Composition</font><font style="font-family:inherit;font-size:10pt;">. On August 8, 2018, the Company announced that Joseph E. Davis, Fred A. deBoom and James F. Sanders have resigned from the Board, effective immediately. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Personnel</font><font style="font-family:inherit;font-size:10pt;">. On August 8, 2018, the Company announced that Robert B. Stewart Jr., President, Edward J. Treska, Executive Vice President, General Counsel and Clayton J. Haynes, Chief Financial Officer, SVP Finance, Treasurer, are transitioning out of their roles at Acacia effective August 10, 2018, pursuant to a board approved transition arrangement. Mr. Treska and Mr. Haynes have agreed to provide consulting services to the Company to aid in the transition of their duties subsequent to August 10, 2018. Severance payments related to the personnel changes described above total </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.0703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Number of Shares Purchased</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Price paid per Share</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Approximate&#160;Dollar&#160;Value&#160;of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Shares that&#160;May&#160;Yet&#160;be</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Purchased&#160;under&#160;the&#160;Program</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plan Expiration</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 1, 2018- May 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190,420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.89</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,366,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Totals for 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the scheduled annual aggregate amortization expense as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:56.640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">For the years ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,534</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,508</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">735</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,099</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock-Based Compensation.</font><font style="font-family:inherit;font-size:10pt;"> The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. The Company accounts for forfeitures of awards as they occur. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Profits Interest Units (&#8220;Units&#8221;) are accounted for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221; The Units vest as described at Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying condensed consolidated statements of operations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition. </font><font style="font-family:inherit;font-size:10pt;">Revenue is recognized upon transfer of control of promised bundled IP rights (hereinafter &#8220;IP Rights&#8221;) and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have been met.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods presented, revenue contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia (&#8220;Paid-up Revenue Agreements&#8221;).&#160;Revenues also included license fees from sales-based revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). IP Rights granted included the following, as applicable:&#160;&#160;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&#160;The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer IP Rights in the contract. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since the promised IP Rights are not individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were &#8220;functional IP rights&#8221; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support or services.&#160;&#160;The contracts provide for the grant (i.e. transfer of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract.&#160;Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectibility is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For sales-based royalties, the Company includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is&#160;probable&#160;that a significant reversal in the amount of cumulative&#160;revenue&#160;recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue&#160;is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the&#160;performance obligation&#160;to which some or all of the sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from contracts with significant financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In general, the Company is required to make certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues were comprised of the following for the periods presented (in thousands):</font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.3984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended <br clear="none"/>June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended <br clear="none"/>June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Paid-up Revenue Agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,183</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,964</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,246</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,160</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recurring Revenue Agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,493</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,151</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,485</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,457</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,578</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,311</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refer to &#8220;Inventor Royalties and Contingent Legal Expenses&#8221; below for information on related direct costs of revenues.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of Revenues</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;Cost of revenues include the costs and expenses incurred in connection with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.&#160;&#160;These costs are included under the caption &#8220;Cost of revenues&#8221; in the accompanying condensed consolidated statements of operations. Cost of revenues for the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> included </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> of costs to acquire certain rights related to revenues recognized in the period.&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventor Royalties and Contingent Legal Expenses. </font><font style="font-family:inherit;font-size:10pt;">Inventor royalties are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized.&#160;&#160;In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia&#8217;s operating subsidiaries are recoverable from future net revenues.&#160;&#160;Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the condensed consolidated statements of operations.&#160;&#160;Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the condensed consolidated statements of operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventor royalty and contingent legal agreements typically provide for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments are received from licensees by the Company.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of equity instruments, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">Two</font><font style="font-family:inherit;font-size:10pt;"> licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">48%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">42%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and one licensee accounted for </font><font style="font-family:inherit;font-size:10pt;">87%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. One licensee accounted for </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and two licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">55%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">26%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. For the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">43%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">6%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and six months ended June 30, 2017, </font><font style="font-family:inherit;font-size:10pt;">90%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">87%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations. Two licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">47%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">43%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. One licensee individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2017. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements.</font><font style="font-family:inherit;font-size:10pt;"> U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(i)</font></div></td><td style="vertical-align:top;padding-left:42px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-42px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:&#160;&#160;Quoted prices in active markets for identical investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(ii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font><font style="font-family:inherit;font-size:10pt;"> - </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pricing Models with Significant Observable Inputs</font><font style="font-family:inherit;font-size:10pt;">:&#160;&#160;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(iii)</font></div></td><td style="vertical-align:top;padding-left:96px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-96px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3 </font><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unobservable Inputs</font><font style="font-family:inherit;font-size:10pt;">:&#160;&#160;Significant unobservable inputs, including the entity&#8217;s own assumptions in determining the fair value of investments.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of June 30, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 5)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets as of December&#160;31, 2017:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment at fair value (Note 5)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December 31, 2017, the Veritone common shares were subject to a lock-up agreement that expired on February 15, 2018 and measured at fair value using level 3 inputs. As of March 31, 2018, the Veritone common shares were not subject to a lock-up agreement and measured at fair value using level 1 inputs. At June 30, 2018, the Veritone common shares are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the activity for fair value measurements categorized within Level 3 for the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investment at Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Opening balance as of January 1, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,754</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total gains and losses included in earnings for the period</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of investment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,782</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total recurring fair value measurements</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,827</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,177</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">____________________</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) </sup></font><font style="font-family:inherit;font-size:8pt;">All gains and losses included in earnings for the period presented relate to assets and liabilities held as of </font><font style="font-family:inherit;font-size:8pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:8pt;">.</font></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock-Based Compensation.</font><font style="font-family:inherit;font-size:10pt;"> The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. The Company accounts for forfeitures of awards as they occur. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Profits Interest Units (&#8220;Units&#8221;) are accounted for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221; The Units vest as described at Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying condensed consolidated statements of operations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</font><font style="font-family:inherit;font-size:10pt;">. Repurchases of the Company&#8217;s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash and Cash Equivalents</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents.&#160;For the periods presented, Acacia&#8217;s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia&#8217;s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term Investments.&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia&#8217;s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders&#8217; equity until realized.&#160;Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method.&#160;Interest is included in other income (expense).</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term marketable securities for the periods presented were comprised of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Security Type</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 30, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government fixed income securities (Maturity dates in 2018)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patents.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Patents include the cost of patents or patent rights (hereinafter, collectively &#8220;patents&#8221;) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">six years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments at Fair Value</font><font style="font-family:inherit;font-size:10pt;">. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Investments</font><font style="font-family:inherit;font-size:10pt;">. Equity investments in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the condensed consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in preferred stock with substantive liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially all of the investee's losses, if any. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The initial determination of whether an investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence over the operating and financial policies of the investee.&#160;That determination is reconsidered if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest. Refer to Note 5 for additional information. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Investments. </font><font style="font-family:inherit;font-size:10pt;">Acacia reviews its investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements of operations and a new cost basis in the investment is established.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-lived Assets.</font><font style="font-family:inherit;font-size:10pt;"> Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset&#8217;s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value is generally estimated using the &#8220;Income Approach,&#8221; focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes.&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia&#8217;s condensed consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for income taxes for interim periods is determined using an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative adjustment is recorded.&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s effective tax rates were (</font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;">) and (</font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;">) for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively and (</font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;">) and (</font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">) for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. Tax expense for the periods presented primarily reflects the impact of state taxes and foreign withholding taxes incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of the changes were effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (&#8220;IRS&#8221;), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately </font><font style="font-family:inherit;font-size:10pt;">$25,261,000</font><font style="font-family:inherit;font-size:10pt;"> in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets for the periods presented herein, the change in tax law did not have a material impact on our condensed consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCKHOLDERS&#8217; EQUITY</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Repurchases of Common Stock. </font><font style="font-family:inherit;font-size:10pt;">In February 2018, Acacia&#8217;s Board of Directors authorized the repurchase of up to&#160;</font><font style="font-family:inherit;font-size:10pt;">$20,000,000</font><font style="font-family:inherit;font-size:10pt;">&#160;of the Company&#8217;s outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion (the &#8220;Stock Repurchase Program&#8221;). In determining whether or not to repurchase any shares of Acacia&#8217;s common stock, Acacia&#8217;s Board of Directors consider such factors as the impact of the repurchase on Acacia&#8217;s cash position, as well as Acacia&#8217;s capital needs and whether there is a better alternative use of Acacia&#8217;s capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding share count and enhance stockholder value. The repurchase shares are expected to be retired. Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.0703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Number of Shares Purchased</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Price paid per Share</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Approximate&#160;Dollar&#160;Value&#160;of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Shares that&#160;May&#160;Yet&#160;be</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Purchased&#160;under&#160;the&#160;Program</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plan Expiration</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 1, 2018- May 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190,420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.89</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,366,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Totals for 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Profits Interest Plan.</font><font style="font-family:inherit;font-size:10pt;"> On February&#160;16, 2017, AIP Operation LLC, a Delaware limited liability company (&#8220;AIP&#8221;), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the&#160;&#8220;Plan&#8221;) that provides for the grant of membership interests in AIP to certain members of management and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each Unit granted pursuant to the Plan is intended to qualify as a &#8220;profits interest&#8221; for U.S. federal income tax purposes and will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership interests. The membership interests are represented by Units reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the&#160;&#8220;LLC Agreement&#8221;). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP&#8217;s achievement of certain performance milestones (one-third upon 150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia&#8217;s aggregate investment in Veritone), subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement. The Units were fully vested as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia owns </font><font style="font-family:inherit;font-size:10pt;">60%</font><font style="font-family:inherit;font-size:10pt;"> of the membership interests in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, AIP holds the Veritone 10% Warrant described at Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Profits interests totaling 400 Units, or 40% of the membership interests in AIP, were granted in February 2017 pursuant to the Plan, with an aggregate grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$722,000</font><font style="font-family:inherit;font-size:10pt;">. The fair value of the Units totaled </font><font style="font-family:inherit;font-size:10pt;">$1,998,000</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. Upon full vesting of the units in September 2017, all previously unrecognized compensation expense was immediately recognized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the Units is estimated utilizing a Geometric Brownian Motion model (&#8220;GBM&#8221;) which considers probable vesting dates and values for the applicable instruments (i.e. common stock and warrants related to Acacia&#8217;s Veritone investment described at Note </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">) underlying or associated with the Units. At the estimated end of the term of the underlying warrant (May 2022), the model estimates the total proceeds from the hypothetical exercise of the warrant and estimates the value of the Units by allocating the proceeds based on the waterfall described in the terms of the underlying agreement. The value of the Units on a marketable basis is the average allocation across all GBM simulation paths discounted to the applicable valuation date using the risk-free rate. This estimated value is adjusted for an estimate of a DLOM using the Finnerty model, based on a security specific volatility calculated by changing Veritone&#8217;s common stock price by 1% and measuring the corresponding change in the value of the Units. For the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, assumptions utilized in the GBM included a term of </font><font style="font-family:inherit;font-size:10pt;">3.9 years</font><font style="font-family:inherit;font-size:10pt;">, stock price of </font><font style="font-family:inherit;font-size:10pt;">$16.82</font><font style="font-family:inherit;font-size:10pt;">, volatility of </font><font style="font-family:inherit;font-size:10pt;">60%</font><font style="font-family:inherit;font-size:10pt;">, and risk free interest rates ranging from </font><font style="font-family:inherit;font-size:10pt;">2.33%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">2.85%</font><font style="font-family:inherit;font-size:10pt;"> for terms ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">10 years</font><font style="font-family:inherit;font-size:10pt;">. The estimated DLOM utilized was </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">, based on assumptions including a term of approximately </font><font style="font-family:inherit;font-size:10pt;">3.9 years</font><font style="font-family:inherit;font-size:10pt;"> and a volatility of </font><font style="font-family:inherit;font-size:10pt;">90%</font><font style="font-family:inherit;font-size:10pt;"> for Veritone&#8217;s common stock. Volatility was estimated based on the historical volatilities of a set of comparable public companies, adjusted for leverage, over a term matching the term of the underlying warrant asset, which was approximately </font><font style="font-family:inherit;font-size:10pt;">3.9 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of equity instruments, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</font></div></div> EX-101.SCH 7 actg-20180630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2116100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - Commitments and Contingencies Details (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Cash Flows Statement link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Description of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - Description of Business and Basis of Presentation Patent Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Income (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Income (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Income (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Investments Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Investments Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Investments (Notes) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Patents link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Patents (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Patents Future Amortization Expense for Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Patents (Tables) link:presentationLink link:calculationLink link:definitionLink 2126100 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 2426402 - Disclosure - Recent Accounting Pronouncements Details (Details) link:presentationLink link:calculationLink link:definitionLink 2326301 - Disclosure - Recent Accounting Pronouncements Details (Tables) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Stockholders' Equity Stockholders Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Stockholders' Equity stockholders equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2427402 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2127100 - Disclosure - Subsequent Events (Notes) link:presentationLink link:calculationLink link:definitionLink 2327301 - Disclosure - Subsequent Events (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Summary of Significant Accounting Policies Concentration Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2304302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - Summary of Significant Accounting Policies Types of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 actg-20180630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 actg-20180630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 actg-20180630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Investments, Debt and Equity Securities [Abstract] Cost and Equity Method Investments Disclosure [Text Block] Cost and Equity Method Investments Disclosure [Text Block] Investments [Abstract] Investment [Table] Investment [Table] Valuation Technique [Axis] Valuation Technique [Axis] Valuation Technique [Domain] Valuation Technique [Domain] Finnerty - Common Stock [Member] Finnerty - Common Stock [Member] Finnerty - Common Stock [Member] Monte Carlo [Member] Monte Carlo [Member] Monte Carlo [Member] Finnerty [Member] Finnerty - Profits Interests [Member] Finnerty - Profits Interests [Member] Black Scholes [Member] Black Scholes [Member] Black Scholes [Member] Finnerty - Warrants [Member] Finnerty - Warrants [Member] Finnerty - Warrants [Member] Contributing shares [Axis] Contributing shares [Axis] Contributing shares [Axis] Contributing shares [Domain] Contributing shares [Domain] [Domain] for Contributing shares [Axis] Veritone Loans [Member] Veritone Loans [Member] Veritone Loans [Member] Primary warrant [Member] Primary warrant [Member] Primary warrant [Member] Bridge Loan [Member] Bridge Loan [Member] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Major Types of Debt Securities [Domain] Veritone [Member] Veritone [Member] Veritone [Member] Common Stock [Member] Common Stock [Member] Warrant [Member] Warrant [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Investment [Line Items] Investment [Line Items] Investment in Miso Robotics Investment in Miso Robotics Investment in Miso Robotics Percentage of ownership, Miso Robotics Percentage of ownership, Miso Robotics Percentage of ownership, Miso Robotics Maximum Investment in Veritone Maximum Investment in Veritone Maximum Investment in Veritone Secured Convertible Promissory Note Secured Convertible Promissory Note Secured Convertible Promissory Note Secured Promissory Note Advance Secured Promissory Note Advance Secured Promissory Note Advance Time-sharing Transactions, Stated Interest Rate for Notes Receivable Time-sharing Transactions, Stated Interest Rate for Notes Receivable First Loan Warrant First Loan Warrant First Loan Warrant Debt Instrument, Convertible, Conversion Price Debt Instrument, Convertible, Conversion Price Loan receivable and accrued interest Long-term Investments and Receivables, Net Common stock, shares outstanding Common Stock, Shares, Outstanding Veritone Primary Warrant Veritone Primary Warrant Veritone Primary Warrant Cash paid for primary warrant exercise Cash paid for primary warrant exercise Cash paid for primary warrant exercise 10% Warrant 10% Warrant 10% Warrant Veritone Bridge Loan Bridge Loan Bridge loan stated interest rate Bridge loan stated interest rate Bridge loan stated interest rate Veritone Bridge Loan Advance 1 Veritone Bridge Loan Advance 1 Veritone Bridge Loan Advance 1 Veritone Bridge Loan Advance 3 and 4 Veritone Bridge Loan Advance 3 and 4 Veritone Bridge Loan Advance 3 and 4 Upfront Shares Upfront Shares Upfront Shares Bridge Installment Shares Bridge Installment Shares Bridge Installment Shares Bridge Warrant Share Bridge Warrant Share Bridge Warrant Share Fair Value Assumptions, Expected Volatility Rate Fair Value Assumptions, Expected Volatility Rate Fair Value Inputs, Probability of Default Fair Value Inputs, Probability of Default Fair Value Inputs, Discount for Lack of Marketability Fair Value Inputs, Discount for Lack of Marketability Fair value inputs recovery Fair value inputs recovery Fair value inputs recovery Interest Income, Other Interest Income, Other Accretion (Amortization) of Discounts and Premiums, Investments Accretion (Amortization) of Discounts and Premiums, Investments Investment Income, Interest Investment Income, Interest Receivable with Imputed Interest, Effective Yield (Interest Rate) Receivable with Imputed Interest, Effective Yield (Interest Rate) Percentage of ownership, Veritone Percentage of ownership, Veritone Percentage of ownership, Veritone Fair Value Assumptions, Risk Free Interest Rate Fair Value Assumptions, Risk Free Interest Rate Fair Value Assumptions, Expected Term Fair Value Assumptions, Expected Term Fair Value Assumptions, Expected Dividend Payments Fair Value Assumptions, Expected Dividend Payments Investment Owned, Balance, Shares Investment Owned, Balance, Shares Investments at fair value Investments at fair value Investments at fair value Revenues Revenues Gross Profit Gross Profit Operating Expenses Operating Expenses Other Operating Income (Expense), Net Other Operating Income (Expense), Net Net Income (Loss) Available to Common Stockholders, Diluted Net Income (Loss) Available to Common Stockholders, Diluted Earnings Per Share, Basic Earnings Per Share, Basic Assets, Current Assets, Current Noncurrent assets Assets, Noncurrent Total assets Assets Current liabilities Liabilities, Current Noncurrent liabilities Liabilities, Noncurrent Total liabilities Liabilities Preferred Stock, Value, Outstanding Preferred Stock, Value, Outstanding Stockholders' Equity Attributable to Parent Stockholders' Equity Attributable to Parent Total liabilities, preferred stock and stockholders' equity Total liabilities, preferred stock and stockholders' equity Total liabilities, preferred stock and stockholders' equity Equity Method Investment, Ownership Percentage Equity Method Investment, Ownership Percentage Cumulative Unrealized Gain (Loss) Since Inception Cumulative Unrealized Gain (Loss) Since Inception Cumulative Unrealized Gain (Loss) Since Inception Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Consolidated Statements of Comprehensive Income [Abstract] Consolidated Statements of Comprehensive Income [Abstract] Statement [Table] Statement [Table] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax Subsequent Events [Abstract] Severance Costs Severance Costs Statement of Comprehensive Income [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Net income (loss) including noncontrolling interests in operating subsidiaries Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Unrealized gain (loss) on short-term investments, net of tax of $0 Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Unrealized gain (loss) on foreign currency translation, net of tax of $0 Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Total other comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss) Attributable to Noncontrolling Interest Net Income (Loss) Attributable to Noncontrolling Interest Comprehensive loss attributable to Acacia Research Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Reported Value Measurement [Member] Reported Value Measurement [Member] Adjustments for New Accounting Pronouncement [Member] Adjustments for New Accounting Pronouncement [Member] Balance before adjustment [Member] Balance before adjustment [Member] Balance before adjustment [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Accounts Receivable, Net, Current Accounts Receivable, Net, Current Royalties and contingent legal fees payable Royalties and contingent legal fees payable Royalties and contingent legal fees payable Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit) Stockholders' Equity Attributable to Noncontrolling Interest Stockholders' Equity Attributable to Noncontrolling Interest Licenses Revenue Licenses Revenue Royalty Expense Royalty Expense Contingent legal fees Contingent legal fees Contingent legal fees paid or payable to external counsel. Subsequent Events [Text Block] Schedule of Subsequent Events [Table Text Block] Income Statement [Abstract] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Statement, Scenario [Axis] Revenues Operating costs and expenses: Operating Costs and Expenses [Abstract] Operating costs and expenses Cost of Revenue [Abstract] Inventor royalties Other Cost of Operating Revenue Other Cost of Operating Revenue Litigation and licensing expenses - patents Litigation and licensing expenses - patents Expenses incurred directly related to litigation and licensing of patents. Amortization of patents Amortization of Intangible Assets General and administrative expenses(1) General and Administrative Expense Other expenses - business development Research, consulting and other expenses - business development Expenses incurred directly related to business development research, consulting and other expenses. Impairment of Intangible Assets (Excluding Goodwill) Impairment of Intangible Assets (Excluding Goodwill) Total operating costs and expenses Operating Costs and Expenses Operating loss Operating Income (Loss) Gain on Conversion of Loan and Accrued Interest Gain on Conversion of Loan and Accrued Interest Gain on Conversion of Loan and Accrued Interest Gain on exercise of warrant Gain on exercise of Primary Warrant Gain on exercise of Primary Warrant Change in fair value of investment, net Unrealized Gain (Loss) on Investments Income (Loss) from Equity Method Investments Income (Loss) from Equity Method Investments Interest income and other Other Nonoperating Income (Expense) Total other income (expense) Nonoperating Income (Expense) Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Provision for income taxes Income Tax Expense (Benefit) Net loss including noncontrolling interests in subsidiaries Net loss attributable to noncontrolling interests in subsidiaries Net loss attributable to Acacia Research Corporation Net Income (Loss) Attributable to Parent Net Income (Loss) Available to Common Stockholders, Basic Net Income (Loss) Available to Common Stockholders, Basic Earnings Per Share, Basic and Diluted Earnings Per Share, Basic and Diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted Average Number of Shares Outstanding, Basic and Diluted General and administrative expenses excluding share-based compensation General and administrative expenses excluding share-based compensation General and administrative expenses excluding share-based compensation Non-cash stock compensation general and administrative Non-cash stock compensation general and administrative Non-cash stock compensation general and administrative Non-cash stock compensation - profits interests Non-cash stock compensation - profits interests Non-cash stock compensation - profits interests Equity [Abstract] Investment [Axis] Investment [Axis] Investment [Domain] Investment [Domain] Geometric Brownian Motion [Member] Geometric Brownian Motion [Member] Geometric Brownian Motion [Member] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Treasury Stock, Shares, Acquired Treasury Stock, Shares, Acquired Treasury Stock Acquired, Average Cost Per Share Treasury Stock Acquired, Average Cost Per Share Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased Stock Repurchase Program Expiration Date Stock Repurchase Program Expiration Date Stock Repurchase Program, Number of Shares Authorized to be Repurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased Beneficial Ownership Percentage Limit Beneficial Ownership Percentage Limit Beneficial Ownership Percentage Limit Fair Value of Profits Interest Fair Value of Profits Interest Fair Value of Profits Interest Share Price Share Price Term specific volatility Term specific volatility Term specific volatility Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Short-term investments Short-term Investments Accounts receivable Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Investment - other Equity Method Investments Patents, net Patents, net of accumulated amortization Carrying value for patents, net of accumulated amortization. Other assets Other Assets, Noncurrent Liabilities and Equity [Abstract] Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Total current liabilities Other liabilities Other Liabilities, Noncurrent Commitments and contingencies (Note 6) Commitments and Contingencies Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding Preferred Stock, Value, Issued Common stock, par value $0.001 per share; 100,000,000 shares authorized; 49,495,064 and 50,639,926 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively Common Stock, Value, Issued Treasury stock, at cost, 2,919,828 and 1,729,408 shares as of June 30, 2018 and December 31, 2017, respectively Treasury Stock, Value Additional paid-in capital Additional Paid in Capital Accumulated comprehensive loss Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Accumulated deficit Total Acacia Research Corporation stockholders' equity Noncontrolling interests in operating subsidiaries Total stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and stockholders' equity Liabilities and Equity Revenues - Paid up Revenues - Paid up Revenues - Paid up Revenues - Sales-based Revenues - Sales-based Revenues - Sales-based Description of Business and Basis of Presentation [Abstract] Description of Business and Basis of Presentation [Abstract] Description of Business and Basis of Presentation Business Description and Basis of Presentation [Text Block] Schedule of Assumptions Used [Table Text Block] Schedule of Assumptions Used [Table Text Block] Fair Value, Assets Measured on Recurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring Basis [Table Text Block] Recent Accounting Pronouncements New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Cost of Revenues Cost of Revenues [Policy Text Block] Disclosure of accounting policy for costs of revenues recognized during the period. Inventor Royalties and Contingent Legal Expenses Inventor royalties and contingent legal expenses [Policy Text Block] Inventor royalties and contingent legal expenses [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Concentrations Concentration Risk, Credit Risk, Policy [Policy Text Block] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Stock-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Treasury Stock [Policy Text Block] Treasury Stock [Policy Text Block] Treasury Stock [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Marketable Securities, Policy [Policy Text Block] Marketable Securities, Policy [Policy Text Block] Patents Patents [Policy Text Block] Patents [Policy Text Block] Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments, Policy [Policy Text Block] Equity Method Investments [Policy Text Block] Equity Method Investments [Policy Text Block] Impairment of investments [Policy Text Block] Impairment of investments [Policy Text Block] Impairment of investments [Policy Text Block] Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Earnings Per Share [Abstract] Earnings Per Share Earnings Per Share [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Other Identifiable Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entities [Table] Entities [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Entity Information [Line Items] Entity Information [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted Earnings Per Share, Diluted Earnings Per Share, Diluted Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Marketable Securities [Table Text Block] Marketable Securities [Table Text Block] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Summary of Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies [Line Items] Investment in common stock Investment in common stock Investment in common stock Investment warrants Investment warrants Investment warrants and shares Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities, Gross Unrealized Gain Available-for-sale Securities, Gross Unrealized Gain Available-for-sale Securities, Gross Unrealized Loss Available-for-sale Securities, Gross Unrealized Loss Useful life of patents and patent rights Finite-Lived Intangible Asset, Useful Life Available-for-sale Securities Available-for-sale Securities Unrealized Gain (Loss) on Investments - Common Stock Unrealized Gain (Loss) on Investments - Common Stock Unrealized Gain (Loss) on Investments - Common Stock Unrealized Gain (Loss) on Investment - Warrants Unrealized Gain (Loss) on Investment - Warrants Unrealized Gain (Loss) on Investment - Warrants Change in fair value of investment, net Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Write-down of deferred tax assets Write-down of deferred tax assets Write-down of deferred tax assets Effective tax rate Effective Income Tax Rate Reconciliation, Percent Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Organization, Consolidation and Presentation of Financial Statements [Abstract] Number of patent portfolios acquired Number of patent portfolios acquired Number of patent portfolios acquired Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Patents, accumulated amortization Patents, Accumulated Amortization Patents, Accumulated Amortization Weighted average useful life of patents and patent rights Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Statement of Stockholders' Equity [Abstract] Report Date [Axis] Report Date [Axis] Financial Statement Filing Date [Domain] Financial Statement Filing Date [Domain] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Adjustments for Change in Accounting Principle [Axis] Adjustments for Change in Accounting Principle [Axis] Adjustments for Change in Accounting Principle [Domain] Adjustments for Change in Accounting Principle [Domain] Adjustments for Error Corrections [Axis] Adjustments for Error Corrections [Axis] Adjustments for Error Correction [Domain] Adjustments for Error Correction [Domain] Class of Treasury Stock [Table Text Block] Class of Treasury Stock [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] For the remainder of 2018 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Total expected amortization expense Finite-Lived Intangible Assets, Net Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss including noncontrolling interests in operating subsidiaries to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Gain on exercise of Primary Warrant Change in fair value of investment, net Depreciation and amortization Depreciation, Depletion and Amortization Non-cash stock compensation Share-based Compensation Other Other Operating Activities, Cash Flow Statement Changes in assets and liabilities: Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Royalties and contingent legal fees payable Increase (decrease) in royalties and contingent legal fees payable Increase (decrease) in royalties and contingent legal fees payable Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Payments to Acquire Other Investments Payments to Acquire Other Investments Advances to Investee Payments to Acquire Notes Receivable Purchase of available-for-sale investments Payments to Acquire Available-for-sale Securities Maturities and sale of available-for-sale investments Proceeds from Sale of Available-for-sale Securities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Repurchase of common stock Proceeds from Issuance of Common Stock Repurchased Restricted Common Stock Payments for Repurchase of Common Stock Proceeds from exercises of stock options Proceeds from Stock Options Exercised Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning Cash and cash equivalents, ending Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Concentration Risk [Table] Concentration Risk [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Licensee 1 [Member] Licensee 1 [Member] Licensee 1 [Member] Licensee 2 [Member] Licensee 2 [Member] Licensee 2 [Member] Licensees in foreign jurisdictions [Member] Licensees in foreign jurisdictions [Member] Licensees in foreign jurisdictions [Member] Concentration Risk by Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] License Revenues [Member] Revenue, Rights Granted [Member] Concentrations Concentration Risk [Line Items] Finite-Lived Intangible Asset, Useful Life Effective Income Tax Rate Reconciliation, Percent Concentration Risk, Percentage - Revenues Concentration Risk, Percentage Concentration Risk, Percentage - Accounts Receivable Licensees contributing to accounts receivable balance Licensees contributing to accounts receivable balance Stockholders' Equity: Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Treasury Stock, Shares Treasury Stock, Shares Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] EX-101.PRE 11 actg-20180630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 graphicactga02a10.jpg begin 644 graphicactga02a10.jpg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htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2018
Aug. 07, 2018
Entity Information [Line Items]    
Entity Registrant Name ACACIA RESEARCH CORP  
Entity Central Index Key 0000934549  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Document Type 10-Q  
Document Period End Date Jun. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Entity Common Stock, Shares Outstanding   49,495,064
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 100,150 $ 136,604
Short-term investments 34,694 0
Accounts receivable 5,629 153
Prepaid expenses and other current assets 3,509 2,938
Total current assets 143,982 139,695
Investments at fair value 75,004 104,754
Investment - other 8,195 2,195
Patents, net 23,099 61,917
Other assets 187 207
Total assets 250,467 308,768
Current liabilities:    
Accounts payable and accrued expenses 8,855 7,956
Royalties and contingent legal fees payable 4,765 1,601
Total current liabilities 13,620 9,557
Other liabilities 2,471 3,552
Total liabilities 16,091 13,109
Commitments and contingencies (Note 6)
Stockholders' equity:    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 49,495,064 and 50,639,926 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively 49 51
Treasury stock, at cost, 2,919,828 and 1,729,408 shares as of June 30, 2018 and December 31, 2017, respectively (39,272) (34,640)
Additional paid-in capital 650,265 648,996
Accumulated comprehensive loss (202) (88)
Accumulated deficit (377,977) (320,018)
Total Acacia Research Corporation stockholders' equity 232,863 294,301
Noncontrolling interests in operating subsidiaries 1,513 1,358
Total stockholders' equity 234,376 295,659
Total liabilities and stockholders' equity $ 250,467 $ 308,768
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2018
Dec. 31, 2017
Stockholders' Equity:    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 49,495,064 50,639,926
Common stock, shares outstanding 49,495,064 50,639,926
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Treasury Stock, Shares 2,919,828 1,729,408
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenues $ 6,485,000 $ 16,457,000 $ 68,578,000 $ 25,311,000
Operating costs and expenses        
Inventor royalties 1,241,000 4,273,000 22,985,000 4,939,000
Contingent legal fees 1,037,000 3,236,000 16,796,000 3,863,000
Other Cost of Operating Revenue 0 0 4,000,000 0
Litigation and licensing expenses - patents 2,130,000 4,134,000 4,875,000 10,520,000
Amortization of patents 5,278,000 5,571,000 10,608,000 11,086,000
General and administrative expenses(1) 7,098,000 6,734,000 10,477,000 13,650,000
Other expenses - business development 327,000 433,000 493,000 753,000
Impairment of Intangible Assets (Excluding Goodwill) 29,210,000 0 29,210,000 0
Total operating costs and expenses 46,321,000 24,381,000 99,444,000 44,811,000
Operating loss (39,836,000) (7,924,000) (30,866,000) (19,500,000)
Gain on Conversion of Loan and Accrued Interest 0 2,671,000 0 2,671,000
Gain on exercise of warrant 0 4,616,000 0 4,616,000
Change in fair value of investment, net 11,347,000 (12,698,000) (29,750,000) (12,698,000)
Income (Loss) from Equity Method Investments 0 (14,000) 0 (14,000)
Interest income and other 268,000 563,000 475,000 1,259,000
Total other income (expense) 11,615,000 (4,862,000) (29,275,000) (4,166,000)
Loss before provision for income taxes (28,221,000) (12,786,000) (60,141,000) (23,666,000)
Provision for income taxes (285,000) (1,478,000) (476,000) (2,719,000)
Net loss including noncontrolling interests in subsidiaries (28,506,000) (14,264,000) (60,617,000) (26,385,000)
Net loss attributable to noncontrolling interests in subsidiaries 79,000 12,000 152,000 303,000
Net loss attributable to Acacia Research Corporation (28,427,000) (14,252,000) (60,465,000) (26,082,000)
Net Income (Loss) Available to Common Stockholders, Basic $ (28,427,000) $ (14,252,000) $ (60,465,000) $ (26,082,000)
Earnings Per Share, Basic and Diluted $ (0.57) $ (0.28) $ (1.20) $ (0.52)
Weighted Average Number of Shares Outstanding, Basic and Diluted 50,061,812 50,499,248 50,345,808 50,416,611
General and administrative expenses excluding share-based compensation $ 5,892,000 $ 5,247,000 $ 10,295,000 $ 10,035,000
Non-cash stock compensation general and administrative 521,000 1,449,000 1,225,000 3,561,000
Non-cash stock compensation - profits interests $ 685,000 $ 38,000 $ (1,043,000) $ 54,000
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Other comprehensive income (loss):        
Net income (loss) including noncontrolling interests in operating subsidiaries $ (28,506) $ (14,264) $ (60,617) $ (26,385)
Unrealized gain (loss) on short-term investments, net of tax of $0 10 (9) (10) 5
Unrealized gain (loss) on foreign currency translation, net of tax of $0 (87) (4) (104) 9
Total other comprehensive loss (28,583) (14,277) (60,731) (26,371)
Comprehensive Income (Loss) Attributable to Noncontrolling Interest (79) (12) (152) (303)
Comprehensive loss attributable to Acacia Research Corporation $ (28,504) $ (14,265) $ (60,579) $ (26,068)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Comprehensive Income (Loss) (Parentheticals) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax $ 0 $ 0 $ 0 $ 0
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows Statement - USD ($)
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net income (loss) including noncontrolling interests in operating subsidiaries $ (60,617,000) $ (26,385,000)
Adjustments to reconcile net loss including noncontrolling interests in operating subsidiaries to net cash provided by operating activities:    
Gain on Conversion of Loan and Accrued Interest 0 2,671,000
Gain on exercise of Primary Warrant 0 (4,616,000)
Change in fair value of investment, net 29,750,000 12,698,000
Depreciation and amortization 10,627,000 11,134,000
Non-cash stock compensation 182,000 3,615,000
Impairment of Intangible Assets (Excluding Goodwill) 29,210,000 0
Other (313,000) (598,000)
Changes in assets and liabilities:    
Accounts receivable (934,000) 12,505,000
Prepaid expenses and other assets (571,000) (1,474,000)
Accounts payable and accrued expenses 861,000 (5,054,000)
Royalties and contingent legal fees payable 1,436,000 (4,481,000)
Net cash provided by operating activities 9,631,000 (5,327,000)
Cash flows from investing activities:    
Payments to Acquire Other Investments (7,000,000) (31,514,000)
Advances to Investee 0 (4,000,000)
Purchase of available-for-sale investments (49,895,000) (331,412,000)
Maturities and sale of available-for-sale investments 15,400,000 295,807,000
Net cash provided by (used in) investing activities (41,495,000) (71,119,000)
Cash flows from financing activities:    
Repurchase of common stock (4,634,000) 0
Repurchased Restricted Common Stock 7,000 35,000
Proceeds from exercises of stock options 51,000 649,000
Net cash used in financing activities (4,590,000) 614,000
Increase (decrease) in cash and cash equivalents (36,454,000) (75,832,000)
Cash and cash equivalents, beginning 136,604,000 139,052,000
Cash and cash equivalents, ending $ 100,150,000 $ 63,220,000
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Description of Business and Basis of Presentation
 6 Months Ended
Jun. 30, 2018
Description of Business and Basis of Presentation [Abstract]  
Description of Business and Basis of Presentation
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia also identifies opportunities to partner with high-growth and potentially disruptive technology companies. These partnerships usually involve an equity or debt investment by Acacia, along with entering into intellectual property (“IP”) related agreements where Acacia provides IP and other patent related services to these companies. Acacia leverages its experience, expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement, and/or supplement Acacia’s primary licensing and enforcement business.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of IP rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.

Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia’s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.    

During the six months ended June 30, 2018, Acacia did not obtain control of any new patent portfolios. During fiscal year 2017 Acacia obtained control of one new patent portfolio. In fiscal year 2016, Acacia obtained control of two new patent portfolios, compared to three new patent portfolios, and six new patent portfolios in fiscal years 2015 and 2014, respectively.

Basis of Presentation.  The accompanying condensed consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.
    
The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly reporting requirements of the Securities and Exchange Commission (“SEC”).  These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2017, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC.  The December 31, 2017 condensed consolidated balance sheet was derived from audited financial statements but does not include all disclosures required by U.S. GAAP.

The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of Acacia’s consolidated financial position as of June 30, 2018, and results of its operations and its cash flows for the interim periods presented.  The consolidated results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the entire fiscal year.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition. Revenue is recognized upon transfer of control of promised bundled IP rights (hereinafter “IP Rights”) and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have been met.

For the periods presented, revenue contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia (“Paid-up Revenue Agreements”). Revenues also included license fees from sales-based revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees (“Recurring Revenue Agreements”). IP Rights granted included the following, as applicable:  (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer IP Rights in the contract.

Since the promised IP Rights are not individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were “functional IP rights” that have significant standalone functionality. Acacia's subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia’s operating subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support or services.  The contracts provide for the grant (i.e. transfer of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectibility is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.
 
For sales-based royalties, the Company includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.

Revenues from contracts with significant financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.
 
In general, the Company is required to make certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.









Revenues were comprised of the following for the periods presented (in thousands):
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
Paid-up Revenue Agreements
$
3,183

 
$
14,964

 
$
63,246

 
$
22,160

Recurring Revenue Agreements
3,302

 
1,493

 
5,332

 
3,151

 
$
6,485

 
$
16,457

 
$
68,578

 
$
25,311


Refer to “Inventor Royalties and Contingent Legal Expenses” below for information on related direct costs of revenues.
 
Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.  These costs are included under the caption “Cost of revenues” in the accompanying condensed consolidated statements of operations. Cost of revenues for the six months ended June 30, 2018 included $4.0 million of costs to acquire certain rights related to revenues recognized in the period.  

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized.  In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues.  Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the condensed consolidated statements of operations.  Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the condensed consolidated statements of operations.

Contingent legal fees are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Inventor royalty and contingent legal agreements typically provide for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments are received from licensees by the Company.

Use of Estimates.  The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of equity instruments, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.

Concentrations. Two licensees individually accounted for 48% and 42% of revenues recognized during the three months ended June 30, 2018, and one licensee accounted for 87% of revenues recognized during the six months ended June 30, 2018. One licensee accounted for 85% of revenues recognized during the three months ended June 30, 2017 and two licensees accounted for 55% and 26% of revenues recognized during the six months ended June 30, 2017. For the three and six months ended June 30, 2018, 43% and 6%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and six months ended June 30, 2017, 90% and 87%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations. Two licensees individually represented approximately 47% and 43% of accounts receivable at June 30, 2018. One licensee individually represented approximately 100% of accounts receivable at December 31, 2017.

Fair Value Measurements. U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

(i)
Level 1 - Observable Inputs:  Quoted prices in active markets for identical investments;
(ii)
Level 2 - Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
(iii)
Level 3 - Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
 
Level 1
 
Level 2
 
Level 3
Assets as of June 30, 2018:
 
 
 
 
 
Short-term investments
$
34,694

 
$
—

 
$
—

Investment at fair value (Note 5)(1)

—

 
—

 
75,004

Total recurring fair value measurements
$
34,694

 
$
—

 
$
75,004

Assets as of December 31, 2017:
 
 
 
 
 
Investment at fair value (Note 5)(1)
$
—

 
$
—

 
$
104,754


____________________
(1)  
As of December 31, 2017, the Veritone common shares were subject to a lock-up agreement that expired on February 15, 2018 and measured at fair value using level 3 inputs. As of March 31, 2018, the Veritone common shares were not subject to a lock-up agreement and measured at fair value using level 1 inputs. At June 30, 2018, the Veritone common shares are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws.

A reconciliation of the activity for fair value measurements categorized within Level 3 for the six months ended June 30, 2018 is as follows (in thousands):
 
Investment at Fair Value
 
Common Stock
 
Warrants
 
Total
Opening balance as of January 1, 2018
$
90,795

 
$
13,959

 
$
104,754

Total gains and losses included in earnings for the period(1)
 
 
 
 
 
Change in fair value of investment, net
(24,968
)
 
(4,782
)
 
(29,750
)
Total recurring fair value measurements(1)
$
65,827

 
$
9,177

 
$
75,004


____________________
(1) All gains and losses included in earnings for the period presented relate to assets and liabilities held as of June 30, 2018.

Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. The Company accounts for forfeitures of awards as they occur.

Profits Interest Units (“Units”) are accounted for in accordance with Accounting Standards Codification (“ASC”) 718-10, “Compensation - Stock Compensation.” The Units vest as described at Note 7, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying condensed consolidated statements of operations.

Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.
 
Short-term Investments.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).

Short-term marketable securities for the periods presented were comprised of the following (in thousands):
 
 
 
Gross Unrealized
 
 
Security Type
Cost
 
Gains
 
Losses
 
Fair Value
June 30, 2018:
 
 
 
 
 
 
 
U.S. government fixed income securities (Maturity dates in 2018)
$
34,704

 
$
1

 
$
(11
)
 
$
34,694



Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to six years.

Investments at Fair Value. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).

Other Investments. Equity investments in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the condensed consolidated statements of operations.

Investments in preferred stock with substantive liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially all of the investee's losses, if any.

The initial determination of whether an investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence over the operating and financial policies of the investee. That determination is reconsidered if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest. Refer to Note 5 for additional information.

Impairment of Investments. Acacia reviews its investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements of operations and a new cost basis in the investment is established.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s condensed consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

The provision for income taxes for interim periods is determined using an estimate of Acacia’s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative adjustment is recorded.  

The Company’s effective tax rates were (1%) and (1%) for the three and six months ended June 30, 2018, respectively and (12%) and (11%) for the three and six months ended June 30, 2017, respectively. Tax expense for the periods presented primarily reflects the impact of state taxes and foreign withholding taxes incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.

On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to 21%, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of the changes were effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (“IRS”), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities.
While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately $25,261,000 in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets for the periods presented herein, the change in tax law did not have a material impact on our condensed consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income (Loss) Per Share
 6 Months Ended
Jun. 30, 2018
Earnings Per Share [Abstract]  
Earnings Per Share
 LOSS PER SHARE

The Company computes net loss attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.” The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted net loss per share:
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
 
2018
 
2017
 
2018
 
2017
Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted
 
50,061,812

 
50,499,248

 
50,345,808

 
50,416,611

Basic and diluted net loss per common share
 
$
(0.57
)
 
$
(0.28
)
 
$
(1.20
)
 
$
(0.52
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share
 
4,793,037

 
4,598,443

 
4,851,737

 
4,598,443

Maximum price of awards excluded from the computation of diluted loss per share
 
$
6.75

 
$
6.75

 
$
6.75

 
$
6.75
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Patents
 6 Months Ended
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Identifiable Intangible Assets
PATENTS

Acacia’s only identifiable intangible assets at June 30, 2018 and December 31, 2017 are patents and patent rights. Patent-related accumulated amortization totaled $421,038,000 and $382,220,000 as of June 30, 2018 and December 31, 2017, respectively. Acacia’s patents have remaining estimated economic useful lives ranging from one to six years. The weighted-average remaining estimated economic useful life of Acacia’s patents is approximately two years.  








The following table presents the scheduled annual aggregate amortization expense as of June 30, 2018 (in thousands):
For the years ending December 31,
 
Remainder of 2018
$
15,534

2019
3,508

2020
1,683

2021
822

2022
817

Thereafter
735

 
$
23,099



During the three months ended June 30, 2018, Acacia recorded impairment of patent-related intangible asset charges of $28,210,000. The impairment charges were realized in the period due to a reduction in expected estimated future net cash flows for certain patents due to second quarter 2018 developments in the ongoing litigation. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of June 30, 2018. Assumptions utilized in the cash flow analysis included margins on estimated net proceeds ranging from 53% to 86% and a discount for the time value of money of zero percent, due to the relatively short time-frame associated with estimated cash flows.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments (Notes)
 6 Months Ended
Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Cost and Equity Method Investments Disclosure [Text Block]
INVESTMENTS

Investment at Fair Value
Veritone Investment Agreement. On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provided for Acacia to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permitted Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum (included in Other Income (Expense) in the condensed consolidated statements of operations). On August 15, 2016, Acacia funded the initial $10 million loan (the “First Loan”). On November 25, 2016, Acacia funded the second $10 million loan (the “Second Loan”). The First Loan and the Second Loan were due and payable on November 25, 2017. In conjunction with the First Loan and Second Loan, Veritone issued Acacia a total of three four-year $700,000 warrants to purchase shares of Veritone’s common stock at an exercise price of $13.6088 per share. Upon Veritone’s consummation of its public offering of its common stock on May 17, 2017 (“IPO”), all outstanding principal and accrued interest under the Veritone Loans, totaling $20.7 million, automatically converted into 1,523,746 shares of Veritone’s common stock based on a conversion price of $13.6088 per share.
In addition, in August 2016, Veritone issued Acacia a five-year Primary Warrant to purchase up to $50.0 million, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at an exercise price of $13.6088 per share. Pursuant to an amendment to the Primary Warrant effective March 15, 2017, the Primary Warrant was exercised automatically upon the consummation of Veritone’s IPO, resulting in the purchase by Acacia of an additional 2,150,335 shares of Veritone common stock, at an aggregate purchase price of $29.3 million. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone issued to Acacia an additional 10% Warrant that provides for the issuance of an additional 809,400 shares of Veritone common stock at an exercise price of $13.6088 per share, with 50% of the shares underlying the 10% warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of the shares underlying the 10% warrant vesting on the first anniversary of the issuance date of the 10% Warrant.
Veritone Bridge Loan. On March 14, 2017, Acacia entered into an additional secured convertible promissory note with Veritone (the “Veritone Bridge Loan”), which permitted Veritone to borrow up to an additional $4.0 million, bearing interest at the rate of 8.0% per annum. On March 17, 2017, Acacia funded the initial $1.0 million advance (the “First Bridge Loan”). On April 14, 2017, Acacia funded the second $1.0 million advance (the “Second Bridge Loan”). All advances and accrued interest under the Veritone Bridge Loan were due and payable on November 25, 2017. In May 2017, pursuant to the terms of the Veritone Bridge Loan, Acacia elected to make an additional advance to Veritone totaling $2.0 million, representing all principal amounts not advanced upon Veritone’s consummation of its IPO. Upon consummation of Veritone’s IPO, the outstanding principal and accrued interest under the Veritone Bridge Loan of $4.0 million and $21,000, respectively, automatically converted into 295,440 shares of Veritone’s common stock at a conversion price of $13.6088 per share.
In conjunction with the Veritone Bridge Loan, Veritone issued to Acacia (i) 60,000 shares of Veritone common stock (“Upfront Shares”), (ii) 90,000 shares of Veritone common stock (the “Bridge Installment Shares”), and (iii) 10-year warrants to purchase up to 157,000 shares of Veritone common stock with other terms and conditions similar to the warrants described above.

All share amounts above have been adjusted to reflect a 0.6-for-1 reverse stock split of Veritone’s common stock, which was effected by Veritone in April 2017. The Veritone common shares and the common shares underlying the warrants are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws. All of the Veritone common stock held by Acacia was unregistered as of the issue date and are unregistered as of June 30, 2018.

Accounting Prior to Veritone IPO. Prior to conversion, Acacia’s Investment Agreement and the Veritone Bridge Loan represented variable interests in Veritone for which Acacia was not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. In addition, the Veritone Loans and Veritone Bridge Loan (the “Loans”) were not considered in-substance common stock, the common stock purchase warrants were unexercised, and the right to receive the Upfront Shares and the Bridge Installment shares (“Veritone Shares”) were considered in-substance common stock, however, application of the equity method was not material, therefore, the equity method of accounting was not applied prior to the IPO.

Prior to conversion, the Loans and the related common stock purchase warrants and Veritone Shares were accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the respective transactions, with the face amount of the loans allocated to (1) the Loans, which were accounted for as long-term loan receivables and (2) the common stock purchase warrants and Veritone Shares. The estimated relative fair value allocation was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone’s equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Loans. Assumptions used in connection with estimating the relative fair values included: (1) volatility ranging from 40% to 50%, (2) financing probabilities ranging from 25% to 75%, (3) marketability discount of 7% and (4) 100% investment recovery assumption. The loan discount, representing the difference between the face amount of the Loans and the relative fair value allocated to the Loans, was accreted over the expected life of the Loans, using the effective interest method, with the related interest amounts reflected in other income (expense) in the condensed consolidated statements of operations. Interest income for the six months ended June 30, 2017 was $1.1 million, including accretion of the loan discount of $630,000. The effective yield on the Loans for the six months ended June 30, 2017 ranged from 9% to 53%.
Accounting Subsequent to Veritone IPO. Upon Veritone’s consummation of its IPO on May 17, 2017, the Loans were converted into shares of Veritone common stock and the Primary Warrant was automatically exercised in full, as described above, resulting in a 20% ownership interest in Veritone (excluding warrants). Based on Acacia’s representation on the Veritone board of directors and Acacia’s 20% ownership interest in Veritone, Acacia management determined that the equity method of accounting was applicable. Upon becoming eligible for the equity method of accounting, Acacia elected to apply the fair value option to account for its equity investment in Veritone, including all of its investments in Veritone common stock and warrants, due to the availability of quoted prices in an active market for the Veritone common stock. As of June 30, 2018, Acacia’s ownership interest in Veritone, on a fully-diluted basis, was approximately 19%.
Acacia’s equity investment in Veritone common shares is recorded at fair value based on the quoted market price of Veritone’s common stock on The NASDAQ Global Market on the applicable valuation date, as adjusted for an estimated discount for lack of marketability (“DLOM”) associated with the restricted nature of the common shares acquired (Level 3 input). Acacia’s investment in Veritone warrants is recorded at fair value, as adjusted for an estimated DLOM, based on the Black-Scholes option-pricing model, utilizing the following assumptions at June 30, 2018: risk-free interest rates ranging from 2.52% to 2.81%; expected terms ranging from 2 years to 9 years; volatility of 60%; and a dividend yield of zero. The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:
 
 
Veritone Common Stock
 
Veritone Warrants
 
 
 
 
IPO Date
 
December 31,
2017
 
June 30,
2018
 
IPO Date
 
December 31,
2017
 
June 30,
2018
Estimated DLOM applied
 
5.7%
 
5%
 
5%
 
5.7%
 
10%
 
10%
-
15%
Volatility assumptions
 
35%
 
37%
 
90%
 
35%
 
72
%
-
87%
 
66%
-
110%
Term assumptions
 
6 months
 
2 months
 
2 months
 
6 months
 
5 months
 
5 months

At June 30, 2018, the fair value of the 4,119,521 shares of Veritone common stock owned by Acacia totaled $65,827,000. At June 30, 2018, the fair value of the 1,120,432 common stock purchase warrants held by Acacia totaled $9,177,000. At June 30, 2018, the cumulative net unrealized gain (since the IPO) on our Veritone investment was $19,776,000. A 10% increase in the DLOM assumptions utilized at all applicable valuation dates would result in an approximate 11% decrease in the fair value of our investment in Veritone warrants at June 30, 2018, and a corresponding decrease in the net investment gain or loss reflected in the condensed consolidated statements of operations for the applicable period. Changes in the fair value of Acacia’s investment in Veritone are recorded as unrealized gains or losses in the condensed consolidated statements of operations.
Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):
 
 
Three Months Ended March 31, 2018
Revenues
 
$
4,388

Gross profit
 
3,824

Operating expenses
 
17,054

Other income (expense), net
 
183

Net loss attributable to common stockholders
 
(13,049
)
 
 
 
Net loss per share attributable to common stockholders - basic and diluted
 
$
(0.81
)
 
 
March 31,
2018
 
December 31, 2017
Current assets
 
$
71,567

 
$
83,805

Noncurrent assets
 
6,161

 
4,753

Total Assets
 
$
77,728

 
$
88,558

 
 
 
 
 
Current liabilities
 
$
26,582

 
$
27,256

Noncurrent liabilities
 
—

 
—

Total liabilities
 
26,582

 
27,256

Preferred stock
 
—

 
—

Total stockholder's equity (deficit)
 
51,146

 
61,302

Total liabilities, preferred stock and stockholders’ equity
 
$
77,728

 
$
88,558


Other Investment
    
In June 2017, Acacia made an investment in the Series A Preferred financing round for Miso Robotics, Inc. (“Miso Robotics”), an innovative leader in robotics and artificial intelligence solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Series A preferred stock of Miso Robotics, and one board seat. In February 2018, Acacia made an additional equity investment in the Series B Preferred financing round for Miso Robotics totaling $6,000,000, increasing its ownership interest (Series B preferred stock) in Miso Robotics to approximately 30%, and acquiring an additional board seat. In addition, in June 2017, Acacia also entered into an IP services agreement with Miso Robotics to help Miso Robotics drive AI-based solutions for the restaurant industry. Miso Robotics will use the funding to deliver an adaptable AI-driven robotic kitchen assistant that will work alongside kitchen staff to improve operational efficiency for the restaurant industry.

As of February 2018, the preferred stock was not deemed to be in-substance common stock due to the substantive liquidation preference associated with the preferred stock. As such, as of February 2018, the cumulative investment in Miso Robotics is recorded at cost and assessed for any impairment at each balance sheet date. Prior to February 2018, the equity method of accounting was applied.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
COMMITMENTS AND CONTINGENCIES
Patent Enforcement
    Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights.  In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions.  In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material.


Other
Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business.  Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s condensed consolidated financial position, results of operations or cash flows.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity
 6 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
STOCKHOLDERS’ EQUITY
    
Repurchases of Common Stock. In February 2018, Acacia’s Board of Directors authorized the repurchase of up to $20,000,000 of the Company’s outstanding common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the Board of Directors at its discretion (the “Stock Repurchase Program”). In determining whether or not to repurchase any shares of Acacia’s common stock, Acacia’s Board of Directors consider such factors as the impact of the repurchase on Acacia’s cash position, as well as Acacia’s capital needs and whether there is a better alternative use of Acacia’s capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding share count and enhance stockholder value. The repurchase shares are expected to be retired. Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were as follows:
 
Total Number of Shares Purchased
Average Price paid per Share
Approximate Dollar Value of
Shares that May Yet be
Purchased under the Program
Plan Expiration
 
 
 
 
 
May 1, 2018- May 30, 2018
1,190,420

$
3.89

$
15,366,000

February 28, 2019
Totals for 2018
1,190,420

$
3.89

 
 


Profits Interest Plan. On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of membership interests in AIP to certain members of management and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each Unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership interests. The membership interests are represented by Units reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones (one-third upon 150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia’s aggregate investment in Veritone), subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement. The Units were fully vested as of June 30, 2018.

Acacia owns 60% of the membership interests in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients. As of June 30, 2018, AIP holds the Veritone 10% Warrant described at Note 5.

Profits interests totaling 400 Units, or 40% of the membership interests in AIP, were granted in February 2017 pursuant to the Plan, with an aggregate grant date fair value of $722,000. The fair value of the Units totaled $1,998,000 as of June 30, 2018. Upon full vesting of the units in September 2017, all previously unrecognized compensation expense was immediately recognized.

The fair value of the Units is estimated utilizing a Geometric Brownian Motion model (“GBM”) which considers probable vesting dates and values for the applicable instruments (i.e. common stock and warrants related to Acacia’s Veritone investment described at Note 5) underlying or associated with the Units. At the estimated end of the term of the underlying warrant (May 2022), the model estimates the total proceeds from the hypothetical exercise of the warrant and estimates the value of the Units by allocating the proceeds based on the waterfall described in the terms of the underlying agreement. The value of the Units on a marketable basis is the average allocation across all GBM simulation paths discounted to the applicable valuation date using the risk-free rate. This estimated value is adjusted for an estimate of a DLOM using the Finnerty model, based on a security specific volatility calculated by changing Veritone’s common stock price by 1% and measuring the corresponding change in the value of the Units. For the three months ended June 30, 2018, assumptions utilized in the GBM included a term of 3.9 years, stock price of $16.82, volatility of 60%, and risk free interest rates ranging from 2.33% to 2.85% for terms ranging from one to 10 years. The estimated DLOM utilized was 30%, based on assumptions including a term of approximately 3.9 years and a volatility of 90% for Veritone’s common stock. Volatility was estimated based on the historical volatilities of a set of comparable public companies, adjusted for leverage, over a term matching the term of the underlying warrant asset, which was approximately 3.9 years.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Recent Accounting Pronouncements
 6 Months Ended
Jun. 30, 2018
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
Recent Accounting Pronouncements
RECENT ACCOUNTING PRONOUNCEMENTS
 
Recent Accounting Pronouncements - Recently Adopted.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In doing so, the Company is required to use more judgment and make more estimates in connection with the accounting for revenue contracts with customers than under previous guidance, as described in Note 2. Under the standard, (i) an entity should account for a promise to provide a customer with a right to access the entity’s IP as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its IP as the performance occurs, and (ii) an entity’s promise to provide a customer with the right to use its IP is satisfied at a point in time. In addition, revenues from contracts with significant financing components should be recognized at an amount that reflects the price that a customer would have paid if the customer had paid cash for the goods or services when they transfer to the customer (i.e. adjustment for the time value of money). For sales and usage based royalties, the new standard requires that the Company include in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The Company used the modified retrospective method of adoption and recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings on January 1, 2018. Comparative prior year periods were not adjusted. The new accounting standard was applied to all contracts at the date of initial application. The cumulative effect of applying the new revenue standard, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods, was as follows (in thousands):
 
 
Balance at December 31, 2017
 
Adjustments
 
Balance at January 1, 2018
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
153

 
$
4,542

 
$
4,695

Royalties and contingent legal fees payable
 
1,601

 
1,728

 
3,329

Accumulated deficit
 
(320,018
)
 
2,506

 
(317,512
)
Noncontrolling interests
 
1,358

 
308

 
1,666



The impact of the adoption of the new accounting standard on the consolidated balance sheet and statement of operations was as follows (in thousands):
 
 
Balance as Reported
 
Balance at January 1, 2018 Prior to Adoption
 
Effect of Change
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
5,629

 
$
3,599

 
$
2,030

Royalties and contingent legal fees payable
 
4,765

 
3,953

 
812

 
 
 
 
 
 
 
Statements of Operations:
 
 
 
 
 
 
Revenues
 
$
68,578

 
$
66,548

 
$
2,030

Inventor royalties
 
22,985

 
22,287

 
698

Contingent legal fees
 
16,796

 
16,682

 
114



In May 2017, the FASB issued amended guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions or the classification of the award changes as a result of the change in terms or conditions. This amendment is effective prospectively for annual periods beginning on or after December 15, 2017. The adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements - Not Yet Adopted.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures and expects to adopt the new standard effective January 1, 2018.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Notes)
 6 Months Ended
Jun. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
SUBSEQUENT EVENTS

Board Composition. On August 8, 2018, the Company announced that Joseph E. Davis, Fred A. deBoom and James F. Sanders have resigned from the Board, effective immediately.

Personnel. On August 8, 2018, the Company announced that Robert B. Stewart Jr., President, Edward J. Treska, Executive Vice President, General Counsel and Clayton J. Haynes, Chief Financial Officer, SVP Finance, Treasurer, are transitioning out of their roles at Acacia effective August 10, 2018, pursuant to a board approved transition arrangement. Mr. Treska and Mr. Haynes have agreed to provide consulting services to the Company to aid in the transition of their duties subsequent to August 10, 2018. Severance payments related to the personnel changes described above total $2.5 million.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Accounting Policies [Abstract]    
Revenue Recognition
Revenue Recognition. Revenue is recognized upon transfer of control of promised bundled IP rights (hereinafter “IP Rights”) and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have been met.

For the periods presented, revenue contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia (“Paid-up Revenue Agreements”). Revenues also included license fees from sales-based revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees (“Recurring Revenue Agreements”). IP Rights granted included the following, as applicable:  (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer IP Rights in the contract.

Since the promised IP Rights are not individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were “functional IP rights” that have significant standalone functionality. Acacia's subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia’s operating subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support or services.  The contracts provide for the grant (i.e. transfer of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectibility is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.
 
For sales-based royalties, the Company includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.

Revenues from contracts with significant financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.
 
In general, the Company is required to make certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.









Revenues were comprised of the following for the periods presented (in thousands):
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
Paid-up Revenue Agreements
$
3,183

 
$
14,964

 
$
63,246

 
$
22,160

Recurring Revenue Agreements
3,302

 
1,493

 
5,332

 
3,151

 
$
6,485

 
$
16,457

 
$
68,578

 
$
25,311


Refer to “Inventor Royalties and Contingent Legal Expenses” below for information on related direct costs of revenues.
  
Cost of Revenues
Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.  These costs are included under the caption “Cost of revenues” in the accompanying condensed consolidated statements of operations. Cost of revenues for the six months ended June 30, 2018 included $4.0 million of costs to acquire certain rights related to revenues recognized in the period.  
  
Inventor Royalties and Contingent Legal Expenses
Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized.  In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues.  Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the condensed consolidated statements of operations.  Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the condensed consolidated statements of operations.

Contingent legal fees are expensed in the condensed consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Inventor royalty and contingent legal agreements typically provide for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments are received from licensees by the Company.

  
Use of Estimates
Use of Estimates.  The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of equity instruments, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.
  
Concentrations
Concentrations. Two licensees individually accounted for 48% and 42% of revenues recognized during the three months ended June 30, 2018, and one licensee accounted for 87% of revenues recognized during the six months ended June 30, 2018. One licensee accounted for 85% of revenues recognized during the three months ended June 30, 2017 and two licensees accounted for 55% and 26% of revenues recognized during the six months ended June 30, 2017. For the three and six months ended June 30, 2018, 43% and 6%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and six months ended June 30, 2017, 90% and 87%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations. Two licensees individually represented approximately 47% and 43% of accounts receivable at June 30, 2018. One licensee individually represented approximately 100% of accounts receivable at December 31, 2017.

 
Fair Value Measurements
Fair Value Measurements. U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

(i)
Level 1 - Observable Inputs:  Quoted prices in active markets for identical investments;
(ii)
Level 2 - Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
(iii)
Level 3 - Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
 
Level 1
 
Level 2
 
Level 3
Assets as of June 30, 2018:
 
 
 
 
 
Short-term investments
$
34,694

 
$
—

 
$
—

Investment at fair value (Note 5)(1)

—

 
—

 
75,004

Total recurring fair value measurements
$
34,694

 
$
—

 
$
75,004

Assets as of December 31, 2017:
 
 
 
 
 
Investment at fair value (Note 5)(1)
$
—

 
$
—

 
$
104,754


____________________
(1)  
As of December 31, 2017, the Veritone common shares were subject to a lock-up agreement that expired on February 15, 2018 and measured at fair value using level 3 inputs. As of March 31, 2018, the Veritone common shares were not subject to a lock-up agreement and measured at fair value using level 1 inputs. At June 30, 2018, the Veritone common shares are subject to a lock-up agreement that expires on August 15, 2018, subsequent to which the shares may be sold pursuant to Rule 144, subject to volume limitations and Rule 144 filing requirements, as well as other restrictions under applicable securities laws.

A reconciliation of the activity for fair value measurements categorized within Level 3 for the six months ended June 30, 2018 is as follows (in thousands):
 
Investment at Fair Value
 
Common Stock
 
Warrants
 
Total
Opening balance as of January 1, 2018
$
90,795

 
$
13,959

 
$
104,754

Total gains and losses included in earnings for the period(1)
 
 
 
 
 
Change in fair value of investment, net
(24,968
)
 
(4,782
)
 
(29,750
)
Total recurring fair value measurements(1)
$
65,827

 
$
9,177

 
$
75,004


____________________
(1) All gains and losses included in earnings for the period presented relate to assets and liabilities held as of June 30, 2018.
  
Stock-Based Compensation
Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and/or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. The Company accounts for forfeitures of awards as they occur.

Profits Interest Units (“Units”) are accounted for in accordance with Accounting Standards Codification (“ASC”) 718-10, “Compensation - Stock Compensation.” The Units vest as described at Note 7, and therefore, the vesting conditions do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying condensed consolidated statements of operations.

  
Treasury Stock [Policy Text Block]  
Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.
  
Marketable Securities, Policy [Policy Text Block]
Short-term Investments.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short-term. The fair values of these investments approximate their carrying values. For the applicable periods presented, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized gains and losses are recorded in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).

Short-term marketable securities for the periods presented were comprised of the following (in thousands):
 
 
 
Gross Unrealized
 
 
Security Type
Cost
 
Gains
 
Losses
 
Fair Value
June 30, 2018:
 
 
 
 
 
 
 
U.S. government fixed income securities (Maturity dates in 2018)
$
34,704

 
$
1

 
$
(11
)
 
$
34,694

  
Patents
Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to six years.

  
Fair Value of Financial Instruments, Policy [Policy Text Block]
Investments at Fair Value. On an individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e. common stock and warrants).
  
Equity Method Investments [Policy Text Block]
Other Investments. Equity investments in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the condensed consolidated statements of operations.

Investments in preferred stock with substantive liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially all of the investee's losses, if any.

The initial determination of whether an investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence over the operating and financial policies of the investee. That determination is reconsidered if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest. Refer to Note 5 for additional information.

 
Impairment of investments [Policy Text Block]
Impairment of Investments. Acacia reviews its investments quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements of operations and a new cost basis in the investment is established.

  
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]
Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.
  
Income Taxes
Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s condensed consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

The provision for income taxes for interim periods is determined using an estimate of Acacia’s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative adjustment is recorded.  

The Company’s effective tax rates were (1%) and (1%) for the three and six months ended June 30, 2018, respectively and (12%) and (11%) for the three and six months ended June 30, 2017, respectively. Tax expense for the periods presented primarily reflects the impact of state taxes and foreign withholding taxes incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.

On December 22, 2017, new U.S. tax legislation was enacted that has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate to 21%, revising the rules governing net operating losses and foreign tax credits, and introducing new anti-base erosion provisions. Many of the changes were effective immediately, without any transition periods or grandfathering for existing transactions. The legislation is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and Internal Revenue Service (“IRS”), any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities.
While our analysis and interpretation of this legislation is ongoing, based on our current evaluation, we reflected a write-down of our deferred income tax assets (including the value of our net operating loss carryforwards and our tax credit carryforwards) due the reduction of the U.S. corporate income tax rate. Based on currently available information, we recorded a reduction of approximately $25,261,000 in the fourth quarter of 2017 related to the revaluation of our deferred tax assets. Given the full valuation allowance provided for net deferred tax assets for the periods presented herein, the change in tax law did not have a material impact on our condensed consolidated financial statements provided herein. There may be additional tax impacts identified in subsequent periods throughout 2018 in accordance with subsequent interpretive guidance issued by the SEC or the IRS. Further, there may be other material adverse effects resulting from the legislation that we have not yet identified. No estimated tax provision has been recorded for tax attributes that are incomplete or subject to change.
  
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
 
Level 1
 
Level 2
 
Level 3
Assets as of June 30, 2018:
 
 
 
 
 
Short-term investments
$
34,694

 
$
—

 
$
—

Investment at fair value (Note 5)(1)

—

 
—

 
75,004

Total recurring fair value measurements
$
34,694

 
$
—

 
$
75,004

Assets as of December 31, 2017:
 
 
 
 
 
Investment at fair value (Note 5)(1)
$
—

 
$
—

 
$
104,754
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
A reconciliation of the activity for fair value measurements categorized within Level 3 for the six months ended June 30, 2018 is as follows (in thousands):
 
Investment at Fair Value
 
Common Stock
 
Warrants
 
Total
Opening balance as of January 1, 2018
$
90,795

 
$
13,959

 
$
104,754

Total gains and losses included in earnings for the period(1)
 
 
 
 
 
Change in fair value of investment, net
(24,968
)
 
(4,782
)
 
(29,750
)
Total recurring fair value measurements(1)
$
65,827

 
$
9,177

 
$
75,004
Marketable Securities [Table Text Block]
Short-term marketable securities for the periods presented were comprised of the following (in thousands):
 
 
 
Gross Unrealized
 
 
Security Type
Cost
 
Gains
 
Losses
 
Fair Value
June 30, 2018:
 
 
 
 
 
 
 
U.S. government fixed income securities (Maturity dates in 2018)
$
34,704

 
$
1

 
$
(11
)
 
$
34,694
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income (Loss) Per Share (Tables)
 6 Months Ended
Jun. 30, 2018
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted net loss per share:
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
 
2018
 
2017
 
2018
 
2017
Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted
 
50,061,812

 
50,499,248

 
50,345,808

 
50,416,611

Basic and diluted net loss per common share
 
$
(0.57
)
 
$
(0.28
)
 
$
(1.20
)
 
$
(0.52
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share
 
4,793,037

 
4,598,443

 
4,851,737

 
4,598,443

Maximum price of awards excluded from the computation of diluted loss per share
 
$
6.75

 
$
6.75

 
$
6.75

 
$
6.75
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Patents (Tables)
 6 Months Ended
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
The following table presents the scheduled annual aggregate amortization expense as of June 30, 2018 (in thousands):
For the years ending December 31,
 
Remainder of 2018
$
15,534

2019
3,508

2020
1,683

2021
822

2022
817

Thereafter
735

 
$
23,099
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments Investments (Tables)
 6 Months Ended
Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Schedule of Assumptions Used [Table Text Block]
The DLOM for the Veritone common stock and warrants was estimated utilizing a Finnerty model with the following results and assumptions:
 
 
Veritone Common Stock
 
Veritone Warrants
 
 
 
 
IPO Date
 
December 31,
2017
 
June 30,
2018
 
IPO Date
 
December 31,
2017
 
June 30,
2018
Estimated DLOM applied
 
5.7%
 
5%
 
0.05
 
5.7%
 
10%
 
10%
-
15%
Volatility assumptions
 
35%
 
37%
 
—
 
35%
 
72
%
-
87%
 
66%
-
110%
Term assumptions
 
6 months
 
2 months
 
2 months
 
6 months
 
5 months
 
5 months
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Summarized financial information for Veritone, presented on a three month lag basis, is as follows (in thousands, except per share amounts):
 
 
Three Months Ended March 31, 2018
Revenues
 
$
4,388

Gross profit
 
3,824

Operating expenses
 
17,054

Other income (expense), net
 
183

Net loss attributable to common stockholders
 
(13,049
)
 
 
 
Net loss per share attributable to common stockholders - basic and diluted
 
$
(0.81
)
 
 
March 31,
2018
 
December 31, 2017
Current assets
 
$
71,567

 
$
83,805

Noncurrent assets
 
6,161

 
4,753

Total Assets
 
$
77,728

 
$
88,558

 
 
 
 
 
Current liabilities
 
$
26,582

 
$
27,256

Noncurrent liabilities
 
—

 
—

Total liabilities
 
26,582

 
27,256

Preferred stock
 
—

 
—

Total stockholder's equity (deficit)
 
51,146

 
61,302

Total liabilities, preferred stock and stockholders’ equity
 
$
77,728

 
$
88,558
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity stockholders equity (Tables)
 6 Months Ended
Jun. 30, 2018
Class of Treasury Stock [Table Text Block]
Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were as follows:
 
Total Number of Shares Purchased
Average Price paid per Share
Approximate Dollar Value of
Shares that May Yet be
Purchased under the Program
Plan Expiration
 
 
 
 
 
May 1, 2018- May 30, 2018
1,190,420

$
3.89

$
15,366,000

February 28, 2019
Totals for 2018
1,190,420

$
3.89

 
 
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Recent Accounting Pronouncements Details (Tables)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
The cumulative effect of applying the new revenue standard, primarily relating to financing components of contracts executed in prior periods and estimates of variable consideration for sales and usage based royalty agreements executed in prior periods, was as follows (in thousands):
 
 
Balance at December 31, 2017
 
Adjustments
 
Balance at January 1, 2018
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
153

 
$
4,542

 
$
4,695

Royalties and contingent legal fees payable
 
1,601

 
1,728

 
3,329

Accumulated deficit
 
(320,018
)
 
2,506

 
(317,512
)
Noncontrolling interests
 
1,358

 
308

 
1,666

The impact of the adoption of the new accounting standard on the consolidated balance sheet and statement of operations was as follows (in thousands):
 
 
Balance as Reported
 
Balance at January 1, 2018 Prior to Adoption
 
Effect of Change
Balance Sheets:
 
 
 
 
 
 
Accounts receivable
 
$
5,629

 
$
3,599

 
$
2,030

Royalties and contingent legal fees payable
 
4,765

 
3,953

 
812

 
 
 
 
 
 
 
Statements of Operations:
 
 
 
 
 
 
Revenues
 
$
68,578

 
$
66,548

 
$
2,030

Inventor royalties
 
22,985

 
22,287

 
698

Contingent legal fees
 
16,796

 
16,682

 
114
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Description of Business and Basis of Presentation Patent Acquisition (Details) - patent_portfolios
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Number of patent portfolios acquired 1 2 3 6
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Feb. 16, 2017
Summary of Significant Accounting Policies [Line Items]            
Investment in common stock $ 65,827,000 $ 90,795,000   $ 65,827,000    
Investment warrants 9,177,000 13,959,000   9,177,000    
Other Cost of Operating Revenue 0   $ 0 4,000,000 $ 0  
Short-term investments 34,694,000 0   34,694,000    
Available-for-sale Securities, Amortized Cost Basis 34,704,000     34,704,000    
Available-for-sale Securities, Gross Unrealized Gain       1,000    
Available-for-sale Securities, Gross Unrealized Loss       (11,000)    
Available-for-sale Securities 34,694,000     34,694,000    
Investments at fair value 75,004,000 104,754,000   75,004,000    
Unrealized Gain (Loss) on Investments - Common Stock (24,968,000)          
Unrealized Gain (Loss) on Investment - Warrants (4,782,000)          
Fair Value of Profits Interest 1,998,000     1,998,000   $ 722,000
Change in fair value of investment, net $ 11,347,000   $ (12,698,000) $ (29,750,000) $ (12,698,000)  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%          
Write-down of deferred tax assets   $ 25,261,000        
Effective tax rate (1.00%)   (12.00%) 1.00% 11.00%  
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $ (28,221,000)   $ (12,786,000) $ (60,141,000) $ (23,666,000)  
Minimum [Member]            
Summary of Significant Accounting Policies [Line Items]            
Useful life of patents and patent rights       1 year    
Maximum [Member]            
Summary of Significant Accounting Policies [Line Items]            
Useful life of patents and patent rights       6 years    
Fair Value Assumptions, Expected Volatility Rate       50.00%    
Geometric Brownian Motion [Member]            
Summary of Significant Accounting Policies [Line Items]            
Fair Value Assumptions, Expected Term       3 years 11 months    
Fair Value Assumptions, Expected Volatility Rate       60.00%    
Geometric Brownian Motion [Member] | Minimum [Member]            
Summary of Significant Accounting Policies [Line Items]            
Fair Value Assumptions, Risk Free Interest Rate       2.00%    
Geometric Brownian Motion [Member] | Maximum [Member]            
Summary of Significant Accounting Policies [Line Items]            
Fair Value Assumptions, Expected Term       10 years    
Fair Value Assumptions, Risk Free Interest Rate       3.00%    
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies Concentration Risk (Details)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Concentrations          
Effective Income Tax Rate Reconciliation, Percent (1.00%) (12.00%) 1.00% 11.00%  
Licensee 1 [Member]          
Concentrations          
Concentration Risk, Percentage - Accounts Receivable 47.00%   47.00%   100.00%
Licensee 1 [Member] | License Revenues [Member]          
Concentrations          
Concentration Risk, Percentage - Revenues 48.00% 85.00% 87.00% 55.00%  
Licensee 2 [Member]          
Concentrations          
Concentration Risk, Percentage - Accounts Receivable 43.00%   43.00%    
Licensee 2 [Member] | License Revenues [Member]          
Concentrations          
Concentration Risk, Percentage - Revenues 42.00%     26.00%  
Licensees in foreign jurisdictions [Member] | License Revenues [Member]          
Concentrations          
Concentration Risk, Percentage - Revenues 43.00% 90.00% 6.00% 87.00%  
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies Types of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Accounting Policies [Abstract]        
Revenues - Paid up $ 3,183 $ 14,964 $ 63,246 $ 22,160
Revenues - Sales-based 3,302 1,493 5,332 3,151
Revenues $ 6,485 $ 16,457 $ 68,578 $ 25,311
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income (Loss) Per Share (Details) - $ / shares
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Weighted Average Number of Shares Outstanding, Basic and Diluted 50,061,812 50,499,248 50,345,808 50,416,611
Earnings Per Share, Basic and Diluted $ (0.57) $ (0.28) $ (1.20) $ (0.52)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 4,793,037 4,598,443 4,851,737 4,598,443
Weighted Average Number of Shares Outstanding, Diluted       50,416,611
Earnings Per Share, Basic     $ (1.20) $ (0.52)
Maximum [Member]        
Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount $ 6.75 $ 6.75 $ 6.75 $ 6.75
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Patents (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]          
Patents, accumulated amortization $ 421,038,000   $ 421,038,000   $ 382,220,000
Weighted average useful life of patents and patent rights     2 years    
Impairment of Intangible Assets (Excluding Goodwill) $ 29,210,000 $ 0 $ 29,210,000 $ 0  
Minimum [Member]          
Finite-Lived Intangible Assets [Line Items]          
Useful life of patents and patent rights     1 year    
Maximum [Member]          
Finite-Lived Intangible Assets [Line Items]          
Useful life of patents and patent rights     6 years    
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Patents Future Amortization Expense for Intangible Assets (Details)
$ in Thousands
Jun. 30, 2018
USD ($)
Finite-Lived Intangible Assets [Line Items]  
For the remainder of 2018 $ 15,534
2019 3,508
2020 1,683
2021 822
2022 817
Thereafter 735
Total expected amortization expense $ 23,099
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments Investments (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
May 17, 2017
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Mar. 14, 2017
Aug. 15, 2016
Investment [Line Items]                  
Investment in Miso Robotics   $ 6,000,000         $ 2,250,000    
Percentage of ownership, Miso Robotics   30.00%     30.00%   22.60%    
Maximum Investment in Veritone                 $ 50,000,000
Secured Convertible Promissory Note                 20,000,000
Secured Promissory Note Advance                 $ 10,000,000
Time-sharing Transactions, Stated Interest Rate for Notes Receivable                 6.00%
First Loan Warrant                 $ 700,000
Debt Instrument, Convertible, Conversion Price $ 13.6088                
Loan receivable and accrued interest $ 20,700,000                
Common stock, shares outstanding   49,495,064     49,495,064   50,639,926    
Veritone Primary Warrant                 $ 50,000,000
Cash paid for primary warrant exercise $ 29,300,000                
10% Warrant 809,400                
Veritone Bridge Loan $ 4,000,000             $ 4,000,000  
Bridge loan stated interest rate               8.00%  
Veritone Bridge Loan Advance 1               $ 1,000,000  
Veritone Bridge Loan Advance 3 and 4               $ 2,000,000  
Upfront Shares               60,000  
Bridge Installment Shares               90,000  
Bridge Warrant Share               157,000  
Interest Income, Other       $ 1,100,000          
Accretion (Amortization) of Discounts and Premiums, Investments           $ 630,000      
Percentage of ownership, Veritone 20.00%                
Investments at fair value   $ 75,004,000     $ 75,004,000   $ 104,754,000    
Revenues   6,485,000   $ 16,457,000 $ 68,578,000 $ 25,311,000      
Earnings Per Share, Basic         $ (1.20) $ (0.52)      
Assets, Current   143,982,000     $ 143,982,000   139,695,000    
Total assets   250,467,000     250,467,000   308,768,000    
Current liabilities   13,620,000     13,620,000   9,557,000    
Total liabilities   16,091,000     16,091,000   13,109,000    
Stockholders' Equity Attributable to Parent   $ 232,863,000     $ 232,863,000   294,301,000    
Equity Method Investment, Ownership Percentage   19.00%     19.00%        
Cumulative Unrealized Gain (Loss) Since Inception   $ 19,776,000     $ 19,776,000        
Minimum [Member]                  
Investment [Line Items]                  
Receivable with Imputed Interest, Effective Yield (Interest Rate)         9.00%        
Maximum [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Volatility Rate         50.00%        
Fair Value Inputs, Probability of Default         75.00%        
Fair value inputs recovery         100.00%        
Receivable with Imputed Interest, Effective Yield (Interest Rate)           53.00%      
Veritone [Member]                  
Investment [Line Items]                  
Investment Income, Interest         $ 21,000        
Revenues     $ 4,388,000            
Gross Profit     3,824,000            
Operating Expenses     17,054,000            
Other Operating Income (Expense), Net     183,000            
Net Income (Loss) Available to Common Stockholders, Diluted     $ (13,049,000)            
Earnings Per Share, Basic     $ (810)            
Assets, Current     $ 71,567,000       83,805,000    
Noncurrent assets     6,161,000       4,753,000    
Total assets     77,728,000       88,558,000    
Current liabilities     26,582,000       27,256,000    
Noncurrent liabilities     0       0    
Total liabilities     26,582,000       27,256,000    
Preferred Stock, Value, Outstanding     0       0    
Stockholders' Equity Attributable to Parent     51,146,000       61,302,000    
Total liabilities, preferred stock and stockholders' equity     $ 77,728,000       $ 88,558,000    
Common Stock [Member]                  
Investment [Line Items]                  
Investment Owned, Balance, Shares             4,119,521    
Investments at fair value   65,827,000     65,827,000        
Warrant [Member]                  
Investment [Line Items]                  
Investment Owned, Balance, Shares             1,120,432    
Investments at fair value   $ 9,177,000     $ 9,177,000        
Veritone Loans [Member] | Veritone [Member]                  
Investment [Line Items]                  
Common stock, shares outstanding 1,523,746                
Primary warrant [Member] | Veritone [Member]                  
Investment [Line Items]                  
Common stock, shares outstanding 2,150,335                
Bridge Loan [Member] | Veritone [Member]                  
Investment [Line Items]                  
Common stock, shares outstanding 295,440                
Finnerty - Common Stock [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Volatility Rate 35.00% 0.00%         37.00%    
Fair Value Inputs, Discount for Lack of Marketability 6.00% 5.00%         5.00%    
Fair Value Assumptions, Expected Term 6 months 2 months         2 months    
Monte Carlo [Member] | Minimum [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Volatility Rate         40.00%        
Fair Value Inputs, Probability of Default         25.00%        
Fair Value Inputs, Discount for Lack of Marketability         7.00%        
Finnerty [Member]                  
Investment [Line Items]                  
Fair Value Inputs, Discount for Lack of Marketability         30.00%        
Fair Value Assumptions, Expected Term         3 years 11 months        
Black Scholes [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Dividend Payments         $ 0        
Black Scholes [Member] | Minimum [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Volatility Rate         60.00%        
Fair Value Assumptions, Risk Free Interest Rate         2.52%        
Fair Value Assumptions, Expected Term         2 years        
Black Scholes [Member] | Maximum [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Risk Free Interest Rate         2.81%        
Fair Value Assumptions, Expected Term         9 years        
Finnerty - Warrants [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Volatility Rate 35.00%                
Fair Value Inputs, Discount for Lack of Marketability 6.00%           10.00%    
Fair Value Assumptions, Expected Term 6 months 5 months         5 months    
Finnerty - Warrants [Member] | Minimum [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Volatility Rate   66.00%         72.00%    
Fair Value Inputs, Discount for Lack of Marketability   10.00%              
Finnerty - Warrants [Member] | Maximum [Member]                  
Investment [Line Items]                  
Fair Value Assumptions, Expected Volatility Rate   110.00%         87.00%    
Fair Value Inputs, Discount for Lack of Marketability   15.00%              
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity Stockholders Equity (Details) - USD ($)
 6 Months Ended
Jun. 30, 2018
Feb. 16, 2017
Treasury Stock, Shares, Acquired 1,190,420  
Treasury Stock Acquired, Average Cost Per Share $ 3.89  
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 15,366,000  
Stock Repurchase Program Expiration Date Feb. 28, 2019  
Stock Repurchase Program, Number of Shares Authorized to be Repurchased 20,000,000  
Beneficial Ownership Percentage Limit   60.00%
Fair Value of Profits Interest $ 1,998,000 $ 722,000
Geometric Brownian Motion [Member]    
Fair Value Assumptions, Expected Term 3 years 11 months  
Fair Value Assumptions, Expected Volatility Rate 60.00%  
Finnerty [Member]    
Fair Value Assumptions, Expected Term 3 years 11 months  
Fair Value Inputs, Discount for Lack of Marketability 30.00%  
Term specific volatility 90.00%  
Minimum [Member] | Geometric Brownian Motion [Member]    
Fair Value Assumptions, Risk Free Interest Rate 2.00%  
Maximum [Member]    
Fair Value Assumptions, Expected Volatility Rate 50.00%  
Maximum [Member] | Geometric Brownian Motion [Member]    
Fair Value Assumptions, Expected Term 10 years  
Fair Value Assumptions, Risk Free Interest Rate 3.00%  
Veritone [Member]    
Share Price $ 16.82  
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Recent Accounting Pronouncements Details (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Jan. 01, 2018
Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Accounts Receivable, Net, Current $ 5,629   $ 5,629   $ 4,695 $ 153
Royalties and contingent legal fees payable 4,765   4,765   3,329 1,601
Retained Earnings (Accumulated Deficit) (377,977)   (377,977)   (317,512) (320,018)
Stockholders' Equity Attributable to Noncontrolling Interest 1,513   1,513   1,666 $ 1,358
Licenses Revenue 6,485 $ 16,457 68,578 $ 25,311    
Royalty Expense 1,241 4,273 22,985 4,939    
Contingent legal fees 1,037 $ 3,236 16,796 $ 3,863    
Adjustments for New Accounting Pronouncement [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Accounts Receivable, Net, Current 2,030   2,030   4,542  
Royalties and contingent legal fees payable 812   812   1,728  
Retained Earnings (Accumulated Deficit)         2,506  
Stockholders' Equity Attributable to Noncontrolling Interest         $ 308  
Licenses Revenue 2,030          
Royalty Expense 698          
Contingent legal fees 114          
Balance before adjustment [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Accounts Receivable, Net, Current 3,599   3,599      
Royalties and contingent legal fees payable 3,953   $ 3,953      
Licenses Revenue 66,548          
Royalty Expense 22,287          
Contingent legal fees $ 16,682          
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2018
USD ($)
Subsequent Events [Abstract]  
Severance Costs $ 2.5
EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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–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end XML 48 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 72 213 1 false 21 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.acaciaresearch.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.acaciaresearch.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.acaciaresearch.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.acaciaresearch.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.acaciaresearch.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 1003501 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Parentheticals) Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossParentheticals Consolidated Statements of Comprehensive Income (Loss) (Parentheticals) Statements 6 false false R7.htm 1004000 - Statement - Condensed Consolidated Statements of Cash Flows Statement Sheet http://www.acaciaresearch.com/role/CondensedConsolidatedStatementsOfCashFlowsStatement Condensed Consolidated Statements of Cash Flows Statement Statements 7 false false R8.htm 2101100 - Disclosure - Description of Business and Basis of Presentation Sheet http://www.acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation Description of Business and Basis of Presentation Notes 8 false false R9.htm 2104100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2107100 - Disclosure - Income (Loss) Per Share Sheet http://www.acaciaresearch.com/role/IncomeLossPerShare Income (Loss) Per Share Notes 10 false false R11.htm 2110100 - Disclosure - Patents Sheet http://www.acaciaresearch.com/role/Patents Patents Notes 11 false false R12.htm 2113100 - Disclosure - Investments (Notes) Notes http://www.acaciaresearch.com/role/InvestmentsNotes Investments (Notes) Notes 12 false false R13.htm 2116100 - Disclosure - Commitments and Contingencies Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 2125100 - Disclosure - Stockholders' Equity Sheet http://www.acaciaresearch.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 2126100 - Disclosure - Recent Accounting Pronouncements Sheet http://www.acaciaresearch.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 15 false false R16.htm 2127100 - Disclosure - Subsequent Events (Notes) Notes http://www.acaciaresearch.com/role/SubsequentEventsNotes Subsequent Events (Notes) Notes 16 false false R17.htm 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 2304302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 2307301 - Disclosure - Income (Loss) Per Share (Tables) Sheet http://www.acaciaresearch.com/role/IncomeLossPerShareTables Income (Loss) Per Share (Tables) Tables http://www.acaciaresearch.com/role/IncomeLossPerShare 19 false false R20.htm 2310301 - Disclosure - Patents (Tables) Sheet http://www.acaciaresearch.com/role/PatentsTables Patents (Tables) Tables http://www.acaciaresearch.com/role/Patents 20 false false R21.htm 2313301 - Disclosure - Investments Investments (Tables) Sheet http://www.acaciaresearch.com/role/InvestmentsInvestmentsTables Investments Investments (Tables) Tables 21 false false R22.htm 2325301 - Disclosure - Stockholders' Equity stockholders equity (Tables) Sheet http://www.acaciaresearch.com/role/StockholdersEquityStockholdersEquityTables Stockholders' Equity stockholders equity (Tables) Tables 22 false false R23.htm 2326301 - Disclosure - Recent Accounting Pronouncements Details (Tables) Sheet http://www.acaciaresearch.com/role/RecentAccountingPronouncementsDetailsTables Recent Accounting Pronouncements Details (Tables) Tables http://www.acaciaresearch.com/role/RecentAccountingPronouncements 23 false false R24.htm 2401401 - Disclosure - Description of Business and Basis of Presentation Patent Acquisition (Details) Sheet http://www.acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPatentAcquisitionDetails Description of Business and Basis of Presentation Patent Acquisition (Details) Details 24 false false R25.htm 2404403 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 2404404 - Disclosure - Summary of Significant Accounting Policies Concentration Risk (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails Summary of Significant Accounting Policies Concentration Risk (Details) Details 26 false false R27.htm 2404405 - Disclosure - Summary of Significant Accounting Policies Types of Revenue (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTypesOfRevenueDetails Summary of Significant Accounting Policies Types of Revenue (Details) Details 27 false false R28.htm 2407402 - Disclosure - Income (Loss) Per Share (Details) Sheet http://www.acaciaresearch.com/role/IncomeLossPerShareDetails Income (Loss) Per Share (Details) Details http://www.acaciaresearch.com/role/IncomeLossPerShareTables 28 false false R29.htm 2410402 - Disclosure - Patents (Details) Sheet http://www.acaciaresearch.com/role/PatentsDetails Patents (Details) Details http://www.acaciaresearch.com/role/PatentsTables 29 false false R30.htm 2410403 - Disclosure - Patents Future Amortization Expense for Intangible Assets (Details) Sheet http://www.acaciaresearch.com/role/PatentsFutureAmortizationExpenseForIntangibleAssetsDetails Patents Future Amortization Expense for Intangible Assets (Details) Details 30 false false R31.htm 2413402 - Disclosure - Investments Investments (Details) Sheet http://www.acaciaresearch.com/role/InvestmentsInvestmentsDetails Investments Investments (Details) Details http://www.acaciaresearch.com/role/InvestmentsInvestmentsTables 31 false false R32.htm 2425402 - Disclosure - Stockholders' Equity Stockholders Equity (Details) Sheet http://www.acaciaresearch.com/role/StockholdersEquityStockholdersEquityDetails Stockholders' Equity Stockholders Equity (Details) Details 32 false false R33.htm 2426402 - Disclosure - Recent Accounting Pronouncements Details (Details) Sheet http://www.acaciaresearch.com/role/RecentAccountingPronouncementsDetailsDetails Recent Accounting Pronouncements Details (Details) Details http://www.acaciaresearch.com/role/RecentAccountingPronouncementsDetailsTables 33 false false R34.htm 2427402 - Disclosure - Subsequent Events (Details) Sheet http://www.acaciaresearch.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.acaciaresearch.com/role/SubsequentEventsNotes 34 false false All Reports Book All Reports actg-20180630.xml actg-20180630.xsd actg-20180630_cal.xml actg-20180630_def.xml actg-20180630_lab.xml actg-20180630_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 53 0000934549-18-000079-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000934549-18-000079-xbrl.zip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�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� M^3%M@[#,^. MAYI/:Z\&-@L3>8 \[D%'; :B\?%!N']XW!=9-H()!NTR:)=!NSR*=MG?#XES M!NUR#^TRU&*^[9#?+?@S#\C;_3AUPP["@]VA4G&# M< W"U8-P_3 %QH["@X/^+-N/7F)L$,Y!./O=I#JZ3T7?03A[#PT'P;P/5PWU M_U9)PHW/9QV'AZ]G6<>%-B@P 8%-BBP MQW3 3L.CD][.O \*;%!@@P(;%-@C*K#]H_!@;T4IL1]5@=V[@OS:H!8]:.9K M,_K?E4:L]8O"Y=?4%T#8#=PAPR<"=)WD%:BM;[CJS$NIC-FJ!3%2I/-UM6*& M=!2(R]S6HDG2$K404-"]DLKD OJT*8B*FP.Q*A_Q>*MDX051'H0W:%L+\W@( M63H+29B>+-BF 5,5E-3*8+AJ-L+/4L2V \NUHQJ'5#722*4IET6GQL!U,1\G M\FJ*^ 4V4L/=%LQ3\)U)!DP9+],TBI*57,'"E*S;VT!900MSJZY/-BY/6@8=JU M[:6YOQ[N[ ;T5(:: +V,C^')*XWV'3.8M,60UC67O,K077C K8+6G?S>FPD8 M_)'E]NJ^WDA?]7=?+]H)Z#2M3OUZ6_?11FVNTZ:L&BY[6^BB4.7$U@1@19S-6G8PLN=OPZ"9CDO0*DJNN3EK-%H6 MT57F;!GD)>6QS$QT-2>!)=QY@QQS?&W-8F2)I=VU.BO**50.(Z+6V M0*[:##62%Y,T1DW@<9.1J1TO*YW(14TB4X]!,57F^"(J#U1#7U,8LBVF) M6C"AM;>F UM>OG(J-IYN4^H\U WQ2HVP/^7'#I K+E*HV&VU%27 MF180UI0K/(UQQX"]=WJPVX%'*Y#D7X*KX@:UH<)[:#44AQBAR(LH(50NUKJX M:-C;G!;Q9V7Z$_UE YQY'>VI97G>5&=PRGE3XN.-%H$YFR_%)1>8QQG,H)Y- MD=%;4DEOKB#WDL)Z![J@GE=72[/%.*U0I,=4SD,QO:3ANS-2*LO&E*Y.V!#:SU)([M)RFY9BN4K2X1\]%X+:4-[W61%*@:I[4E[X*T M'6HH<=[ET\Z'G>#7\_/WIB(/-%\>74H*PA3G<65XN$QE5363J:A^<=E<)58: M!7D!K2I2]+C2J2!H4Y2^-$Y^0@*0%94N*NT)XK)WI!._!O826]4Y?^>;M0;9 MRE.V4U9:'-U+J=0'0L1(QH3EG&C69%RM!I7&DG2,C"L+9,WY$DL\4W,62=24 MNA/JA;8*GE?CQBMK-"U0#0UCL56K82/3/)PO@&2?G"]-V%%---3U"KDRD+ , MUA]%2;>%]DACCE/F.E)N1 1DZ4@?I:6I M0KJ0@B)/X#+E8JB\_#)&4R(H\@N1+G/MC0^*1CK:H]&B^F =?=$+[0:,>D8W MXHE$EQ&(P#YQ@OPYUZF*OMAFM*@$F-T$R2AH3%X30\G\H*7-?E+IX[!=7 MU6K0Q4^4%,\!F;8\O'@(D3[>%/WDLISA;I4E;U<'[Z6KP]._]3-D"$\_(]KO M:42^#O>R?)X&KQD:7'*Y&Y*&U=6S>NI\@G>(C(V0\= M-\SP]N/='*R;-/+ZIJ"U4:*FM6^TDP0N*69I)M) M;U*4@+*_95HE::SKPMKR[6!H_S<; $H=:%U,5C9YI>KNS*;G_-J]\QG9:(HB MXSPX$QU'94GQHB1CK3"UY*#-PJ9&!\MP3_QRMKMN_-*7;[A2AMD)/G95-^>J M[_@&Z9<2R2#SMK_5]+%ETEL16*EY?O"F1SZI1_MT)??W5\TUI>^0BY& MG*-*9ZEY7:-Z[37_G)O]F/RPM]N7^"\G_POZ-!FI,CC8$\W5XU[KD)*Z1TKJ M5926P3^CC"S/6Q4A![XD0?@@!G!Y_42-:>95,$9_U]R?/>C ==J1P;_AW/7( MWU'"@8A<4IZ!-H;J2UIWOF6/'NIJ\EQ@7M+V,[L[3%Y^G$Y)"5-KG#7ELPAU M=*F*!KL.);93<8Z U'/)^Z6MJO(C5=\HE9L'^7PCVN/\O70Q<73D/0+)GD19 M52 )3Q*05E>(VGQ:7*5D"9I@\2P[&%'UU&:X7LQ2^Q";&=D[#*O-VK )9]K%5_EZ9^PA6Z@3%$])7_$ M::77%#LQNFINU4LIW#45XMX*XP;+AK2\\.S9\5WN1;6O@ZRJXF5=3.]S'61A MI>=FW[KRQ"O]31INH7[(5OKLUF6]RQT:FO+<..][3^V^!X1\]M^6WGJERAO6 M XNWBQZDY;>_V>]8-$[=PW[GE-UK5G:]3.#GKMWL?S0%G\PK^8 ,#()LIXGB ME]/=*=8'?.(=7*]NUR)WN8PT:)H-U32K4#5W6Y"^5(WTM@)5LPB\M^:JYCT) M/A+";XM$996<8/C@G8UX1%7TCF_8^ ;22FJ)7?+-M#EQW]B)I&F2ZJLJ<36P?R(SE M<*%..C5BT=&7S1:9 W[F1'E%$4J)I%M<%_0O=C[0E-U^,FDUER8;*5!.#TLN M1Y@;!YIT>C&::FEJ".2">U'H8ZARIOT:;I2>4U?F:R=X94_++CEX:X:%1?/E MGY0%4H:ZX@.M3&IV\D M!YQ!UH(QV=OUS5AO#M7P_\!S \_=->DW\-S W9O8TWJQ^NBK+>1J;8 MWY=X2KE=^X)7_>%#?XW'[EH [2FAGP\.P^.SPY639%T6'^\-I0B_$Q=A[;EM M4#6+3'.ZO[>_>G%;%PX8],V@;P9],^B;3=$WWYZIW/R8ZK5#AF\?_MCZK:A5 M<+1X5O&A*U4UTUM.,]YR+O-D6LO1R3T9##7TU57>$ Z\3\WJARCQ)RT]O0*5 MM"Y2LVI/9W!H!KD8Y&*0BQ]*+DZ.PMW=WK)SWXM(K'!'8..=UX]%S0B]YH1R M]P'PWG8(5E-FK/_DM4?IF%*;L>7?BP03=",8;!HTY: I!TVY%KPZ:,IU#:<')=E_E/Y]!>.M0^\&A])#\=2 E&M\ GZS MCHJN'W>M'7T&_AGX9^"?X:CZ<*RBIV,5:QO=K,NZ;T8 LS8QREIE<]:%AX:$ MS9IZ1(-*&U3:H-(&E3:HM$&E_4@J;6_W,#PY6H-4\KKP3X_9XC9"JO_\HPW, M(]HMX>+IPXAF7_M_'?_=.JRG!+C>.[V+_&T:P#76HJ7/6_B7#UC3;\H_'+G\ M0Q"T,A#]63D,H4?B?0NMSEO[(K8^ET#F_A-OH0YT7$PF11Y45U%I*N?IDO/ MA(V"K(@_;Q/%H\M2"88NX^&J+U-&^J577ZE1V43E+-@[$L@A1GM=@O#:5#@V MF6GL;4&@W0EDJ&^!'FO&>?KU<:(DWU?&>L>1[+F1U&WXI%M'$=V+6%Q6ZKRY M;*K:DBK$^Y7ZLU$"*NP C'47DPA(OMC#3%HU)W]O2%7M'1Z&_@"NBZR9H-;< M)*UUG4H0P#P;C-,,<]8@P[IZ0 1J9AEOHW%Y I02*'4AQ(!,(LION>J6%4NTCPP:/?C/HOZ;EIEY'X*.@(+_!YPU!X++9C" 3[ZCAZ*C.EX_VE1 MB \V&03Y&U\_V^3!?^/KIP-^]$8FHMQP][X&K-K*$"R>&NN'O&L&L]K>,G;U M8Q_@TJWS$;3U9&=AP8[@=B.+Y(O%)#NT8[E*O<&7DW55Q);A1E7%=+0Z!'N:0DE\3] ZS9 M &O6_=[9;GAR=K1RDJS+XC\H*SJ1%S$7I7=59Y2 M:T6R0.2'KN 3WC0:+N(-V:_A(N? /P/_K"%]5ID/W=UTNWUQ%>67"N;9.QY6 MC+T"5F&0J_HAO/@U -A>([ G18;=VC\,SXY[RQM_E3".C5875?3.:8M7RH?( M_>G0E[\CX:-8]71U%:<'V1MD;Y"]I8;O+#PYVAV$KQ?AVY T4O]IH_LCI&]@ MCN@>IUKZNN>\"&^H[/)T2;A!@0T* M[.ZGIL*]DT%_#?IKT%]KP'F#_EI[Z/)-8*-O56 #YLP=,&=N&U9+03% C']? M?'NOC3GPK4/_IF!Z.;3*P^-\!V22/>P<2C M586['$E0JBRJ%8-T:-!XM)1& MHS03+(LKE27Z[D ?0^X=?L"V?#O@1G_L=/8P=CI;F9#.J[I5P6_(1SS^;;(^8?V1C##B*"1D*6 &@+4R&7.<"$1 M1 . -300A?2&U&2:%3.E+ CER2^5 ,Q4:0VTF/(Z MC:U ;EVJ7)4THQF_C UIY CUKWIL>+F>R1"?:40'+)D]KCZ*)JE4YH6DFP4B&."V+I(EK,[:\82PE^J3Q M>6B!T$8EQ Z*GI5\!-XJ"YUE$C/,AOBHR#)8;V<9 \/.D2%2V(S=M-7.U M6-!P 7.AT AH,G91::H_T4^T>F-@E>#V55SD22K(08Q\%(W'P"8R"ZUYK4QX MW-E,*^RB4J8#],GK S@C>LO,)/=F3"^-55H3ZPFJ1ON^+,:0BM>X28EE_,1"LF74 MQ/[N+_R-_;SWRS.&T]++)ZL,VXXORH29BYGO7!X 4WRHB0-Y12^*)!V3M\)L MZW=R_N&BU<7)WNGV'EEC[Q%?F0?;(@US&MZUP*PFE(GJJL*5V/6%-"D93FR@EIB11XS1/#?"4%OC0:+*E0A\* M0<:L06GQB/P@.0.\54U\)?T+_;#:<4;N&*V<&![CCVG=3VK]C?W&?U)+<:F6 M0;MIE>BI8%'^V_9YUJFEFA:E;X#F .*(RS)G+:&\R'6L,Y7LM/C#ZDG@0B5_ M-%6]M /P=,SGLZJY UID9TJCW,3PX$V'^[74I)8 S2HQIM=8,!C(L%N-WT0M M2[\VMAWC&J?7RMCR3U,:VK@AM\>TT79:Y"U6WEC*I.%]1CQ07Y5*:40R#2;V M04UKC7^X:_ /*2RX3HNFHI$VN4>1I51+)Q.5I+0\](;W?)I[P89(VDU*PR9Y MH&$W'&Z,%$^E]1[;4S)5G9P0>GSG!,4RWF]DO^.HNM+^2^>0)=AA$^I:8=,[ MSL2X4H]ZM7C444(^3PI>J+$.EI]S#3D7BVTU.@,_@EHYYRTB\:;H'P&?H\4J MB"2"/_CP:.6'M)U+8H^/)>NMV1)0E(>09"?X74V;DEBP$M^H=CY42]Z+IJY@ M9^<]U0YK+:Y:S9%,!6-"GETBWID'(#F-C,YCAQO>-=XOBXEPVY14(7FHT-IQ M- 493(?2F0UJ&!\/M@B<6)=-S,Q;JEIC6_*L#.6T=WU.8J>^Q*JR<^:A+CPI M2A!RTQHND:N\%,E", T6IR%,HS0A;C###;6U,<)&"J2]@&8&+0DR^ 75%=G@ M;Y";M+\@+;P[2LB 0I8FW$B0YUUMA_ZH8:H#4PF<#J9_)B M)_ 88E94JJ010SAI.J$/6YM658,!EL%E$W'4[L+]3SL?=H)+"'\N*D240$36 M,N;.^8%1E),0CXAO(^/V$A.)G6>(S!JFE6U]:;6L P4&S/ =Z7DK=O&?30%J MK^I4!;THF==M&?/8_#9U M09P('@7/Y&W=P7EQ* _^"9#7\,KY:T&']H7:HP75X;[N$-%E:VP SD9(.X)+$"50% RB MK9U:U]-\RLUX!NP N_;8+_G"&2C\2D_'45FR3RRO[01&?_K.SJ(JA<*G'CHT MP#*]KQ;H9$F[3:3=KDAA&+4(XDC8V1451][!3 GV1)-4)"Z<0,$"C1#8\>A% M=P1;6I<\"X6I3'R!X$FKN8[M&8D"31*3U\?C3IL&Q&SH!W*SV.,C^T%,)\Z; M,!R;%$6FK()[1\J>E'RPA6Z>,G+X^]*A"PGU M\ R[+(EO\+N1"QF8#IZ>P<'6/:#MVVC5ZK"5N*^F*L:Z!"GTETMQ:=?:S<;F MV=+VSMB2L:V]=MUL=W/>$HBG,P^?/U[F;FF)]UTI"7@ . YQ_4XAQ\_V=\Z. M3T^.>L0=/^X%=_SPB8&_-QH\>YC\-[S^Q(#W/]+D-^2NSMH=PMPPG->UH]_ M7W?DKY,GX*\U0PW^M:2((?AD8XF!S08UM@[TVQ#;N:*]D059Y7X21/0BN@^HS9JQYGK)\\!L7S/$R.$-W#9P MVZ-PVQO.$P_L-K#;H[#;=UL);)5G8UI5@Q=3\@/2XY ?&9!"!_Y9/_H,_#/P MS\ _ZY086R-(QE5Z3/-G+X3W6??'QWE!IZ3MQ%]:>VP95X[^W-VB90NO'Y/JKEBN?\^+]1#=N_= ?F7E<+M6"J?P,B#_\9L)17P1:N2J9Y-*YQ M^QGW9Q3C(V0S'_M(O]Y&88K_;-+203*D9;(]C4JY.EH&Q:B.#+Q/7.0YFBUR MN1@XPFU"7-2,B\F(.A<(D$ FP&.6RV[1!. VN O7U&F6_B?5L!%M-!JYY&;A M:-(R*-6$^L;3BKHN)FD<-)4:-UF0T=2J,"BC_!(_\]![61!BSU[:P>W[7AJJ MTB\"E--+:\--P"?1&?ZM[:@.;CEP\:!%#=[E0,S#)>GK-&FBS+M/+/=^#:(# M7Y-6T V,::(15@1ZK76Q7"" ^%XY7\+VX&*"*P'4"PQ6%[6DO@!^H5*MF\5I M/J8I N2$95K?HF5T/](VI"]R06PHB$ZI0Z61D2@5MN\S[P2OQPOHEH*2F%9R M!ULCM>3^]/FV^$W19/I"^PU&.5J LL&)71^QRBBCL7F0QAT&:3W?EUSNYF'9 M":7Z\7V& BZ:V8 <&RE0 &#QT M@Y8PLR *S20L^] %%!E]6'7P9B2L:!EOT_A_:]*7$^&DY$3]5L)DB']+28'R. M5%;D*:_>]J#NSX?'X$#UYF5F1^ MXR%F" "8I0-K/]W"237O&E90MVA>FL6243%BJ#?VU/=G>,97@GY2LWI9TH@@ M8U6^W@V%C:(6@*@J@1:"CD)0DD%:T)1&@;0P5"T8:C>6VZ:1.U91RO%&U8S' M\-1R)C(Q+D(^8)^*MKUUC/.T&:DXHE@N-"I876L0&&],X3SY&&T3Z\3Q:9PB MG&5,F-:2>SZ9F0,QHJA_(\G?@ *]_BKZL0S,1Z8P@] Z]\. V%+8P*[3G-*I M[B:?#'K1=$4H"PV$0E9K93>$B2LE+6'-XG8UGYG-\;"9P($VD%JDH;_-"Z%E) M/8$NA]%:V;B9-)D UMHV1RH59"L'H31OL#JH6SL ?<2&"]ZPF0BST>),@/0T M5LRR#/]])%Z&_R!CE3*6^*!G5I)/<=X;K:\/O-=/TDW'*,"-5C<2HOB>UY\- MV1_VVB1SPMAT15E9$+-MH.EM4_! 44U4SCQO$^AS7N$)416,L8V:!;YL_]$D ME_+&ZYQTX6<16GK7_&!S.AZXJ(7@HR'"!1-Y@3JC+S+SF::5&$NO8*I%ZTT+ MY&TY@]&B[]ST;2+&)*7;*AYPNRH1HODPUWJPNC^8XHC4_:6&+!N3S!(%0XM3 MK=%"/:#-"T35'P=80D6EP*^MJ4+GB2_.+O< F$1@JCRX%A)\,38JT;HT* M,RP@BFN:%V3VL)'['9.M*#J7O;74;DMX?E'G>,UPRKV\];77 MS)MM5]QM<\NOKHB,8SFWD> =77@M]X3. A7Z1I7,3RCHX!%[@W!T]P M ]M2X$T8:&J2!)IYYMG1KXUCF[SM4,*81/FE?I+UD>Z?CV5LU]$77VD*?GZ. MPU&B90R4NQ"GOBJ+YO+*IX&15,3@_OP]:?;KII5:0Y2*!I'KU*U?+FU$OIX4 MTDDG'G:SP/6+);,>&">&K5?YTG;"$T(RQ4RIGDV1M:85M;I(^21!:8Q"MJG* M8D8.](P'ZO!Q/3CMEN?K=EW=%+6V)"%N5&XL7U);#&PF_&W2P-TC9,F)*7U%%08O:ZUL%5$>%PBH1:Q M: [;Q7A[6L28IL9S1D6[JHA3;IDSYI&+7^9YN&4(91@FPZ6@^6)1VR06EV6D MP=%)FVH_'TR>>11S.W3W*&1HV !^C+VJE]16XEQJ]+-WCMHZB7U5X)B4# M(DY"<&D.G=01MX6K@1FA2'M%Y7.ER[I*D'0'ZR[!X8?M9?NAU!)*VQ=4.?&\3;A\-Y'>%?-B=RBZ$E6@ M5"<5X!9G&6>8*[2OCP6$MJ: ?HZW@B8%GTRBYT9=6=-X;!6WRD/2:2JNNTP@)(NM63 M4/D"V?Z)Q=5O+_5"/=DEQ3@D$@\4%[!%I,:NT:W##)/S%:8 M7616*V>C%Y>W_KI1G) M5:W9D(P1[:4Y*9S$_FKZI9]\8JMV:2]- I?,B:T!*.NE:=ZQG=I[!3TN]_X: MLN# @_WR8%\%KGT>W$$XT*I;WUU@QQ4/U&4ZJ[F#>^SH&J\_9TM/5D"NN:#8 M%">D^%=R/Z0.,>_;+;DS1.,W'+34]_-&5: M4;2K[]!LAL7JW=[.W7[)GINISXLI-CE7".]S.D;71!?].7MBTL*=176YO-)/ MR21'6P^K5D#&S-S3!:3]GA1AR+MF-K5;-AF)@L!!X3ND5-P!+%,IS1-%CGN) M &FMZV^2BVUSN5@@''C81IXO4&51Z?20! XD4&_Y9,_8G!'B'31VHIQWY97] M#NWY>KS&9W,E>#>Z!=5$Z=MD'"&,-.>4;'+1/\TK.36?:R3FA-! TS0A=9J M,F5).8WXD*TYL.RV#R/2-(F^2X0C$;RM@W/"Q NE7,^34\PWBF)DE#-'@$3* ML/;VW$GU9:RR,%H*>IM,_Z@+H]H*QGB8J\UAK^1WK? ^Z%+P6WZ"_O]MR%Z&27['-DXXTGDR\U=W$,':^*&UW$ M<8F,N45'YB#B1==J7TKS@8)&%FW1^3$1'>G]RK:(1Z16(K=L#O26^@1-JJ]3 MX39%U?_KBBQ64#2EEQT6(?1X2U:-=WI;W%[DEP7G?&T:'@V9 MU+&R62.BN_(K:0"W=W=_OQ)%-3J;TI:YO8P.!A1>>/495NV1?6UBWJ M3O KJ6;=;D.2VY5A9#V?Z 0-5KHKL[C<.Y2KTZ%G&G@FD-/H)DC2A/.*G%?% M!4IDF_0ICKBVO'R/5*H=KG3,]@&UGZ,97TQT6],8@M&'IB*H>(TX1,T)X-K. M1^\7PF8AXI,S!^ E)I&]6*'?LG(+PW>)$_>2JN52V=H&?'AY$6BBD7+?"5YA M69&IJOWQR@:*)8O1XV)6.X^&^,I!KF[SY]? M')Z\?/[RY.+5P8N__'W.>/@R_)7BG%TP&ZLZG M.I\"-7Y?_N/3ZX__[L->(N^9CF>/?H*N*[/:>[9UE='>"D[N_:[,727V^B[D M&L@'N6O5CZ4CQ_&5&I4-SF)#G,*N'8#G!2Z\T0A>I"4?R"6GH*$@H.0=-#%9 M]E85/=9,27OTO/WXU_U=F./>3+(;7M&Z)M.:.)D,'"%,Y%2$?PDGA\^4VS-I M;IE*I%2NX>W8+_4E-3Y* A-/_\H)!UTGGD_ZVH-M^AEPMV2YJ M7R:\&S>9LQ.RB:C/T@31?"YJGM.ZMVYQ^F!:5#H8\J*]SH?E8E#.!_/UD5*> MO'>O:*3JFH_J<:S'?H$^P[F\17N:'J8X+[R#,!WT=,<\L9PM1G/P"\N6P5*)]=]<5WBK6L ^0=+8)SPSD(?>1%2WK7X#4C.(S-^=./[577?3)0A#D (#(#&2CA M&;U%WA97Z)ADI4>>I:YN:"Y'2GC+Y#.OX0@S7ZSD:(.^IK6,.75[%90^SL%X;;3@YM:]T/G)SN[)[L'>?I^ESG=[*75^ M_]?TG??UXDP>_=_JDW>\?#/6V'P-TTPYW_UZUR_9_C-IE'PLX-K\U MO&%#ANN#V,WWQJ@]A-#W*Q+W@Q#Z7)^9?<]P$M.(YDONA=![(/*W$WFQ)R&[ M2_LZ[?$"/D/I/@N4G!?JW=41>_+I:7%%DLZ-_VTTSVCK-S&D@ M.WJ.NX.U/L8ZNH]8I677Z:I;*3?E:Z;7K]IWGO1 M\<_^;M^IP-5Z,H](T(TEXE<-Z$#$@8BK).+:$&YC=>*&A,2KO*5&OEZP)V>4 MMP-\6'IB^1'+4JQ-P86]<.]L-SS<7]P,>B UUF79\=XJ:TD]XJJO;\V13>+T M@YW3LX')!R;_KIE\[R@\.#[NW-P?6'U]G9Y^\Q4"@F)/HYRRNW-GW;?"!,7> MQCN3O!D@V]]]NI#M9-K!]$N0% WVBTTVK==@1_?&>]0+>;OU465]>Z8/)_(J M"/9#*,BU+\ V5-];E8N\]DO?@[QL:I)O2.QMY%&-S:GV^.1R^KV=8']?%F.< M:7UM<.FQ^]@3XBQJNYEHP3'EWK&YFGS^^GWPSN I!V_>7 #CY87*HAN<'4N+@,MT/<,R3Z>R1U2CSQ334TS5Q_J$4-8=L.5 M^IP6YMHT7W,M\FPF5ZLTIJ3!RZT-PJ]?3(\G8V_FXF[5K-#$\Q[3Y1-P58S/ M,B<>/E'70LG1YLXEC!A?RYVK'LV8B'QIC(COEU@RO>%LLES8=&?&6=JX%WF; MBP]EPF=CWC'"H?BP1FF);R1 MI)5<-N/KT_/KCB?>:"%\8X705)IX9V^DGAL(B8"3#7S+#PA2S*0V6V#$?KEH MD0)P;2W9KD\N/R ]"B]3M:G"K;H_[<9 M>$-:VSO:_1N/4@$Q4VY+Y.8^CX%RK6\*>:>2EPYVYU[":CLQZ8 /N[P$=%S= M1JW/@W]"L].(GH7^E4.-E$\KC^N66M&XNQ]Q.DVYP /KX5+-ORIU8P0IP%8I M:"T?_[5\X0P!6MSBBQ"?[,=]VQFOBUP.H!YZL6DKA"AZ.";?C^L4:1-8W! 3 M];((Q[O]((;<9E6,]M6WRG"MI>:K&&SW&-NWR,0XZ_DM*![63/PD7Q7&UVC1 M E+(M7%V!.*F%%!.[PZ[P[1UY37I-5%]YEH461]==\_4#FHI139E6KB@M?C. MG+OH!I7/>K/2!DCT I V-T(:Q3L5(F AC3(,]DB[_DLJVWJU%FD=&:*]E[Z/ M^M$GWW/]IE4IE/=S_BNX%]$2V=G#W5V1 (9F/20V^+J,ZWMFQH%(VW=Y3SI= M[5#?]\L]PRSA!+NK;:^W%T[YZ\G^?F_7=L44MT=96^/,U.P+J^VO>^'9V6E_ M&" ;XB<$G^#F":*($LPF3>,F%]X-/BB*;@4(C"-MV)@I,*R*IB*_J,D]?.56 M\&CPZ. >>YA2'A[S]^RF/"9:ZC()$%OPHDV*1&6MK,BOS]^VDA0&R,J4#*.X9\371@T#"6XO/!)=>KNCHD&: MHSJCX,!\I>2[[VQT1!S6F'H!QUK;TF<2LF=FG@,R5GEB M5AC!CY-5VZ"F6K"%0X3[N_O[SR0*DG5U116X";XTQL4#<"'> M-+JNF"EJ;V@1X>'HY+X&%A%,3S*,FJT>!01N&J\@L$:1/K M,;3#8V++ZFJWH&#(]AAHI8*"Q74/W8K:"C M=.TYG.XH>/'FW5NOT5=IGBN@ M:?*R>GABD?'29ZX4QG6!:4C6,\KB1J1II"$9T:21H:70#KIZ,KVS]S=>>2GX M9(;#B'O5M-#8&:UJK(L+LQ.\T@I!4%PW#/R7Y+693"79(#K5,2OX1M#7.!]L M9+27G@]VSH(9F:BJIWGX"]N;][=WO'.ZW], /;[M:WQ]A>22DI):0&!A6XE7 M4,E++5>L47OI<'_GX*"G;$)O@*@[IT<]#8D=!-;S_5,.:FVMZ+:WVZ,8B_%S MYD3LA-%*\+S[T3V]R8VS5)X:]"H?AJ[^SY\\.58R@^<4&M3Q+;6)+UM-0= M<(92Q$=!0LQ.8R/L6[R M-*S ?PK:LP96*[C>HE<6M[O^%CXGEN5$R&U!P&7O2"?^EOA]@&'=OF1KD+IL MHE0-U%7/=2' Q,4B\A*C4"LI+W0NQ0U-^3R!X$[2,"%MIKU;8RB:0YM&/L-4<@PC*DX]"("N/L35!6'8N>4@!5P4=4XZ^PU]"+[P5V4!/7)5U].??_KIYN9F MY\NHS':*\O*G_=W=@Y_P\T]X\"_Z^7HVI>?YJ H%E7]!TS\MM/WW__J?G]!. M^C/^_^__'U!+ P04 " !3EPE-P"Q:JTL- "(B0 $0 &%C=&'-D[5U?<]LV$G_OI^#IY7H/LB3+3BZ>.!W'CCON.+''=IJ^=2 2 ME' F 08 9:F?_@"0H$@*_"OEQ!X]DYG0P.YB%S]@%TL"T/M?5KYG+2%EB.#S MP>1H/+ @MHF#\/Q\\/5Q>/%X>7,S^.7#3^__,1S^\?'AUKHB=NA#S*U+"@&' MCO6"^,+ZYD#V;+F4^-8W0I_1$@R'$9.E'E;,.6/V OK IQ3- LYO";4OX(N M"#U^/@CQ]Q!XR$70$2IX4#:1(4A5#SY]_C-5)@FC,7L#-A\WI3'0_@YP[.:4>^(T+F@'$]' MLGH&&-3DF& <^F8&A],17P=P)(B&@@I29"=\U4Q9!DG@\(0GK=7I**I,DZ(2 M&Q!F'& [L6&U9?/+5%%/WKU[-U*U"2ES3(1"[&3TQ^?;1P7\X,-/EJ4& O(# M0KF%MP!T 9LISI -YP $$H:WP_%D.)T,K&CXW!(;<#58TR8;&4?0XTR7##>B MCH0. VO43!U*/,CVI(^2M:M"14 O8;#Z$J\ #&'!"U]?B[WJ:>91FI'S:")$JOI,J M3M[LH**2C.%<>O+Z*J6Y]JI'@V[1'#NW;_;'==1(H33M-VJMACATU MYX]FD V?-FN20?MH3I8CFX28TW5MEV;BTW^T\659H2&E8B'40ILT8_+7SOHX M$$F))TU4T3SR8;AA;J< 7-F+QIV1,*FGG3L!X25D7 J<-M$BQ18_#SBK1 6!,N!(DBW1A M$"#LDJA$E,F0?:;C]@-T+;4R/8NC9OGZ=110$D#*D5A)I9;P2L""0O=\('.% MH4X&_K2!=R16O)IDJX'LBD)%*,%BAYXRXG:CI)8@??;Y@(G.]F!L^?_<* >Z M38T2+ BC#MOD@5E3FP0+]#IJ3D!A4W,"F6T/K"C'; M(RRD4/R1DF8![%@9>>]'>2DY^2&#SAW^H)[S/14SQR0EC+FI79LO.WN,;'&A M!J(=/%>0 ^3I__8&5DYL&70GDSH^A0]49.H1?+M-)"K5BJ%8E]Q2S5 MQ_<"& +:X]\L*2PCT@ M7-% .?LIAF+N)9LR%(M;2I>D4X!07QAX4+0H"6\P0)!>$O8/CQRG5;* M,9^VQ3S=FA4U9_TL&WR=Y"E0[L1B7>FX;[13@LL!/FX)\*:!?N'99&YE@EMS MA'=HJF)2&\-UBZFCB>&]#8E78*KY:M\2;4@2]-MO$)JZOE[,4,PO["_AXBIYELEP_MHL#1- M'D\,:7+C(6!%C5NIUGN91>L=*@*A3Y@COK[!+J%^FSE>)JD$T7&2.2>[95*/ M$L!(G)62UR. 4O$0TL>%Z/AFL!CXRSWL6X.'S49((] M/1D?UP2EEVYLNU^?P,QK^M:]4$H9.-/QV^EV0"H$)Y+8+VSD9V2U]DX]MIP^ M9:+*WZY/C5,H$9)Y[N<4,O5MNVE4(JET*DVFQJE4 %*OI](7PG? )>(N_Y(X M-2X$4OVOA/2I^Z.+1 MCMY5-X.A0E9I #HV[1N*!%H;B596Y"M.<4?LLGNHD>12)WC\QA#5JC#L]1ZB M6GW?QB,V$5SJ+X_?&/QE?4S[YU ?.;&?%\1S(&6?OH>(KYLA9^ O=YRG!L>9 M%O)/*Q+3:PRV2UKYRB:"RUWEJ<%5FE#+%.JR/KK*.EW?QE,VD%ON*$\-CM*( M*$LC"F-$>^@HPQD3U@L#/BU;)]U%0LHGG^EKQD:2%8GJYRS+]6>+MWQF$>4Q MS/3-SP!([U[XY?NRE8,SRRAW9J9/2@9 ^NBU?!_0]9W[B.88N<@&F64V\5#S MPS8U999_-C\Q3B$E6.X]28G.K-MCX:\(YGK[DF"9XT3[,1\0>VX9GG9JJ_R; M_(GXUQYQ*].J)9OM:<2K ]$/1+\VV%OOEQN _8IL4??_2)==RW4?CT^.3<&V M/K;ZZ17@73G/D"Q# W;;83;I:%* M3WVZ ^BJ24D8-_K_[KK?CW(71<0%F>LDU&42\45S:IS((_=_7DS&WP"E0![C MDW=?G \R);J!N?TYQ!EU (G/^$ MT4:6S]"?0:HMJ")J8U1TP=V90WR <)E53DCCC=?;9FW,@%A +2:5=_>"(64+ M%-Q#*I>28 YOD8\2-&I1MC)(6!-$DO8.D@?LYT=[(<8HRR%CJND '!0Y;)$Z\+J TV/G.+Q=(TWEJ=USM5T0UV/ $G+H8,PAT*LS)]RBA?2 M'&:H)Q;(,\,!0([P+ %%,AZ]1%T,5Z(!Q!(SZA"VA\,G6 0TNLZ;,XL\GQCV M<"8]PW[FQC*0;6K'N,$XY%2N!G1U"//)>$ M\61M'.6ZZR>XXA\]8C]O+"@GVL$,KL7L;DGHJR7O$G[%8M7EH;^@\ZOH(GEX MXA&)D2QF.0PB,;%933C^+KZRP=')O*]LQWHH7UG< R5G"+=,KD=[\'AP#1#] M'7@A) (&XB)Y*"):EFA+2BDZ-G@S9BVET@@'(6<4VF0)Z3IMD[GZ!Z["6HVY M:X1%EAC*NSK996@E6*R&XE\_(*[4&V#GPK:%ID[>HS6@_X$FVU2D@(V7 MOSFC=^ M\DY,1^1:L@ZDEV*[B^E:#Q6ZH%^AR#7%JL#^2,D+1@!_)E)&UA-5$1W>(=WX M@8C.LDPX_\V!OH(,HC9U)U()L>X7^0"#5S#Z_P8_D#7PY.VQZ;LY-PGX/5A+ MK1-KV_-W;1BG^D1N%R*TQ)+X.%3A&-A%0D?&A1ZY"']&C#R0F9B6-DM;6%#? M:5RUSK9:G*JMK2:3LM5=76:D3A<#[NH,8MN>7&WWS8G?WQI&6ZJF8V841L%; M9,N9#B?9N+==W+T<0NMX;%;]^/"J;ZG*TN\@GTC\R9K)(T!H*76,OUCF;6G MU[%/@(D%-_B:4(CF^+>0(N8@6VK$S-!5$7S -)0??@Q^(=@& M;*'6 >DD;%Z0PVEC6O!U=F06V1)$K\+T-V-69;N!OKLVAW(($C=0CD/^6(TK MENF$ 7G[(96_9A;;6DW7WD;94W-(=Q[$L?<3$2WZ" 2=],T.VI1*JH.\>*JS M;(PU_P+YG5O/R K2CKG2O*$%.6=A;2?RRHC\"!3+[[S1F1J.FQ(HU>H77AA MNEL$?H1V2-4/$2SE#X\)'>\I\1%CA*[E&5AM:0VZKL;>6/6LOA?.,OTJH8*F M8Z85AH)Z1PUNA6N4^B2!NSE;Y[;3-#A*T\SJIT8SV.%GB[6,\^$,[GMK7V+K M$Z0^"Z M=5X2N3?,4W>_1&85UAYH-\I&;2(WAB,PDPJ)G@TH="$5LT[EFR*Q M3M]6 >/[;&*;6K%VUND^R>]M(8VN_RC("2IH.I$9;&]()'CSCNM;[DM ;>K. M+M/*+6"I75/U;,YQ='=5]#5P*&2!-R'T#,5=W[]*;U-&M_>,6W%#5O]RJL[=A0 M2LSY)O2%#GG!Q'7B]0$'*Z#NN=5&5= ?O[Y MR6\?T;./+]Z\>?+7O_SAS_^%T#^>?WA[\K+Q\[,XG9V\:*.=Q7#RI9Z=GOP] MQ.[WD]0V9R=_;]K?ZPN+T++2R>*/23W]_4_YA[-=//G:U7_J_&D\LV\;;V>+ MOD]GL_,_/7WZYW'Q3A1/>UF M=NKCD[_\X>1DR8ZVF<0/,9WDW[]]>'.C$>NMKVT;NVA;?_J3;\Z>YF)/7S1G M9_4L\[][-@TOFND,9@IFK(X=T+-H]K2-Z>M)\Z;Y] MN=.P^C59>&C-V7D;3Z%,?1'?@(P^BV^;;C?P/:#=LH-\=Q[;A3X8/JZ[38T] ME(>P\\;:Z#.XX8V/.MR7L?-M?9[Y^2X]GW?U-'99&C^W70V$O<\UIK,%O[<- M;H>F#C64]\#ZZ>R9_^>\[NK\14^--6(7XPY]9;L!*:] B\XNWTQ3TY[UF[8> M=4/R@7([ROS>Q!!-XH/RI12WFWE99;Q?9!0D^0K2^]#X)>SV?S M-CX[:]I9_:^%7'WU]3S;.*^;]@VHB^GG&K#RK.OB0XD?T/(^!MIOO:PM/"HY M'Z)?Z%[?S!<^Y?NVF<*??FEN;:.O7^V"!#_,J]ZEK?*#Z0>5'9H:=2@?9XW_ M_;29A-AVK\"2FUUNH_C^&GLF[.XW/?&R0U/%A](/+0]O:=R!S%T7_SD'9+ZZ M>( >VE)MKR3V,A\V5MHK>3VG?6.MD0D\.[/MY;OTL?X\K1.XY3>D$[CV?0*V M#VOE -XT4RSW%V&63[4W>^]H3Q&ZP<8\*CC._QPQ@7B$0"RKR!X>%N'& QT MV;U+'R)(JWG?$,,(3=\[5&\G?CY9+,>W\'E5/(]HK*VK9=?Q*QC^(89"G6\R M=?=#RL.V@[[1D"FXHF'2^!M(6/6[V-1,MG.++_X4$**>QLFLN_HF M8T8A3%9[I']IOD?=ZF7?'QOE'['<-V?74-SWZJ5 MXS)Q%2G2SC$$(PN(>(N1\UPEK1.G3O89S354KXZA*UAD4N%%(4N40]\DAZ806E&)GE-X=!_38 M<3 V):]VGVSV6"9[ M*%-*37+>A<^*&WYE!_W"3A:J?/;"MNTEJ/+_L9-YW##YO>I76 5+@N.(*JP1 MYUPB3@5&)(4@C)!$BUYZ[?":8*<9;!5 MND5G-?+"8P2#D2A08Z$KC0-U6"9L'X=.& ,1([&HF&98.CY=#@\#?,&? _NF MAZ+84*T*02DE?$")6X>$Q H9QP@B,1J=0!)K,L!(**DWQ@#$R*PJ!8SW;3RW M=5AM@H&,NV;S;,='C]H5I89':2E2#L;.60PH8.J1"TDQIY,%P;@[3/@C@\E^ M.%8*+>0]F"S&>>3YUY)@<7C0,4@ MHW,\]FR'P#TAA6O=VEFR=7MQCP&YH73E.:!2$XDB%PIYQ@0BW/"50ZP M-'M M/IWBV*=S7-:46LUO:^OJ23VK8XX$WK\/NV99;ZM:$6&"=Q@C1U1$1(%X5-AH MY"*'?RECN#"[Q,5&LH?O$/QFZB?SL @,MPOTS69M[>:SK,@_-=G[;Z8S@!.0 M\OG-=!9;F.I-%O0H'508<\ZXHD)8')ZPD_?@9[Z9OK#G]>S[(;1U09[U-2H:2/9!%-*. M&#"$ QC"FC,D' O44*>2&Z ZRL1W1L;!>*PJ&/B[VL%<1!KN.3?U[,+6DZP] M7S?M1SN)'Z.?MTN;+?S??.G5+'9$/]FOF^.%8_=61::#D-2C2$!M!T%AJ6DO M4=(R:$L %6; ]E292,'8,#P*-I>"\(>;'+'M ME2LLA7>P7+-):)'WQB&A!$4T19L4#QB3 0'*,K&+D0&V%ZZ5PLNG-MINWE[V MLG[N%JXXEDIG/\%S2I!-4B%'@8])2I9,2C29 ?L:\CL>T.,!Q"AL*@6 7^II MTRZ\Q*UQFMM%*^\$ !M8PX2GP!H0@UPJBA(!2S\*X@D;$'$YE/%;W%\>@:\' MB(+V"WA603NG*4DH$"&0"3Q'K9A&BDFP_Q/W8 0>.T;V&I4;QJRBJ7+72.V? M+[>V4I4HK!:C/8A6+! V 8,9Q2("V'-.F3?*XV,/FNP\<^LRY\9BTP$DP?:M M[[N%JR0BY=(G%#4&KF'LD-K@YR.2%3M-\3T)-/MA MW\[;XQ^:2SM9JIMC;^%SP:,M&^X(*W;6YB&W>Q4\?+,^W?9] M;.N<)>.S+QI?QN7O!V^5E]LPU\?--U\RRH%M>L76U\ M;=Q"WE*W"LX%$0Q!T0F-DM4$4248"B: %K#!,SLQB( M[.5"F[QNV@_Q? X*"-96;Q1MK5QI2[C!H.%9WF(3A%%$4J2(2B4LK%$7[(!3 M*;1,:+84CO;!SD-(HP6M[Q97"':OOL;6UUT,/:71VKI5P#PDQCD8HL$B3"E% M*L50ID^^7KP239XLZR[X<9 M'R*^;E6M(B7:>8D1SMD'2=. 2) $$9F"!:,S"C_@Y##[L676<&8>#$*+3,!AF MM*]II.*<.Y(S]Q-7%G$?@0G@$R'!5%+ '*?] (.JC"]X:*-]'+X6-*A2/;O^ MLL=Z-Y&7]OE$R7GD[B8I^FV2_@>4KUBRF'/2$ B:)>!IS/$C^4TML30P\'I]5U1B]79Z/77FOT((#U M:;#R.7_8@3,,+BM#GD8/O&+@&S.78HC>>3,@%E#HA,[!(+IFW*'-U) MRFUJL%(L&F&L1HR",RV-BDA*)Y"6,0E+#5=R0"Z"^I%4:3$.[YSE>Y?"87F_ MN[97B0A>CE$<&:WR]:%2( [VQ2JEU2GN]("=%_TCH*HT@XM=]9,?&'QN%RFZ M9UDF;_,DUU>H(HO1)YV/8QJ,N) *:2L,$@Y;L%(5F*,#[FTP/P*$1N?@SH(G M!S^:*>!U]?)\D]XV=FJ_R<,-9U@?5+_R.'&9][:I9A)L2>"0\OA[KKS58L F M',$_A-&T;Y8.A$E<)5TUZ7U;Y\=-_F[;UJX-#?2H53&+I;52@K=J%:)4 *^H M9U>O& BKR9 [OG^(R/9^^%C,5CX#2[_-08IWZ?;KEJ^^KLZ$_ZUIPI=ZLNF* MH >U4S%%':5&(JRP0/&->.#GH\,!!TT=&-XWWS-G#'GCJ\6+[ M37)+'C*Z2T^/&XXVU*JX,9@(#_J 2(QL#'G?P@(8-([:9+];*2XN 'YBLLIY+3D?*>=SG%OU8N+E[,]V!>5UTHV3- M<+]O)/YW,UE(RV_[B=1ZG+?NGC=M#!; MT^4Y?7_Y"=R8#CR=Y<;YXM-RAJ^6R[CB<\3>JT #DQ06J,H'G S!#(QAT)V2 M*,^%]T)P?^R)$L<$Z^.NSQQF!3^XKA6X*=Q^,LK\(,\-^#^<*Y6?ECAU"1S/WMRWF4?A="DMO:Y\-C^Y#O(C3C3=CWRI9*N';T5_@,GJL[MUP.Y5%Q&?*BZ68Y16:5]M=+DMRN4^'H M GB9'M'\!+H742/OC$1@Q6L<"*8ICG/3Z3X]E;'!,":[2L%BF31UN:)T Q9N M%JRP\%9BX_-Y"H6TT0DQEJ^6)X9[&TSD[NB?!Q]IOFX_G3"443OGB*Q)>KLO M,61-T^NLAB2]D,N12H3(!YW2D=DUU9_M M*LZV5#= S=6PWMO9/4<6^U>N&)8T&,>14(H@Z1;74_#P+2.2\#!@+9<)H>YA MXO?%O%*B_?KYM[NY)1M$_>:*E8W*2"\ \AXZ#1(,9FF91\R)$*@'Y4F._CVF M_8C^T1E7"BI_BU/@QR1GX8>S>EIWL\R=B[C=+-A2LP*GGI#()?+Y+),E*=\% M[<"[XDF!1I1.BP$A[3)O*^T'+.-S;F<=\V$5G\[!Z/EDD=RV.@QT-=+GM>@I\S:<[O.8ZZ>V,5I\(PI@DR021D<5X;(C\^[XT0^0IP496;A M_>AN]FV'8_IY>R1B0ZW*.:L#A\7!A<]7F":)$@93C"7-0!M;D'45E3EWM!T7E\I/WO)O93)N;\9[MQLV]=2KCM.'6@<>7M$!4 M$PRRU@30U=0:AY.0:4 LM(RO?*SQ]#&Y7G;3$7BT(O4Y&'=IX[ND]]2H%.CG MH$7>E94@E*.$X3F24++6"XLY<4->7B\461UUMV\,'OTG?^C1Y ^-EZ[PHV4, M/>14S8W'A>[+(1KQ=:&7L?-M?;Z,?%SY)&"#/+==#52^SS7 >KA^H/DHB%F& M\1:W9';U\@:IF:V+<*SQ\SR'V5 #U9N?2@5M>U:(1=>0$MO%*>A#]%F,V7>[ M_I0%09&>OUUI=^W/S0,O$!O>&@->W0(CL5".!"0E6%P:_ =H41 DO5")62*M MZ;4UL,]1]'B8\7JY2ENNL)3@[$JJ\YVZ!'$3'(H!&QN]5\D/B%^7V;K<97IN M!ZL',J78-L:"SEYO\]XN6GD*[H>3%.ED$J(L*,3!54 <6X,9QT:3HW_,>[2I M'L27^_C.<(GA1_7F]*/ZDGAA[XKOOZM;!^E==)'E'00*-@@D=7< M(^J-]"H(DT;RZ![7] _B4#&7;;WI=P##<_&$Q/Y[O)6,LO>.BGD/J_Y>SV?S M-E[?Y%_%I5XW[>W0^*$-_-?U%%;EV_IB<5W1#=)^C9ODT.:*%3=$*\>S!9(" M I,1(T<(1\JD!#:)Y8P=\'C/!N+73-NO,!^?OL3)1?REF+Y(O3(G4'$&HJHS8%U:IU-;/':S+$GEAX7\'9DZ_%"[W4S;T=% M7FX0G(+HG D:&>Y8]C 2PC8MTG,#Q]X"CP9<"E$F1?6H@+F6S7X\+=;EP]3MP]2[/8C@Z^ M&ZU6R6A'\H-)B<;\;(0,2!--D-=*BE6'2H%S6EIN;CK/&_GS836*Y= M?@IR=GF(/N]^4VPV^A!3;#+FKHO_G ,,7ET4#5C>[KA0 /AVM^7X?):OXWZ7 M/M:?IW6JO;VQ'IM)[>OCH>-%,\T"8YEC^Z'N?B\(BS[T'1DYQS9]QP7J3]!_ M]RZMSG5LG[J5(9)_.-O%O_SA_P%02P,$% @ 4Y<)3:O656WF1P -5$# M !4 !A8W1G+3(P,3@P-C,P7V1E9BYX;6SM?5F7VT:6YGO_"H_GV5;L2YVN MGA.K1S.R4T>2R]-/<2@F,A-M)I$%DBFI?OT$F 1RXP)B(RAW+7(J'0'$_>Y% MQ-WBWG__7U]O9S_<)_DBS>9__Q'^#'[\(9E/L\MT?OWW'W__^)/Z:-Z^_?%_ M_<>__?O_^.FG_Z<_O/O!9M/5;3)?_F#R9+),+G_XDBYO?OCC,EG\^<-5GMW^ M\$>6_YG>3W[ZZ6'2#^L?9NG\S[\5?WR>+)(?OB[2ORVF-\GMY%TVG2S7[[Y9 M+N_^]N;-ER]??O[Z.9_]G.77;Q ^$TU:^>(XF\_E<-^*G[U$T0_8?CSU\7E MCS]$"N>+];MKO*0<7OS;RV4UX>E@^N;A7U9#7SWZ"UZ/A5+*-^M_6PU=I-L& MQH?"-__OUW1J9&Y:;*(ZUD_]B9/ MKO[^XV2ZO(ZH00$8!@5F_[/&U.6WN^3O/R[2V[M9!.U-;TNUR7*2SLI_M%CX M]@=U3,;\,IDODN+%BVR67A;?AY[,"F9^O$F298WUUWW"P M_'V?-ES?),IU. M9NVIV/JX_DGZN(Q_KJ7CXLI,%C=^EGU95+]L1%:]1PY,6G9[ER(:_"H4Y'R/D(_7ZKI/U?I(BU^ M4?/$ZO 5W9*^4?/B4EP\19??WLZOLORV'MMJS.UTL4_D.\D_WL01AY:X>T;/ M"ZLI%@%S,K],H*VJQ2(Y=?(LG]T%HO>]EZ^!.E_,AF:[/WFFV6MN4[_-L'G^< M/JA;A]97;_: "S[.JF[RK.&)J26W0RO> M/:/GA;W^34UY:?"HP4FI)RW'/ZE;0E:?%\D_5U$RW?T1Y]"!:;TNL9;ZL'=2 MK\NKR?:]LSI>X.WM)/]V<@ "3S8M]]\'- M\B%=_%E;E+MX^@D([I2^TY/3K2".0"#K;@3'/^L4Q,17+BZN/B1QMUK5=3%T M\.B=I$8B2FHW/SXEN(JFI?/EF\OT]LUFS)O)[$5L84>\K@S!%;$^NB;FRT?5";^+S\NGJ<_)3!4W#Y>YYTLY%1Z%)YVNW[[OXU\WH8EU=!8,?WIQ\ MC:;T97(YS+OWV8Z]K.2X\&JUA&(!Y1)FV70;U]<%_;GX=JMA-I"MY&W^LEC*;?$YF?_\QOC;L'AP< MH=(!3(BB!DG%E"$0>$>%,0AQ+)\3-BO2+K)\ ^U E*V/R3I4K0<&3J6GDD%@ MF8%. *4YWU $O4&J#D6/XJ+RZ0]9'JVVO_\(RYF;#_NHF.&5F'",3% MQE^L=YJ_36=9E/*__[C,5\GC+^.7%R7:S=:OB)M,+0 92TE0S!\ ML\3?YXN[9!K5R^32/E,CMC%]UYR@L%7$8V<,0=(QQ*25)8T$012VJE2]"L!. M=6X/^YOQ[:44=(S2]RD1IY&$9_2,5Q!.(P /02/U>;',HS6ZA^O/!P:).7%2 M6L&L-AQ83&5)#9+Q;!V2U=OLC%Y5@E98#,M9L\J+Y*+:#'XQ/@"'I9$*88L9)V08D>JR@TYF'6/TJ#G?,W6;[\E.2W M3Y)$]AWQ6X8'RJG5S$LAD?8*.&E)21FF0I#&_$?GP?\.0!EL[W]P&2^*P'H4 MU&C?_)8L-SCL.P+V3 M.8H0LMU0C:)4B#@I34BJ9L(W9C\^#_1V",Y08O,^3 MNTEZN4D6BGO7Q?(FR9_!LD<::LP.CG'D* '*0B,$YQJ*4DW&VA#?6"C(>0A% M]QB=1#VLJQ8&@ 1C1##E/"A.-D4E+FG!U#3W_]'SX'<;- YS]G4\L/A->'+> M3)97DS2_WZ'/[1D=G";:>\"TQUI3CQRO]&!L@09C/;T;*_+=@3'4)_F0NO1K MLKS)+NOI:3MF1,&T0AAFF&7&:415%.X-?81RW=PGV_-9W=IJZP:0QE_J)NOBF:*MM^6N10BRS?UK/9^V M[;[A[I$9ZH-^H@S\ELVG!\_:K>,#DU!%M0%Z!@F22" @;$D;9I".]PZM1!/2H4IB(CFGN%E-6.\*B"E*N'TC1G)ALY,QO1/Q3WWJ63S^DL0IH4 MV1"OTXEKN$_K/B)03#DA!G&G'0?0>D,K!!S!S3VJO2EB'7K.>T+I!')2W[&^ M>U+0!A.M-&=1(8WV X(8EVX#HHUMKI3WYE+MGH&[):0=6D/[VMY/OA5.H8A* M_$V^2BY?4U+#]5;C*0$"QY S'@(%D%/2(Z@W.%"B%!NUU#1FZ@YW7/> -=;^ M/V3?)K/-EU%EU"W?)=>3F4^2$:) MU=)Q&R6<*ZY=Z;QBCI$11MZ&U!*/A&>PG(S#R?W;,C%VSPK,4>P0$<9ISZ,1 M;J$J,U0C *;YUM^;]Z]W,>@.KL$2,9KX%O8@YY$JO#&&"VMP/$TA?J02,-7< M)=R;<[!WH>@,K0'#]%=)/+(>P#B4K+5E=*2+ *"2UNOQP:H$%>2& \E8 A)H!U%3J2VA&J@#VPNB4J M0_'Y4YY,%JO\6RU.OQX<#*18.^"0A A1R0BKC!ING8;C4_QZX'5K7 9S!%Y> MKG&>S-Y/TLNW/E52W.?VVSP@ 846B!0N,$PQ1S3$J\THXYK*YPM^; MIM<#W[L!9T OLA76 M@>Y/DZ_[O<5=ORT8H@D%@%+L@8- &,M5B2O3+H9IT$)!@2-&S3V4DJO!36E[<;C!] \1-4;]T]@EAZ)TE"\_S6= M9_FZ0/ RR9/%OGW@Y= N"0>TT@*HU$3T_%HK@YG*VCS?'!^MGQOB='IOOAX MW,U6E^NR0_F:&\MEGGY>+8MS[U-6^-FS^3)"'9=R74-6NGE!X%Q)9:%W'KMH MS4?0;'6:*L>;JRGB;"7L),B.)36K14I6X$I9ZKTL',):6R88+R,'0L,QIDD/ MF(IU)#J/\O#O;UX $]?ZYW#5@O:T,3FCTD%>&P 9Y< JZ"@BQ.*H#1)!G.70 M@UINOIXI.[9TD*$4.BSBYF:\XX0JATJ*J+1#WB0_MG10;68<*!UT% *3[[]T M$, F/A];2@GQ5&-BG2\!F@NGRM53KH.% &4P\[+11C9+1MG96. M:<28A2$+#;56(#J$Z 1![JB27^1K6B[7 ;R7 M[9WVQ[UWS0X"4:>)MRQ:I]Q#"HC %=U&-7F_BDJS=63DY:R :=3!%!"<8P-AD2%(34FG ;1Y"+7_6U9]RT9+K$XF M$V\7B]5Q\O P(U OO5*8(JRX%EI*;JH#F=HQ5JX96!8:X70R.;A8+8M>S(5[ M\QAA>#(M&"4XLUHQS#Q''#)"*XN-,#[*!(M!):(Y6*=)FFR@8=1[0$!"$<$] MP8( CAF)GT1U8 KJF^=@]9@6T:>H] +;:83F"%5C_\2 (ZW2.,6B?H\\@Y0C M5H$)5:U"[T,G.PPG)"WA.J5P'-0Y=D\*4AF%BSQCBBPAAGJ*-ONF@U'U;IZ4 MW5LL?'BA: 35*06BGO)Q8&9@%!?7E8"2A'++F@MB#V\:#3' MZR3IW0^+WB,36T8'1;6!4C#F1!1]!&R$K:1+@19)CC$/@+A**I]5Q8%*EG0'--.?6V!(09=RZA MZ-I\K16*/@Z4\PP\%I=)B-211JH=)@9KITL:$0'T'$/1M?E6.P+9#*7O4R+. M*!0]O""<1@"*2NQ1X7J?9_=I5*KTM]_C&?5V?A$WTDE1$D!-E^G]0ZKCX;CT M\0\+PAG(H34$>*FEPMH8M$'%0]&B,.N00>JFJD7O> UG[V=7Z;*XW[77M"\' M!8F(TYY[8 M,=:2/"U;L_Y!;BDTR==H/::+)+MZGZ=%,_D_)GD^V5IQKL:L$)4"@K&%#K*H M'2"OHBKYL'8!4/PFQ[?%C$U .H)VJ'/Q]WF>3&9%G*Y8?H'6Q;Q>-XH#,X/P MS&$E >?."0JHYUZ7]%K?HMIQ?UTIQB!*_< [E#C9Y"Z/)N2Z34/\>9:L>3<_ MU!/CF.G!8:810=9::>./VKBR#X\ *JH.XTOG&95@]8#Q8)Z?(D:D)^M S&W1 M@^N0/&V?$*@"4@FBA)&*$:&X!15U3-OFL?K^>FR,28(Z074HF7E[>S=)\X<8 M9E31)O/KM"@@ONY/X;YN+D[_DF677]+9ONI-1STG6$2DMPQZ0BDS2F!-J]V9 M4=(\Y-]?XX\Q25B?8 \E>.N*0EO *6/%KT+%NXI#UWE&X%!;9S4QSF-##)52 M;1JU""B0:WZCJK?THU$)7%] #[;+S:=%,D5BDX=_1I2>4_30UF?^M%]"A+J& M)ZOEDX, SGL868&<+"K?"%K6:Q:0RQ9NT][,@ &=5L.">SIA?-U-]RB)>ST] MH"(U3'@.N)=*0QLW?U=2CK1O[@OMS9,U&*\/REAK.$\G2)L.O':30+BU$^]1 MHE7G@8%YQJ4R7EOD*$6T @6?7.P MU1)B:I ADN6]J:)?G(%+4&9 # M)@Y/D^1RX2.,Q8(OKII)U!&/"1 *2 1!0L.H7BH',"NW8DRB]7HVNG0O(M4? MDN/3ICO1HH-UT (J,:(6 T4A%Y26*!C9HLY>;QD0 \I3;SB>6)I\.I_,IQW9 M9GL>%A@V5CL%"* &"L5\<2-I@PJ,G]OX#L#^;;/N\#K%.5=4[BB*KE] M5?-PVSHW,(6T<])+K"!C#G*$;76V$]+\1!O:-NN$L7M.M"[@&UK7CL?NA^1N ME4]O)HOZ,G-P7A[:_^A"BWG <2IJ*U1<1O?B/HK31?;08 MBY!QDJ?9Y?Q T5:2,N'S'8]NIM676;L+V%V M' *3LRAA]E!&L=@)LOEZ9ZM9RFS;O$ TYCIN@'%_Y,#I,)Q2 D' @( K+.,E;19I-V9E#1KQ[>L M/Z2^+VDXC134+6]X=^@I]OPV8)SVRKHJ2H)SR?RWR6UR MN,YA#Z\+$CB'E ,(%5GQ#%!D5,4?AL2X3YB&4E+KSOM)@/UOT>T.X5$>AV2U$Z*0@O C768(X"B?@"5-MZ7EJK +:0E@H332 M1A.FG 1:&8 $*FE4B*EQGV\M^5:[%G SE+Y/B1CEL3$603B- +Q+IX5?>_$A MN4_F>R,O+T8&B8R#VBH"+<(*2T84+.EQS#3O^39HS^&&;M9V8 Q62Z>\%F>R MQ?J:Y^8:>9W\Q8-S@[,(2 =L)%?&HS(J-U*6-#."FA=K&O(J65,!Z!J>P>*O M<;D75QNQK2$&6\<'XQ62!#*ON=0DTNA!)>[0C[&H=X?\>M46M#U"0W'_X2+V MMPWM>]C^?&!0!#."XX&(C)7"2&((*ZFASHRP=']+KF0=PM&X\,&6J_);6+9K M:+!4"VTHX](P2VFT014M5TEHBU3AWO;G;IC6$2"#'=+%_=$'RJM-ZK VMF=6 ML%8:IUF1[Z.T]\ 94^FN2,GFY?=!T2#!:V> M5 Q^7:=S7Q1K[\0@M2S*YCM,@9(*@&B%@)):P$QS?;RWI+=N/_M.X1E*&'Y) MYG&'FA4%EBYO(_0%!LOT/CFLHAV8&9BU @+%B&0LHJFM@Y5EX[P98=N3_G3T M;K%J?"I\V.05%DF$J]GZ3N2FH%M)J5[%?2Q9+&S\)F;9W8XZM\T?%JBPD3K) MD> "2,\>/P*F&_1RJ0WW:![J1@,OJ$VD=,4Z^;$1@4J;LF<2!/-'H'B,5NZ M2.,V.SX%I+\-ID_D3NXM;.(E#,![H: 7%'#'#?..4E/2*./',SYMI#_IZ JE MP27A=8;]/AEX'!T(-T@I:ZA&VHEXJ#X)GVB#FG._MT+^ W"_,3Z-%8[!.J0Y M%Y5K*8C#(&YM F)/JQT-2M2\-J.X^+=4UC M?MV",YAQ4)TZQ6WUA^SN7Y/E37%EM(Y(U)H?-$'":XVP $H618(1$(\6M&Z> M4]W;@=^A8/0!T:#AA]_BN?5<2SGL?]H_,0 F*29*8R&PPMAC**KCCCLQPLXZ M768'=(G-4)+01 AVT\@<=YH[8!A2GA >-\,*.FM=\UPP<0;\[PJ6TYP1#['3 M55S[XZUFG5QE^>;&]:?)UV3AOD:K*+(DG4=U:(U6)+JX'QHAGZW)WFE:#/#6 MP(T37!&*J;44. @B*ZNSV/KFT3%Y!N(W'F"'%>!(R>8[T\D\,N^P\+V:$9QQ MC#)"69$#CC74RI'*-V= BZL/X&PDIRTJ0W']?9[%Q1UP3ST."IYJY14'1F(I M'/'$VHH*"UD+WIY#SFIC( 930)XV,53+99Y^7BV+RQF?LJ//EJ.?%80VVD<3 M3GA O<< _%HRF/50CC.(9^U;[Q.(D-UY2,XX04B"ADO*,\.D;JXM MP#'[+[O XC1[0UFG^E/VI$SC33:+F"_T9)%.:^\,!Y\4.(M'')%*QNT2.R<- M(O+1J].B;SH=Q[RI*I95W-].IFE_:=+9:[BV4>6!FT;P! M%QL>]]*Q:,TY3_"C.FR;YU/ <_"(=HO.4-+P1Y)>W\3EJ?MH#ETGOZT*O"ZN MUA1A.OK"TFS!P:(D+4>,.:)1@I1[1[1$5$-:RX[Y^ T'02TYF&T MAXRQN(;)LXRQ9!,53LJDCD6QWL_%7?#ID_OB.^-L[1X;A"L:Q5 FH8)6%&WX M?.4Y1%BTN(@Q9K?J":!K+#B%MCQ9W"R*D_'I^Z]W+'^7I!S[G""I9Q(+J9CT M0$;%G)$*U/B=M!"-,7M(TDM"H M+L[P@G#"M*@M6MAC#N#_SF;K2QU5*N!CMT25I\5U5!O_.K]^:,_P:?+U4"Y5 MMV\+5E)A,2"8,84MAD!(4&W]W*=K%^GTV6DW2G2=/A&K/I:EVQ M<7[IYLMT^>WM_"K+;_S6233GZ^S^S>725KL,Z3XH=A>R)/M)?XJO'KO M/BMJ_X2@K./.80<1DA8C!+T@#S(IM9:NUIWOSFB*G\XNL^G5F("+/B-,:< @ M5)*1=>+C9N44VB'+AVVUF+H"/NL&@ $,IKJ\7A=4>8!FAV&T950@0$N#C6/2 M6@4P@YBB"C *6[@G^S&'6C LZPJ%XY2=X_:?G>KLRR$!8X68TPQ[QBBWAE&( MRS43*$=:Q[H5^B\_VG90G <;1V6$G(1[PW'M0W*]#D;,ET61Z+W<>SXT1+N+ M.,\5C'N/4Q8B*G1) Y.D139*UUI]7P=H.T3ZY*J)YVT^F;V-6N/7_YM\V\O6 M%V.#T]1XI2UP2GO(+"OJB6ZH<%XUYVOGR8>]\;4=)/TPUJSR(N+BT\5T,OO/ M:$NX^:6-MLL.WNX:'@BFD ,G)([_M:"H^NY*6J"HUUMMF/O1/;"W(U3Z_'1] M.DMR$]=TG>7[/]QG(P/F(NXY"D'F%8\_.\=X28%1+8+NG><&]O;9M@&D'Y:6 M-G[1BV$'+Y\."45N&G'&&DB\1MXR2*L31$:1;,S$SE/X>F!B"R3ZY=Z#XVW_ M?KMU;*! *4RT\D07E;PT1AJ45XII'YVEU/?*S#23],O;Q'/#Q-[O\!SM& MAZCV6VP*=4]23JR.2CRM*&&^>=)DYPEP/3*W'2A#L/=!_.HS^,GXX*,.[PQC M! %,@"R**LB2&H1Y\_VX\T2VWEG<')9^F*SBTB[7RYM-KGO$DX7J_V;IG8K#1"G>< M8$2Q5,86Z;:J4N>-:EXEJ/NKL_T9L=T!-% $\4EVX>861^]!N->OW!_^&W]& MH]!0*0F@0QP9HY"SR +OJ-#>T'@:GU]&(_ D[E5.8.J)]-)!#,B&(HTX&]+1 M>&Q&8VUF[,]H/ Z!46RV4=#((9*35JO[]=G!]LN=CZ,"E@#"2@1EE)AH268<5#2(8P$XXS@ MM>#'-HZVPN)\>3NJL-YI6'H:5OX:(;U=W1YDYK-Q@8EHQ5,%+(:0206H!-79 M)25M7K6_MZR]1IS(NL-@,'Y.OM;CY]-Q@5+)/98"1/L!N*(]E#4E+4*WJ"K2 M6U&13OC9 H._WBUP3HG$P$1KDP%L->$5.HS3$47T>U"Y!\%L*(GJK\H$9\ B MKH7B*GZ"GF-'RU/26N>:UZ<9LC114QGI%IRAA$'-E^EEL<+T/GE,+7_H!9%< M/M3EN[U;+3?MBEX2J6ZSU=9RW9T^/R#MJ='0*J4PP!Y;R5")G3*\><^H(>L> M-16L4T X4O&KROQ$XI[LN[]'OG8MB0=?%3S"U$&'-6&4(T0Y=[A$5$HRHJ2* MTPMEUVB.0?M:O#SY&RI=KYX3H&,4* R-Q!HBPH7F!5-TU!^B2H&;!X^'+-;4 MAZ[5%JH3B\U&%:@3RVKXI& \D)I12SV!%"K-/= />"@&G/#C22H93G0Z NND M^OFQ6GDPEE/E@"M\$M1P)GG1ZJ&@S0L$8?.+2T-68.I4%S\2DE.Q^W@SK+0P MK'+$>\"D%5P:ZPG%#_11Y#7$S;_](2LK=<7R9J"<+)B]C@7U?Z_T2:./)S]V M$]8N?M!@RCCT'I84:L#]N./@;=EV4 I:H?0] MRL,H8^=C$8-CV;^C1J9/Y_,D?Y8XN3/$NG]"X!!ZC"U!7DA2]%,%RI4K9LX. MRLYZ:GI[\+,>D&G,RU\+WI M>XMO=6L,LRMX>BWI?X/99 6IF)<0.48>L!=117@E;)*IY^F!O M,:5^/L-.X&G,6CV;3/_\.+V),!Q@Y^N1H4A]IR12&"T.X;U"!NK*]&#U"K0. M&X'IEH6M(6G]16X:#-?\$I^/#CXN%3CGN43<8F4Q>EPKA*IY *VW,$<_7V K M6!JSL.BWMVZ?5-:B7^RP4O>,#I9Y&M4VC@W%+BX<4UO9=EJW^ *//Q&'-%&[ M@Z1#]NTT,/:.#TK8HJJEQI*2^!/G@,MRO4)*.TYKLQ,.[.=F*WS&S]=168WC M86=';/Q'DJ?+;)Z\RR;S Z?CEJ&!(,PHYIYY3Y0$CEN)RU5:QP>M@K7_:.P( M[:Q30!JS[7V>WD[R;U\>3N3]?-LV-EC$XT$2E3 )H(]D(Z]YI7]%I6P\)F(/ MC.L D:'\R $\WIP )Q2Q9PD'D("G9"LO%U=6,"\N6Y[/)M/$7YIC?F8CGC0Y7YH:L# ^VAT):WZSH+=@ M3'=P;].Y&\%R#DH;Y5H+[R0N0A8:4:A8%7BDC WIJ3H5HSO"9BANUPFU[AP; MH&<24"Z+ZH[(&T>*ZR\;FKPAS7L-]A;>Z8W?;<$9+&O^@-6]=5S T'D-H06, M"0<4M02"ROA@+MT'5@!]["H(TP^)\ M>3M*0VA8EI[(^FU4X\5BRZ'DPFH?-R_C+9255JBQ&-2N/;XF2&U.[*WQ9"$@V0B*86?-Q66KB .W=IYSVQ-(N8!E*S?T4C;@B82&=7W_*)_-%I"."OEA?&K\L\]4_ MQ+_X+"^H67Q(IDEZ?Z" =(NG!A<51@$D=E(RRN,NYF&E/CI,FZMCG5?7Z%!\ MA@>N15IZOE@6@8V-)W37'O%R7"!$.4FC10>= /'40H96^QGGO'EYVLZK972] M+[2$8JB]H/"3OYTOEOFZZ\B3@^GAQ\+5\SY/IPG<\^77?D8PTAO,#(,6$H^A M=PY6\1$C3/,LOLXK:?3PG?<%TU"B\BZ+&U22/]%)B^[NCYO1XK=D7YVX.M,# M(E)C+:TWSA*GE,5*E)0#U>+R6.?M8GH0D!X0.D%,^9@J7'O;I2!EC*'15H56 M L.YXZ2B%"K0_!I3]_UD>A"&#J%IG?FSR3\^)HN;NTEZ>97E=\\2R).O23Y-%SLMO8,3 Y78*.^C MMNDLL]AIP2JGL3"XN:<-CM[5UC4XC=FK(#CP03Z.")"#8J_@V"&A&"7*R$?E M$^H6EY9&[TEKC,+PV7>U\N[B]H&T4I(X*CP&1!HLJQODSJ#FU1+@F/UGK8%H M_*$]O'%67)I:F^3IQB3/MS>F/3@GH+@VZCV)5J#ER!FM;77G2EG8/& (1^\M MZQ"7UEK-HR1MW'7;;-P#,P+WT5"C4B*%O2,R'N>V\L5CIEOD.8_9==4M*MUS M$D<]F1S-S?6LX"DQ<:D*&JFLAO'\IH^ZM7G9E?X8CH[>9]4I,HVY^OM=I'"^ M?+!Z=C'QV:" L(8>&L:\I( Y$E=6G01&NQ9?X9@=2ZV!:'DD%LZLR6Q6$+&? M63N&!\N!D8)C8R*M@@#!2>7GXDBWR(0:L[NG0TA:,G"C%S_K^KJ==T]'!N<] MUU8X03R/1BR-9%<&3M3%FD=KT)@=,]V@,911X2=I7E352=1BL;J]6T>4W->[ M9!J5KG]DL\DRG:7+;Q^VJ[#'/R0@PIW%0 OD>5'WG7A0%=?9Y\7B^ZN$KQ+%MZGYSLGAT ]P84\ JA%+!"0/#XF5C7 M0D#&[#+J#Z$3289-%].BKXS/\G>3Z9\75[].\C^3Y8:8^C*R_SE!0Z*8MA 1 M9ZP! HC'.[.,M.@!A,;LKQH"J^8Y '%1]\6BTO6B\F2:W2?Y-I;O&QZDCEI, M- @]X?%_D%&E*TP0DRV2-,?LO>H0DJ$^_#+SY*&GPL7R9F]*_);1049E2#(* MA$:8\"BB0%>":42+.NMHS'ZN[A 9BM-J.LV3-<2W6;Y,_[7I+59N.T40^GV> MW*:KVZ?-+?8(0[,'!BVA$YA)R"0'6$LB6>5?4!*UN$@Q9E_:H* -MWF4*WP0 M__)CV+N#;)\2,#(@*LJ",:FE%\B1QV WL[*%+C!FAUS'L QVN['*5ODC7=Z\ M+5H5/B8QNJNK:!*E]\E_ILGL66KC'KEH^,1@HU6NI8F:LQ:>>D&0?"R>Q6AS MGR :LT]P6-2ZO05TZ*;(WDE!0"4(U4! XYUP J'JAHOC5KJ$5S!=[O]%78P,A6%.(<=&) M D#$&)2^4C.):QX2PN?@X&N+QV \+B(8U6(?G)&;)>^_^+=_8D#24LSCR8X4 MC HB%8I4J@(AOH4-=@Y^ND[!&4H4XLH>.ZVK^TDZ*QR-G[(G=]9NLEEDPF+3 M+7Z/=!S]K."EA%1YRJ#U F&,&-;5H=9*7QNSHV\HO(:2(3?)YT7CC/=)OK89 M]&213O?(R=;Q 0,$B+$*>1Y-2\H)K&H+.HYE\PQ2<@Z>O2XP&2S(O%@DRX59 MY7FR]<;:UG&!&6B%%M9Z;Z.^:HOB@"4MAJ'F?A=R#@ZZ-E@,R]??LOFT)FL? MAP9#D .2>0DA(49"0GV9K>ZP:E$.@IR#5ZTE',,R^"!;@Y5.6 J9U"X>,EH* MCLK,=2>4;QYO)>?@#6L$PE L?)<^Y JF28T-^/7@X D0@"HGN?,*6P>,JR*( M1K1P=)(Q>\@Z ^0$;*ZU'V\='X!A6G.LK8L;$,5&"U'M0M)(TIS9Y^ ZZP*3 M$_"['I?7J0""<\Z@@9Y1&17"RIRT3C?/R"3GX$=KCL10''T?GY5$D;M7(.'K9.P1E*%)Y:\NZ?J_V7 M*UX/#D KC:+YIPE3$EJ@L2M3C1WET#=G^3FXU5H#TC@D^2DK;G0^[C1WI? M MBB5%D5L\65JRB[%-'Q4LX\PA #PWVO*HB#)>"3/QHGFDA(S9.3807(/YQM:+ M^S59WF27S\/LZ\R^QW2_??ZRNL\(F@ :+4[)N884&NEDU:7,6>.;BPP]"Q]: M3S@UWD#,ZG95W!B]3WZ?Y\EDEOXKN?PE@E+X>S^F\VGR-OY_G8.S:]^H_X0@ MF)7&:D2-@@9AZX&N(OW*M2B<0,?L7^L7I4?.__N;%P#%)?^Y_A=;?K]YQC.L MOGSY\O-D.IFF15)-$A]\\_,TNWVSANM)[L:3']=]L1;/%Y1\72;SRR(*\Z:' MEZ]+$O?^PO>3Y=-\OK[?8Y/E))WM>MT .8X%"OYD?EW4B7WP,55B MOR^WL<;T@ 53R$B@G$? *N*T*%K)2^I(T;VPEO>U)]UW>I-0CX= MJ$=>_R'!">ZM]%!Q8DE4!KQCH$("JA8E*H_>!*,&\WKKZX>M+U7FOO!:[X<% MP9?+OTUGV2*Y_/N/RWR=IK?Y95943URZ65)L*'__<9% E84)U+;GA0BS$#ZPB0B*D)#$%7T\?." M?-S:72^Y95.0( 8M(=[/8VF%V=3]U"=?O_X?9%FN7NI-[6W5X]D#Y@-EC0[_>0[_9)EEU_2QS##MJH'QSPG*$8Q]\X93" R0CDH=(&%E/$G M*YL;:)TG!P\B5WV"-U!H>7- ^]5RE2=/S^;-S42?Y2\I^RL$3*%6"D@4E9/( M*8>09GR39E!D#O):%P^_CX I=TXK38V74'(A"\%5)1+<@B&UV?8!T]IL;1XP M/0ZO40=,AW< "JB4L$Y#:T!Q7]7C,OG>6,?]]Q!TK2T?+1R Q\%X>K.J;[<, M5*BHH4$EQ- ZS##'I,0CGOC?D0.P-N=;^F>:(?K?DG;V#L"Q"-CH!&N+[OQ; M/+@_?4EF]\FO\12_:7A(UGAPX ( [04FP$O!"D^:825:0NKF=3).ZW)LJJX- MBN8X9>\_HYWWZ4O6FOD! A9?9<,T>95&D[KMQQ&TIJ! M.&(!BZ]OY@G?^\00]6. 0=SF)1!6>ZP=!]4'R&"+$JQ_%2%K .-XQ&*BCNO#F$L01E/%KM&53!6,MXBTNO_]%A*P!BB.6L3BV6QF+8X-CAD@$ M#&$N:A-<$(QAA8YL4M[C;TGG%AQ%*6QLH1R!R^^MR[I\8BAQ3I166CDFFK'<451\8\+2Y MUZ+SDA&G%ISCT1HVCC?0G="BY=!\J:;K=F7I_/I]GLWCC]/D=I";F_M?OXE/ MGCI,^5OR9=<*+W)S4R21OYT_'9'.I^G=+*D3PVS][" \9UI%NQ,HC)&0\6"5 M4'N F/82HA/>"&U*VZ&89ZOG!H@IAL@3) 6PG&DJ"CQTK)%T^N.PZ #2L:K M:K7#X3OJL*FZ_*_5YL*\S_(]L!P(G![UG "C8D*4Q%R2HFZ\TUK1$D (Z9!Q M^J-"IP.)SL]U)122.-/GD%5 M4N8@L^..C/;$Q:PWX+XGT1AE*'/$$G$:23"3//\6J?^0W$63=YU^7[27+[M\ M%2V'X_FYR@_?J3[R24%(SJ.^H"VRUA(B&;8,&J"L<9H;U?QB9V\QR79LS8:$ M:RCQV?T%'9270U.#)5!+H4RTS1D U!LJ48DL(F*$H<1.!:1C?!K?@=IT<_N< M7&5Y,JGVSYW\/3PI$,4T,]%P,,@:H0CRAI0K9T8U[\_;6_RN$\YVCLQP5U@> M^LX_=I+^+5G6Z-^P9UJ@BA*O#$;88B,%@J* \H%2X/B0A99JRL#I3.<.@6R\ M#7S(ODUF12U--;\TV9K"HO!>-4]N?]K(O.G>7H"')P?LE->* M8T#CN6B@DD!L#D8C/7-B?,?+Z;:6SN$L1I*5%"$@FJ=#]I;:<3H!:0G>4.+P+IVN.R9N^IWND887(X.V$&'# M83SNG)*613M+5>(-6E1'[RT'XW3"T Z[P'X;1.XWW>6/!L8))724HN9 M<1)3;KG6N*2&FQ8]J'K+CSCAN=$&NL9*Z!959Y?&N65H<%*0:%)%_5A(Q*TN MDFJKK4O*YG9G;WD,)U(OVX,W4%I#K4C_0$D/N]MT#/C*U[\Y=9[#QV54)I\5 M:=^S([\>'#B$5#%/%;$<-6$I04" T3S%\GTY^OL_LU#9X%"!/#F MYX+Y^ GS7_4>V!&EWSHN&&X%=A84_0D(Q51"0TO"'99#!LV.N\#;*+LZTP.5\>CRK: M?5K6=J3K_R/)TV4VWQUXWC(J2 DXP8@ BK5$2BL7%[I9FU=R1+7U6J.;=87" M8&;Y4?T51-0OHA$9;4E'%((0, 5+38.0%J6D^J[UV^ZD; O$H,P\JLZ^]L9) MCJTG7'*@(;:,E71X#^0X3\D6_-A3<+\9%N?+VU&=CJ=AZ"HWYV0*#H?A9Y/JM;QE^2J8W\_2?JT,*TO8) 1FA95&+4ACE MO=#*0E)A1.V0&56GT)8Z0>5T/#]89FK7E "0\)$@Z[A"#DDBO4$EA5HI-&ZE MJBW;#DI!*Y2^1WD8I2(V%C'HR''Q2Y+=)LL\G>H\^S)/)_-?L[VW+ Y/"@!: M@KFPV.JX? &0D[IK3^3S)E]_>Y]E56G3:?4B( M6>QG[/Y901)!%&92:N.$:Y:;ZI9MYSM%)ZA=NSWL\F\J$5X M0%=[.BP( *&@4'FD)2'"TZCJ5$**9//4UN-SSDZAH;7 8FBN'CQ]GP^,E@5S M'F%&F?*:H6BB,%^=4T+Y<>M@S1BS@[NM$#EW/H]2MSH%>T_#UD]Y,EFL\H<, MF(\W1;9,V==C#X_WS IQCS.>2@*]8%Q@Y9W@D4Z)B.+$M+B UIO6U6'&1G? MG$0 RK5N^K68;+%\G^1K.NI*PYY'!*:MDE 28Z2WTA#'B8T(*$@%M0R/T*/6 MEVATA])0]H?D;I5/;R:+)&J>U_GD]D-2P)C.KW];%4!>7&UD?K6\R?+T M7\GEITPGC[/V[2G=O" 4;9PCAX0 ,GY7\2M#L-"GE5':> N;7Y#N[1I+IPEC M)\#PM!+HOMZE^=JRLA'&H^7K^?0@O>+&2N59U,PIL)[JPBC6!#I%#6^NK?1V MQZ5WZ6F%T&EEHZ]-J>YWA"B)V[@E7EH-H&,0KPMB((LE1 XWMUY[NR33NS3U M UWS:_K)?'U?;S*[^#)/\L5->A?/X2([/I[*[]+;K9I[:WFS$=L+\?<)J['\O2(-G5"V?93M?CSAD!:\H54U@S'75W MPJWFMEPS!:KY]]S;39BN&-H9*$,="-6"U6*QNEW7GU@4UZZFR[C7)/GMGCW_ MT-3@%744,XT,05("A 2G%<4(-%]7-<1C#U_V/;!:UU5FZ_/9AOT%0_R'1)&=Q M5_-%J PP&K7=(M>M3'5CN,4%%' &XM ;4*<4EP_IXD^?)TEYCC40EFV/"-!$ ME=598P21V!D" *W"JM2)%J)R#O[/GF :7%#>SN]6RT513FY=7R[+WTVF?UY< M_3K)_TR6D\]K@:\C+76>$Z*E Z4'Q)AH2CNM@22/27:,M?"8GX-?M$^L&IL- MA2:SB#M<&JV8^VJ+VV4R;!\=D% :"1]UGN+I@D!LJ\ 10+S%5C!F7V1WB QT M&[[.=?"]E^''?QL<135<6B.D\()R)HF!A19'/8Z&MW5G>!N<^BA\0G.M/0>4 M>0"QV% $C1NT)>BQM\%K,V/_;?#C$!C@-G@'0O!QFLPG>9H=2!':.C[$O<1K M2J+VB8V+FQ112E> 6#SD=9HVN4*U^;I+/%J ,I@UOEGB[_/-(9%<'LPKV3DG M^,+J,#0JCM)Y0AWGGI0T"D7AN%.)6O+MI11TC-+W*1&C3#H:BR"<1@!,GE1! MQ@/;_\NA@1J%G6+<.DM QS7D'(@>;C/@J:,S(;#*N_DK2,\I@8 MEY"<*MUCL]0'Z]QDMW?9O$;SI[WSXO[+I4)QS[7&=U&A,D>(EC5#PYJGJ MPUX\:WT6M 1F,.OQR3(/?O:O!P=M$#5:* ^)1!(:H8J>91NJM!YY18 .N/72 MI.P*HN]% ,:]Z9^2[Z?A]VG:P5KI*9"(0@0L9$P;9T 9NG%*-Z]!?'Q"]RE. MA3[!&NR^VY:>9'OD8VL+,^JC B6DA((JCQVT'I**,J;5N$^+GKA8IYMG,^"^ M)]$8Y3DR8HD8P^FRIV/$4:?+@>>$>%YC);%"3EJG/#5,F1(+P6'ST^7X^R*G M/UVZ!6LP-73WJ@^W CXT-T@+H[W-N!!*4.L8)AJ6-!M$1EXSHR?^OM1@>T+Q MKR%!9W \C5=P3N3TS/,(2I;GR72=;JWFEW'A6?X^B7]>/L'N0[(H-VK][3PQ?O M_2U;#M'-\<5;AVHBN;J]G>3?+JX^IM?SXL[1Y%E[RVR63M/1+,-D\Z(2QD-- MG>)RY*E[3;Y:T+L:MXQV3PH>P6@C&:,)\IPPJ:3@ #('E(8 F%K5>0>B]-"M MH^T3@@*<".PPML832B7DTI440@"'//3WWC[J@DDOS>0N$!GU;:17%.IOA>OZ M4%+Z[EE!(,N=L'N60$HP@G2AAM&H1=:4BY+.K72=-S6:2<B1!Y)@2*/U@45+R_3!*56/C7LG!Z\@]=PIH%7\!^"48%12(J%L_C7V5H&C-^9V"=3) M3EC]32?SZ4VTL@^E=A^:&I"&#%..*(I8&BBI<-6NA#T8[:71_I7R-CB=3C+* M11^O@+V8&H#%\4-#Q!N'*1 >,5*BA$ (T\&[XZA!R6E$]S^"A)S+GK[2 3E M- +R(;E/YJOD0WI]LUS\DD_FR^3R<#_GG9."A,Y'S.)&',]MY+VQMCI2&6&# MMG=NJ'LT9MS+EL]=H324+/@"]>1=>I]X]&(9!Y^GE5Q'T_99L8\.)#,DW2^\)^M;TZ$$# '98-DB=3((FB<,[)#;>J]]MR\K MRB!V0QJ$6Q,$^F57-@AJHTXB^'7R7UE>N&X7%U%DNLHC5Y-# M-Y-K/B$4S;@4LD KK92#%C+ 2M",'K3?9BT_9G]2D0T!X%!Z8HW5'_1;U7Y& M8/'$Q5$WTD9X 3"FS- 2 Q+_,FZ79^>43F6^WMYF M\W7^]>'KB"_'!N U%M9!(XB#$$:E 8"2)DW8H+?CZYDI/?#KE=W:#J6A./_' M)"\Y_FQ W MN/3\NKZO\U \Y#49!Y6-HYX3L*<$*025$HP"72!2?8]>F)'GUG;-\%WRU".4 M?VWQ&J4^>U92=6)I>FA M@9E=])OC5E!<6,$]DI81B5DT59X/-(!EX/6%:^G M]/3$Q_VMWEI@=DK9V)U?7&-6H$IZX9R@%B/$#'+@D4Z';/.;O+TIQ*>3C6:8 MG5(V<"/9P*4I *B T'N,1?P/$H0*5-))N6YN+/46QSV=;#3#;"C9*%:[CFQ^ M2J8W\_2?JT/7![=/"%CY")14S%NHH(MGM*L00[J%PZ2GE@2#F4>=X'4Z:3BH MFNZ:$N(GPQC@G @OI<8<1YPJQR-S;MQ&3ENV'92"5BA]C_(P2JMD+&+04=K/ M+TEVFRSS=*KS[,L\GD)GL 3RHH#@@7.^&A.%'4LB-!9(:H< +UHU531 T-P0Z*G#Q&!'>U.(!F7S MX8L!CZ,"0AH2BH!TG$B$E0">5%^ 0"/O2M> ']LXV@J+\^7M*,_?85EZHF2' M".GMZO8@,Y^-"Y0J88D'7EI#XHX50:A4$"',"*_O-^+$RZR$%A@,E[SRM1X_ MGXX+W'*.$&/:H@A+<4=658@@VB([KC=W6R?\;(%!8RWX[?P^>:CCF!9W,VZS M^6*YO?KAON'!:X(49R+*'[#:8BP5+E?+L!ZTH.9^C@V71-L-5AUP]LM#ZL+. M#/#7(X.0V&.H-.50(6ZM8+1RWL;_-K=D.O\"3\'/AC -M>E>+&^2W&2+Y<75 MYF;5_'ISF7//%KQG5L"$,:HQX8RI:!0()TFE< C\B&$HV/ M-UF^_)3DMX_"O+?5XI;A 6I+B2:0"T0DX8@I2A_/-]!\;^C\VM*@PM !5D-) M@;J?I+/"W/=9_G$R2YZDR=Y&(M)_)9>%5.\1C)I/"(9@X8I=46(,*'>.:ED% M 85O[N@\OO?:F&2E'_A.+SZ_Y-EB\?L\3R:S@H9?(N![.RT=]: *9=%Q@%B MGB *M)"H2M^.*G)S)?/X5DOG(4P=H#@ZF7H7_]:%2!7/"1H[3XDQ)&IOQ95S M*:FNL*"R>:3V^!8F9RE1#4 I=,E\EE<4K7R?;8,35H MY!W%QD.IF!)<0 DJV]PKVUP=%FR6]-!"9 MRO7HL=;-A>@\_;0] WBBI%:;+M801>WMW63ZY\75KY/\SV0Y^;S^%.JGN>Y_ M3H!(DJC@.4.$,O%/9Q\-"<=X"V$Z3R?Q$"B>WAQK9'L%P9$4#$-H%9"F*'L+ M*AO!RC:7*\[;@]P99!V$B1:3Y544W?M"= ^'BIZ.#I *1I'F!$.+I>;*RVI; ME BW2'P[3Y]P=U@UYNMSMT]AJ&?S)RMZ(PD0CM00*2CA1LE*RXX MNA6?9YN MVOZP:RP'E8:27;W/LZMTN2B5W%V\WSTCV*@)8Z*4A%$AUBHBP*IS2DG5HB+N M>3I1N\5K*(7OM8!>S.O%B _,#-%*BGL8%XZ3""40VI.*7FU0\_MQ\+R]I=WB M-I2K7A>MEODAT,H\L6ZJE3R*O)K.BL>PJ\O7;LPK M>Z2JT_<$"H5!3$*#A!*8*2AP=;Y&A%N8JN?M?STERD-)[/;BT\\);BZG'3P] M8,MMD<4M.-?&.HBQKK+(O!;-3U!TWJ[=X;%MK%']$8WVY#+[,L^N(B>2/$\N MEY.ODR*2L5.?WC&ULW+UMD]PXDB;X?7\% MKW?/IMHLU47P';,SNP:"0*_N5"69I.K:M;:Q,"J"FD2M$??P \<#@^MK5M5Y6?S[G]!?[#]96;$M M=WEQ\^]_^N73&_*)OGW[I__Y/_[+O_U?;][\[_CC.RLIMP]W6=%8M,K2)MM9 MO^?-K?7K+JM_LZZK\L[ZM:Q^R[^F;][T?\GJ?K'/B]_^M?V?+VF=6=_J_%_K M[6UVE[XKMVG3V;YMFOM__?''WW___2_?OE3[OY35S8^.;;L_CG_K[$^TOWLS M_-B;]H_>(.>-B_[RK=[]R1(>%G5G6\+(\./?GOW\[V[WTPAC_&/W;\U$U:;+,__8__8ED]'56YSSYFUU;[SU\^OCV+#O_8 M_L2/17;3\OTAJ_)R]ZE)J^9=^B7;"QC=UVZK[/KE3^RKZM$76H9PRQ *6H;^ MZRL?;K[?9__^ISJ_N]\+>GZ<@5\!?U8Q=+V2C/:-LTKWFGO'LDVB=^=?C!]NL3 M\ML9/XCJR8>S;TU6[+)=)YJ//FWENW__D_C5YJ%^L;MJ)J4ZR M+PTI=NP?#WGS_5.V?:CR)L]J\J5NJG3;;%!,?(HY__7AT^!'MY?:E?M0AO$[K+QW, S<"+@I_S/9-/?S) MF_9/WMCH,"O_5SB)3UNBW)ILB9[8?1N=E-6A9S_J@*3:6F6URRH1-0U_*:VV MK[3@X2=^W)8B%+AOWCQJS#9Z,N]8:;P7]]P)5U_B[=G I65]M/I3UMR6NU-, M>;W=E_5#E7T68A +!\6!2\--,\Y@KPYB_=8A M8[DY,]5.#.@6\.D8[C%;)Z"M(VKK[RUNJP-^?F OU2QRLGK9%H&IJX'&,**R M8$XGQ-9<^ZQ#&'GP M&$GZTXL$0VL(>&"1#9B_=0RG61Z#%F+*)HPK! C*FN$)29/ M 0RXH% E4"[06( [F'(HT&8DWGB9F(F08R:3ZX@ZYCI1:NU=_2O-C$ M#G98B"AQ$'7]($2U1XE7EY3'[&6NMGPO"BRJOE.R[N[LOC4E-O??LKNOF35 M)D2(NV[B.3S"GC DQ(X-Q@*62&G/3!.&E6< 9KVQ>FQ6!\[Z>P]/4GWFTCBM M/0LR"%.>=9"W.Y2F=,-E#20^ F2>S"=2WCK:"G1D!Z[=R?.TZR^(LR:N+BO- MNIPHM?8?@"S_5!9-1M-J7QYLV"&)*>>A[[@H(I0BQ(+11N0A:34&?]FP"'=X MK Z0BG; B9+06Z,#U882Y#OA?;H9O$$>?$H2@>K-# E]I44?VV8:WN M$%D'2"HBHT*7A$@;9@HFS! MGJ$0]OZ:5E5:C.+,A2&;,1YB)TQ@'8#-B=*@Y $B M78.\*4>XEZ!,(: U2-WL0%:>0EC\^MCGU^)61896(+)S/7@I3IW%AI38TK)H MJOS+0Y,7-_5M*KI*M_>?!-PGKA>ZU'>9,.OZR5AE%,> &%7Q^X;%]A25U<," M5?W,HDY":A=@#2:U%R4,(+0+$*Y F75=5M:"&GRV'DP/8:O48:@/TTJLQ(B4%O\MJ_*F++)W95H, MD;7GN('OACS@W"/89F&"W<%,PL)(6H95/FY8@0=(5H=)986LQ)B$[IHF"R:Y M%^()(+2F^5+36"AOQ2E\WK* '3-8!E(HTJ)$FH:'&^8*)Z,6H M LBH<_E)7'X&=B(JK?'?3B?;!3.R[U$%) MY(O/NP[QD$O&_ ,*[0!R$@K\<=,5 AV>+E0 :H,Z7=,JN@A3,!$%D63DA--3 M,EX0C-F\K>-$DSK\4E/_4;W.Y+/X>UV^T@Y]GP0,>QPA#[$(!Y%W+%L*0:>T M%3YO6#%.+BEH(2F=SE8A34XU#/,%TPT@589O@!D(F=".&>RM0SWF.'#V^A=% M+F05Y*?T/\NJM5&_OVXOQ3O>A7?(N;DV#_W )D[".6<41=U?Q'EZ^^9%#FF_QM>$+&FC>ATBI<^= MTE"75,C>#_6' :,X\:.8NH@2S\;\KM+Y>QG9*%E&0(DZ@V0 MHYBC7X 7A<2\ 7YFYN0U9^/E$O% &E:0.%)%_E+Z7$[*Z\>NC1+:+&(\12NP@B)A-_,1#]IB:"@*IH\-J7S:L M%[\J;3LIDB0G$^;X@4F$-#5&U.'75[:?YK&U#E50Q%[JZ"\P-?@H.D:?8O*% MQH0A"MJR \SUW/ML;Z*,%NJ\ G^5<,JT %12A0#B)$;_68X@8U\*3J,C/K1 M^XD1#V=H':-= 7[H6S% M34*$PRB)N>"[>> OFQX]!_ *$;[0)(D=VF,\0/ MRRD+4QLM2FRM0PD4L3_=0IG!@/R&[[<3&Z%-G= 6:PH:8![SD"+JCR@K Z5ZDM M -:F-6(APF!" >7*S+- (Q,OB(4&VE;V/)"" ^>>"%+E0JKRXF@F+W[*Z_)C M^:5L\FV]B4.>A(2%28+\*. >C>,Q1^DP5VH'L)1=A#5"_L0A[:I4<*BS*U72<<_I<=<=LDE90YS'?AU)GMX&*8N,!G(E-'I97F%BO49*(4!GD>I<\)G,XU0Z7AAO+$0U$B8?0,4,@=U)CMI&%TGJ/ M Z$!'>1]D#E$2LC[4ARJI?XN2Q_DI96%:%1\=$6-3LGG5\Z[?DZV=;"U L'6 MXD:IN1SLI"Z/QDEU@$>7(L4N917=?,TJBGZI1F$*[EY)N>I.)11 MD(*_Z/PKZCV/L/4H]TP_7E!M'NH#1)A-E&&8)IW\+D@-[_,DB2ZLM? MTF3)OO?UV,=SP;$R%RL(B-6QESIZ RSP;6]D>EO43=7UCI-$2?_+6O26#U6^ MS="&8D[=@ 8H01YW$6<,C5<.T(A*7=ZMWZIA*>UN*3LBO3K- @Z_:=%:'5Q8 M^*J1>KE@]3*LP^19$^%&@E!I_B9"3OUML(X TX!?I>G>"U/*=Z6(8[/J9+>P M)L7N&+/6/V?-QO%P[,8XX90E'B,D<4DTF+8)!]V9HL6@87WL0H-JA&2EQ+B#,.TL(7W1G!X6DA0=Q2?0+RR!,AE=5"&M@D) MU,KZ.M1/KTNEP5ZJ?)'FU2VXJ^%)N/*(3_FF.05*Y71M,39A>G9Z_]R5U2.[LMY+ M,&GZ+KIG+$W(EQ9RUR%;>EPY?UG=7'Y =_T>'F,9ELN^%W'J4.(B@EPO\FWB MC46V?H3ELWN*WSNDAX%AMRSU*G]>U]FN^NR^K^T8-7V;>LVN9U MMO&Q2PGG$4Z+W3QYC&U!"WEZ> M3ZZ$'B_+*S J7"&ED'>M%Z563;YG4BSYOO5K1)S3=7T,KD#B-3I3&NEE .$G MR!ZF%13:;<@>NLR)2.![A.+CYA.*Y5]N!7S3L)0C^_]6B (AG$@(LR$Z8 IL MG@F GAIB1$TX99B14\>C6^=D4,'Q%>B="NIR7G.K/IPJ8F,G)@1[S(^X:WN8 MNIB-147406I/IK[ZV:4R 2>WX*P>W;@9:[7X +/\/#(E(J#%>%02C\M3" B=%J-2+9A2 MIE0NPIKR_ES,I86Q%41A>OPH=?YYZ_M^V M_.;/3#N7E&BWJ\KS=&B-)*ESQ%H_GQH%>WDJ=4BW?DH-R/=KU,X4\8X#L)## MF%NSF ,]D1)T%7:D1/V7>^%6T?056AO'C1%'- @X]NV ><+ F(6A,9,/L6&? M-2S9!S"'2D. H@#)D=!B<[S I''$KW^[8W'$PEH4UQ%+J4$HPCSXY";SPD%#JQ_*VHJ@:6R0&? MX((/>F7NI/.^9FE32OE>AC%PFM3>\P@<4" M1I:TLAKC24E4EZ0(+*7&J)JEHG*4003TU,]I[51B9#6RJ8;^N6+.8$&V.HFG M>?6W=/^0D;I^N+OO+DABW^ZS;9/M_E;N1RQ+7CR.%AXG// MXW8\GO!T$>C^#8UF#4MLB]3JH%HG6*^L :UUA-O=50:K?-))_[0R7YAYF&AK M(]U(>94\A1/E5P;:81WE628<*XWW8475?%OF?CH\.B=[VMA2U+LDK[?E0]'PLGJ7;G][?_U3 M6OV6-07D-' !W!]]:R.U(?01Z MEA[.;0DE95RP$69KY S^E]#+:2KEE5-3DZQ20W7Y-JVF6AF4NP]8 /C: L@[ M %6V+;]FU?<-CITX=+V(>Z'X?Q3X)!X?Q78"+%_/I&I@"97L<%D],&M !KD( M5Y4\B?SE$KPI"-O%*(-<(;P =8HW"<,IE+Q1^&67S^4WYS*T@B3G;!=*C3T& M%L@.M[Z_+;;E7?:^NJ$0>3L>I9T*E8>$JRK?-RRWXTL* M/:8KJT,%BSJ5:).++4TS!A-:(%E&0L07&)D(!.?PMXYP;Y8'I;[>!%,2LMU6 M63L#D;NR:O)_=K.16(S@8 M*RD)=J2.?QJ&8%B/1M36#Z>X_]REL ;H7:'P /[J]/I9F'"9:B4Y;5M! \'D MSU3;&-%)-78GI-1P!XYO@0_!S0 -&@RJLB@;$2Y (#0LA'-G*#9\F9O) '$F MG>O0K?EN/ L5M? BJSW'Z])_S9O;MW=BL7M\A(Q=7V?;)O^:_9\\VS]ZFFR3 MA&+=BRE+6!QQGT>>@YWQZ$W@2YV,,8W!L'(=85N_"]S6 ?@X!*^L$;O5@;=^ M>/1\X)]A^F:LI>3D;PV-!%-'<^UC1$,5"9Z06---M@X%-NYEN>Q &S5?,A$ MSR^:]"8KK\O?"R%AM_G]<&9R$R$2>7YL1XAR%K'(<8+ARF,6)K'4M6X:S!A6 MX2.X=C4XPKNR!H" K8B9?$KLX2Q')4PK5\0B8%MG.3;5-G?4697;XYGT_]Q. MCQ[25K#?H\F14GN'FE_J_C&O?^-5ECV:0&R'V6Z(0Q[%L4\2QR5LN%V*B>D$ M])ZZ-J/+E2X]JKANL5HMV,K,#])?YDZI-T M-<$Z8F#];DF4MFO@3<=QH/8)N$WHAS9C/@FQ[1+LXXCR<)1FDF@[!"1E[$*: M.)Y":4'J.^\CQZ^Z AJC5H_RR;&Z^(&>%@U0YY2(7J^^J;D#.+*CP),./4OR MK_DN*W8?TN_]IE/@1 D**//L,$$1=6T_\@<(@4^I+FT#&[ZTS@V K0&Q/M&# M-\)\ 33*OV8QE*=^<65\2J.B2BJWQOH54]TU@'K.Y ^^=_Y>K-=W<;IOKX<[ M7.3APEWAG&5IN#[T#=V4=X%V!;NK1PRET-]TP MG^K/V=):F]]!KGKT#$]KIS=8Y_-C]0^S4D)4=I<#Y7E&Q8S)["C M,,01YC3&-/*&'2'&7(=);] H?G\Q5:JMM+&NQY,.@+T$5>8DMF(6($U5>Y;G M"[#IL@!O:KLM=OC<]LI,>E:PKS+7@U)?9X'6,GW-B@Q1P1/_:&R]X9\F#5[-(?-5YMU.. %@W)4B(7MAEA R:3KQ)AJ#JGMSI9 M;@/D9AT1%ASVLX(8);]E1_5?J[)N+Y6XSIN-XQ$4<]=#(8H1]2,7X3$;%]@) M:&!#OFMX;'=0K!X+;'R#R)$;XJ9X@8UR*4J,C/03_R<&NPI+ZQCO2LC+^7T$ M-NK?WV>5"/^*FS:?5-2MNGAN["/7#5WJV\@) H2'*V18Z#&I^P?4OVY8 49 MUH (I@,*=,FI@5FF8)H (,F(,CSC8D(?U'E;ATK,P%_JZD% Q6A/U8[&^L,3 M!Y,_9T*F<.*[H5C;.02QP/>2I9.CF3U2WRYM_1. MQ%;D:YKOVS,>M:WMV5Q:>FW/YV6^X%H762[]LS!QN.,?()]P.4\,AQ72=P MXW&])9D_-F?=L,H)P.,X;#'_V1I16TUI];BM4^#MK6L==)CV&6@7.3F\;)/ M%-)$:QC133"I$U)JKH'6H:X&_2N7ZNHP#69I50C%KS]D5;<;&*=UOMVXMF-[ M-"$.#WU*_=!#-A[C51=+/8DTSX)A+1U 60)5O\_=[GL+8#"E5&1/3@W-$P=3 M/#AG1O3L15HF-&L>C>O0I9D^E#H[%O!VIKK.FIH^5%56-)N HB2*HR3A//&< M((EC=SC1SVC@@ H[85\VK"<]F"OK =X-Q*,(SGU,$K4V(K'2#IJ*)D"X@LB"(9K4E.$(YA+B<+3^JCXHL+8FB5"!_Z)**/, $XI- M@EF4^"C ,1/KG1A'H3.\2L@BPMU-4S;I'B(/KWX2) JC=>DN_[G]*S/TX'5* M("J@E0V5L7^)\?[J*)=F94UC6Q[TBR,:Z+/L.'Z7][?VY]D867#/CFR?,!PR M3MR$V92--PK0"'9 0>'SAB?] PQK?T0&&^8JC,D-><-DP8;_"9@+K0R>TS$A M##.X6X=(S'&@U-:/E,7C)."P:1#'H1LG3,0:ODOC*!H##DRQIZ@? O+K1MT MJ B$.K"0&&)MAI9<:BWQ(BERBJ) XNI$1<6'\[JBS(B"M'17'$5A& :((A[X MV&/AN+6=L#B&+#(@WUUDI:%#05YG"*P;6LE15HN+*82<+DB3M#HUD$=^7@. MWLN._ ^B13,A+;MNA[4[R?W^H:F;M-CEQ*V44 M] +-3%.&PXP175^B<-7??7!EG4"$*<9<9N5$9$%28;HRAT\C>C/-U(0$::)X M':JDRYG22#>$:==I40C[QT/[&*(=D]BAU(^]@&"4V+'+AA=UF!\B#M$KA<\; MUJA31/]B]9@LTC15_N6A&0JM/J3P#5<5)N7TR3"),$W2P9\1;7K.TH0>S:!T M'1HTQX%26_<"7-[0K1U.E@[W@]K5K7FA1Z/I,XI&C-N6*>>K;6NK!&UU<'M7FJJ'PW''CK@H@,CK3*M:JMH$)CF_8'; M G CQ:7;1.VZ"A-M(W>AA0)?+\Q(QJE?P5481MTK%^K"P!+H[N,_9T0-_9(3QX9O+)& ML-81+;!^6A_U&V(>:D5@7T MX>YAG[8O_?Q25%FZS_^9[?Z:YD5[@.53+AAZV['4QBY1D&":Q(Y/":*.FW [ M'B\[(HQ)/96FVZ;QRH\!J76$:K58A^-A'5YK! R(-G4R+Q'P7XATF$C^4?@& M!/47XETMEM?'OUP$+T_.N<#= +TKB-=->%6:[92PZ+P]$)GW]^F18D?+HCV@ MGA5;L61HWR[>E_5#E9$O=5,)O&*%$"$[P"YQB.T% 8VP>RA%"MT@Q+)WP.@U M:E %CSB[I?,CI-81JO7W >Q_+!LO@HB[S7=JTY0?B?SLP[Z\% MLOLJN\V*6@1K_=T2HYQSREW/QSBR_*D^R=5/&*(+63,FR8Z@RZI2'R:HH)<+6$:NI@G]6#36# [ N?-IF15KE M)?F6UQL4!#S -(H#YF";$QLG\6#+;V=Q%7D 65A*):ZL 9:8B 4P5;F T0=4 M#6/, <5#DBFSTG%*AHR"*)&W,B%1\^&K[;)M?Y]DN*>_2 MO-@$[<+0#0.;4![C(+9=@@9[G(6@K)>Z%=/R<@!V99U L_[>@X-*C#J5DC*S M"(MJ4@,DT(SRG.-G2GUF<[H2!9KOQU,5TL0,.,!YEQ?96_'+>I.$7H)1R'WN M<0\EF!(Z&G*H#SH&I_#YY19 +2:K Z4:U@!( \8T9OA27@W)4&4VKAD)D0EJ MX.RM1$]F.' NG%'E O0.Q0L9FV/%P/\J]^W!N*%PX'WQ*=L^5%W=+ZGR6ORK M1/RVN/F0">';?4Z_;1+L1XEK>VX0$#=QD1UA>T3J,%#^Y1+X#&M8_S[#B^G2 MOOSFZK0LY^#>H_*<]G+RT4GKX*75NVGU?EY9PE.%9S.6[@IRPKKV7@!3YA5T M '.O?.AMI8GIXI)]8AWSS449>.D1DHNVAG3,_/"E/9,BYE;VM=L*'O8F?!X@ M%WLVLI$3,\3=F/N(4\:(C9(01;)!H.KW#8:"(R2KQW2QFK)SY$R%A7/Y7,=@ MG>_&TQ!1#R_2PR;[FE7MP_.TK)L:;2(6.$D21PE'PEP24TICQ!,O=7Y*@!B1[';WE(;A4E$(H]B?+@?RO8=C&2?2=!M=HEC MLX'FI68NU#;:,S'M6X%"M(47%]/H^10KI%$,M-\ZE'Q)AR63),:XEK]:L[S. MFQ;&AG@LCI%M<^1& >%1X/G.8(!QV/XAX+.&];<=Q8_TMOW=_J%+K!:BWY1% M(SZ];W^;%^+[F8B6Q:^L^GK-@;X)753@>!WZI@+\V169BKY?:M=Q$,\- M"5T2^$$8"=0>2<) +&\'N-BCH-K.BX$TK(4G>TLWW9[2?MA3JF_%L'TC/GDG MM&^XHJ2^LHH^!FI$#"3^\=_LR^XKRC?V9387C;3S*G<8C['Q.@+BN2VVX&XC MN).L8W*Y/ V&]QT5VV7NQ,?+*LMOBOY5GNWWSU5:U"+<%R$4*7;=[_;=0;W! MBRGD#G*1P_TP=@,[<8@3AL-CP+:?8!<4P:\![\6FP^O>26M[\-)JCHZ9FA07 M[0CSYL>U]@'M4^7!46OPU#IQM;MXX,391Y/H'V3:U-B0"C/H);K1NB?3BS B M.:]>KK4 %]4\!3U8'/,3A_3$:7;B<_DX-S&D)C9V&-L($X^CD*"8^2Q*1I21 M'8 >F5H:&VCJ5'VHJGQA;Z.=0\%WW2S;;'*3WYI;##;12>YR_&&R>)I;9F+F MNE0?6,<\%6D)U]!*3CGHX4CMCQ0]^G#D4V0=1S7$2# 0'/-LPX5-^A?N51'U[8. MV$1^'"81QS9*.(IB)_3(N*L5A-33%-._:L=P?$Z?Q>16^F0@DVVZS5/K8U9G M@MA;BY;5?5FE\K=N:Z%[=BRNE6E#XX"'%O*;(K_.MVG1/+=]O 4V1K'/ M8^PEE-N>&T4NIJ-Q[F/8;6%Z3!I>DWUZN+M+J^_MO'4"V'IA] %/1FDB7$[! M+L U3,U>X?:"EU;+43=U%$0O]^O0/-U./3WX88(S^:S5[R=&J[(0O]QFXTW9 MMZ+?9O7;XO1G\F*;W^]/5)HGE)#$M7F<^)$;.3ZR.8JY[00Q3V)7/D]B'HK) MS,GOCP;S(_S])?6]!VUQ\:,?')RX6$2C@?C)_,IRS;H.O5C4XVV(NX^FMBD>NW6\:>$]E"^UCH$#\:,,48 7/E)I$8/\\PI3-E=9"9VG"/8+=$'M>NT$;Q\0?," $.XBFU[)A;3\!VY:@6M/*H7*Q MM^:&D$PI7JP-@%E&G?2;R3U"F)Q*1QIID76HKB'?GB8M#3(HJZJ?Q4^_OR:[ MLGO)\Z?L[DM6;2B)$B["==_WD2]^Q0-$!E,,!:! 6-I7OTMW3]DQQ?S#B@B'(88.7'B)$GB>3APDP!1FR24Q2$EH M?=-LV MK$8#3*M#9_V4I2VV_N[M'B%0E[1S+UE@<4':86HVAW$SA14PZJ:*+0PUPCK4 MT)AW3XLRC+(X/]MY,)MX*,81H31B[9.BG/K8&:3;\2*J)Z$I:6Q%ZUI%W9S/ M]]PDI &JS2U?+Z25K[&GE#@$$K\.-=3GCG3Z3XDGJ<>-XW3?WC3Z)6O/3:=C M-SP8]$@0!]3U;.HD-"*>PZDW& PH03)*I\&,88T[@+-Z=-81'E#0=! Z+64+ M3DZU5YOGD&KW"O-DP2\(.L:65O!R\N:'"FU]ZAEMNC?C4\5 M13P,8A)ASR:NZT18(,0#+A%D+[)-+X]F[5OU[U0?.EN@(;Q*;L4O12@P=:',I,DC/B^R-+6KKH/<=:B>'E=>/NBC@Q^IM,3'\GNZ M[V[[:U]2Z$2R?5LMJ0-D5I6]'G-:^!6I="Z36?0\5L-36Q;5$ZN("- .WJ%;-,""K<0&F MU=(;.AB7RW/(47(NX:&9T!5D/G1[5)KK?K H]V/6I"*0WK&T*H3A6DQ>#W_"%$,+&^9Q:R02?IVQB7A8(]WKB(IU.E0:ZYHPG?LI M+\HJ;[X?;T=+ AXF)!06./.=)'9P,)AQ[(C!5 W\>>,:]JDIM[_=EGO15^I_ ML=@_'@0Z,S>.P:F5DS&CG,)$RPB91I3L*6D3NJ7,[SI42AU^J:F?P13H7;[- MBCJK/V9?L^(AV\0)? 9!U0 33%#!9 M8H4LFLO0[G'$78"9/8BX>R&!&@8"Q? M:JCR<<-Y>_I25A.0/U;B2R(=;YHJF$)FXA?J#=R:NS_5]FIM-?H.-<[GP.WV>YA MG[V__O3PI<[^\2!LLJ]M_AZN?-#;K#=>4CI(O=/GB&FHDQ-9?,=8RCV5Z4>KL8,#88[/0Y__8F]+(8 M[SOQ8C>,;0<[+ X#CL. (&>PZ7 7@Z*"698,QP.''8\C**5;F6:2*1D#+,8C M3(C %)J9Y:?8F9K?M;"Z#D72Y,O3.5TC0[+J],14?]_-!OD1"Y'OA7:$;-M. M6!(ZJUE86(T4[T929$].ALP3-T]^+G0[THNT3.C./!K7H3TAO>[$7OS]^#,?TN_="JT%=D17[#Z(#O9S>I<=I O;C#F$ MV8[CVIP%MN]0,D#%@1.!%E&7 +A,M-,/1+5(YS+M)KE>6WN3*<59DJUE9HUG M@-&II>$E&W ="GY9"IXN1"_?'N#LVJ=M5J157G9S5YO&2Y@;.K8C(EI$8LIY M;XN&D4M]6-V3F@WCY4\CK"MK ';9A- I/3*)("4Z5S)>#K4VQW?A5AK]*4UU2^#=\\+<^^N#:HZV*"<.]E# XQ#'GK#)[5$]$7=!.S=J%BZH M7, +Y-4(E!,K\]S!!*K%TU:-'1!=3)->Y&5"A^;QN [MF>G#TUO;-3"B>)R( M>&[@N6)1XM $1Q1[U L&(SZC#D1<@)\VK"IOB[9VKJRL:KA)XX]Q8D:6MG4, M!%7PTR=F8!Q(+QB:VZSJQ]HXY0Q+E"3!E,6!^%^;Q)S;C-)Q9>X0'("6"C/L MF)YJ6VC6,',<)UZEX[BS^)1<("Q$)7!IH,BBF27!>8JF%@,:B%V' FGQY.D" M0!L[4J?YWN5-?M,GY(M=GSP1!H=%QX>T:?/S&X=X09BX)$$A\CS?8XF=#(9= M-PFES_?I,6=8J8X@N_7 ?H YK@RL-]9]#Q5PPDT3T]/B=2&281JV:GX!9PJ7 MYUGME.&8.LJ+;7OKY\[:Y56V;?;?K2KK;[EJ2M$,9UI%S#.'UIA[ZE"*L!=F M#@-LK^!DHF:'2F,]$UBC=U=63?[/SOK[Z[>BLQ8W^9=]1NHZ:]I"((P#WV6N M;Q-,!&C=D!!B?&9IDQ7\9V@.QE$P%J^F6S*Q;H+$@F;*IYR>(1F]=@6 MKOZ;Y&FJ'% /P>L(>W4Y\[1@4"='LFKUUZP00?9>R"39W>5%WB; FOQK-J0# M@B2)D$T"#P>!AX(X88B-^X><@IX+G&O+L%X=X'6S?_H(X!B8_8" =XS.IE=. MOY9D%B9@IZ0^QG:9RW1>86I"PG1QO X-T^9-::8G0J[;S^I,_. M+8OZ8=_F M"X3U+HTP!'SQ@PC_LKI.LJ_9OKR_Z^[]CQ)A'(=.%-I.1"-N'^4TX$0JZVC0 M_"+)R)/UYI<#1FMW! FY)-Y,&T@L]B]//TP0![Q7[77Q!\2=.I9_C":!7.-_ M\:8QF2]XJ7G$OY=JW;F)!"5FSR46S#;3"A(-AATL%^ORP*M%[N[3O&H-/%]- ML&_;_<-.P/MK6>Y^S_?[3>@EG-LAXJ&'J<]HY*!PK(\5BPY(H*_7LNG-ZA'L MBPMLZX<1L35 !BX"-#>$W)+@^7;(0AIPYOMTL(>%L&^:LDGWDG4,RE9 :CD"DAZNG]N_ M8I7:R@9GT"E9QK (D\ BAHGZYI44-4_5+\QF=!V:I<$/V>)E(#-@+>KOX'I7 MUO7&"ZE#2$+]V(E9% 3>R3FGF#IJ*@3XOF'].0Z=O4"CJ#40NH J8X@I57TY MW+;W0PMHX;#I!4ID1$6!P)7)B8H'YX1$F0VIS.E?T[PH"[%6_2J637E9E-?O MRK00LQ'9;JN';#<^P,(8Q@&./.;:(J:*D,O],91"V/&DDZ7:+)K>"Q(XK;*P MCDC;U4F+M=_)Z-$"WV?2S+E$6;)O6;7-ZZR\_E#E=VGU_=>TO?6BV=" A'[BA2&G M*"))Z'$^GN'C?F)OBNRFS;-_!DTKRN:DQAKNQ]HS9.#Q-L!L1]OO/4*PJJDS M*SUKF&5SUEQQRN !G/7KXDR"9X5%&)TW%Z@P"]'_:[P MFMB133K\4E19NL__F>U:\^W2Y'W1'OBKF^XNHXW'H]AQ0@]%..%>8// 'S>S M/)\ED(VDN;8,KQ+H;7N%DR6&SG6:5];7=/_0C9Q\A'AE%1GP]=;9_,IE+):D M%J;R1V16)TM]\J)5IQ-\R^8R7B%K(J^AB^9UY#BT>5.:Z8PJ;V^TUKCPM+\H M\*>LN2UWI[9CSXEX'#MN9!/,N,T=.SI6K,6@6W;U6#2](7Z:,[3:3C \L-Q# ME1J&)@F7W !?G&O@QK<.F@V^C/(*[*!J3 R&+0/(WTY1QW>OS(6W97SLRQ[(]A:/Y M,_B4W'!:CDK@WE-7Z'B*;-R$.H!;>A]JDJFI+2D]%*]#OW0Y\])I?5T7L!"UD<,IL&#N&>%XHX<3Q=D"0,]"JDNA7#.G4HP>G&V4&J?LA>&UJZB913 MJ64XA G4BJ1)197F4[H.0=+@1ZF[L\U9/O;/XSX(VX?-^[*HX^RZK++^YSZG MW[*:?6NJ5%";%VGU_6V3W=4"M""L$+;#-EB 3PN M>!,>0JIX+HG3<#50ZY3UI4-OW5?EU[S;Q12_'82Q:;V9LTA=N%E5EK;K;='9 M"^*C:];1MZ'!#S_?N7=E/78'O&MM8N6LM6&DU]N7Z0[KF%16P<3DVOZ2K0.; MV 22P_P99T5VG3<;1EG@!YX?T#ARW1C%A'EC03VU(\"N_5Q3R^S8?] ZI2@0 M"ID.#)$X1\H%I*&NW?KA@&KIPSLO<_.JFJJSN28EG.'%BRHVEQ59!1(#3WR\ M*WOE?DPX"6V*71PQCWM),AI(4!!!(F' 9PT'KC]G35? WHK*X71;\3B R0\: MW_Z(53]\J?-=GE:+7Z5[I&QBR"CPNHY1H@*\G-VG@-FNK#F&$*1IJOS+0Y-^ MV6>?RS-10133F'L\BKCM<^[:KAT=ZSYQS P^CK/T!'-[>G^=HPU, M\U2BR%B3K6/L&O3O:6+),)-*2K!A$8\/R05E-7 MR9A7-EG5DF9QA8HDCWU*;8 ,J,447]-\W\L9+>_NRN)34VY_NRWW@JXZ3NM\ MNPD#$IXHYYY/@+5=.JV;7BW[87A-&!NQU*/VCJ%?65UP&=( MDHX641"MA1MCMJS-;(<%(KA7"96.W_0US0JU4J=WD[&;;A9E]9:E52'BP_I# M5@TO_>9;4NR2?/\@%C8;5QAK0\.08Q:$/&#<[IH7H?.:?.F--,983KV M:Y;?W(K/DZ]9E=YD/S_@-HZP+9ZW.UAH0YY;9U@GRV(III)3B=7T$(P^336.$:4 M58W>"<$UW%[KT&'33I:+C@'(2?S^0FYA[_&=]L-U;=EP;U[=8ON2UME.A,OM MO^O/-4I\>-,Y89UZ M 3F>;KKAIM5\=6T&T_3__S47Y+J!%36;XGT$9IM/\LJ">32^,.4NVCIKN/1@ M*5?+"_1^P"3<;A.F]6W=IIM.;=V<@;K!/@^P&V$28&YCCT>!-U:LB[A ?M;5 M;METNKTLWK2 K0[QH]%LW9P5!8!.ZV\*B7GTHJT S+/_\1H ,#->M"'4ID+- M#2(W]4%Y.C?7&>-[!9.;.=_*)7JLANGKOJM]J\?BJ0WRD.]X3*Q=;8J-=4![K"[3()-PSF?,3T;IUC*91]TEFAIG)F/3>>'?;"?G23F#;9A-&D1M@S)GG^4Z, M2$X7 FZ.%_J0;WF]H6$2N2RQ.2&T/<>'$?4'&\S%4I5U:E\V'!D= MT8B^+_"<[_?MUJ@7NB!2^Z M_X(4S*/ILDHP$WNIHZ,HZD!2WJ5YL2'BLX@C%#F(N(YO!XC2P8KM)+:2$DA^ M>T$MZ!&IJH$L5T ],$"3NB*\QI 93>BMRJ@"D*R5Z0(4_3EE4&)!^O,N: M*M_&5?E[D:?%3V4;CO^4M34$&QLEGAM&B9O$3L(B$8GCN#=(;>KZ%+ ?/\>, M\=WV SAK0&?U\*R_]P E!40'H5+[Y$MQ"=T%7P^-H/WKI>A4W9U6IE5VYWF" M@//[RCI86T&Z0Y,CI?8>!;S$0/29G].[K(LA(UO,$3XB7"PD/2_BOA/8HPD' MNY 26-"'#0MUB\5JP8!6>6H4R65^C+$#DUYI8LQ8'C#MNX >$QX$3VG' !R,\(EQ%!R0_O9P2@-9XJD3!U, M1\IZ,&.!-U\1SJ[S9C*V+E6 @C^C"THW<(L3]H0+;_>,BK M;+YCSW$HR",7,)9% J+V/%(Z-%(:I6GPXYAS1B@]>=VKP['+:ZL 1], M0681*B=%#IF%?8M_N\O^TP29ML@SD) M:8()#YPX\.V$^W&[:1%[B!&?AJ!,HA:#%YH3K"-,J\6I0^JA5,\1;I_OWOA1"\V_S^0R:&2M&D-]F[_"YO-AZ+* L8IG[H!)C$&(5D MV(&+:21U@YPN6X;U^XC0&B%:1XQ6!Q)0MJ>#W6G]O02Q,(5=(Z> >LB%N54K MBIS'L5Q=Y.M$G"N.U$CA"BHD=7I3FNEH /WG:5[]+=T_9.5U_YI./3ZDX<9^ M2 +BQD',HM +DSA,!FN^3:2B^KDV#.M]B\SJH+5QW@'-%H@',"JDH#?-9TPJ1%8G50@$D/ #.2&0PSI #3$1)\F$DI MC-Y/Y0?@%*UDL:\ _.G*7=5WJ3#LD" MA%D+T*868H'IDPNN7O;W7& UDYT5!%5S/2CU]17H'E?:9&VW>7_-\R(MVJ7V MA[+.VTXTWCL3D] G"'F4LP@1GS/7#6S._(A2Q'Q??CM$@RV3NQX'>.UB8P1H M#0@O=F.2#&V3^Q<:65])Y*+5I6>[$=KYDAV,I*ZSIAZ-8#?T&,9)%"0Q#>W$ M]3$^&'%P %O= #]M.,8AGSZQSY]@BQLH.7*:9) 7F/KT0"XF,H]YF) 31<+6 M(1RJX$LMG49%#.A#U;Z-.]JRF8LI)BA,8M]G2>02Q 9;S&8A7!.@%@Q+PP&. ME7;@_E5%(\"<0:3")%TJBG%E#8Q=5CJ>\/*J@JCRN"8A4?;A13V9QXBLK-"T MOB7%KOU'>[ODUW0O;-:DH6E5?<^+FRZ5N^'81F[@ Z-&>>"\\VHV;S(;TVVV[+!_'YC]DV$UKV99_]G#6'^&W#L.LX M29CXL8,20CR&(CJ8Q$$DM3^EQ9#I),X!FU6-X!9>>$R0,[7^T,'I.L:/'E>> MKD;T\2-])UF5W:?YCO4/XHDXX7USFU6/ED4;%H0.\SV;)(A&41C&*/('RS'U M8!>5:;!G>'0=(!Y?EVP#Z;*%:6T?I4B EYKI8%INAE^:9-B$/_![@-?1VP&T MGN15%KX5[772)J1-)^7K4#BM'CV]5$T[6TJYW8WM1$'@10%AW&Y7/,3'[F## M]2G9-&63[A5RNJ]^&:1A(PCYXH+VK\C*E?GQ3.4@@ ["7 ME7[*FMMR=QJDVT[[K&U @R2@+'9\PFQ^L.;Y8?,EJ+BM29:,?TJ;] MM%BTO+\6:YF'NX>]^),=N2NK)O]G7ZS'460[7LA8D# QP<<)3X:]%<]S$OGG MK'48,[V2Z"%>644&.8"BA<9I];D(@\!EP@EY;5U8>D1HI2<0ER864'NZ-,%J MA:CC=M#7[KS/=5E9]Y+<_V5FL:H$02_HO79N5U#&JM6=TE ?A,6<)VNZ]EW1 M0WP;8$3$:@[Q 'D.=B+'CI+!EAL@'Q)QJEDP+/I]*D,E0Z1(F%R<:9XKF+P_ MSO@<(2T;9+[(RD2(.8_%=028,WTH=?8KF**\R],O;4E^GM6DV'67E]R6>T%7 M_>2Y5M_U0\^C3LAB%MHHX=0?S3//!=7J:3-J6'=.<'8I5?G7A@US+:=/%Z$9 M)EGJ#!O1+EG&)N1,.^GK4#C];I6&.ZNR#CXM78RIZ\4D#@,6>ZX3.,AUAUU" M+Z9R3\=J,&.Z9O"0V-X?$0+KE>=0"!8TD^PI2]CERY?/,R0G6:JTKDZDE!TY M+TOSN(%6XWQ(O[?5"D(+Q9]4#]GN.9(-LEG@,,J136R'$V MF;"[5*W.?8^UBQS2'NU88@ \:Z&3=3DQNQ3A,'4;N?YPPO4!J/62]%VF:DJ" M1(DB*IU-L0Y%-.+9F1(K_>RI!V\;''/$21PYF#G$LQ/?I]%@R$WL&%*&H/#Y M16L13D*V2T<;H"A#FL5UC*4Y#KP:50"Y "6,3ZR=Y),X\GP'!S["(8^#V.%Q M- Y%VX$=R)YA9I'4L07^7DMISR/U'5HC@Y' M7LHNZ^!&^I!F>7>7]Q42[:&ILFCRXB8KML+V)F"^RQPOHBSF8>BQ!)'P8#'P M/0H[FCG#CNGDRA%:?R[S%)SUP\]EDUG!GX&G,^?0*J=-2S$*$Z>G9#["M?#1 MR_,$3:B3#EK7(4]:/'EZN%(;.Z"G45Y.-G.'M)=AT#!*J.MZ,7*/!NV @)Y? MG6'&L#R=(ON7[KQX\QV8_)W#H9P8+40?3(L>,W?8O2)-4^5?'IHN7]*4UH?T MHCEAI6TL#6RO0Z)T./+2$Q\ZN &<*+O.1(C6;XL=3I<[GFT3EOC(MX,HQH[O MQZ,41@ATY%OE^X8E:81DU?VKZ_=I=:BF^V_V7VP;6?=BA5*W5[;^=PO95[;= M_;?_$Q$7C"^L_'>K*(<_S>NZ35N6E54^-'4C@@/#\7-I,-R#JO+$[,(.KP"-N4 M^]@.G""R$S:*(?834(8)_/$%5G1E(2=.D^KDX2L/^U=VX'6+&=^^"EQ\A9W@ MB6AU)V:/JF6E=5M%_/\\%)GEVE=66PC<_4R2;;/N63,7=7\:7EGB*_?9MLF_ M9GO)FX35FU1^86FL->&K2=&0EQ>YIYR\LH!4HF\=\J8._X6EX@P>9(7MN,YQ_#MT0P^[P4;1ANB1HA&6UMR"\R0MKVR,#U@&I4BBG M*4NP!Q.6$^):2)8@CKY"G)E"GI>9F2K:FNQ[2LKKQ.D43 M,J"1WW6,:IT.E<;ZXMQBB@V) COR1=SI-X,*08)(@SKC+'+_%E(SA)F$A MZ'300I 6F<5 ,]5%&T@NB[#"MH$E#EZJ+[RR1B>L@Q?/2@Z?*.S@R:6C#A7V M09&*T>9=AV0O[?2K$=$"G.NZS6@3$I+XG..V7#R.DR *PN&&SBA&[>6\2L=" MU8PM(NDG1]^ZW??Y$C^?9#GQ7I1?F"R_?&W1NNXJFM!-;OJ"> M9'4;K\9IG=?OKS^(7C)TG^-SW(Z# M8Q\1.PQ]E[A12'VW@\%LCIWPM7I&8W;-J<@)VK9B9L#;+=\ZQ.V?GF(&7_-K MKC$ 8G3I1E%3*R.-(Z=I"H2=$SV3W*] %8VZ5R[4AV'YQ,'X":*7<7S.OC6Q M8.JW3>108==UW)C[=N0R%GMT $*8'T'V;0V8-QS0@@W]- MZOKAKD-2_R(BZ<_=]M)H'2?4=1!'H>N%?AS;Q(^M0'G1K09=.PU@XP MV_%\ M1JD8HQW6T%RXQLL[Q+;M1?@'+@3KPFMLWLM,O1-[65KKD!UJ&8VKUZ MNAENA#59;>1I7G7G2?NW@G[JCIEFN_?%Q[;4OLJ+FTZPCS!0X"2$VHAPAP;, MBP(OP ,,% 6@ERRT&S>LEBW>X7J''K(U8+9$##2B/L1(<_53?]O(">E%FP6F MJ.9:Q(C&0IF=$%MCC;0.U37G7KE09X?I\,_9[X<[\-LBJ*HLQ"^WV7B#Y:WH M]%G]MCC]F;S8YO?[[ 2:[X8\2+R 1,@.7!%'.[8S)(89MEV(-B\"R/C6V+:] M-/&(T7KL"$R.EVDB.8E>7>O 9%O /]\J_86\O0MM-?^C'QR\N&#"00?W$\*^ M:-.N0^R7=;F\X%""GCWM]OZ$C)4W17__#0Y5::VZR] MK#8O=W^964@QR=BYD@D]-*^@.$*3(Z7V+@A0^;>%,"48_%A^3_>'0P_C^QO- MN^PFW;/#ZYI/T9 0A39Q*0_L(+%1XD=DG'.(ETB]DV$:@^'Y84!NC= ?OT[3 M6!UZBX$>*#7>,!*3RTK:!#;SC,U1/6J.[;$Y]EUS#._%SIR93#818-I:25.I MS6E&FTQN$E/G[]P,MT"+K&#Z6\++1W:9/5FR1R,;=9 M["3$LUT4A2P:C= HD#JVI_AIP].<0-.&E",>6!8'2I-J6(&/E%!0@0W "#J@FLRB4DY:EN(.F54Y0 M62V8*ZL'=OC-6F1G@KX)#=)!^CH$28LGSUX]T<4.N-#L4&'1AO9]SWH:7'F) MG;@(89^P*&*!C9-HS$HDKJU683;;ZF*E9=8)5*"6:>183MDN0R],YUYF=CWR M)LVA3#&8MG98A_09\.M<^9=FYJ3/)K3O',7ML=[V"FRQV.P4^?UP6N)M)]/Y MU^R#Z-.'9>B&XS @KH=]STX"%#,>\5&@0QZ#CH>9L&]8*KL[=-YTF*U3T,## M"2:(EU/-2W,.T\\.;7_T_Q'=5];[XZ&P$;/5@5Z-N"I0/2&S)AMN'8)KU,.G M!Q^,LRFU8_7H::VGHA\@'K&$)C'V?.&;8#Z3VI658,"^KC MA^%F;F+,HU-B)VDQ)F$RN2(2 7L]BY&IMILS@U2YO9HI_\_MQFCA; 7[+7K\ M*'7W)F &-*UOVWT;\8_V/L6OZ;Y=-C^U3:E'(AOY#&&4\,!&'B?#M.&&5$K& M]5HT76@FT/6E ^TO3G JK7M-,B^90EV<=& R52O?9M*H,A1.)52U-L$ZPEW- M/CU-LAI@3/HMD+3Z+>NNSSZ^F76(H2,2VS[S:!!A!_LLPBA"@T&/!Q[H51!U M,X85\(CLY-T[?>HWAU\YR5N(6IC.Z6/5S*,K9SF;$#8-1*]#S70X\O1)%EW< M2"W%/Z3-2PK)0N+@@& 2V$X<88_&:,R\VIZ#I!?ABM\WK%0'5(#EH2I/$JOK M!2B"*9$6VSS=ORWJINJZTZ#H"?$Q#YCO.RP)N4?"6 2E!]L<45#!H1Z+RVVZ ME]?6B-,Z :HO8M34!L"-^<7H5]Z4U\J\V1WZ*3)E=N>U-,8Z8DW-/IW;E=?( MF*Q6]L^R_)0UM^6N+1'O7YD>;,9A&'G8\5PW3)*8A2Y.XL%F3!R01LZS9%@; M>W!6C\XZ@3=?"6 RY$+4SX]O!K1N4G*)O1-#]7KT#5-OI0F.B/D&.;= MO9#0UDAYG3\U>!)M)B2@S+=M'B*7> GR7#Y6I:-(JI)(ISW#FG9$V48=N0Y- MT\JVQ/K\ D3#]&WM'$,.0B[/M>*A1RV<2YYNE"+E7 Y ,Z4KR GH]J@TUP%A MO[LD[W[Z_?E<7-N_QKMNNO2QS?;7TK^FQQDW_9'^Y1?+F&UO:Q MBP+?/N!\]&W\ ME[J2%A?I!'(!_MK;7WW:7+SIC:PF#+3/Q!KDDKUA'2N7BS)0KF=L F>Y8EO> M99_3;\\F52I681@'+O>3D%/;I+/,:54(Z:L_9%5W#F)\A,Q- M8D*0CP.A=B&E,;:'1\@X3Q"1/7.N_'V#F<\#)$M@LCI0"B_P:KA177<',=I(L8BIGX0^\2+:40=&[/!GFLS"MJ94;9B>E?F MV1@";KVHTZ>F.V:8FR\\E]MD.4<00'O@I*Y3?!3\>$5]5)F1E9^_EN7N]WR_ M[\XG/EZU'&]3'24P<#A-?!Q%=N@SGT8>1G&'(4D2)_9DMS+U&C4WS@::]T%,3@Q(,RVRCD%JR+=RB3YM8#"?O/% (DH\.W CU[%99#M1 M[ P@HL #E7YH-FTXZG@TL-\WMV(:?;MK#V=?Y]U1@&=C'1:4Z&X'C:IJI@F, MR>K%HAH8F7.5%=XJ?R!I57!.15M5.90J/TD.V]@" 1,RT7Q_6UR7U=V3Y]9Q MQ)B+./(T (8(#+PQ9-'S?1XG4T3/X5TTGD0Y@#L^A2FJ/ CG3 FZ6%V"*2):2B>BI MSK9_N2F__BC\:@,GK_U%JQ[>2;STS.<7=$*=E\OJP0S(3^^^WO=.T$A MW_)ZX]DQIBYE 4X28KL!! M'R8T\)$[?-Y#6*H*$?S1)>9TT9][-- I79H9R1G=!"D*$[H$'[KF\X/'4],Y ME)3+CVTUV$\GD$?JDH8X7F]3??_ M)TLK5NR2M,DVGNNCT&81=L5_$CN.<, &4RBRI8I,9ADPK!H'7%8/S&J160*: MU6*35PYU^EX7CT68@^F'$FD:-.0<%6=D9#9SEU>2^2Z4&GL2-/[@^3ZKJ+!P M4U;?-VX8B>"&."C@)!2_9BP(Q[U1XDOO;*A\>YG8H\-D#:"@@0>0+=FPPQQ1 M2D&')$?:(HY'[D_&&VI$75XC9J%_%FO,84%&&88RBL_B;VRP^)S':$*1QV.' M)P'RQX4/%B(D*PF@CQK6@K'LIP4CKP$P7EX?_,8H@8UZ.38TC/93?\\,A1ISO>7THS357.'#*X:8.KD=<,D:XK* M(4^81NUXPL,KZJ'*VGKT0]F#%Q1D'AMP#>D5J[?%D>,S&@2>8[N>C:/8;*C'A' QSW)X_GN:(622]^0'[JF']&,%8+1IY MQ0!2\[I*F&,%I@R2A&C0@D<>GQG_:JQ,+-2FTY*ZWN8$AG +M:21NTJTD/^"K%^F<==QL\G"/I>7'$Y&YY*? MLZ:_B5: .YGH?BGRY@"3.Z[/$'-C+_!#Q_'#D+D#3(P]J;*>BX%;XPPCO+)Z MMZXZ:3KQS&I=6V2^T=#N1J:>99M\@5EH=FNO84YZM57T34_Z.L ?9R2NK XS;$+1W!!RL\7E MV@ V%6BEWXC"@YB!0EL%G$-NJIL>UW*>G!#B[:J-\]MG[:Y[FU=_2_^JK^3NW"+R^GJ>AL;IL:7:6JZU229F@4.(R] M@(>$BR#>HX'C<]L>4'I1!)JIEL9F>*YZ0;\I:O/'E M)JTUMSMLVKIHDQN9O32WS<3\=:E>L(X9[&+>E^L8B[!9[*>T^BUK6N/';=2C M31I01!T:)R$A#HN03V-OM&G#RF7F63(\PQS!G=9"S)TE9I(KI_G+\0I3\-F4 M&E'A2;8F-%4/R^M02$V^E";Z(>"=M$\/=W=I]?W]]:?\ILBO\VU:-&2[; 7/ MVQEQJS3<,Z'A\W^657M55?W^.LF^=._M_>,A;[X?Y\#N41XJS!,GL6,2$\)0 M@@([&*S3.**P0%J/3>,AM8#9W:16MX.Q1=H_+MEA?103 E[8TDZ\;)"]/.?0 M<%L3W8;";BG^)@-PO2VPEE!:]5'2ZGH4$O0RF0'ZM:FD >:-Z>2,Y\^,*N79U]+,M<,?1BVA?L'U M4HDY\*9B_'W\Y?_*LTK\_=OO[[*O@NA.KL/VQ7E._2#TW8#$/DW88)PP5^K> M,,TF%]P"'-$I18ZZ* ;NR"W'KOI&FS2Q9C?()JF2V??2P_4Z-$^W4^=VJ71R M!E:[P^98F^VIG\,8GL#DON<0!Q$2!;X=MTA&Q>4152N0T&)Y,>T[':%*(:%F MQH$:N#C9JE((X=FL%LI0)B.)6JE?F3+J]>V<0!I@$*R378% W[*E&R.)^=T:S8[818Y'?OBH<4(?9 M1XO,2;RY*B5KYV(JY6A4*6E2U57*!)^Z5$J"RL54RE%2*2B[ZU4IL"<2*J7& MSAR5<@\6F>U'"''NNI'X/R?R_,@9+/IA+'6CK@X[%U,I5Z-*29.JKE(F^-2E M4A)4+J92KI)*0=E=KTJ!/9%0*35V-!8VOLN+[&V3W=6;&-MM.67BXR@BV$6V MC\;2%M=QI1)C1@ROJ,"Q!6UUJ/67W %:8EKK+MX(,/'[ _*OO>S13#N8+WV4 M:0^=]8\C3_-J(.%T_V'J(!5<@]="JO(G-6^]+;YF==/VV[R];/&N+.KVXOD- MCSV'A$'$;6XGL?@\)NY@*G#C1'I^4C5@>!XZPK+RPNJ!61TR@-0IDRK4U%Z!0CE!/^/R.>&>R] *!'JV"Z7&'J,DN+^G524$O]Y$ MV.4N(K$?(N*$21(%_I@T$?_!FZ]9]:4$JJWTUR&]_A2(2J,^2)R'K+0$0>5 M6NJR:3B>'6&^N2ZK-W7ZZ 1W=\5_C]5JP?87< "?=]#%O5SJ^!*TPT1;)^-F MGEB0HW BPZR[$=:1;=;NU=-W#HRP-E\C_UJ5=?U+467IOL7PUS0OZ@WR0]R6 M%C@!]QS?CB/LC(>(;&Q+K?,-F;ZL8G:0K2-FJP6M2S+5FF*NZ)CC5MAH8U KQEH,6@X6NV16'L!I=TKOA=2/.2\^E]; M5?OX!% W]5 M)Y>+LPQ3R1[>FPZ?=0387V1Z91WX;T$N7!LF0=M4D9A.UM>A MA'I=>EHVII^O^;'E)@H=' 4N0@FQ,25VZ-FCT"88=F!HAIE+KLAU!82O<23!+'(#1E-8LP9MT,Z6,?41]*E0AIMFH[&'F>EK!]:L']N+SD_P6N]L7K( MUB=@D8Q.\J?5[)*\PZ3M#T0Y8'/]0M2K;;IK;0*YK7AY?LYMT1M@> 5;]R:\ M*LWV2VV3SZ]#D0%W'6P[KK#MXBTMX))1XR^7^$51+KX MGCW7&*%:_SQS69:U32]&V#8WM:O+FO%*7'HK?I>UI>?7[1G8 MK]VU2>6U^(,!Y)559,VRB8)76)O(%NCB>QTI VW>E&9Z)6SDO6WKZ+//Z;?' M3R.-?\R^W6=%G<59D5WG#6EX]O^U=W8];N-8&KZ?7Z&[[0&J 7U0HK@7 U 4 M.<@BG0J2S X6?6&H;%5*,XZ5D>WJU/SZ)27+=BI5-C\E9K' H#N=2>J\YZ7X MZ/!#)+>W6G_D[XT];X6GT]^O=O4BC7(29R@B<8[S),-1GAQK3*Z\4)G_G%:9 MXYJ0WM_7RUWS*.Y/$[("KBL0PI[?I%;M@D,BP3&3YW^GW[2XW[S>_WUH:;G9 M67\;6:T:G;9]G?#=:E-<>!O,T^1^O#MFRKWUH=.IO9>.'>J[8-\+OJ8L*6$9 MAS#)(2Q(2:,D*8X?-[ B3U3>1E/H\>0==",)J?7>/;XUJ9LW MCJW6=/+.L= $%]XT4S:P'^^723-NY^M."G/4?^^:7;UJ_]BT]ZOZONZZ>K6K MOE7]O;$+%$,@-H=$>9'BG+ HRX[Q0)%(O2',HSCF?J_M5R%.S"&,\@*N+Q@$ M*LR-FKDI,>\\F9%JM/7'0X59Y;2V M'R8;8P#2BM,?]LWF\^U7_BH1C]QV4> 889JDB($HB4*4E?'Q&[T"1$IW7%D, M.UE%+SH-%_7ZGE?G!IO4W,Z]=55:>U0TO^2A<3_YW^3>\DB?WVPX?^KM M3NR9)EG"0I 70FP:Y^GI:V>6*)W3.Z=.Q^@]D.&P_BT>P^"47W!*,+CK,SPC MB?B6Z_N<@C&I.29\G;3.U>G?>9\)/TCEA1,O3@W[T#JR++SM/E>;YM^].*YW MVZZ;U3#7L%F]YW''8,*^<@!FW'+()3&L'O8R(3G\YM MQ?P+Y)JVS]\TOFU[7;W7%N[K9;_VC=\9+Q( MPX+%".4Q*R")2$0Q+,>8(&'RQX8;1W))P:A186[,W%B).<9) M/54#L'=V*DPW3FJKWI2CD;URLX[77'AMYM&:>Q[,/MK+I77Q?*D5F/W7$P_M MFANV'>ZK?M?NZK+9+M>MN+3P4_UM5ZS%%Q8H0VF9TI!ADB8H+,J$H3Y^R2*< MYEAEZ&POJN,7P+G0_QAO>A=:@Y/8X'*'8MM\,?A34#O)J73_ BKQ# ( M2A"&C-$L#".&4@IR&F'%;?T6 SO?X3]J/0RB7S_19!OQE#DJ'PK7+/=#4BE3;Q$4OLMX0E*'23VG*6NO#,_8VM; M//58Z*F OS7;15C"-*,PB7&2,!8#QF ^*D"H1':.VE*/Z[@ 5<2GD*QZ Z/- M1I##YUS^J_'3JO43G\KU@X\7$.JB-?Q@J)/,I(_J,G7/ D5/\=]57^JR_5(U MFP7'=X@8YW8,,!<$XA2GHXH(14K'>-F./2M-;[[KT$)U\/N@VQY2]5K$&*O. M&\,F6G7:86J^OF2H'F.-FL9[SIIE)\]:"RY:X.W;XR6)29[AF* 04Q:')0:T MR-&Q8(Z9THT&5@+.6Z>JW^)JUVUC@+HQVFI!JG,SJW-.OKUP>ZL3V[TGHD9* M\AC4]4MJ7\#[X;AGO%SNO^S7XAC^PU4RP_(I!"2+0IB5"88I8C$%83)&!&$N M=3R"C3B.27=0=Q-4)WU!=290807;U%&)[0 3FJE&LZ./9]("/(^/"OL )O13 M;Q> OJ]R6P N&_#:!@!+MGFP_&\KD];^0Z5XTO=A9\&%U\G?:W&UP#6[\VZ7!LRH/Z^6Y;,''Z0IT]20/Z47]/D^KSL]&G\U=^ M>]=AP_#M_8\[)XY[B&&:)PBE,8L!CJ.TP!1%44%3%K&2HB*3WEQD(YC+C44' M?0+,+^XRFFMSOY1S%_<3V73>CRYL.:O?#]CPC\6RVVC"\HCDH$890F240YF-H&!9*Z[E6 KI?:GC^61ZO[=?B4^.A"VFMV=JQ6HX]D[NLO,Y@ M9K 32LF8=H%<5CWW@V9V4VH=/J.:@Y9^/?=0H/64+;(LR_,L+I*\@*1(TAC# M,5Z4PUCM&Q3=*([Y-FQ[&(&V,9NB,]+CL+,QA!TE!XI04.6810#&*2(YQ>@Q4%$K T?CQ$Y-&JW#2 M<4URB.;6,#.ZS%(#_>C(I;&:OGU^$,4D@>?C-5,OI!?55O_8'^ZT8&TW7'7R M9H.72W'D/:^@WW<-+Z>^KH=1(T=8@E&"8XI*BEE*,DP.&HH<1D!I%S"*9BY:55+R=-X@7V?%W+H8/2M=GK40]C451&F)49S'.I6= MN>>2A=ZD=KLEY3QUX34#+Y6)ULSW@XD6\WE>1%IV2OJDZ*[CV&V[3IS+VFZV M_?E@3=N]K_D_5VS_SC\P#YX=KSMX?>3,8SX8%P42:]YB?B,/ 8EI 97F;&W%G&J=:%0Y+H+T MAP,%^LO$&F7O4HM]M/25RU+<_YJN.J.P(QW MET5*TT*(OQ=*D(]BREAML<:1!/?\C5SS5\YJ5_BU[O)D]!7*?8>O MT&B5O4K-];.B5RU)8_)J>.H0O/S/+FA& (I# C*:@!#F($FBHQA49H[!*R/! M/7ACY^"5LMH9>&V[/!UX^=_Q'KS\S]H%KTIS_;3@54K2'+SJGKH!+[[GB#HJ M8FF9$")NFBE"$B8L+0YWQ7)%#.+0'7W5=#A&\*>'NJLKH<@EB!6M=T%C=ZY/ M@>2^A7X.,']GM#4ZZS7?SXAHS4R-.&WBK@58OZMWBPBE&!/C M&R)D*5SLVEVU-N:Q3"@EY!Y5R2-7_)6@YLXOG]^+T/\N;P]K+)9RUABWMDVU M2U2NSAM>;:7-JFQ_6[?U2_0M=^]=K83E1): MY*#(<1&7-(HIHH?9WQP"4"0Z&T$G$>;-5M&;8$CIQ6));W_]-"TK1UIO&U6- MRY;:TYN=_3::0V(3\:2M[L>K8I[47]F(/(/_&E<5D&K[P-;M']OC0>P81S3! M"#-*009*FL11'/+W7TY@&<>Y\K&5.C$KD-MSU MI--:2>7U.P=,_9'M5+QJ%*'>=^UCLZI7Q=/?MJ+?WWZMNTH<8(*7N^:QV37U M24A.202CDH@=JP7"24'(*(1%>:ETY*6#\([KM+[WW?>]3SP503M*#:JCUO]4 MJ\)0' M3%TFV$[VQ&N?GO&I_5 +IYIUS>6]V2S;+_7;=LM_7U4J#@DJ25D"B,(\H2A/ M,!VEIA I;2>=1:!C>)^?'[%K@V[,*MAPMJQY1IPDR_5^)2BRX?]7N]GQ4&OQ MG\V&QZNW._%'SJ"_W=]MFU53=8(V_$>*'[04D/IZ!BD+[XAY'A>YMXCW3XK: M>^;90W),2$RE!D-*P2\BJ3^+__MG>2.Y:*0+[ZQ9GPD_WFKS6O#ZL2ESM8?4 M%>)_K1H.WOI;W2V;;=W>O^^:+U7W]/>JZZK-;@$3"I*DC&B4T2*,&0ZS<(B8 MAS%_0TM?(6X8Q_%[2J@+^@6Q09\8]A\4!@>)AI;![K0V=?Y"P3TP8AA)3F:9@RR(HQ:LG* M<+&I/XO[I#_)5X:F(:4Z#QHZSP_JY ?JQW-X[ZNF"QZK];[O1\U1Z8VHUJ9] M"U^Q[L(+U9;I?KP;K673NGDT56_A^\J'$LUPX5_]=5V+7PQ',)[N:*=)5L0@ M+L6./_[+@E"4C*$Q'U^JW<)G(:#C=]BYQOYV\_.M'JI7[]GP5VXP,[FU:H.3 M^P$XNRG]=;^D%^$>JJXN*CXT(.T7 ML?8W!$MQB' .<$X0SD".81D>@V5%"1:/=7?72N_KT NBTNO.];7_O) MG6U_Z-[R3)SBO@M-%R47,=W;I[A\*03]>B<4!43&-#>+EB_:ZT=AE2QJ*$ MHIBB+&$H3RD;54&4*)W/Z%J+ZXT;_7Q0OWQ7#4>NBC'3^J15<47.>=/( =:G M5E'#[J@\^&74_F?1.#_0^-189RGT'S;,MIAF:/H%5$_5G'X ?+)LVWDZC2GL M#Q>);3_4R[IY[(\!CD$*RYS!$#*$BZB,&*!CZ+A@1&,^WTK<:2;U1V%BZ\9! MF2FU=3S61;,K7VWR]VCQA^L63P37'VU3(JB!Z[YBTB2EJRPT]DL?>.^[^FO5 MK,KZONZZ>C5^H+M9]7P>L+S(6 81)JPH8YJF,4P)AJ.8) F9%01:43(-% ]2 MQ\]GAUJI[9&\2&&1XQ#0.$IR"'($ 1@G M@B,:06@VX6!%@NL]QF/]]'40.:Q]#S*/B+95M)JUA6D9.UDSV"ULWY\US$'X M^=3"W&26<5>K_K727+Z2V6Z2TC6R14^E]L?^J.1#^U2M^VVYFQ5I^UO'Z\WN M+:\FUZRN1X&+(HYHC$%2%BA*4A(3@+*#EA@7*9;>.>M,@6,N'U7V_7YYU!FL MA=#@GBL=D2U'9\?M<1G._C2%+IM7YVSN?K+&6;7+O5CV&5:__6^D[_3ZT%AR MN]1UO7MM_[KSMO!@9[O['-LIGVY7G[,O$$4,A'&9YBA-44E8!L:MP#&),ZQR MY)K%L$IO0?7CU][)?I_HZA/VZ[[+C4IFLESM;:?QR;JOWZE?&'$X: H_1ADN M$M/^'EW1.T-B#A]-O/S9'XUP!,JH9!2GJ,!E5F3C8D"=8\?YE/ZX:O+1\ MXVKUYGH+V%ZUL6J^\]4:7Y=HK"S-2#>%'_QTD9CV4HRB=X;L9,VFVBQ?7@O* M$E(6%(<@3$F4XXS1\%@21YSG%M:^3<)/O/9]/TJUOO9MU 9&%)W*?JLT/8KV M>.W[@K'J@+712EZ#UDJ"%^)#_U)._#YQ& M .,\25 8X9B /(O(^(TN ("JX"W?-?U=WU+]SYG#:NL\$YFK MN;QSWW;!]R^-&=EVU3&)M1P+=GM"-XL)O;)R8\TKK04;$>?VJ_B,;$L/-UVL M%B3&,4XS$&.0HB(L>,D(QK@D-EBET8KFF&[?%QCC=1];T0N' MR1I+,,[]-5IWZ=T\R N.^F9<:7G)+MGE%2.K/8&;O7PN+:18<,K^#.""L#*, M<5BD<G)8,'EQRL_5C-]USVW/]%FUV_D,GZ_3 M>E:F\Z2;P@\VNDA,>_I.T3M96HKHXJMN_B_ZKWWS6*U%/?J^[IIV]?Q#\$5( MBB2D44ZXC#)&@)5H7.X&.8F("B^M!G9,S%<.3>@AVI^7('Y1G[)0@Z?=)I## MYVSNJP&4C [WOSA3>A,,6H,7#H::%J$J3EZ J),&\0.C;E)K)WB@;: 4<\!W MW1-G^7^+ZPH7?""?8!+G11J&,2(LHW%\',\7>;GXVFO^N*NZG0E)5>.J=.+G M$M7[\W-BW@1W]>=FL^%R?>B^S\Q3[K>ZYOO<8;5SDNJI9H[9[:(@S>(L"TF* M<@I#DL,L/,9.0D@/791N5C8[Z+6HZAUT%&BC>]:;U?_1OBGK^\_4-Z5STNJ; M:HY)7T.X?*A7>['AEE:=>!&(MW=_-UG9K/<[,3@:YL7)NMIN/]7?=L5:3) S M&"=IB2-Q8 I _'^$@H* '% 409@J;=]RI<'Q]/4H6\Q7C\)%@1STTF^"HMHV MR[YC'])0O-K05"M,&G/]KA M-X/?ZMT#'^G\_JD_X5;D%_0)3KP%3+,9+O#9=O0@U_OME8-E)P'K3)-X7D[:\$2;-,73 M)_X#\+=FNQ!'!%!*XS0E+(]""J(B'R.6&5/:S& 29WKF"&G![T*<*7=4[-2$ MCR,GC0DD8^(T%#HYI((B#5\]Y9%.)M>@I.V.?@W$_WK9?JF:S2+$ (*X()!D M:<3R J40C1$+7*1FA9!\G+G(-,@SKHD4#-4MC-QX:8E-UVRJ14**D[ MZRF==#*Y6C+INB-U]\C;9BDN+ZJCW^HO=W6WB%C,0@22*(60)#F/AJ,Q!"W" M3/I*$=4?[)@_HYP@"GX?%$DB1\^ERXQQ;I :5";V1N&>#9<>Z5V?H>*5W'T8 MSW)\ 9Q&5GAP>X6V]-;"HZ#!PO@0 I0Q#GD!"##- $& @:0<0[!<;M"H]8.G M8F%LTM^E75)@H0N#-%DXC3<:+'3AD2$+);Q28V$LQT)5*SQBH;+TEUBHE[\2 M"[=O-JSMZN;SYK_V7;-=- Z,(J5>+9N$F MXN:VWS,_R S^<:[3A!F&3BM0=CJ3]=CKI;\:I)[.9S-^F_BMQO6+CERCO1T[ M/7H'6$KHI3>#3:\,UE^*>K-\^%)U_^PG5^,BRI(4QFF<1HQ$*,WIL61/6&BV MYJL:;/KYSKNGX"C1UHJ,HL':RS+NO#6>_Y3V=*H%FN^\4ENET;/9T\E0[72N MK]>8^*2/LS'H.!M;)AC &#!"DS3,PY#A; S+#8S-<*88;'J2SC.WE'BF:;2O/---YRK/C'R2Y=F'^K'>[.L/S>>'W?:O7;79 MU:M#/8@BRC@U(XA"#&+&2%D>Z\$,9$B%9 9AIAF^!P>%JH-)&S[*$6LB"]58 M=1!U$PRR@H,NY1&B'4R];M$%0%GPU0\TV4BDM?[,&997;YM-_697?]DN6!S! M/">DX-$@#X!1#L> 84C,-NO)AYFRI%+]8MS /,VJR8UOQO72[T)7T N;NU(Z M.J12(ZG;Z@>";"1RK2[2]4860:S9-+OZ;?,H3MS8\0>MN5O7>+NM=W_;UO?[ M]=OFOEX@&N8D*7&61B7A0TR8G=96:(&2Q6/=W;6R.+(24J6#G:N3[F>#RE][ MF<%)9] +O0D&J8'0.FV7DW'O0N>S:KX?W=!N2JW#AU6M:]+[^UJG M<()QE98$CE)."X3*)R'&TE,)8K8-: M#.R\FQZU!H/8@*L-A%QQ3R9_?IIUTTOMSTH1:)VVM\I;>:'/.F@//WJNB\1: MY\^R88U_> ZKSW6TR%F9 DQP&N4EA)A \4GY.&L;8:F] U8"33YU>NR/7%[P MZW$^PG (H.2MYB# E:VFPX!S1V<>!9Q9I#(.T''6#Y#92>7:6$#?'[7M3H*. M77.W%W<5B>LTE^U^LSN[AKBHUN((^D5)TP2&L&1IBHL$H2R!1PU1&D7J.Y]L M19X;9Z-RFE3T[B#VTMGMW;^_Z@[8=V MS;W=BA.<=D_':Y]@&B&<1PE_;\9A"EA>AG0XWZ.$<2*N"E4X)\E*1,>OJG-E M_Q$,VEZ_R<[-F3DR/EVH$^WZ[$?!:#FGYZ??.'!,?KQ[O+;C?=7==KV657]F MVG@$SR*/4UH 5F:80LBB- 1YZEC7 M@J^R0]YI+54=^9YN!.)E-W>S[8)!8M!K/!TR-O4P^*IM%T?#]DSW@W%6,_IA M;&S;+0V^]6&V>+][:+OFW_5JD:0T+G"80YB0*&)9"E(R1B1AJKBY6S_.I#S; M]NJ"ZBA/FVOJ?BKSS*F5)AP;A 7XNHNNV?7<(CEF:1OK':OT,WF=48;N:+-) MW!;)HZ4,,8R3-$XP+/("(4C8&"TM:K+(@7WF'+H) MWERV;AH(#2)4 *3HIJ?P4.AC-9:G3&JQP')(QT@ZJC0<^=DR6 Y0,WBKQJN3K?X- >7,NP TR^[[P3?; M2?UPQZ(#S_3H]V.=QT,B0G$FSI1F693".#N.02.L]%6)8:BI:6%QRY M0!L3__P@C%$&K;VG2?HR(L(0,C@(#)"))I;G>(GEV42'/)SB) M#;[/:+B$?CJ,=-K@;@^5K;\864-MKETB[<>1X M/]X@"]?>/L=5]G*YNO<\8?%5;[\_!]_^>W7']6OYLV;O_SO__4__OW_^?''_ZL_O/W!%O.[VVRY^<&L MLMDFN_KACWQS\\,_KK+U[S]SU;9.INMYC=_G1>W/Y7-?C+%[6V^*?%?J^65*9:; M**DHL3Q;Q_ELA[U99=?_\9?9?/,Y0@$%8!B40/S/!ETWW[YD__&7=7[[91&1 M^*FWJ=IL,\L7U3\2)O[Z0!TO8WF5+==9^[Z[UW3I?9NM2&^O9.H\3>U_V6&ZV>)]:7(NA M+K64]Q'ZY4;-_WF7K_/R+QKN6!W^1+=+W]MN<2HN[J*;;V^6U\7JMIG8&O3M M=+*/^)VM?KV)+4Y-\7"/GB?6D!8G._8\S8^S3XO3=N*I?AU/\CY;[VR[1W]L MC&>#S@-,MRFNI_OV-=E?BLU9$WS2OM-)[?3=R;D\:];'%!J2[/76?4S(WVWN M5IFZ+5:;_%];O>J^?BEM'%^LWL3M8ODYCUQ1ZW5V[N031NYCHSM;?7MW_6O^>9E?1[?\B7:* MKGV3@.UYHUQ@ :98EGIW%V;YD*]_;TSE+D:_P(([7=_EE],M$4= R*:*X/RQ M+K&8^)/K=]W:X\%J_Q6KU MI%MYC"?+8SS(M@M[;;2.9_I+MNEVLL\'['B^[[-57ERY9<<0OSYL+W/_=3-; M=8SYH8$[GO_':"EFW<[\Y9!=S[G8S!8=S_G%D-W-N04Q-B^GV9 %7QZ%Y-_& MO]BW+\?MZEQ^]]O9UTVVO,JNMGD U:\OBOEKR]PN\7JV_K1=Y]WZQ\^SV9>( M$>0_98O-NOJ;<@?@/P*XSWCXG_N_#L?.S?/U?%&LRZ#0IW4TL>;UH>:BA.L_ M_A)G%%J-$RP3$#")%5* ,&:$Q$ ;(HCCF'&IGL*Q*/,_BM5>%B/ XV,4D(Z_ M_WLJ(/5 @2"FG/,4$PLA-E9A16I$ *!-$'G,3[6:_U"LHJ_Z'W^!?_DA_C?7 MV6JUWQJ/I+AL>;IYH60BCU^P_&G'?8N?OFR/&7^U0Y=ZHWS)]L3ND;* UFG0/6G&J("3& M.P$5]0Y'<7A'A3'048HOIRSJZ6_]@";KW#8,G$I/)8/ LK@$ 93FO%J1-ZB1 M^OM^/O9NA5QTB.S#-SP03WZ=9\M9M#W5UWS=A"Z/VP<(J5910R$@@05&$2MI MM39+L9LH:\X4["%^)$ Y&$WV4_QMN?Z2S:-CGEW9XG:6+X]1Y5"?H+!5Q&-G M#$'2,<2DE=4:"8)HHG1I)^?GK.D(U<$53#0OLC?QCXVT2]TX.$*E Y@010V2 MBBE#X'Y5"'$L$[B"1LR5CE1+6QR'8L?NS+Z!.?:T89"8$R>E%B29G:7GK/\1_EJ??];+'UIS=FMEI]B_[TWV>+NV.N3Z/^P4L M,:,>,X6E=)AC5)G_2%"BITBCUO)_'N;H >'!#)>;8K7YF*UN'^45'C-=7FD> M**=6,R^%1-HKX*0EU5R1Y-%R^R7;['$X MMFT=Z1:@='./(40*4A48(SC44E<.)M2$^@5!DZH3J'M^+F-)-3>@ MD&","*: MY:O[ [;OD=;!::*]!TQ[K#7UR/':9\ 6:#!%:Z6UP]0=D$.I@EUF\,_9YJ:X M:F;3'N@126V%,,PPRXS3B*KX8>S71RC7*>'^T=HFR9YU-V"VUA#[ZRC1$'IW M'>VCN]N[17E6^_A2S2%UT:!K\/'W$.'.,>OB/JBMMY6V) 39E)#^:*V+--W1 M/:I#*9)'QL\OQ7)^TK9XM7U@$JIH)D'/($$2"02$K=:&&4Q)*SG?QA@[8[J$ MD+X AQK M?E!TN%/0!A.M-&?1>(]^&H(85V$AHHU-<7Y&&.;O7OB'V96&]- QW/>S;V7 M,*(2_V9U%R7V8B4-0KH-1@D0.(:<\1 H@)R2'D&]QX$2I=AD&=>:$ ?"O-V# MW=K+^E!\FRWV7U6=U;MYFWV>+7R653,]Y&@UZQT<)49(#1W4C%'LG=/5(0BE M.LE@&N&6UR%Q^@/Y6;M=D-I#K[1 TB%%@*74B&I596AJT,A-[[9V#SHG M&=-!G?1'LVWNJ;_:*7A(:/1(*)3<:Z:1UZ)6H E95R-6^GT8Q]UAO0%-$\S ME1.,9Y18+1VW\>O@BFM7!3:98V38$^PA=4WO%O69T Z6CW7Z$N%YM]$"7>*=0=U,-EC[>('1U!SB-51ML,%];@: % M_+!*P%3*,<4(@\Z]$ZHSI =,L]E):#OS4PFBK[2.ZR( *&NU="/AE+DTBJ$/N9\6R$5.>-PW0("\D,)Y*P! 3P+H:'4GMQ,SE M'FB2B.A0'/FXRF;KN]6W1BQYV3@82+%VP"$)$:*2$58[C]PZ#0+]++]ZLS2S+_GFX;V!UV+*K_<( &%%*#7 .,$0U1RC M*K6,8RY3_*L1&L<]<*8;8 <\H*AR1+;!@P/%]-7]+%^4$4Q?K'Z=+;)?L_G= M:F<"7OW7W2[I:)MS\G'V]?A!1M>_%@S1A ) *?; 02",Y:K"E>DD;VZ$QGRIMLRNW*SU3+ZJ.M'*[?9=3[/C_E_ISL' B3RF CMO"71LL#> M5=%]GGB$=XT "Z)QS0NA=%H>>IH3M0&A14T MY>H-'Y^VZ9TSB?A>3M/$+7IQ=[4M9+K:RG&S6>6?[C;E7OVQ*(^ BN4F(AVG M\KD!S[KY@<"YDLI"[SQVB):@V=H"4(ZGF&7BOS7:,%(92V9G0D9GX$I9ZKTL MSQNTMDPP7AUJ"0T'OE72.P\'S.0\$]D'+HV@?."11QDG5DN00,*YH]Q Y044 M#D@@=C4>+;<*-3I8Z'GUY]82-)1"AT54H,8[3JARJ%H1E79B!5BZ%?*)6H)G M(3NLNC;NF5PA1AQ;704G)3FYC4 M3JT85L<[!AS7*HU3+/I"R#-(.6(UF%"E/$XPRC2BX0B6"/4EB772QCK<*4AE M%"XO/5!D"3'44[37UPY&-R7E=LD(,T6&)U0KF"])IF;&UHF>@5%@%'18 M2>6=(XQ8AU&4S#9[AEN$1*,[P^-*S$!:8J2M)X("BP@UE.Z3OKD#WD[U#"-) MN,<3,LY#]/M*R*#6MR&C%9?UW< MZI3DG3&?3G6D6MKB.!0[RD=WXH;[?E74?-- M?K]+6SYMHIT_6!#.0 ZM(CUQ^+ M#]F\6,[S[;-A#]>J/Q;=:;,^?BXH8*0UUA(N@FW4*MUC8*-_4AH*$;:+,IVGF]E M'O^\R+;"7YYZ?>V<[L%AIA%!UEIIXQ^U<=5+DP*H:/5,*Z=N5*3L03Z#1?#* MPT<]VY[NW9:OVY[BXNL= E5 *D&4,%(Q(A2WH%X=TS8E<>7L5+MH"'TJ_DS\ MZT0F0S'NS>V76;[:G<=%VW2V_)R7C[=LWS-S7_>5,OY6%%=_Y(MC91'/&B=8 M1*2W#'I"*3-*8$WK?8%1DI(!,\),O5&QLT]!#47:;;F]5\"I#I1?9#X<>ERC MR1B!0VV=U<0XCPTQ5$JU?Q100(%QA%@9PL2[L)6KU9(2"72;'U$=X@&C Z M.:Q@+D?DZKFWJ"*R_/Y$QE.3[@&5&9K"<\"]5!K:N.FX:N5(^Y2 >?.0Y=#N M_&!T.4G39(E:SV-EDP, \XU(9KRUR ME").356L54 <3?M!HJ!_7K[V(*/+:]-CCV>VTJ_'!@R4:Z$ <0ABP8F0G)#* M)84.\I228",T L9#W1Z$T_J Z.7LTEY-;3M>T B6+S9BJR7$U"!#Y+Y M4!* M4S6MB.G09!Q2-N/+:.LDDRU()ST!R%(A*8W^K&>D"H8@@]BP#.V]).J /E-O M,K@P$W='81WE5AX9+#BH(+'0>J>HU,HRS2I#'5'@)G8@WW]N97=8#Y9;.?NV MC]FI^3_O\E6VW4Z:G;.?[!N,@:*TM"N3I_<>)Z0 MV;$$+L:Z7XI-UBPD=*IKP,!(IGE9:AT088#@"%8KMMRD."?C=:\OR;DT 5R, M(\*C)_JM"+<_3O&W6%]B;VYK#=5/F;S[OI1F<:&&_*K M?0-32#LGO<0*,N8@1]C6]@@A*;OP"*_9]$F*([MP%] /[9Y$4^%#]N5N-;^9 MK9OS[63G0"%12F L 53($,&@J0XT"2$NA7 CC/0-2;BNL;^(\U'.\]V74K!K MM[\F=+SVX8F^P2"%%&4$*1(M%Z CMJ1:LT%);L8(-] +*;@NH!^?1=>))1>, MMP IH"FB7B%&,)"^1L&J%-_B^SETZX. O,_RD* ]]$S+W,J MLE5>7#T_Z3["Q7.&"RLK?)\+ E%C@"-G8H3_1(\J7Y9N* M7]%J]2U^,-O2VV<3[5G_$*T+K P2F@* I/',(50;&3KI:8>S8RE?MN*)+%AM MOF^>I8$\+8(1RA!CP% I' =&< ;JM6/ 4S+_S[Y[M2.86UY-BU[G0?Q KQ$4 MCRUNXV_VHLYGE=4MLE(00&A,4=&"VZ%BG:. ME/N'U0!%LME.W^/MMP."BD;=N^N/LZ^O;ZP-8$H?/)#X24EA*7+.0TBH==97 MR'$L4]+D1A@3ZXU7KUV%&U(P8ZT*IXC3&@+@(19,>?'PB Z@SM.)/3$[I-@/ M5XD[#_-!KP&_@LU#59+_4RRVUYGKXB0/1[=JE:_C?V7CORX_[Q"L\&RA'E-_ MLC1(%*.,BP@T498SHV&%L"0FQ2H;85SW@JP>B00O_8WX8I7EGY?F+K)B.?_V M<35;KB.LNTHIVW];;'E4H=#MY]+AKP<$,42>*2]YL5OFGNTV9+O2Q^*6(C9>;*-\X MI\]'BCOV]$L!< V@5,1#KJ!VU E;XUF6G9E6O/*"'\=E!3?@X<\#HHE4/WNL MH!'EM+Q]!H&"AB ,#:LP@2KI]>01/B!Y03+W+9H1Z.UV.C@(JLN*"!) ZZ'0 MB!-5.T*,FY3":N<7KOJ3ZM,SA3"F\.K^1F/\;R\64=UA64^J6:FAUWI$6TT* MP(U7RACC(*38,>BM\T@+:W$C==QSU/C,E[B\@@(X+12+NZ[1 G./JQ5)RX>I M0#/D%?0TN1Y_A.L\, >KL%E-3?7DPUROM@^0"LR)[ M^,*0GMC#)AW)N>@>V:%8H_Z8K:X^QI\\H62>M O1WS/6&P8D%V4=&(]YO19O MX;2?XVJK5%(@'&P/>K5 L"J+^'_>68KZVT.;?6+R=F$/JUM>O5_,EK_,;K/3 MCP/V\'-! N>0<@"ALB@1 Q095_:L$H T4Z4 M:-$AE*>)<:#$\BN%=5\1]Z&FP5(MM*&,2\,LI='A5[2:):%)-29&N*=T(_". MP!PX2[-<>:T<3UNN1WH%:Z5QFI47)Y7V'CAC:B\0*9GR_N\(LR*[U1+=X=I: M9;S--_GGV3Z'>> %&'<8F6CI48B]9T%MEH)QC:E MON8(_=\.U4H?\ YV$O7H#T:8FM>MNND4VJ&(]+=L&37CHGRZXNHV7^8E!IO\/CMMSI[H&9BU @+%B&0L MHJFM@[4'Z;Q)2<(9H;G3GR_4+< MV&@PQJV $VFB>RE0- VJ@YFHWJ=E)1Z#;1YP"\%PIZ00%WW##O M*#75&F7\\ :UOOK/2N^-65TA/#B+7E;J.,:?A]:!<(.4LH9JI)V(AL"CPV)M M4 ISQGB?H7_FM,:VM8%57JLLEG%;OH\Z/8J@N'Y;S):S^DVY(U>QSNH?G(N. MB!3$81!5JH#8TUJ30HE2[KZ,T(SJX&RK3W@3Z9+MJTP6U^]7^>UL]>T?LS(- M[01)#O4*ABE.+>'UY^-IS:ES'9STV;H)S*Z94A'V ZU]3R42WBH MD]#LM:D3/0.)("+$"132>L* 9Q0\1.C=Q&YY=GB$WBVP@_EB]8995L+=9?7_ MG&UNRCN%3>C4J'_0! FO-<("*%F^E(F > AVZ)1<^O/MG.^)5'W .^BIVB]Q MRWUJG)T.41[O& "3%!.EL1!88>PQ%/5.S9U((1.?-)DZQ76PF@%1"=?06>M2LD[%I+G3%:27V==VJ0AW<>X/5\!U=EVL]G?;/\Z^ M9FOW-3JA49CY,II_6[3.+JK1XZ\&;IS@BE!,K:7 01!%6=L/UJ<<&,OQQ0IZ MVT,O*91AR1]7LO]&=;;,KO/3Q'W1(SCC&&6$LC))'6NHE2-U^-: I'MF8,JN M9;? #D6<JJ55QP8B:5PQ!-KZU58R)+H<7XVY/>DE%J#.)C===%:4T(; M[:/'+#R@WF. @7B(NF"51*SQ/C_,E99@Z#L%# MFJG4*;82/#]8_CWII10<+Z.:JM=A/Q:/'@N[*1916FL]6^?SQHKIY$B!L[@[ M$ZEDU-;8.6D0D0\Q/)@2'(4C3"+H31]UC?1@]6=FJV74F>7#.56E@'RNEE6?;^+T MU'UT0C]GO]S=?LI6[ZZW*WAWMUEO9LLRCZ8YP=H-&"!"UGK F"<:*42U>T!' M1.LSA7?3#LT/ GC[<^9=^FFC>4B:A@E8((Z"O8\P(BZ3;<],,WE\ ]M:D*SV+V?IF7>[FCW__\X'I M'V+9N>,$23V36$C%I >2E"]DU*#&;RR)5M.,ZP^!<^<\^K(-FJSSO9.([P-?AB@5?,X#;.^W\-YD MFWP^6[0I'GSX:G+3:1PI;M!VJ."-QX1**0!EU#+JE;>[2LY2 Z4:U3WHQSQN M6T)8"L( (8XY49I5FCBZ7Y&B2."4),D1W<[O7^#':PN?A_)0+E4W1>]@M,R9 M-$(SAR3P"DBKJ[71AM_$^!F4*MA&)>_.@W(PFG1:\HYA%E'G#"CCM60:8 6K M-7K'4VX5C9DN[>3:@.KF#>MBMY9SFQ$G)//?$$6FF4J5>%3-+3B2.\ M6MNU:FF+X\!%1#I[V6[8EQ#+ASVLI,)B0#!C"EL,@9"@QA6YB1A/71"KYT<- MSQ?&@*Z3S=;S5?YE5RZANG2LEE=EH#.:G^\?#=^=HW3&CYYRE%H,%?_$*0:6Q#@5QJYZCYK_\R[JQ/(O;+:9Y:TB+AUMZJO/ ML^6^.,R#P[V3QN.)O[OV^7*VC.M?//CB34J:=C%^$ J)2#(>O7N.@9/6PIT! M'O%ZO;KDV-([]R MTK9HT#< *9R++A D" &*-(G^Y!DT0VB MY[FR37FPK M[Q"4=3SJ/0>C>Y@A$)IRQ$5.AJ#4R2I(3H$5(A49 O>)&$9I^,,!&-U6SQ)AK17_^_ M[-M12CQK&YRFQBMM@5/:0V99^0[)?A7.JQ1.C%$]=,V)-#C[(86Y6Y58^'P] MGRW^,[IE;GEEH_]X@!>'F@>"*>3 "8GC_UI0/I'GJK5$/RSE^OV(:ECU0(V. M$.U39?A\D:U,G-/G8G5<83QI&3 74=L@<1KY"V#M-[U9*1S @%&=/.E!P(DH-BO MY'>GF,?WB%?;!@J4PD0K3W19$5MCI$&U"DR2+I2/Z#9*CUQ(@;-?4CSL73[^ MS2&W\T#K$+UNBTUI&DO*B=71AZ;U2IA/N:LH>,Z/Y'[_1H#VD_!%%Q:E?;Z2UFGP^0XDF; M8(B+O':$8B&=%)806H?DM1,I'L:(+G3T0(04&'N-1#Q<$-]>K5P_NEMY/"QQ MI&.PGBO'"4842V5L>3M.U6Z342D5<\^H:_0]\J1S< <\0'YTH6=_6?QBB27/ M;ZTWR!4YU"5@JY6"5#*)(3=&2U E&7EOH6J4.C',*ILDH1WL$ZR+GHR)BHBJ M2%-AREKQU3HQ<"E/$XTHV-R=N$\42F@+[$4_V$LGA'7YW3IJI>/<:.=U]-<= MP80 [ZC0/FI?WBIMZ[+7[X GT6IP E-/I)<.8E"O"'$VD>.@[@1[_)K=>6@. M=<_APVSY.3MQM:YN$X1@@I1I[%(QC80@7KEJ#=PE!?=&R(BV GS^3G)+^ :E MP,]9F4=XB@2[5@%K$+'A\-6LCO-0:TPFXH#OR< M+_/;N]N3+'C2+C#!H^FB@,40,JD E<#NUV*DI!,SX5I)L>@.O\&X,/O:C N/ MVP5*)?=8"A!MSFAD_7QOT['#TA[:C2T2BD,L,=6 M,E1AIPQ/R=L>4?9=#Z2\!/PCI6Y=QSDN[I&^_VV9;[IF\2FJG._N5MZ858YX#YBT@DMC/:%XMSZ*O(8X1>>,*.UR +JT _2BF1C; MB.5$$C$<]]@(2202UG 'M*URH2%%\I)UD.I>&8Q6Z^; MI%>U'#%X'DU\JR RB!$9_\^X*E<0WCR9Y*!GK]8:!"4*($]0 :H5AS,"J;@71G)ND1_#&]\4FR;+H$,BA MK+B_SQ9W^Q* \YME_L^[4TE9KW<(F$!&O&682 B(!TI96ZVNO#PV#9JDBK;H M 5DP?-#78)&$CD.HZD+#::,0^]AM4(->(K%/R*V="7FDZQIA>IIWAPH M;>?SY3);/;F]<3!GYWB'P"'T&%N"?+2%XFPC"*Z:,7-V\CPX5W!%#ZBVYL'/ MQ7*3F=EJ41P7__-V ?"X?WK/*<)0*&,@=*R>GR 32\[I5NJ)8"9_]+L7Q]?5 M>\_K9E_^Z[T"U,Q*B!VB#ED+J*.\)FI<5$I:]PB/DOOY_#N!MC4M]&(V_SUZ MI1&%$U1XV3*4=P8IB2O$5@OO%3+[PK.E<\J27K(8X<%KM^)/AC-9$_QCMBI+ MCC74 $];!Q^G"ISSO"Q?CI7%Z&&N$*J4,_<1GF[V\^4G0=I:_"9N0*O\T]VF M>B=T?TP:3V5-VPZ\A:[ [)#H1_T_8ZV#TK8 M\CTFC24E\4^< RZK^0HI)Y(QVXG$CDN_%9ZMY?_W;)5OBF7VMI@M3RC\5YH& M@C"CF'OF/5$2.&XEKF9I'9](U=^.)%5T"F9KD;]?Y;>SU;<_=IO,<9F_UC98 MQ*.6BS:)!-#'99Q!Z!V@.%1/4J_SJ\Y:=)V]M/6\:-,4& M02MH7 E&BD"L:D4(.4A).%AXV3@ 3JEB3A(/ M(8%.2%95EBF=6)YB)HZ((AT?*B3C.-Q]S_\J5N4& HI9 M4!.?)97Q&6' OS>2I( Z%$'.J^]$([4YAZP,91#I,,&@]H.4 RD!HA$1HV-# MORU\@U+@K/I.QF$-,=(4(5&^D86=K8T-HLQ$DL@2Y'>DOM-YV WFX[6J[V2Q MY5!R8;6/7X;Q%LHZ,TIC,3'OK944C]9W.@^_X?S]-O6=.#"(@[C!&2:]]N5; MLK0.D8&D>[ C=$(ZX4("?N=Q(2$+_>V1NDZ'&P>+HKE$L%?*<*>IDA+7S#9> MI^P0(\H;Z,A0Z S'UE& M&*UK(QCFA'Z$)@1?=PMC]#S%;S$O'/67%=_+&,N-WD7YKPX&3'@"+_ M&2:0*XLXM1A85J\ 4Y+R0L.(MH6N"=$UKNUSAW=[U&."5H''0YPXTB5$$P=! M2#47DFB 1/2!X<,FEQ3N'U'TJ6LV=(=H:QYL8R+9E2GB'%:;/.YR[^-R\_6Z M6'W[I7CUV:]&_8*(RDU@2EWYC 0G!@)2IT5;D506=,P1A41&= QK*BV>_KBZ MNI\MYZ_N0_"'=]+Q=($0Y M2346T D0=UID*'MPY7A*'8015]XLUYO5]DV\1YOI[H_K M**_WJWR>P2,:I_$8P4AO,#,,6D@\AMXY6!\0&F%2\BQ'5#VG!_W2%\1#T>QM M$15CMGIDOZ_5\NI!":Y_R8Z5K6C2/2 B-=;2>N,L<4I9K$2U6J$A[O&?",=Q.T&Q_\6NVOODRRZ^N MB]67)]<2LJ_9:IZO#WKC)SL&*K%1WD?+W%EFL=."U<=;PN"4""Z<< BW:V!; M4T-!<$(1/+0(D(-21W'LD%",$F7D@Z$.==*]OPE':%LC./P%H".6P4.CJ+:0 M5DH21X7'@$B#95V6P!F44OH#3C,NFPQB^]H.VU]- H(:^BA8+ =&"HZ-B6L5! A.ZO@I1SHI MGW>:8<0.X4P4_M[_V/[T<;D_;AF<]UQ;X03Q7&%(X[)K)S3:K2FGGFB: ;]N MD!S*\?.S?%66MGUW^V5[,NN^?LGFT4#]>[&(,EODFV\?7G<5SA\D(,*= MQ4 +Y'GY9@KQH*YN53K&*7R:9O2P=Y 'I]J;Y9>[S?K]JO@T^[2=='FO[GIV MMSAVS-6@=P#<&U#"*X12P H!P<,G9ET2N:89BNP/W0NQRN;K>?D&G2]6;V?S MW]]=_SQ;_9YM]HMISJ_CXP0-B6+:0D2*0WT#6IC4AZ8P%-,W[:'9I# ML43-YZML*YS;8K7)_[5_.[52=V42R?M5=IO?W3Y^,.<(D=H-&+2$3F F(9,< M8"V)9'7\2$F4=.URFC':00$?3FE5,]Q].M6'=%1SO=XE8&1 ="H$8U)++Y C M#\DJS,HDVV>:@=Z.(1VL\$.=Y?:/?'/SIGP"^B%AVUU?1]]2C+A('67H%XR>/DA7__N5UG64",U'2( Y #FDGNA M(Z068>6J WH7/X^DPFC3#(3W#/$8(N1E9GC+N'C9-7#*@7-4<0FPDE0*XWG] M62F;$K#$?]YH> MHQT FF]_G5UGT*F;?3CF#YPP3&!(6,N,(X!8*@P$5U1TZ MQZ@Q*23[DT3%NX=Y>,?O7=S4K_1L4>:6'#S^;](M4!_A@U!8Y&W\52V K5=* M;=(E$#SMX'>'L+8VN1\%*V:;ZRKT>LC6?KUU<-I%"U!P+H7T)CH*T4&HYNHP M2GKQ;<*1[D[0',[]O\^6=T?51-4D$,0AT@K&%3CMH:*:5(F+#I*D,".>=DB[ M)81#D>!OJV*]WKU->(0'CUH%1!34OBP]!#4T5& H:\.+ 9M$A6E'G-NC.!0; MWGW)5K/R]9/2"EJNC^J&%VT#(5A3B''Y9A: B#$H?6V2$Y=R/(JG'3A.Q7(P M?I0G M1_>?<@+K:N".8YF2+4^F'3'N L_!$CW6ZVRS-G>K$J-C^1N/VP5FH!5:6.N] MC;:]+;5] (9IS;&V+BH^BHT6HM9^TDB20I1IAV2[P/,"7&G&D&TJC^"< M,VB@9U1&X[EV^:U+>GJ#G!^?_9[VE?8H#L6&]Q7X6U][>W3=K.C?\8[!1(_+ M*L#+2S@2&88EK-UTXY(>]"+3CMQV"NQ0-'HYEXP"TTBBZZ)HP M):$%&KOJ2H:C'/H4NDP[7)L,9NNT@(^E)EX\:+@:Y'4YI4C7]:.I98=(T7:H M8!EG+F+ON=&61Z.=\?I#(%ZDG!J2:09=!X)ZL)CK=G(_9YN;XNIIFLPV$_DA M/?E8'+;I&$$30"$DDG,-*33226;K[=OX%+K1B<=F>\*XM>(R=[=W9?6#^^RW MY2J;+?)_95=_F^7+\@SBUWPYS][$_]_F[AW25\U'"()9::Q&U"AH$+8>Z#I3 M1[FDHD=TFG';?A%^8,V___0"W#CIW[?_U:O_S7Z<%WC-YK-Y7B;D97'PF[_. MB]L=VH]RMQ[]I366%P MWNRFWZE! A2><(;A7S6Y!]&2SSF^RJ[M%]N[Z4;+N;^OL M:BNACU$F.O[P[\<,V68C!&D-1M!#CDGT^3105* * Q+MM 0=,"(5T"6WBT_E B5K]Z4QY?K)@P\=Z@ &;+* *A\]!T=$8PP M62$"!4NIQ3ZBLZ(!J=BS!"ZS76T?5?KS;%%:42.]0]H!);T!/#K0I42L]DZ# M1B\&]H.$*=8/,W]N06\KX2R*DFY-5,798P7$G:$($!B-;RW+?"^UBU];(QDV M$WN,O0_"O'C1HU\1#*@LWL\VCV^<#:XC_E845W_DBT6$\TU'+XA'$S5QWD"!*F$4B?ZUP @X M 9#8.U\1D;BU)=5P'I^.Z(DMS[/Z^Q3!\#K"9IM9OOC3J0KM 6% M,5 AX:!*>O[I7!5QGZT^%>-2$DUY4:$NV4P@2K:@V*@Y1GG$>XS_0AW.>W"%M".R@]?LYN/QTMEOBH53",2\HM M9M&GIM! 2#&NUN%14OK2""G20GZO,: 5=D-QX.=(_MN[VY,L>-(N0""AE%Q1 MQ!GFWBL(4*U175(:[%AY<*X4B^[P&XP+LZ_-N/"X78A.,C2,(,0P\1*P\L6, M:BU0TJ3ZNA/E0@)^@P70#V^*^MO/L_\J5F8Q6Z]/&!=GC!* Y90YCI'"V'M$ MO.>BPD%*F_2HQ?AX-(#YT1_X(R#AP_Q_F=UFMKB=Y<=>23QSI!!A!M)'?!%1 M$1J"J*(/'R6<6%RV%Z8T9V,'$A@!(]]6V1CM:%AW#U@PA8P$RGD$K")."UE_ M[RCM7OWXN'=91=@6]=:)4?N G9K/=]DWV=7C2M:'DJ&.]PJ<& 8!9Q8K3J5' MT8"H#1$"Q,22'[H59]$7S)=72;^ML^N[Q=O\^FBMU0;= X7<.@ L40J)\FXO MIP\K9R8E-#1"VZP7@O6(]V"79.?_O,NCF([@\X\L_WQ3?C?WV6KV.6O$P)1A M@Q<&:,@0XYY$0T$Y8FHQ$$HGMEGVRLP!Y3 48]_=^G.DPXENERSCA!,8JY=\Y@ I$1RL'=>8.4\4]6IGBR([H,/ @G^P1^^&-: M?[V13[JD^^6+TXQ_I3'NDJQ+ERW$BH".4<8\7VU<9-W Q%HQ(LTSC2 MYX[*POCA0PVIA!A:AQGFF%1X1+OB3QR5 M;1(8 2,[B\I"K120B$$0/W6'D&;<5BLWDJ<4H!QA".2RBK MZB/@ MVRO&_2_1:O_X1[:XSWXNEIN;EDQL,'#@ @#M!2; 2\'*$*5A%5I"ZA2.?E_Z ML06!FK.S>TF,D[?_&9W8CW\4G=%U/UYP5!)B+=9$QIV$$R!DO8T$,&)RQI]O=[1Q=,00=S. 031G)!!6>ZP=!_7'RV#2VTS_3= >1#!> MBOKB[E@F7;L! W54ER%V@CB",G[)MGJ9UEB+>%(5P?\F:/<2&#$_8]MN^1G; M!L<,D0@8PERT@+@@&,,:'9GTVLR(BER.E9_G2V"<_%3747:=D_3)J,%3BXTI MT]DT, ![JA_$XGG2Q:D1/8LT0J:FB&$$=#W^<,[QCJ',ZE9:8>F89,IZ1U'] M<0)/4\*8Y]?M[*W6ZZ5)=S[2PQ\(7[A0U87.>$F$7C.%-.*4NNB% E%79XD\ MN/P9;W$LZGGP$/_LFE9=_$R0SC@MB!9*(^L@L.Y"PNB:*JXOA M0YFBQ2QA2D# ,,$( 52AYR28F,(:E&\O7GX;7%RC45_[]+E+9]&-7YEY:Y2R M&'AMJ< "40@\U!X@IKW5N%$"]>#8O5OM%O?JVDXEX26-&R"F&")/D !8",>1 MHJ+"2TN8DG ^4?75F&'-U5?G,I?&>-$Z"QGBB) MN23E"]9.:T4K+""<6G'<@7CS_/9$CQ(9BIT?XZ^]NU97Q;;:[\DZ$*\U#T8) MZ^/W32F%-/[),ZBJE3G()J8?>Y)ZT3G00U'(S%:K;W'U'[(OT3'>7J",<-05 M?!^<])/L.G.D("3G$B)MD;66$,FP9= 9:/[S4VSL-+W0[PT2CPOFMHKU$-1 M[_#7=Y)KI[H&2Z"60ADCRCOGU!LJ484L(LWNI7P_.4N=DJMC;%O?O->SQ2S^ M\*?LNEAELUIO'^3&Z4Z!**:9P0089(U0!'E#JIDSH^"T$H4Z847GJ%Y>NQRW M*M\V2$!/'CL(SYE60A*@,$9"1O1DA5G4U"E6UPCUTV4L_*&E--RU_NV4UV5 M+;\O(?HEVYQ^!OE8MT 5)5X9C+#%1@H$A:]]?N#XY K2#LB-%[?V.Q-#ZZWU M0_%MMMB6[U]>F6*[POCK;[//LX7/LO7[V;<#(;DS>@< E,+13 # BO+Y<(M8 M#1#&).7<8$(JKCVA^I/%4(KL0QGL7V97;K9:QHD_KN-CL^M\GA]39Z<[!^R4 MUXIC0*.=:J"20.P-52,],>G*W)NV4NM<&(.54,V7Q2K??'NSC"HB6Q\C MW/.F 5CFN54\+J9,5+(:25:M" &1.M)ZU#-I"A TO3VR=DI9)SE7]<8"DMY[/3L">-I72D!]L9]QNZ]_V"4K' M=L$G#8.D4EIJ,3-.8LHMUQI7J^'&I+B59Z='3YM'2<"W-MQ?,?$.6>FO- U. M"D*0CSZ%D(A;7=XBK-6FE"GQK_,3F:=JDJ<#/[:DG MG/3^:7;&(MF2C5)O# MG0(5S"B-/$+8ET=ZA,']"ZA06DD;W<;K-Y_YW77/B8'=_E H7_W#6$:22RTT M))Q[7B/JV,12!+N@UL%"5Q>0QX#JYM=-G-Y-L8BB7>^>?+R85MG]? --\K1A MW.DM4D9QSA12D#K)S/YI.0^IN*CV> %N^6;M>4\=-AXC2!:1H YX92B60%OL M986#HF)BQ_=M2?#\.^\)WHM^PB__YM)9O&V_;2X$9E)Z1PA%6BKM-83:(8(T M4UPU*I[7U[<]VVQW@9,5*Y\T#!8QX"V5"A,"R[>P"&75BG#2"?@1$W9_^^A)Y@,9IZ^V"X9;@9V- MZD090C&5T-!J#0[+B67YM15@T1V$@]'@8-'& RV#BA.''D*!H,*( @:-J=8! MD!WTJ+<_*B3*\! 36F'8.MSS]VR5;XKEX=S+5UH%*0$G&!% '0"9:78\K)PO^'N@2 A(\+LHXKY) DTAM4K5 KE:)+1KBO MI(KY)&M:H=K:O?Q;5MQFFU4^UZOBCV4^6_Y<'+U'>KI3 - 2S(7%MBR>(P!R M4E;N($])Q!VAQ=$M*SJ%=J@MYOUBMBQ?(3EA@CQN%@2 4%"H M/-*2$.%IW(MK@B.9DD0PPB+)'1D>"0@.S8631L;3AM',9LXCS"A37C,4[77F MZUU5J)2T$>8 -K1 0 M(.7\8H3%JCO2$\DX#E;29)7-UG>K75+!KS=E D+USNT1FASI%2)4QE-)H!>, M"ZS\MIBDDX@H3DQ2*8 1ZI$403^O8M(9J!K[3J:,NG( M$(%IJR24Q!CIK33$<6(C JK,_[$,3RR*UA>MND-XN.TK3OM#]N5N-;^9K;-H MEG]>S6X_9.6.FR\__W)7FN7OKO??R]WFIECE_\JN/A8Z>^AU3)=U\P-!@?(8 M-,H$R/A-QB\4P=+94$9IXRU,R<\;+=W\L([HW^9=H M.Y3WF:(E\3:_?;5\0,.>@3AA''/24(Z85%I"7A_X:B-2GD0:X4,S'5"G'V#; MQ[&K8GC%];/(Z<$8]L$> 6O*%5-8,UT^ L"MYK::,P4J18^,\-YD5V3H#-"A M-K%ZPFJ]OKO=5DU;EQ=\YYNHX[+5[9%]ZE37X!5U%#.-#$%2 H0$I_6*$4@Q MQ\4D*=03LH,91.4>^7Z5SX^:TW6C8)W @"L2S3D?33FAB*B_".]52I1*3IH? MK3$<@U;Y>[&(TEKDFV\?CCM>S0<)+"I5;GUY3@P8C9Y!F?M8I3ZR9@\$'(IW M@DE3J3>0+TFU#_GZ=[_*LFKO;4&TUX8(T$3SWEEC!)'8&0( K?,1J!-)-)MV M7+TGB S3]F-IPK0FXX3H44+I M 3%&:^BT!I(\)%TREG2*,^UX>Y\XMW;/2LMM'35K'KW%^UJU'G+-7F\=4/E$ MF_#1QBM'%P1B6Q^3 \235- T8]S=H3FR&^<7+E%3B^;=]> ,@\@%ML5806- RDO MZX[9ANA&RL=OK9\'[>#)/[_.L^5LE1$XL M$8BJ:JT.)I53'+-;VY%YTP&D0]'GV51/FCBOM@\6 A2_B^@O8*F\+3,L?+4V MH,Q4S9LT.1?=(SNXTC&+V7J]]R6;*ISG?8)FC G!D,;QHS,:4Z1XM48H>$H> M\YBS]3I2-HEP#F85/YKF22WSLG'0!E&CA?*02"2A$:I\"'6_*JTG=LV[ ^D^ M-Y)3(1V**)=Y[]I*3X%$%")@(8M>I3-@CX5V2J=4J1QSGF::#NH3XL$N['3P M@#7U<9,74D)!E<<.6@])O3*F)U:(N">I-WG ^CR@+Z.QCCSK<);&.C%.B'L M5A(KY*1URE/#E*FP$!RF:*PQIP=WJ;&ZA7@P2^KPK$^_D'ZJ;Y 61C^#<2&4 MH&6E?J)AM6:#R,3NO/?$A^>V5\>H#Q8<6*TB*$64UWR;(J265W'BQ>I]%O_S MZA%V'[)U]7WJ;X_^9=]PN7\>_H3^Z^/G@L=8.A^DHE(D5/K\L=8YN M]UV(YWLI48( 0M(:(847E#-)#+35JN+FE5*B9,R7/3J*J;7%<;CDA.JQIB>E M#/2W;93GO.>WCHX0)-521\@ %TAK61YZE2:/ ,0@I_G$7N]((<#!][2Z!'C( MG,>[3^OLGW?E,<=]]O 2W^42')_-ITE.XX$N44$PB"4!$$"D'?18>PJ]<4X! M:#EL5 VPIU5F91F2Y7Q;AV0-CRWN:<'OLGR^:QI?I14^ZC_)>;3&M&%41NEM12[!VP!U'Y*P2CO>(BZ2P4,-(-&1[Y!LW$0LCI%#BXVW8%\06_Z*,W M"?9SZNB';V]GJV\1M/SSLKR+,7OR$._^:=&+Z9:N7]T5&C'# .464XZB)B?: M[]XDC6X?DXV2XWK2+\?P;Z1B&@T0HF-+O9;$&@\(%G$O,S4"GDHW+2W3!16> MZYD^H>@ (^L=AA'"A(:]U$N7;7":!I/+.C8A:B?G]ET M@>M@1X+/)ZN_E>?GIVX?'.X5!++<.86R6J=6>F+AB$XD?E(#M46W]1WY MMWF&6M-V&W@S-9V.LW2U^LLN@-_+]W MJWQ]E>].;9M1X&CGX!6DGCL%M(K_ )P2C&K+"\H4+3#".T2]$:-+D"]HC^IL M.;^)ON>I:R*GN@:D(2N==HK*N#Z45+A:&V(/)G9%MG_+- 7=R_&IFO3Y-NJS MK@%8'#]/1+QQF (!@%>L6G$4V,0NEG1'@)/,2L)Y*&9]R.ZSY5WV(?]\LUG_ M;35;;K*KT\];'^P4)'0^8A:_QZCTD??&VEH?,\(F5A>D.Z$_?P2[*X0OIJ'> M-LC;.MPI> 2Y$,;HN$0>5Z6DX-4J 3 I5O5W83QUN\NUQ74H]OA\F6^RM_E] M=O4F"FSY.8_+5^MUMOEMG5W?+=[FUT)"@M%6-6*RB%T5Y9#.NP.Z))=[K/MM*_4[;UAO;% M]L2'AQB.);8=ZQ:$MY0HHR@4EG-E.&*U08&AFGI0(9U5':*;'GPJR;S*/]V5 M)W6A1$I Z&CWOMJ91"[B<5PNA!Q,0C20UD:/\_^JUB5 ??UNVN; M?=JHY=6^3',VOUOEFQ*BXV'GAB.$\MT[A2S02BOEH(4,L&K]1D_E*=_^:%$, M ?N(:'(V%== (XN(N@1$&H%J3)FQBUPUZD/4+KRH-X:%8\X_9 MJ@RFGV3,DW8AFO%(* \4E PX"Z21JEI+F58YK2/7_MF2@NY@(>GJS1;]K?[C M_\FS5>E(?7N;W6>+$Q95LP&"X>53']Y0QBEF2E-C7;5ZY7#*E801<6LP@ZH7 MU ?GW,_;&].[*F(OEW'2ICIKG( ])4@AJ)1@%.@2D?HK]L),+%.U:X(3 PSH=LBG5.4:T>5Z>5^WPOB2O<"M>X")1$: M"R2U0X"7[S_5:X#-J@F-/]=CL%VG+;"#DN-TYOY#JX"0AH0B(!TG$F$E@"?U M=R/0Q)SR%O)[C0&ML!OL/#9?YK=WMR=9\*1=H%0)2SSPTAH2/X<(0KVC"F$F M=ENYE12?GYTFX#?'KF"TV:8H"6@1A-+I1!*1BLK[J35ZC#"*2<%(WHDJ'>38@#L M6S/KS?(^VU4,S\NL^]MBN=Z\7GKM6//@-4&*,Q&U(K ZSE J7,V683V1\DO] M"K+H'.<.6/''[NC^H$IYV3((B3V&2E,.%>+6"D;KH''\WQ0W=51782[!AI8@ M#V6$O-O<9*NRH/"[Z_UMG>7G_=76(R;)D5X!$\:HQH0SIJ*J%4Z2VG@7..F! MY^\SEMJ>2MW#/12M?KTI5IN/V>KVX4,X^CS$*\T#U)8232 7B$C"$5.4/MA[ M($4K?9_AD70B=8#S4 Q2][-\41IOOEC].EMDCY)J;^,B\G]E5^47<814#4<( MAF#A2FTL,0:4.T>UK(],A4\)VG^?-G,ZS_J!_O+4^]NJ6*]_6ZZRV:)XDB(V($$1L?'M_'?NJ!C M.4[0V'E*C"'16BVO;4M)=8T%E2EGXLV?I9,[-BZSS[--=O7Q3T;*%G(8/*-' MK==WM]L7<-?NZY=LOA/3;9.TG@-=@T;>46P\E(HIP064H [1>653/(@1O0PV M*.4ZQGPPE@U2=<9;+Q0"1B/#RY RKR'E *8\)RO_K&SK'O;^F.H[@+JF*.?BSTJ\O^"])PK(ZAE]E M6?R@LBCO30L*OC9$D-)@"P6QW"OII8'(U/%IC[5.(>"?[2"@9_ OE*UM\_46 MHFBMOIW-?W]W_?-L]7NVF7W:?D;-\[>/CQ,@DB0:M,X0H4S\3V!(1 M1W2R?1DB]B"!RWN_K5S=(#B2@F$(K0+2E 4<0>U/69EVT^G/>D#1&=P=G'^N M9YOK2/O[DO:GST ?MPZ0"D:1Y@1#BZ7FRLM:'4N$D])U_VQ'#MWAW)H33Z-[ M93"E6#Z:T:.*"(=XTGR$LC"=A4Y@[HS5TCL/N*G79&A*X3;X9SM&Z!?[GOCT MCQ-Y%\UZ!X^1! C'U1 I*.%&R=HCB0"FA"/@G^T4H#_<6W.HMLB*Z_>KXCK? MK"N'X!!O#O<(-GH-F"@E870>M(H(L'IO55(E%4QN'J.?$%-[%]20D.Q_?6JYD\7W)[C'8P>L.6VO!8E.-?& M.HBQKE-)O18I^S[ZLQX:#"^7UC;D/U;Y)KLJ_E@6UU=[26UF7V?E^=I![^-8 MGR 1)^4Q'!2:*F$\9*R>-]$XB4]_MC. KM&^K-;K[_F-:$)+Y7#TK B,J$IF M49WZIPFHGLM:_\4BSN_S$5]Z@%\M4QH,PQX0H4N(*1+T(9W5XXD5)>J!T^,1SL-' M,)*G'JI_/IWF=_S6@W<2 \7+$MC(>\(%$19Z9RG&@H%FC^_VL]+J:;]H^T6! ME&+=3O[;QXBV7KQ^7-"X;P <:.,I=T02X*S6BM?K=A&*%+?TNU(2C0EPX.7% MKB!N;8?O;F3MI[,^S9'3G8( P#CDA?:>6PZC%@6HQH33B3T=W"$Y.LLLW?7;KW);Z.K1(][5A*>0['CQ6ML)LHDWY1_.D*5([T"0P)NS&.S!^9T!^_@Z:./BM7NU&-S,[KQ&(%88#&$DBHGA(M( M6E'OZA:#%)][1.D2/1*L+ZB'*S40D=.S=7FE^+;5")R M1+D.?=I9/< \%,6J:QR/$^]/[G2'.P6A-*".&"8DDM0)"+.,R[^[?5A$$Y?M6/]@%96>.4J1L]P3Q774I?NU___E M74N/VC 0OO?7V&/'CTLE/Z5*6R%5ZCEB-VPW$B6(E/[^.H&D[$I P F!["47 M;-DS\S$>?3,>>VRBGO6<-L,]I)YO5F12OU+Y??'GK<@.RE[/8NODO%3SH#P) ME!!NK7:<2*L;6;6"*$Q-F^4>0K_7)TY^KP.TJX6+U_SC)LXG23K-3IU5S+@$ M(<\Q4=1B2GS+O&(1U6]AVE3V<%J^6<%1N_G9QN;ENBCGR]GK4['Z5;Q<4EY*80ZP6HH223!+*%B#K9&*4\%:KTYM%'KOZ)+A@)YN M?*O<_-+&!9 ],B5U)KA\*1GQ28@F#*+$B#9B=3KJ8O3G8-E[4NW=E:75_?6G M4Y2FJ0?03! .4E(A".98&RJH4QXP[N1@!TISO+PMLNVRBOH/NLL$GZ16V5.^ M:^$1)-DG<;+9ZD=%/&R"D'I>YCL[=?$!O:Z36F*]8,(02A(FM0<5OGM]$@$3 M>[FZ#V!]3(V,:(XQVET%R8[)\G-5/)>+S=]*I+J?S?O+.1>EE?M9*95<4^:Y M"KX[H89!XA%J]!F,' /OQR(SKH7WN 89DY_O M>3\U+###9@M.5*@1.XNJ;4 MRHKHYZGMNQ9\?:KW_@*SL*VR+8:U0V(1U128Y,P@ZVKC>."6 MD4Y-O#K24FTY\3S/MNMC]-/[4:DBCGB4,) 8I,=@#/AF?X!)%"7Y4/_-SH8J M^E+FU?QCLVK5P*Q\KJI1SAG[_\C4*>UDHH!9QQ"'Q!#6RLFQBGE$XK$B@2B# M7ZW06YWDS49/>*UF2,HLHX1K;25PQ)FC"">-!)[)F.#PL<[G2R$1JWKEW]02P$"% ,4 " !3EPE->CJ-13 ! 0 , @P $0 M @ $ 86-T9RTR,#$X,#8S,"YX;6Q02P$"% ,4 " !3EPE-P"Q: MJTL- "(B0 $0 @ %? 0$ 86-T9RTR,#$X,#8S,"YX&UL4$L! A0#% @ 4Y<)3:O656WF1P M-5$# !4 ( !P20! &%C=&&UL4$L% 3!@ & 8 B@$ "U" @ $! end